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Endoscopy has had a big role in the development of modern gastroenterology. Modern 
endoscopy will certainly be more therapeutic. It started with endoscopic hemostasis and 
polipectomy, than beginning of the 1970’s with the advent of endoscopic sphincterotomy 
extended to biliopancreatic pathology and has a huge impact in this difficult pathology.  
Plastic stents made the first steps in endoscopic palliation of neoplastic jaundice, metallic 
stents, covered or uncovered are better for biliary palliation and can be used also for 
palliation neoplastic obstruction at different levels of the digestive tube. Resection of 
digestive tumors has evolved now to sub-mucosal resection, looking to have one-piece 
complete resection. Interventional endoscopy is now very complex and takes a lot of time 
for endoscopists to learn properly these techniques. This book is a very good up-to-date 
overview of new techniques of interventional endoscopy for those who want to learn or 
develop their knowledges in this field.
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From the invention of the fiber optic to the modern high-definition CCD chips, 
endoscopy has been evolving continuously in a strive to improve image. Now it is 
aiming to see even further into the possibility of immediate histology. With an ever 
improving and rapid diagnosis, therapy becomes more adapted and aggressive. 
This book is an up-to-date overview of new technological achievements in the 
diagnostic tools of endoscopy. Standard endoscopy needs to be replaced by high 
definition endoscopy, magnification endoscopy and chromoendscopy for better 
detection and characterization of lesions. Confocal microscopy is still limited by its 
cost, but will certainly have a place in the refined assessment of gastrointestinal 
lesions. The small intestine, the last frontier of endoscopy is now explored more 
intensively. Its pathology is growing as the examination techniques advances. Capsule 
endoscopy is very temptive by its acceptance by the patients, still needs certain 
advances in technology, notably guidance, possibility of biopsy. Because of this, classic 
endoscopy for small intensive makes progress, and spiral enteroscopy looks 
promising. 
Endoscopy has had a big role in the development of modern gastroenterology. 
Modern endoscopy will certainly be more therapeutic. It started at the beginning with 
endoscopic hemostasis and polipectomy, then at the beginning of the 70's with the 
advent of endoscopic sphincterotomy extended to biliopancreatic pathology and has a 
huge impact in this difficult pathology.  
Plastic stents made the first steps in endoscopic palliation of neoplastic jaundice. 
Metallic stents, covered or uncovered are better for biliary palliation and can be used 
also for palliation neoplastic obstruction at different levels of the digestive tube. 
Resection of digestive tumors has evolved now to sub-mucosal resection, looking to 
have one-piece complete resection. 
Interventional endoscopy is now very complex and takes a lot of time for the 
endoscopists to learn these techniques properly. 
This book is a very good up-to-date overview of the new techniques of interventional 
endoscopy for those who want to learn or develop their knowledge in this field. 
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Different chapters are written by experienced endoscopists in a clear, concise and 
comprehensive way.  
We thank all the authors for their excellent work and we also thank InTech for the idea 
of this book and the selection of authors. 
Lecture of this collection of personal experience of expert endoscopists is very useful 
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Endoscopic Resection for  
Undifferentiated-Type Early Gastric Cancer 
Yorimasa Yamamoto et al.*  
Division of Gastroenterology, Cancer Institute Hospital 
Japan 
1. Introduction 
Currently, endoscopic resection (ER) is the standard treatment for early gastric cancer 
(EGC), not only in Japan but also in other parts of the world. (Gotoda T et al., 2006) 
A new endoscopic resection procedure, called endoscopic submucosal dissection (ESD), 
allows the direct dissection of the submucosa and has made en bloc resection of large 
intramucosal or ulcerated lesions feasible. However, at present, the indications for use of ER 
are limited to EGC without lymph node metastasis. 
Gotoda et al. studied surgically resected specimens from EGC patients and decided upon 
the following four indication criteria for endoscopic resection of EGC without lymph node 
metastasis. (Gotoda T et al.,2000) (Fig 1)  
1. differentiated intramucosal cancer without ulceration, regardless of size 
2. differentiated intramucosal cancer with ulceration, 30mm or less in size  
3. differentiated minute submucosal penetrative cancer (SM1), 30mm or less in size 
4. undifferentiated intramucosal cancer without ulceration, 20mm or less in size 
 
 
Fig. 1. Extended criteria for endoscopic resection (Tumor size is shown in millimeters).  
EMR: Endoscopic mucosal resecton.  ESD: Endoscopic submucosal dissection. 
UL: ulcerative findings.  SM: submucosal 
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Hiroshi Takahashi2 and Masahiro Igarashi1 
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2 Department of Gastroenterology, Showa University Fujigaoka Hospital, Japan. 
1 
Endoscopic Resection for  
Undifferentiated-Type Early Gastric Cancer 
Yorimasa Yamamoto et al.*  
Division of Gastroenterology, Cancer Institute Hospital 
Japan 
1. Introduction 
Currently, endoscopic resection (ER) is the standard treatment for early gastric cancer 
(EGC), not only in Japan but also in other parts of the world. (Gotoda T et al., 2006) 
A new endoscopic resection procedure, called endoscopic submucosal dissection (ESD), 
allows the direct dissection of the submucosa and has made en bloc resection of large 
intramucosal or ulcerated lesions feasible. However, at present, the indications for use of ER 
are limited to EGC without lymph node metastasis. 
Gotoda et al. studied surgically resected specimens from EGC patients and decided upon 
the following four indication criteria for endoscopic resection of EGC without lymph node 
metastasis. (Gotoda T et al.,2000) (Fig 1)  
1. differentiated intramucosal cancer without ulceration, regardless of size 
2. differentiated intramucosal cancer with ulceration, 30mm or less in size  
3. differentiated minute submucosal penetrative cancer (SM1), 30mm or less in size 
4. undifferentiated intramucosal cancer without ulceration, 20mm or less in size 
 
 
Fig. 1. Extended criteria for endoscopic resection (Tumor size is shown in millimeters).  
EMR: Endoscopic mucosal resecton.  ESD: Endoscopic submucosal dissection. 
UL: ulcerative findings.  SM: submucosal 
                                                 
* Junko Fujisaki1, Toshiaki Hirasawa1, Takanori Suganuma1, Masami Omae1, Kazuhisa Okada1,  
Susumu Sawada2, Akiyoshi Ishiyama1, Tomohiro Tuchida1, Etuo Hoshino1,  
Hiroshi Takahashi2 and Masahiro Igarashi1 
1 Division of Gastroenterology, Cancer Institute Hospital, Japan, 
2 Department of Gastroenterology, Showa University Fujigaoka Hospital, Japan. 
 
Therapeutic Gastrointestinal Endoscopy 
 
2 
Expansion of the indications for ER to include undifferentiated-type EGC is not widely 
accepted at this time because undifferentiated-type EGC has been associated with higher 
rates of lymph node metastasis than has differentiated-type EGC. (Sano T et al.,1992 ;  
Yamao T et al.,1996)  
Furthermore, it is sometimes difficult to delineate carcinomatous areas in cases where 
undifferentiated-type EGC is not exposed on the mucosa surface. (Ninomiya Y et al.,2000)  
As a result, successful endoscopic resection is reportedly less common in patients with 
undifferentiated-type EGC compared to those with differentiated EGC. (Miyata M et 
al.,2000) To avoid invasive surgery, and thereby optimize the patient’s quality of life, it is 
important to expand the ER indication to include undifferentiated-type EGC in patients at a 
very low risk of lymph node metastasis. 
Recently, several studies for undifferentiated-type EGC treated by endoscopic resection have 
been reported from different institutions. (Kim JH et al., 2009 ; Kang HY et al.,2010 ; Yamamoto 
Y et al.,2010) According to these reports, endoscopic resection for undifferentiated-type EGC 
was technically feasible and might be considered an alternative treatment modality. 
In this review, we described the state of diagnostic and therapeutic endoscopy for 
undifferentiated-type EGC.  
2. Undifferentiated-type EGC without lymph node metastasis 
Because ER involves only local treatment without lymph node dissection, as a rule, it is 
performed only if lymph node metastases are not present.  
In the study by Gotoda et al., the criteria for undifferentiated-type EGC without lymph node 
metastasis was intramucosal cancer without ulceration and a diameter of no more than 
20mm (expanded-indication lesion). (Gotoda T et al.,2000) 
However, this category of tumor was diagnosed in only 141 cases, and the 95% confidence 
interval for the frequency of positive lymph node metastases was 0-2.6%. This corresponds 
to a 5-year survival rate worse than the 99% associated with surgically resected 
intramucosal gastric carcinoma. Therefore, expansion of the indications for ER to include 
undifferentiated-type EGC was not widely accepted at that time. 
Recently, Hirasawa et al. added to Gotoda’s findings, by reporting on cases of 
undifferentiated-type EGC resected at their institutions over the past 9 years; they reported 
the lymph node metastasis rate and the validity of ER for undifferentiated-type EGC. 
(Hirasawa T et al,.2009) In the study, the number of expanded-indication lesion reached 310, 
and no lymph node metastasis was found in any of these cases. (Table 1) 
 
 
Table 1. Lymph node metastasis by tumor size without UL and LVI in undifferentiated-type 
intramucosal EGC  LNM: lymph node metastasis   LVI: lymphatic-vascular capillary 
involvement   UL: ulcerative findings 
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Thus, the 95% confidence interval decreased to 0-0.96%, with an upper limit of 1% or less. 
Therefore, it is suggested that the expanded-indication lesion of undifferentiated-type EGC 
could be considered suitable for curative ER due to the negligible risk of lymph node 
metastasis. 
Several studies have proved that none of the cases of surgically resected expanded-
indication lesions was associated with positive lymph nodes. (Ha TK et al.,2008 ; Li C et 
al.,2008 ; Li H et al.,2008 ; Ye BD et al.,2008 ; Kunisaki C et al.,2009 ; Li H et al.,2010) 
However, even if the lesion met the criteria for expanded-indication lesion pathologically, 
in the previous study, some lesions with lymph node metastasis were reported. In three 
studies of surgically resected undifferentiated-type EGC that were 20mm or smaller in 
diameter and had neither ulceration nor lymphovascular invasion, a few were found to 
have metastasized. Lymph node metastases were found by Abe et al. in two cases with 10-
mm or 12-mm lesions, (Abe N et al.,2004) by Nasu et al. in one case with a 13-mm lesion, 
(Nasu J et al.,2006) and by Park et al. in one case with a 17-mm lesion. (Park YD et 
al.,2008) 
Even though the expanded-indication lesions of undifferentiated-type EGC have a very low 
risk of lymph node metastasis according to the report of Hirasawa et al, we should remain 
aware of the fact that a few of the expanded-indication lesion cases may have lymph node 
metastases. 
What kind of mechanism would permit such a lesion to metastasize to the lymph nodes?  
In normal gastric mucosa, lymphatic vessels are not found in the upper and middle part  
of the lamina propria; they exist in the deep lamina propria adjacent to the muscularis 
mucosa.     
These morphologic findings correlate with clinicopathological observations on early gastric 
cancer. The particularly low incidence of lymph node metastases in the subtype of early 
gastric cancer that remains confined to the mucosa may be explained by the rarity of lymph 
capillaries in the mucosa. (Lehnert T et al.,1985 ; Listrom MB et al.,1987) 
Sako et al. studied the distribution of lymphatic vessels in the gastric wall by 
immunostaining for D2-40. (Sako A et al., 2006) The densest distribution of lymphatic 
vessels was seen in the muscularis mucosa layer. If cancer cells reached the muscularis 
mucosa layer, they might have the greatest chance of invading the lymphatic vessels.  
The morphological detection of intralymphatic tumor cells might be more difficult in 
undifferentiated-type EGC than differentiated-type EGC. The reason for this was 
presumed to be that undifferentiated-type EGC are often associated with a loss of 
glandular formation in the gastric wall, and the cancer cells may be more scattered in the 
lymphatic vessels.     
Therefore, it is possible that if undifferentiated-type EGC reached the deep layer of the 
mucosa or the muscularis mucosa, the cancer cell could metastasize to the lymph node 
without invading the general lymphatic system. 
However, it is noteworthy that no case with expanded-indication lesions of 
undifferentiated-type EGC less than 10mm in diameter had lymph node metastases. ER is 
therefore indicated in such lesions.  
We suggest that ER should be used for the treatment of expanded-indication lesions of 
undifferentiated-type EGC in order to avoid unnecessary invasive surgery and optimize the 
quality of life. 
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3. The characteristics of expanded-indication lesion of undifferentiated-type 
EGC 
Most patients with EGC treatable using ER have presented with no cancer related symptom: 
they have undergone an endoscopy because of symptoms of gastritis or esophagitis, and the 
cancers have been diagnosed incidentally. 
Because an undifferentiated-type EGC indicated for ER has a diameter less than 20mm,  
it is important for an endoscopist to fully understand the endoscopic finding of such a 
lesion.  
We performed a retrospective analysis of 60 patients who had histologically expanded-
indication lesions of undifferentiated-type EGC in whom an ESD was performed at the 
Cancer Institute Hospital between March 2005 and August 2009. The patient characteristics 
and the endoscopic findings are shown in Table 2. 
 
 
Table 2. Patient characteristics (n=60) 
The mean age of the patients was 58.3±10.8 years (range, 33-81 years), and number of male 
and female patients was 24 (40%) and 36 (60%) respectively.  
The locations of lesions were as follows: lower third of stomach in 12 cases (20%); middle 
third in 45 cases (75%); upper third in 3 cases (5%).  
Regarding the gross type, 11 lesions (18%) were flat, and 49(82%) were depressed,  
and regarding the tumor color, 52 (87%) were discolored, and 8 (13%) were reddish. 
Twenty-eight lesions (47%) were less than 10mm in diameter, and 32(53%) were larger than 
10mm.    
Regarding the histological findings, 40(67%) were signet ring cell carcinoma, and 20(33%) 
were poorly-differentiated adenocarcinoma.  
Regarding the association between tumor size and histological finding, 22 of 28 lesions 
(79%) less than 10mm in diameter were histologically signet ring cell carcinoma, 18 of 32 
lesions (56%) greater than 10mm in diameter were poorly-differentiated adenocarcinoma; 
lesions greater than 10mm in diameter frequently showed poorly-differentiated 
adenocarcinoma.    
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With respect to Helicobacter pylori (HP) infection, 17 of 60 patients (17%) showed no HP 
infection and no atrophic change in the gastric mucosa, these 17 patients were negative for 
serum HP antibody and serum pepsinogen; undifferentiated-type EGC was found in the 
patients who were negative for HP infection.  
In summary, undifferentiated-type EGC tended to be found more frequently in females than 
in males, located in the middle third of the stomach, be ‘discolored’ in appearance, and was 
most frequently of the depressed type. (Fig 2) 
 
 
a: Routine observation: A discolored area with biopsy scar in the central was located on the lower-body 
lesser curvature.. (yellow arrows) 
b: Indigo carmine spraying: Dye spraying revealed a discolored lesion with depression. (yellow arrows). 
c: Narrow band imaging with magnifying view : NBI showed irregular vascular pattern in the depressed 
lesion. (yellow arrows) 
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Fig. 2. Undifferentiated EGC met expand-indication criteria for ESD. 
In the development of gastric cancer, it was very interesting that undifferentiated-type EGC 
was even found in the patients with no evidence of HP infection. (Fig 3)  
In a depressed-type EGC, encroachment of the border is one important malignant sign to 
look for in endoscopic findings. (Oohara et al.,1984 ; Fujii T et al.,1994) However, Takahashi 
et al. reported that encroachment of the border was found in only 20% patients with 
undifferentiated-type EGC with diameters less than 10mm. (Takahashi H et al.,2009) 
To diagnose undifferentiated-type EGC treatable by ER, an endoscopist should take care 
when performing an endoscopic examination in order not to overlook a depressed and 
discolored lesion with no encroachment of the border. 
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a: Routine observation: A discolored area was located on the lower-body anterior wall. (yellow arrows) 
This patient had not H.pylori infection 
b: Closed view: The border of discolored area was clearly distinguished from the adjacent mucosa. 
c: Indigo carmine spraying: Dye spraying revealed a discolored lesion without depression. (yellow 
arrows). The macroscopic appearance suggested type 0-IIb early gastric cancer. 
d: Resected specimen: specimen size 28×23 mm, tumor size 13×9 mm(red line), type 0-IIc, sig, UL(-), pM, 
ly0, v0, LM(-), VM(-). 
e: HE staining: Tubular structure in the middle layer of the lesion was not recognized. 
f: PAS staining: Signet-ring cells with PAS staining positive were observed in the middle layer of the 
mucosa. (yellow arrows) 
Fig. 3. A case of undifferentiated EGC without H.pylori infection. 
4. Diagnosis of tumor margin and narrow band imaging for undifferentiated-
type EGC  
Narrow band imaging (NBI) is a new electronic endoscopy system ideally suited to the 
observation of surface structures, including capillaries. With NBI, short wavelength light 
radiated through a narrow band filter is strongly absorbed by hemoglobin, thereby allowing 
surface vascular structures to be distinctly visualized. (Gono K et al.,2004)    
The NBI-magnifying endoscopy is capable of predicting the histological characteristics of 
gastric cancer lesions in not only well-differentiated-type ECG but also in undifferentiated-
type. 
Nakayoshi et al. reported that microvascular structures can be observed using the NBI 
magnifying endoscopy, with a fine network pattern visible in well-differentiated-type EGC, 
and, in contrast, a corkscrew pattern in undifferentiated-type EGC. (Nakayoshi T et al.,2004)  
Taken together, these findings suggest that, if a discolored depressed lesion without 
encroachment found by conventional endoscopy showed a corkscrew pattern by NBI, the 
lesion is probably undifferentiated-type EGC. 
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It is well known that it is more difficult to determine the lesion margin in undifferentiated-
type EGC than in well-differentiated-type. In some cases of undifferentiated-type EGC, the 
lesion margin estimated macroscopically with the naked eye differs from that determined 
by pathology. (Ninomiya et al.,2000)     
This difference occurs when the tumor extends along the proliferative zone in the middle 
layer of the mucosa, leaving normal ducts covering the superficial mucosa. When this 
extension of cancer cells along the proliferative zone occurs, it is difficult to diagnosis the 
area of the lesion, even using NBI-magnifying endoscopy. To achieve a more accurate 
diagnosis, circumferential biopsies of the lesion should be done in all cases of 
undifferentiated-type EGC.     
Recently, we have reported that the width of the proliferative zone in 40 cases of expanded-
indication lesion of undifferentiated-type EGC ranged from 0 to 2,390μm (average 605.5μm). 
(Sawada S et al.,2010) (Fig.4) 
In no cases was the width of the proliferative zone over 3mm. (Table 3) 
From these results, we recommend that markings around a lesion should be placed 5mm 
beyond the endoscopically determined lesion margin, and mucosal incisions should be 
made outside these markings for ER of undifferentiated-type EGC. 
 
 
M : mucosa   MM : musucularis mucosa   SM : submucosa 
Fig. 4. Width of proliferative zone 
 
 
Table 3. Width of proliferative zone  (0-Ⅱc type undifferentiated-type intramucosal EGC) 
5. Therapeutic outcomes of ESD of undifferentiated-type EGC 
Endoscopic resections for EGD were divided into two types of procedures, endoscopic 
mucosal resection (EMR) and endoscopic submucosal dissection (ESD).  There are several 
EMR procedures, including the strip biopsy method (Okazaki Y et al.,1991), double channel 
method (Takekoshi T et al.,1986), EMR-cap method (Takeshita et al.,1997) These EMR 
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procedures, however, cannot be used for the en bloc resection of lesions larger than 2cm. 
(Hyun DH et al.,2003)   
On the other hand, ESD techniques can make en bloc resection of large lesions or ulcerated 
lesions feasible. It is important for the success of the ER of undifferentiated-type EGC that 
the histological findings are evaluated in detail. If the lesion is non-curative pathologically, 
the patient must undergo additional surgical resection of the stomach. Therefore, ER of 
undifferentiated-type EGC should be performed with an en bloc resection by ESD 
procedure.  
We reviewed 58 patients with preoperatively diagnosed undifferentiated-type  
EGC (expanded-indication lesion) who underwent ESD at the Cancer Institute Hospital 
between September 2003 and August 2008. 9 We carried out ESD using the insulation- 
tipped diathemic knife method, and glycerol or hyaluronic acid as the local injection 
material. 
The therapeutic outcomes of ESD are shown in Table 4.  
The mean diameter of resected specimens was 30mm (range, 15-48mm), the mean diameter 
of lesions was 11mm (range, 2-28mm), the median operation time was 70 min (range, 23-340 
min), the en bloc resection rate was 98 % (57/58 patients), the complete en bloc resection (R0 
resection) rate was 90 % (52/58 patients), the curative resection rate was 79 % (46/58 
patients). 
Bleeding complications occurred in five cases (8.6 %). No cases required blood transfusion 
or surgery. Perforation occurred in two cases (3.4%), both of which were conservatively and 




Table 4. ESD for undifferentiated-type EGC  treatment results  (N=58) 
Pathological examination revealed that expanded-indication lesions were present in 47 cases 
and non-indication lesions in 11. The therapeutic outcomes were compared between the two 
groups, as shown in Table 5.  
 





Table 5. ESD for undifferentiated type EGC treatment results by lesion group (N=58) 
With the limited expanded-indication lesions, the mean diameter of the resected specimens 
was 29mm (range, 15-48mm), the mean diameter of lesions was 8.9mm (range, 2-18mm), the 
median operation time was 65 min (range, 23-340 min), the en bloc resection rate was 100 % 
(47/47 patients), the complete en bloc resection rate was 98 % (46/47 patients), and the 
curative resection rate was 98 % (46/47 patients). 
From these results, it can be seen that ESD of expanded-indication lesions for 
undifferentiated-type EGC was associated with good therapeutic outcomes. 
However, non-curative resection was pathologically identified in 12 (21%) of the 58 patients. 
Eleven of the 12 non-curative resection cases had non-indication lesions. The reasons for 
incurability were the presence of submucosal invasion in seven cases (12 % of 58 patients), 
tumor diameter of 21mm or more in five (8.6%), and the presence of ulcer scarring in two 
(3.4 %); some cases had more than one reason.  
The most common factor responsible for non-curative resection was incorrect diagnosis of 
the depth of invasion. (Table 6)  
 
 
Table 6. Factors responsible for non-curative resection of non-indication lesions (N=11)* 
Six of the seven patients who were found to have submucosal invasion had undergone EUS 
that resulted in a diagnosis of intramucosal carcinoma.  
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It has been reported previously that EUS correctly diagnosed the depth of invasion of EGC 
in 64-78% of cases, and the correct diagnosis rate was lower in cases of undifferentiated-type 
compared to differentiated-type. (Akahoshi K et al.,1998 ; Hizawa K et al.,2002) Although 
more accurate diagnosis of the invasive depth is necessary, the currently available 
assessment methods have limitations in their precision. (Kim JH et al.,2007) 
In terms of the technological aspects of ESD, resectable expanded-indication lesions of 
undifferentiated-type EGC are less than 20mm in diameter and have no ulceration, the ESD 
procedures are easier than for lesions with diameters greater than 20mm or for ulcerated 
differentiated-type EGC. Therefore, we consider that the ideal method for diagnosing the 
invasion depth might be to first carry out ESD followed by pathological examination of 
resected specimens.  
However, if this diagnostic ESD determines that a tumor diameter exceeds 20mm, it is 
probable that ESD will result in non-curative resection, so more precise preoperative 
diagnosis of the lesion area using circumferential biopsies is essential. 
6. Conclusion  
Endoscopic resection of differentiated-type EGC is now standard treatment not only in 
Japan but also in other parts of the world. Undifferentiated-type EGC has a high rate of 
lymph node metastasis compared with differentiated-type EGC, and endoscopic resection of 
undifferentiated-type EGC remains controversial.  
However, if the tumor is detected at an early stage and meets the criteria for expanded-
indication lesion of undifferentiated-type EGC, then the lymph node metastasis is very rare.  
We propose that endoscopic resection should be performed on such lesions to avoid 
unnecessary invasive surgery and optimize the quality of life. In this review, we have 
described our therapeutic outcomes of endoscopic resection for undifferentiated-type EGC.   
An interesting result amongst our cases was the observation that some patients who were H. 
pylori negative had undifferentiated-type EGC. The rate of H. pylori infection is predicted 
to decrease in the future. We should take care in the management of cases of 
undifferentiated-type EGC without H. pylori infection.  
It is necessary to study further cases, with a longer follow up period, to prove the validity of 
the concept of endoscopic resection of undifferentiated-EGC which we have proposed here.  
We hope that multicenter, prospective studies will be carried out to asses further this 
expanded-indication for ER of undifferentiated-type EGC.  
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1. Introduction 
Endoscopic resection has been accepted as a curative modality for early gastric cancer (EGC) 
in indication of complete resection without the risk of metastasis. Since conventional 
endoscopic mucosal resection (EMR) has been introduced from 1984, many improvements 
of endoscopic accessories and techniques have been achieved. Recently, endoscopic 
submucosal dissection (ESD) using various electrosurgical knives has been performed for 
complete resection of EGC, and enables complete resection of EGC which had many 
technical difficulties in complete resection in the era of conventional EMR.  
As the proportion of early gastric cancer has been increasing by early detection with 
national cancer screening program in Korea (biannual upper endoscopy or barium study for 
all population over age of 40), endoscopic treatment for early gastric cancer has been 
expanded with the progress of endoscopic technique and accessories. In this review, 
endoscopic resection for early gastric cancer would be presented as the history, indication, 
risk of lymph node metastasis and clinical results.  
2. Endoscopic resection for EGC 
2.1 History of endoscopic resection for EGC 
Since endoscopic resection with electrosurgical snare has been introduced for colorectal 
polyp in 1973, endoscopic resection has been performed for polypoid-type EGC as curative 
intent. In 1984, strip biopsy method has been developed for resection of flat-type EGC. In 
this method, the flat lesion is changed to polypoid lesion by submucosal injection of mixture 
of normal saline with diluted epinephrine, and resected by grasper forcep and 
electrosurgical snare through 2-channel endoscope. Although this method had advantages 
of easy technique, short procedure time and less complication, complete resection rate was 
around 50 – 70%, which was lower than expected for large-sized or depressed-type EGC 
(Hirao et al., 1988).     
In 1988, EMR-precutting method has been developed, in which after hypertonic saline with 
diluted epinephrine is injected to submucosal layer around the lesion, circumferential 
incision around the lesion with needle knife and final resection of the lesion is performed 
with electrosurgical snare. This method has enabled complete en-bloc resection rather than 
conventional EMR, but risk of perforation was higher during the circumferential incision, 
which necessitated higher expertise. Moreover, en-bloc complete resection was still difficult 
for large-sized or depressed-type EGC.  
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endoscopic resection for early gastric cancer would be presented as the history, indication, 
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Since endoscopic resection with electrosurgical snare has been introduced for colorectal 
polyp in 1973, endoscopic resection has been performed for polypoid-type EGC as curative 
intent. In 1984, strip biopsy method has been developed for resection of flat-type EGC. In 
this method, the flat lesion is changed to polypoid lesion by submucosal injection of mixture 
of normal saline with diluted epinephrine, and resected by grasper forcep and 
electrosurgical snare through 2-channel endoscope. Although this method had advantages 
of easy technique, short procedure time and less complication, complete resection rate was 
around 50 – 70%, which was lower than expected for large-sized or depressed-type EGC 
(Hirao et al., 1988).     
In 1988, EMR-precutting method has been developed, in which after hypertonic saline with 
diluted epinephrine is injected to submucosal layer around the lesion, circumferential 
incision around the lesion with needle knife and final resection of the lesion is performed 
with electrosurgical snare. This method has enabled complete en-bloc resection rather than 
conventional EMR, but risk of perforation was higher during the circumferential incision, 
which necessitated higher expertise. Moreover, en-bloc complete resection was still difficult 
for large-sized or depressed-type EGC.  
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In 1992, EMR by the cap-fitted method (EMR-C) has been developed, in which en-bloc 
resection was performed with electrosurgical snare after suction of the lesion by cap-fitted 
endoscope (Inoue et al., 1993). Although this method was easier and safer than conventional 
EMR for en-bloc resection of small-sized EGC, en-bloc complete resection was still 
impossible for larger-sized EGC than diameter of the cap (Akiyama et al., 1997). 
To overcome the disadvantages of previous methods, endoscopic submucosal dissection 
method (ESD) has been developed in late 1990’s. In ESD, circumferential incision and direct 
dissection of submucosal layer of EGC has been possible with various knives, which has 
enabled en-bloc complete resection even in large-sized or depressed-type EGC. Various 
knives have been introduced for safe and complete ESD for EGC, and have different 
advantages/disadvantages according to the lesion. In present, insulation-tipped (IT), 
triangle-tipped (TT), flex, hook, fork, flush and splash knives are available for ESD.    
2.2 Procedure of endoscopic submucosal dissection 
Endoscopic submucosal dissection is usually performed under sedation with intravenous 
midazolam or propofol. With a standard single-channel endoscope, thorough examination is 
mandatory for the evaluation of whole stomach including the target lesion. After the 
chromo-endoscopic observation with indigo carmine, marking dots 5 mm outside the tumor 
margin are made using a conventional needle knife with a forced 20 W coagulation current 
(VIO 300D; Erbe, Tübingen, Germany) or argon plasma coagulation. Then a mixture of 
normal saline and indigo carmine with diluted epinephrine (1:100,000) is injected into the 
submucosal layer along with the marking dots to make the submucosal cushion beneath the 
lesion. After a small initial incision is made with the needle knife, a circumferential mucosal 
incision is made around the marking spots, and the submucosal layer is dissected using 
various knives in 80 W endocut mode. Hemostasis is usually performed for bleeding spots 
or visible vessels with a coagrasper or argon plasma coagulation. After ESD, the patients is 
administered proton pump inhibitors intravenously at the day of procedure and then orally 
for four weeks for the healing of iatrogenic ulcer, pain control and prevention of perforation 
or post-procedural bleeding 
2.3 Selection of knife 
Knife is divided into blade- and tip-type according to resection site. Blade-type; needle, 
insulation-tipped and triangle-tipped knife, Tip-type; flex, hook, fork, flush and splash 
knife.  
Needle knife is usually used in sphincterotomy during endoscopic retrograde 
cholangiopancreatography, and generates both cutting and coagulation current by 
electrosurgical unit. It has been used in submucosal dissection for the first time as a 
simple type. 
At first, needle knife is used in marking around the lesion with coagulation current by 
adjustment of needle length up to 6 mm. Long needle has the risk of bleeding or perforation 
by attachment of needle to coagulated mucosa. Circumferential incision should be 
performed with cutting current by step by step for the prevention of perforation. In 
submucosal dissection, caution should be kept whether dissection is accurately made in 
submucosal layer.  
Needle knife usually necessitates transparent cap at the tip of endoscope for prevention of 
perforation. Although needle knife has a high speed in resection, longer time can be 
needed in a beginner for the risk of perforation. Nowadays, needle knife is used for 
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making the hole at the beginning rather than circumferential incision or submucosal 
dissection.  
IT knife has an insulated tip of 2.2 mm in diameter for the prevention of perforation (Gotoda 
et al., 1999). Since Hosokawa from Japan has introduced in 1996, IT knife has been used in 
endoscopic submucosal dissection. It can be used in circumferential incision and 
submucosal dissection, even in hemostasis of minor bleeding with coagulation current.  
After making the incision hole with needle knife, circumferential incision around the lesion 
is made with IT knife. Insulated tip has an advantage of prevention of perforation even in 
dead angle. Pull-method with angle of 45 degree from distant part is favorable in incision. In 
submucosal dissection, full utilization of blade with insulated tip has advantages of shorter 
procedure time with fast dissection and prevention of perforation even in dead angle. Push-
method from nearest part or pull-method from distant part is favorable in submucosal 
dissection. 
The lesion in perpendicular plane such as fundus or greater curvature of upper body is 
limited in resection with IT knife, and perforation can occur even with insulated tip by 
whole-blade resection. Although easy procedure and short procedure time can be 
advantages to experts, unexpected perforation may be a disadvantage to beginners (Ono et 
al., 2008).  
TT knife has a triangle diathermic disc at the tip of 4.5 mm in length, and can be used in 
marking around the lesion, circumferential incision and submucosal dissection, even in 
hemostasis of minor bleeding with coagulation current.  
After hole-making with TT knife alone, circumferential incision around the lesion is 
performed with pull-method from distant part. In submucosal dissection, pull-method with 
diathermic disc is performed from distant part by step by step. Apart from IT knife, 
dissection with diathermic disc alone needs longer procedure time. The risk of perforation 
in dead angle can be reduced by fitting transparent cap which enables direct vision of 
dissection.  
Flex knife has a tip of soft semicircular snare, and can be used in marking around the lesion, 
circumferential incision and submucosal dissection, even in hemostasis of minor bleeding 
with coagulation current (Kodashima et al., 2006). Soft semicircular snare is contained in soft 
plastic case, and can be adjusted in length.  
After marking, circumferential incision around the lesion is performed with 1 mm in length 
from distant part. Push-method is used with 1-1.5 mm in length from proximal part in 
submucosal dissection. The risk of perforation is minimized because of bending of knife 
with soft nature even in jerky movement. Submucosal dissection by step by step has longer 
procedure time, and dead angle necessitates fitting transparent cap to prevent perforation. 
But accurate dissection can be performed by direct vision of dissected submucosa. Also, flex 
knife with soft nature enables dissection in every direction, even in perpendicular plane. 
Fixed maintenance of length of knife is indispensible to prevent unexpected perforation in 
jerky movement.  
Hook knife has a hooked tip with 4.5 mm long and 1.3 mm in transverse, and can be used in 
marking around the lesion, circumferential incision and submucosal dissection, even in 
hemostasis of minor bleeding with coagulation current. The tip is rotatable in 360 degree to 
dissect in every direction. Methods of marking, submucosal injection, circumferential 
incision and submucosal dissection are same as TT knife. 
Fork knife developed in Korea has an advantage of marking, incision, dissection, 
hemostasis, injection and irrigation by one knife without changing accessories (Kim et al., 
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hemostasis, injection and irrigation by one knife without changing accessories (Kim et al., 
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2008). Fork knife is composed of needle used in marking and incision and fork used in 
injection and dissection, which can be handled separately. Methods of marking, submucosal 
injection, circumferential incision and submucosal dissection are same as flush knife. Major 
advantage of fork knife is time-saving because of total procedure in one knife without 
changing accessories. But, needle knife has a risk of perforation during incision, and 
difficulties in procedure in case of inaccessible location. Submucosal dissection with fork by 
step by step has longer procedure time, and dead angle necessitates fitting transparent cap 
to prevent perforation. But accurate dissection can be performed by direct vision of 
dissected submucosa.  
Flush knife has an advantage of marking, incision, dissection, hemostasis, injection and 
irrigation by one needle-type without changing accessories. Methods of marking, 
submucosal injection, circumferential incision and submucosal dissection are same as fork 
knife.  
Splash knife has an advantage of marking, incision, dissection, hemostasis, injection and 
irrigation by one needle-type without changing accessories (Fujishiro et al., 2008). Knife is 
2.5 mm long and controllable. Methods of marking, submucosal injection, circumferential 
incision and submucosal dissection are same as flush knife.  
Selection of knife is dependent on the lesion by each characteristic. Although most 
procedure is performed with one knife, various knives can be utilized for accurate and 
safe procedure by case by case. Decision factors of knife are location, morphology, size of 
the lesion and type of procedure. But most of all, familiarity to operator is most 




Fig. 1. ESD for EGC from marking, submucosal injection, circumferential incision to 
submucosal dissection 
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In cases of stomach, the lesion of greater curvature of high body, fundus and angle is 
difficult to manage. The lesion of greater curvature of high body and fundus is 
perpendicular with knife, and is difficult to manage with IT and TT knife. On the other 
hand, the lesion of angle can be difficult to approach and manage with flex, fork, flush 
and splash knife which should contact the lesion to dissect because of excessive air 
inflation during procedure. IT knife has an advantage in management of inaccessible 
lesion.  
Submucosal dissection can be difficult for excessive fibrosis in the lesion with submucosal 
fibrosis or underlying scar formation. IT knife has an advantage of wide dissection plane 
and shorter procedure time in experts. To shorten the procedure time for large lesion, IT 
knife has an advantage of wide dissection plane, and fork, flush or splash knife has an 
advantage of total procedure with one knife to shorten the procedure time.  
 
 
Fig. 2. Various knives used in ESD. A; IT knife, B; TT knife, C; flex knife, D; hook knife, E; 
fork knife, F; flush knife, G; splash knife 
2.4 Conventional indication of endoscopic resection for EGC 
As the technical progress has achieved from conventional EMR to ESD, most of limiting 
factors in complete en-bloc resection have been overcome irrespective of size, shape or 
location of the tumor, which has resulted in the expansion of the indication of endoscopic 
resection for EGC. Moreover, ESD has been substituted for surgical resection with 
increased portion of old age and co-morbidity and importance of postoperative quality  
of life. 
Prior to expansion of indication of endoscopic resection for EGC, the prerequisite is to 
maintain the quality of life without the sacrifice of survival, which means that the expanded 
indication should only include EGC without lymph node or distant metastasis, enable 
complete en-bloc resection without serious complication, and ensure long-term survival not 
inferior to surgical resection. Therefore, the expansion of indication of endoscopic resection 
for EGC has a pitfall in the possibility of sacrifice of survival in the setting of insufficient 
results of long-term survival after endoscopic resection for EGC. 
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2008). Fork knife is composed of needle used in marking and incision and fork used in 
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advantage of fork knife is time-saving because of total procedure in one knife without 
changing accessories. But, needle knife has a risk of perforation during incision, and 
difficulties in procedure in case of inaccessible location. Submucosal dissection with fork by 
step by step has longer procedure time, and dead angle necessitates fitting transparent cap 
to prevent perforation. But accurate dissection can be performed by direct vision of 
dissected submucosa.  
Flush knife has an advantage of marking, incision, dissection, hemostasis, injection and 
irrigation by one needle-type without changing accessories. Methods of marking, 
submucosal injection, circumferential incision and submucosal dissection are same as fork 
knife.  
Splash knife has an advantage of marking, incision, dissection, hemostasis, injection and 
irrigation by one needle-type without changing accessories (Fujishiro et al., 2008). Knife is 
2.5 mm long and controllable. Methods of marking, submucosal injection, circumferential 
incision and submucosal dissection are same as flush knife.  
Selection of knife is dependent on the lesion by each characteristic. Although most 
procedure is performed with one knife, various knives can be utilized for accurate and 
safe procedure by case by case. Decision factors of knife are location, morphology, size of 
the lesion and type of procedure. But most of all, familiarity to operator is most 




Fig. 1. ESD for EGC from marking, submucosal injection, circumferential incision to 
submucosal dissection 
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In cases of stomach, the lesion of greater curvature of high body, fundus and angle is 
difficult to manage. The lesion of greater curvature of high body and fundus is 
perpendicular with knife, and is difficult to manage with IT and TT knife. On the other 
hand, the lesion of angle can be difficult to approach and manage with flex, fork, flush 
and splash knife which should contact the lesion to dissect because of excessive air 
inflation during procedure. IT knife has an advantage in management of inaccessible 
lesion.  
Submucosal dissection can be difficult for excessive fibrosis in the lesion with submucosal 
fibrosis or underlying scar formation. IT knife has an advantage of wide dissection plane 
and shorter procedure time in experts. To shorten the procedure time for large lesion, IT 
knife has an advantage of wide dissection plane, and fork, flush or splash knife has an 
advantage of total procedure with one knife to shorten the procedure time.  
 
 
Fig. 2. Various knives used in ESD. A; IT knife, B; TT knife, C; flex knife, D; hook knife, E; 
fork knife, F; flush knife, G; splash knife 
2.4 Conventional indication of endoscopic resection for EGC 
As the technical progress has achieved from conventional EMR to ESD, most of limiting 
factors in complete en-bloc resection have been overcome irrespective of size, shape or 
location of the tumor, which has resulted in the expansion of the indication of endoscopic 
resection for EGC. Moreover, ESD has been substituted for surgical resection with 
increased portion of old age and co-morbidity and importance of postoperative quality  
of life. 
Prior to expansion of indication of endoscopic resection for EGC, the prerequisite is to 
maintain the quality of life without the sacrifice of survival, which means that the expanded 
indication should only include EGC without lymph node or distant metastasis, enable 
complete en-bloc resection without serious complication, and ensure long-term survival not 
inferior to surgical resection. Therefore, the expansion of indication of endoscopic resection 
for EGC has a pitfall in the possibility of sacrifice of survival in the setting of insufficient 
results of long-term survival after endoscopic resection for EGC. 
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Conventional indication of endoscopic resection for EGC is as follows, 1) differentiated 
adenocarcinoma confined to mucosa, 2) elevated type  2 cm, 3) depressed type without 
ulcer  1 cm. In this indication, the tumor rarely metastasizes to regional lymph node or 
distant organ and can be resected endoscopically with negligible risk of recurrence (Ono et 
al., 2001). Beyond the conventional indication, the tumor in most cases could not be resected 
completely by conventional EMR with low cure rate in spite of the possibility of candidates 
of endoscopic resection. Therefore, indication of endoscopic resection was confined to small-
sized, superficial tumor which could be resected with en-bloc fashion in the era of 
conventional EMR.  
In the era of ESD, most limiting factors have been overcome in complete resection, and the 
indication of ESD is decided by the risk factors of lymph node or distant metastasis 
(Miyata et al., 2000). Although the risk factors of lymph node or distant metastasis are 
generally accepted as 1) tumor size, 2) differentiation of tumor, 3) invasion depth of 
tumor, and 4) angiolymphatic invasion of tumor, definite indications of endoscopic 
resection for EGC are variable according to the studies because of 1) different indication 
according to studies, 2) retrospective manner, 3) small sample size, and 4) short-term 
follow-up period.  
2.5 Risk factors of lymph node metastasis in EGC 
Although the risk of lymph node metastasis in EGC increases with tumor size, depth of 
tumor invasion and undifferentiated histology, definite indication of endoscopic resection 
for EGC is variable according to the studies, and the standard indication is not established 
(Abe et al., 2004).  
In a retrospective study with surgically-resected cases with EGC, the expanded indication of 
endoscopic resection for EGC was proposed with no evidence of lymph node metastasis in; 
1) differentiated mucosal cancer without ulcer irrespective of size, 2) differentiated mucosal 
cancer with ulcer  3 cm, 3) undifferentiated mucosal cancer  2 cm, 4) differentiated 
submucosal cancer  500 m depth of invasion (sm1)  3 cm in size without angiolymphatic 





Ulcer (-) Ulcer (+)  sm1 > sm1 
 20 mm > 20 mm  30 mm > 30 mm  30 mm Any size 
Differentiated A B B D B D 
Undifferentiated C D D D D D 
Table 1. Expanded indication of endoscopic treatment for early gastric cancer. A, definite 
indication by guideline; B, expanded indication; C, surgery, but need for more 
consideration; D, surgery; m, mucosa; sm, submucosa (Soetikno et al., 2005)  
On the other hand, lymph node metastasis was found in 4.5% of mucosal cancer and 22.8% 
of submucosal cancer in another retrospective study with 2173 surgically-resected cases of 
EGC (Kwak et al., 2000). Of those, lymph node metastasis was found in some of 
differentiated mucosal cancer without ulcer and 2 cm differentiated mucosal cancer with 
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ulcer, which explains that the risk of lymph node metastasis is not negligible even in the 
expanded indication of endoscopic resection for EGC. 
Although undifferentiated histology is not considered to be the indication of endoscopic 
resection with higher risk of lymph node metastasis rather than differentiated histology, 
some portion may be the indication of endoscopic resection with negligible risk of lymph 
node metastasis. In a retrospective study with 591 surgically-resected cases of 
undifferentiated EGC, there was no lymph node metastasis in 119 cases with tumor size less 
than 2.5 cm, confined to mucosa or sm1, and without angiolymphatic invasion, which might 
be the expanded indication of endoscopic resection (Ye et al., 2008). 
In the expanded indication of endoscopic resection for EGC, the pre-evaluation of 
regional lymph node and distant metastasis is very important with the increment of risk 
of metastasis (Gotoda et al., 2005). As the risk factors of lymph node metastasis such as 
accurate tumor size, differentiation, depth of tumor invasion and angiolymphatic invasion 
cannot be known prior to endoscopic or surgical resection, the risk of lymph node 
metastasis is restricted to assumption in pretreatment staging. Although endoscopic 
ultrasonography, computerized tomography, positron emission tomography have been 
used in cancer staging, diagnostic accuracy for lymph node or distant metastasis varies in 
50 – 80%. To expand the indication of endoscopic resection for EGC, new diagnostic 
modality is mandatory for the evaluation of lymph node metastasis prior to definitive 
treatment. 
Most of all, long-term survival after endoscopic resection should be proven to be not inferior 
to that after surgical resection to expand the indication of endoscopic resection for EGC. 
Although conventional EMR for conventional indication have shown long-term survival not 
inferior to surgical resection in completely-resected cases, long-term survival after ESD has 
not been established without sufficient data. Long-term prospective study is warranted for 
long-term survival after ESD for EGC.  
2.6 Standardization of risk factors of lymph node metastasis in EGC 
Risk factors of lymph node metastasis in EGC are known to be tumor size, depth of tumor 
invasion, differentiation and angiolymphatic invasion, which have variable criteria 
according to the studies (Yokoda et al., 2004). In tumor size, discrepancy may exist between 
surgically-resected and endoscopically-resected specimen. In surgical resection, the tumor 
size is measured after fixation with formalin, which may be reduced by shrinkage. On the 
other hand, the specimen is creased and fixed with pin in endoscopic resection, which may 
be exaggerated in size. Therefore, the study with endoscopically-resected cases may show 
the result of expanded indication in tumor size rather than the study with surgically-
resected cases.  
Depth of tumor invasion can be confused in endoscopically-resected cases. On the contrary 
to surgically-resected specimen, endoscopically-resected specimen does not include all 
layers of stomach but mucosa and partial submucosa. In the cases of submucosal invasion of 
tumor, accurate depth of tumor invasion cannot be verified in endoscopically-resected 
specimen because of lack of muscularis propria which can be the standard of interpretation. 
Although submucosal layer is divided by 3 with 500 m, depth of tumor invasion can be 
much influenced by tissue preparation after endoscopic resection.  
Intra- or inter-observer variation among pathologists can exist in the evaluation of 
differentiation of tumor. High grade dysplasia vs. intraepithelial carcinoma is the main 
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Conventional indication of endoscopic resection for EGC is as follows, 1) differentiated 
adenocarcinoma confined to mucosa, 2) elevated type  2 cm, 3) depressed type without 
ulcer  1 cm. In this indication, the tumor rarely metastasizes to regional lymph node or 
distant organ and can be resected endoscopically with negligible risk of recurrence (Ono et 
al., 2001). Beyond the conventional indication, the tumor in most cases could not be resected 
completely by conventional EMR with low cure rate in spite of the possibility of candidates 
of endoscopic resection. Therefore, indication of endoscopic resection was confined to small-
sized, superficial tumor which could be resected with en-bloc fashion in the era of 
conventional EMR.  
In the era of ESD, most limiting factors have been overcome in complete resection, and the 
indication of ESD is decided by the risk factors of lymph node or distant metastasis 
(Miyata et al., 2000). Although the risk factors of lymph node or distant metastasis are 
generally accepted as 1) tumor size, 2) differentiation of tumor, 3) invasion depth of 
tumor, and 4) angiolymphatic invasion of tumor, definite indications of endoscopic 
resection for EGC are variable according to the studies because of 1) different indication 
according to studies, 2) retrospective manner, 3) small sample size, and 4) short-term 
follow-up period.  
2.5 Risk factors of lymph node metastasis in EGC 
Although the risk of lymph node metastasis in EGC increases with tumor size, depth of 
tumor invasion and undifferentiated histology, definite indication of endoscopic resection 
for EGC is variable according to the studies, and the standard indication is not established 
(Abe et al., 2004).  
In a retrospective study with surgically-resected cases with EGC, the expanded indication of 
endoscopic resection for EGC was proposed with no evidence of lymph node metastasis in; 
1) differentiated mucosal cancer without ulcer irrespective of size, 2) differentiated mucosal 
cancer with ulcer  3 cm, 3) undifferentiated mucosal cancer  2 cm, 4) differentiated 
submucosal cancer  500 m depth of invasion (sm1)  3 cm in size without angiolymphatic 
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Table 1. Expanded indication of endoscopic treatment for early gastric cancer. A, definite 
indication by guideline; B, expanded indication; C, surgery, but need for more 
consideration; D, surgery; m, mucosa; sm, submucosa (Soetikno et al., 2005)  
On the other hand, lymph node metastasis was found in 4.5% of mucosal cancer and 22.8% 
of submucosal cancer in another retrospective study with 2173 surgically-resected cases of 
EGC (Kwak et al., 2000). Of those, lymph node metastasis was found in some of 
differentiated mucosal cancer without ulcer and 2 cm differentiated mucosal cancer with 
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ulcer, which explains that the risk of lymph node metastasis is not negligible even in the 
expanded indication of endoscopic resection for EGC. 
Although undifferentiated histology is not considered to be the indication of endoscopic 
resection with higher risk of lymph node metastasis rather than differentiated histology, 
some portion may be the indication of endoscopic resection with negligible risk of lymph 
node metastasis. In a retrospective study with 591 surgically-resected cases of 
undifferentiated EGC, there was no lymph node metastasis in 119 cases with tumor size less 
than 2.5 cm, confined to mucosa or sm1, and without angiolymphatic invasion, which might 
be the expanded indication of endoscopic resection (Ye et al., 2008). 
In the expanded indication of endoscopic resection for EGC, the pre-evaluation of 
regional lymph node and distant metastasis is very important with the increment of risk 
of metastasis (Gotoda et al., 2005). As the risk factors of lymph node metastasis such as 
accurate tumor size, differentiation, depth of tumor invasion and angiolymphatic invasion 
cannot be known prior to endoscopic or surgical resection, the risk of lymph node 
metastasis is restricted to assumption in pretreatment staging. Although endoscopic 
ultrasonography, computerized tomography, positron emission tomography have been 
used in cancer staging, diagnostic accuracy for lymph node or distant metastasis varies in 
50 – 80%. To expand the indication of endoscopic resection for EGC, new diagnostic 
modality is mandatory for the evaluation of lymph node metastasis prior to definitive 
treatment. 
Most of all, long-term survival after endoscopic resection should be proven to be not inferior 
to that after surgical resection to expand the indication of endoscopic resection for EGC. 
Although conventional EMR for conventional indication have shown long-term survival not 
inferior to surgical resection in completely-resected cases, long-term survival after ESD has 
not been established without sufficient data. Long-term prospective study is warranted for 
long-term survival after ESD for EGC.  
2.6 Standardization of risk factors of lymph node metastasis in EGC 
Risk factors of lymph node metastasis in EGC are known to be tumor size, depth of tumor 
invasion, differentiation and angiolymphatic invasion, which have variable criteria 
according to the studies (Yokoda et al., 2004). In tumor size, discrepancy may exist between 
surgically-resected and endoscopically-resected specimen. In surgical resection, the tumor 
size is measured after fixation with formalin, which may be reduced by shrinkage. On the 
other hand, the specimen is creased and fixed with pin in endoscopic resection, which may 
be exaggerated in size. Therefore, the study with endoscopically-resected cases may show 
the result of expanded indication in tumor size rather than the study with surgically-
resected cases.  
Depth of tumor invasion can be confused in endoscopically-resected cases. On the contrary 
to surgically-resected specimen, endoscopically-resected specimen does not include all 
layers of stomach but mucosa and partial submucosa. In the cases of submucosal invasion of 
tumor, accurate depth of tumor invasion cannot be verified in endoscopically-resected 
specimen because of lack of muscularis propria which can be the standard of interpretation. 
Although submucosal layer is divided by 3 with 500 m, depth of tumor invasion can be 
much influenced by tissue preparation after endoscopic resection.  
Intra- or inter-observer variation among pathologists can exist in the evaluation of 
differentiation of tumor. High grade dysplasia vs. intraepithelial carcinoma is the main 
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diagnostic problem among the pathologists. In favor of diagnosis of cancer rather than 
dysplasia, the indication of endoscopic resection may be expanded without the risk of lymph 
node metastasis. To standardize the risk of lymph node metastasis in EGC, the definition of 
size, depth of invasion and differentiation of tumor should be also standardized.  
2.7 Clinical results of endoscopic resection for EGC 
Conventional EMR has shown unsatisfied results in terms of en-bloc complete resection, 
which lay from 53 – 74% according to size, shape or location of EGC (Kojima et al., 1998). On 
the other hand, there is no limiting factor in ESD in terms of size, shape or location of EGC. 
ESD enables en-bloc complete resection of larger-sized, depressed-type with submucosal 
fibrosis or difficult-located EGC. But ESD has disadvantages of longer procedure time and 
higher complication rate in terms of bleeding or perforation rather than conventional EMR, 
and necessitates a longer learning curve and expertise (Choi IJ et al., 2005). Therefore, 
conventional EMR can be still applied for small-sized, polypoid-type EGC rather than ESD 
regarding to risk and benefit.          
Success rate of conventional EMR was influenced by tumor size, shape and location, and 
lowered in larger size than 2 cm, depressed type and location of body lesser curvature or 
posterior wall (Kim et al., 2007). On the contrary to conventional EMR, ESD has much 
improved the complete en-bloc resection rate. Although complete resection was achieved in 
77.6% in a study with conventional EMR, another study with ESD in 1000 cases has revealed 
en-bloc resection rate of 95.3% and complete resection rate of 87.7% (Chung IK et al., 2009). 
From 2005 to 2010, a total of 690 cases with EGC were treated by ESD in Seoul National 
University Hospital. En-bloc resection was achieved in all cases, and complete resection rate 
was 94.2% in cases with expanded indication.  
ESD has a higher risk of complication and longer procedure time than conventional EMR 
because of larger and deeper dissection. Bleeding and perforation are the most common 
complication of ESD, which can be reduced by expertise. In a study, major bleeding rate was 
0.6% and perforation rate was 1.2% with mean procedure time of 47.8 minutes. Most of 
bleeding and perforation can be managed by endoscopic hemostasis and clipping without 
surgical management. 
After confirmation of complete resection of EGC at pathological mapping, periodic 
regular follow-up is performed to detect recurrence. 5-year recurrence free survival is 
estimated to 99% and overall survival is estimated to 95%, which is comparable to surgical 
resection. Among 620 cases complete-treated by endoscopic resection in Seoul National 
University Hospital, 1 case of mortality by cardiovascular event was reported, and 
disease-free survival was 100% during follow-up. Considering the quality of life after 
treatment, ESD is a safe and effective treatment for EGC without sacrifice of survival 
compared to surgical resection.    
2.8 Recurrence after endoscopic resection for EGC 
Recurrence can be defined as the relapse of previous lesion, which includes local recurrence, 
synchronous or metachronous lesion, and distant metastasis. However, recurrence of 
narrow definition is remnant lesions at the site of treatment or metastatic lesions related 
with previous lesions treated. 
Local recurrence is defined as remnant or relapsed cancer at same site after endoscopic 
resection during follow-up. ESD which enables en-bloc complete resection of larger tumor 
has reduced the rate of local recurrence of tumor compared with conventional EMR. 
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Although local recurrence usually develops in a short-term period less than 6 months after 
initial resection, minute remnant cancer can grow up to gross mass after 1 year. 
Local recurrence originates from remnant tumor in incompletely-resected site. In case of 
positive lateral resection margin at post-resection pathological mapping, remnant tumor 
around resection margin can grow with healing of iatrogenic ulcer after resection. On the 
contrary, remnant tumor can infiltrate submucosal or deeper layer in case of positive 
vertical resection margin in post-resection pathological mapping.  
Local recurrence can develop even after complete resection of tumor. Overlooked skipped 
tumor is not rare around main lesion in EGC, which can lead to local recurrence when the 
skipped lesion is not included in the resected specimen. To prevent overlooking the 
skipped lesion, sufficient resection margin should be guaranteed in case of ill-defined 
tumor margin.  
If the post-resection pathological mapping has revealed the positive lateral resection margin, 
remnant tumor can exist around resection margin. All cases with positive lateral resection 
margin, however, have not remnant tumor. Mucosal cancers with positive lateral resection 
margin have been reported to have remnant tumor only in 5.8%. Because cautery effect can 
ablate the remnant tumor around the circumferential incision during ESD, local recurrence 
can be prevented even in incomplete resection in terms of lateral margin. Therefore, 
frequent short-term endoscopic follow-up can be applied for detection of local recurrence in 
case of minute involvement of tumor in lateral resection margin.  
When the local recurrence has developed in case of positive lateral resection margin, 
definitive treatment should be made for remnant cancer. If the remnant cancer is still 
confined to mucosa and the result of previous pathologic mapping has shown the negligible 
risk of lymph node metastasis in criteria of tumor size, differentiation and depth of tumor 
invasion, additional endoscopic resection can be applied to remnant cancer. However, 
secondary endoscopic resection could be more difficult in technique because of submucosal 
fibrosis after healing of iatrogenic ulcer. Sufficient resection margin should be ensured to 
prevent repetitive recurrence after additional endoscopic resection. Therefore, endoscopic 
ablation treatment with argon plasma coagulation (APC) can be applied at the site of 
repeated ESD as additional therapy. If the result of previous pathological mapping has 
revealed beyond the indication of endoscopic resection such as larger tumor size, positive 
angiolymphatic tumor invasion or undifferentiated histology, additional gastrectomy with 
conventional lymph node dissection should be made for the removal of risk of lymph node 
metastasis as well as remnant cancer.  
Endoscopic ablation treatment can be applied to remnant tumor in endoscopically-
unresectable and surgically-inoperable cases such as old age or significant co-morbidity. 
APC is useful for the ablation of superficial tumor and can be repeated with interval until 
complete resolution of remnant tumor.  
When the local recurrence has developed in case of positive vertical resection margin, tumor 
can infiltrate submucosal or deeper layer because the method of ESD removes most of 
mucosal and submucosal layer. Therefore, additional gastrectomy and lymph node 
dissection should be made in case of positive vertical resection margin.  
Synchronous lesion is defined as multiple tumors at diagnosis or newly-detected tumor 
within one year after initial resection. One-year interval is arbitrary because exact time of 
tumor initiation cannot be resolved. A tumor detected within one year after initial resection 
might exist at initial diagnosis because conventional endoscopy could not detect minute 
tumor less than 5 mm in size at initial diagnosis. Especially, tumor more than 5 mm in size 
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diagnostic problem among the pathologists. In favor of diagnosis of cancer rather than 
dysplasia, the indication of endoscopic resection may be expanded without the risk of lymph 
node metastasis. To standardize the risk of lymph node metastasis in EGC, the definition of 
size, depth of invasion and differentiation of tumor should be also standardized.  
2.7 Clinical results of endoscopic resection for EGC 
Conventional EMR has shown unsatisfied results in terms of en-bloc complete resection, 
which lay from 53 – 74% according to size, shape or location of EGC (Kojima et al., 1998). On 
the other hand, there is no limiting factor in ESD in terms of size, shape or location of EGC. 
ESD enables en-bloc complete resection of larger-sized, depressed-type with submucosal 
fibrosis or difficult-located EGC. But ESD has disadvantages of longer procedure time and 
higher complication rate in terms of bleeding or perforation rather than conventional EMR, 
and necessitates a longer learning curve and expertise (Choi IJ et al., 2005). Therefore, 
conventional EMR can be still applied for small-sized, polypoid-type EGC rather than ESD 
regarding to risk and benefit.          
Success rate of conventional EMR was influenced by tumor size, shape and location, and 
lowered in larger size than 2 cm, depressed type and location of body lesser curvature or 
posterior wall (Kim et al., 2007). On the contrary to conventional EMR, ESD has much 
improved the complete en-bloc resection rate. Although complete resection was achieved in 
77.6% in a study with conventional EMR, another study with ESD in 1000 cases has revealed 
en-bloc resection rate of 95.3% and complete resection rate of 87.7% (Chung IK et al., 2009). 
From 2005 to 2010, a total of 690 cases with EGC were treated by ESD in Seoul National 
University Hospital. En-bloc resection was achieved in all cases, and complete resection rate 
was 94.2% in cases with expanded indication.  
ESD has a higher risk of complication and longer procedure time than conventional EMR 
because of larger and deeper dissection. Bleeding and perforation are the most common 
complication of ESD, which can be reduced by expertise. In a study, major bleeding rate was 
0.6% and perforation rate was 1.2% with mean procedure time of 47.8 minutes. Most of 
bleeding and perforation can be managed by endoscopic hemostasis and clipping without 
surgical management. 
After confirmation of complete resection of EGC at pathological mapping, periodic 
regular follow-up is performed to detect recurrence. 5-year recurrence free survival is 
estimated to 99% and overall survival is estimated to 95%, which is comparable to surgical 
resection. Among 620 cases complete-treated by endoscopic resection in Seoul National 
University Hospital, 1 case of mortality by cardiovascular event was reported, and 
disease-free survival was 100% during follow-up. Considering the quality of life after 
treatment, ESD is a safe and effective treatment for EGC without sacrifice of survival 
compared to surgical resection.    
2.8 Recurrence after endoscopic resection for EGC 
Recurrence can be defined as the relapse of previous lesion, which includes local recurrence, 
synchronous or metachronous lesion, and distant metastasis. However, recurrence of 
narrow definition is remnant lesions at the site of treatment or metastatic lesions related 
with previous lesions treated. 
Local recurrence is defined as remnant or relapsed cancer at same site after endoscopic 
resection during follow-up. ESD which enables en-bloc complete resection of larger tumor 
has reduced the rate of local recurrence of tumor compared with conventional EMR. 
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Although local recurrence usually develops in a short-term period less than 6 months after 
initial resection, minute remnant cancer can grow up to gross mass after 1 year. 
Local recurrence originates from remnant tumor in incompletely-resected site. In case of 
positive lateral resection margin at post-resection pathological mapping, remnant tumor 
around resection margin can grow with healing of iatrogenic ulcer after resection. On the 
contrary, remnant tumor can infiltrate submucosal or deeper layer in case of positive 
vertical resection margin in post-resection pathological mapping.  
Local recurrence can develop even after complete resection of tumor. Overlooked skipped 
tumor is not rare around main lesion in EGC, which can lead to local recurrence when the 
skipped lesion is not included in the resected specimen. To prevent overlooking the 
skipped lesion, sufficient resection margin should be guaranteed in case of ill-defined 
tumor margin.  
If the post-resection pathological mapping has revealed the positive lateral resection margin, 
remnant tumor can exist around resection margin. All cases with positive lateral resection 
margin, however, have not remnant tumor. Mucosal cancers with positive lateral resection 
margin have been reported to have remnant tumor only in 5.8%. Because cautery effect can 
ablate the remnant tumor around the circumferential incision during ESD, local recurrence 
can be prevented even in incomplete resection in terms of lateral margin. Therefore, 
frequent short-term endoscopic follow-up can be applied for detection of local recurrence in 
case of minute involvement of tumor in lateral resection margin.  
When the local recurrence has developed in case of positive lateral resection margin, 
definitive treatment should be made for remnant cancer. If the remnant cancer is still 
confined to mucosa and the result of previous pathologic mapping has shown the negligible 
risk of lymph node metastasis in criteria of tumor size, differentiation and depth of tumor 
invasion, additional endoscopic resection can be applied to remnant cancer. However, 
secondary endoscopic resection could be more difficult in technique because of submucosal 
fibrosis after healing of iatrogenic ulcer. Sufficient resection margin should be ensured to 
prevent repetitive recurrence after additional endoscopic resection. Therefore, endoscopic 
ablation treatment with argon plasma coagulation (APC) can be applied at the site of 
repeated ESD as additional therapy. If the result of previous pathological mapping has 
revealed beyond the indication of endoscopic resection such as larger tumor size, positive 
angiolymphatic tumor invasion or undifferentiated histology, additional gastrectomy with 
conventional lymph node dissection should be made for the removal of risk of lymph node 
metastasis as well as remnant cancer.  
Endoscopic ablation treatment can be applied to remnant tumor in endoscopically-
unresectable and surgically-inoperable cases such as old age or significant co-morbidity. 
APC is useful for the ablation of superficial tumor and can be repeated with interval until 
complete resolution of remnant tumor.  
When the local recurrence has developed in case of positive vertical resection margin, tumor 
can infiltrate submucosal or deeper layer because the method of ESD removes most of 
mucosal and submucosal layer. Therefore, additional gastrectomy and lymph node 
dissection should be made in case of positive vertical resection margin.  
Synchronous lesion is defined as multiple tumors at diagnosis or newly-detected tumor 
within one year after initial resection. One-year interval is arbitrary because exact time of 
tumor initiation cannot be resolved. A tumor detected within one year after initial resection 
might exist at initial diagnosis because conventional endoscopy could not detect minute 
tumor less than 5 mm in size at initial diagnosis. Especially, tumor more than 5 mm in size 
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within one year after initial resection could be exist even at initial diagnosis in viewpoint of 
doubling time of tumor. Metachronous tumor is defined as newly-developed tumor after 
one year of endoscopic resection. During follow-up after endoscopic resection, 
metachronous tumor develops at rate of 1 – 3% per year.  
The management of synchronous or metachronous tumor depends on status of respective 
tumor. If the tumor is indicated in endoscopic resection, ESD can be applied for complete 
resection. On the contrary, surgical resection should be applied in case beyond indication of 
endoscopic resection.  
3. Conclusion 
ESD has been a curative treatment modality of EGC in selective indications. The complete 
resection rate, long-term disease-free results and survival has been comparable to surgical 
treatment with the progress of endoscopic technique and accessories. After complete 
resection, regular follow-up examination is mandatory for the detection of metachronous 
tumor development.  
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within one year after initial resection could be exist even at initial diagnosis in viewpoint of 
doubling time of tumor. Metachronous tumor is defined as newly-developed tumor after 
one year of endoscopic resection. During follow-up after endoscopic resection, 
metachronous tumor develops at rate of 1 – 3% per year.  
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3. Conclusion 
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treatment with the progress of endoscopic technique and accessories. After complete 
resection, regular follow-up examination is mandatory for the detection of metachronous 
tumor development.  
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1. Introduction 
For superficial esophageal cancer, conventional endoscopic mucosal resection with cap 
(EMRC) has been widely prevailed for reliable and safety treatment1. Recent innovations of 
diagnostic endoscopy including high-resolution endoscopy, narrow band imaging (NBI), and 
magnified endoscopy allow detect and identify more small lesions of the GI tract, and 
endoscopist are forced to develop their skills for endocopic treatment. Recently, endoscopic 
submucosal dissection (ESD) has been developed for en bloc resection of larger superficial 
tumor in the GI tract than conventional EMR. In this decade, ESD has been widely accepted as 
a more reliable therapeutic procedure than EMR in Japan, and various devices are developed.  
Of the esophageal cancers, squamous cell carcinoma is the most common carcinoma in 
Japan, and iodine staining endoscopy has been widely used to detect esophageal SCC. 
Conventional EMRC has been performed for these 10 years, however, since conventional 
EMRC were carried out with small size cap, 12mm in diameter, there has been the risk to be 
piecemeal and residual lesions. Recently, newly classification of intrapapillary capillary loop 
pattern (IPCL) has developed for diagnose the early esophageal neoplasm, and because of 
these diagnostic innovation, therefore, many endoscopist are forced to remove larger en bloc 
resection for reliable ESD as well as gastric or colorectal lesions. Therefore, in Japan, ESD for 
large superficial esophageal neoplasm has been applied; however, esophageal ESD is 
considered as more difficult and challenging than gastric ESD, and only few studies have 
elucidated the technical feasibility of ESD in the esophagus.  
Needle knife has been used for early gastric and colorectal ESD, and it has been considered 
causing high complications for esophageal ESD because of its sharpness. For this reason, 
using other knives, some clinical case series are reported for esophageal ESD, and the safety 
of esophageal ESD using needle knife is still unclear. In this study, we conducted 
consecutive esophageal ESD with needle knife and compared EMR to evaluate safety and 
reliability of needle knife as esophageal ESD device.      
2. Patients and methods 
Between February 2001 and March 2009, a total of 82 patients with esophageal squamous 
cell neoplasm were treated by ESD or EMRC at our institution. Data was stored 
 
Therapeutic Gastrointestinal Endoscopy 24
Yokoda, T., Ishiyama, S. & Saito, T. (2004). Lymph node metastasis as a significant 
prognostic factor in gastric cancer: a multiple logistic regression analysis. 
Scandinavian Journal of Gastroenterology, Vol.39, No.4, (April 2004), pp. 380-384, ISSN 
0036-5521 
3 
Endoscopic Submucosal Dissection, 
 a New Technique for en Bloc Resection of  
Large Superficial Tumor in the Esophagus 
Makoto Nishimura, Masafumi Sakaguchi, Hideki Kitada,  
Michio Hifumi and Hiroto Kita 
International Medical Center, Saitama Medical University 
Japan 
1. Introduction 
For superficial esophageal cancer, conventional endoscopic mucosal resection with cap 
(EMRC) has been widely prevailed for reliable and safety treatment1. Recent innovations of 
diagnostic endoscopy including high-resolution endoscopy, narrow band imaging (NBI), and 
magnified endoscopy allow detect and identify more small lesions of the GI tract, and 
endoscopist are forced to develop their skills for endocopic treatment. Recently, endoscopic 
submucosal dissection (ESD) has been developed for en bloc resection of larger superficial 
tumor in the GI tract than conventional EMR. In this decade, ESD has been widely accepted as 
a more reliable therapeutic procedure than EMR in Japan, and various devices are developed.  
Of the esophageal cancers, squamous cell carcinoma is the most common carcinoma in 
Japan, and iodine staining endoscopy has been widely used to detect esophageal SCC. 
Conventional EMRC has been performed for these 10 years, however, since conventional 
EMRC were carried out with small size cap, 12mm in diameter, there has been the risk to be 
piecemeal and residual lesions. Recently, newly classification of intrapapillary capillary loop 
pattern (IPCL) has developed for diagnose the early esophageal neoplasm, and because of 
these diagnostic innovation, therefore, many endoscopist are forced to remove larger en bloc 
resection for reliable ESD as well as gastric or colorectal lesions. Therefore, in Japan, ESD for 
large superficial esophageal neoplasm has been applied; however, esophageal ESD is 
considered as more difficult and challenging than gastric ESD, and only few studies have 
elucidated the technical feasibility of ESD in the esophagus.  
Needle knife has been used for early gastric and colorectal ESD, and it has been considered 
causing high complications for esophageal ESD because of its sharpness. For this reason, 
using other knives, some clinical case series are reported for esophageal ESD, and the safety 
of esophageal ESD using needle knife is still unclear. In this study, we conducted 
consecutive esophageal ESD with needle knife and compared EMR to evaluate safety and 
reliability of needle knife as esophageal ESD device.      
2. Patients and methods 
Between February 2001 and March 2009, a total of 82 patients with esophageal squamous 
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consecutively in the database that include patients information, lesion sizes, histopathologic 
findings (depth, negative rate of lateral margin, negative rate of vertical margin, 
lymphovascular invasion), treatment type, complications, and prognosis. Based on initial 
endoscopic evaluation, patients were selected endoscopic treatment, radiation, 
chemoradiation, or surgery. Criteria of endoscopic treatment for superficial esophageal 
tumor at our institution were the follows; (1) previously proven squamous-cell carcinoma 
(SCC) or dysplasia which cannot rule out concomitant with SCC, up to 75% circumference, 
(2) supposed to be mucosal or mild submucosal invasion endoscopically, (3) no obvious 
evidence of lymphovascular invasion echoendoscopically, (4) no prior esophageal surgery, 
(5) no severe cardiovascular complications. Ulcerated lesion, advanced SCC, 
adenocarcinoma, 100% circumferential lesion, and patients with severe cardiopulmonary 
complications were excluded. Written informed consent was obtained from each patient, 
while conventional surgery or standard chemoradiation with 5-FU/CDDP+RT were offered 
as options before treatment. After initial treatment, all cases were observed (mean period: 
37.2 months, range: 8-103 months), and the local recurrence rate and overall survival period 
of each group were analyzed.  
2.1 Statistical analysis 
Data were collected and analyzed. Comparisons between groups were performed χ2 test for 
categorical variables. A P value < .05 was considered statistically significant. All analysis 
were performed on a personal computer by using IBM SPSS version 15 (IBM SPSS 19, IBM, 
Co, Sorners, NY). 
2.2 Cap-EMR technique 
With standard panendoscope (GIF-240Z, Olympus Optical, Tokyo, Japan), endoscopic 
mucosal resection using a cap (EMRC) was carried out under conscious sedation as 
followed; marking were placed with needle knife, 2) EMR cap was fitted to the tip of 
standard panendoscope, 3) targeted lesion was elevated by the submucosal injection, 4) the 
lesion was then sucked into the cap and strangulated by closing the snare, 5) the lesion was 
resected by the application of electric current.   
2.3 ESD technique  
For ESD, standard endoscope was used with an attachment (D-201-11804; Olympus, Japan). 
Briefly, ESD was conducted under conscious sedation as followed; 1) marking were placed 
with needle knife (KD-10Q-1; Olympus, Tokyo, Japan) around the targeted lesion, 2) 0.5ml 
normal saline and 1.0% of sodium hyaluronate were injected into submucosal layer, 3) using 
electrocosurgical generator (VAIO, Erbe Co, Tubingen, Germany), needle knife was used for 
circumferential cutting and submucosal dissection, and the elevated lesion was performed 
en-bloc resection. Hemostastic forceps (Coaglaspa, Olympus, Japan) was used for 
hemostasis. In both groups, all resected specimen were retrieved and histopathologically 
evaluated.  
3. Results 
From the database, we corrected 82 patients who underwent esophageal treatment 
endoscopically. The feature of the patients and lesions are shown in Table 1. Complete 
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resection was achieved in all 82 patients. Sixty-one patients were treated by ESD (57 
males, median age 67.5, range 38-87) and 21 patients were treated by EMRC (19 males, 
median age 66.0, range 46-83). Between both groups, there were no significant differences 
in patients characteristics; age and sex (p=0.530 vs p=0.653). The tumor size was 
significantly larger in the ESD group than EMRC group; the mean resected specimen size 
was 21.4 mm in diameter (range 12-40 mm) for EMRC and 31.3 mm in diameter (range 8-
50 mm) for ESD (P<0.001). The en-bloc resection rate was 61.9% and 98.4% in the EMRC 
and ESD groups, respectively (P<0.01). Histopathologically, there were 52 cases of 
squamous cell carcinoma (SCC) and 9 dysplasias in the ESD group, while 14 cases of SCC 
and 7 dysplasias in the EMRC group. The negative horizontal margin rate was 85.7% and 
90.1% for the EMRC and ESD groups, respectively (p=0.574). The negative vertical margin 
rate was 95.2% and 90.8% for the EMRC and ESD groups, respectively (P=0.726). There 
were 0 cases in the EMRC group and 9 cases of complications in the ESD group (5 cases of 
stenosis and 4 cases of perforation). Among the patients with perforation in ESD group, 1 
case was successfully treated by emergency surgery and others were managed 
conservatively, however, could not evaluated tumor depth histopathologically because of 
the patient’s status. The local recurrence rate was 5.0 in the EMRC group and 1.6% in the 
ESD group (P=0.42). 2 patients died from radiative pneumonia and 1 patient died from 
acute myocardial infarction in the EMRC group, and 1 patient died from pancreatic cancer 
in the ESD group, and. No patient in either group died from any associated complications 
or esophageal cancer. 
 
 
  EMRC ESD P value 
Patients characteristics  
Number of patients 21 61 
 Mean age (y) 66 67.5 0.530 
 Male/ Female 19/2 57/4 0.653 
Characteristic of lesions 
 Histologic type 0.152 
   Mild dysplasia    1 0 
   Moderate dysplasia 4 4 
   Severe dysplasia 2 4 
   Squamous cell carcinoma 14 53 
Table 1. Patient characteristics 
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      EMRC ESD   
mean resected size(mean [SD]) (cm) 21.48±2.63 31.34±2.97 p<0.001 
en-bloc resection no, rate (%) 13/21 (61.9%) 60/61 (98.4%) p<0.001 
Deapth of the tumos 
Dysplasias 7 9 
 m1 2 30 
 m2 5 7 
 m3  5 9 
 sm1 1 2 
sm2 0 3 
sm3 1 0 
unknown       1   
LM negative no, rate (%) 18/21 (85.7%) 55/61 (90.1%) p=0.574 
VM negative no, rate (%) 20/21 (95.2%) 55/61 (90.1%) p=0.726 
local recurrence no, rate (%) 1/20 (5%) 1/61 (1.6%) p=0.42 
Resected size; Manan-Whiteney test p<0.001 
En-bloc/piecemeal Peasonχ2 test p<0.001 
LM negative rate Peasonχ2 test p=0.574 
VM negative rate Peasonχ2 test p=0.726 
Prognosis Peasonχ2 test p<0.001 
Local recurrence rate Peason χ2 test p=0.42 
Table 2. Results 
4. Discussion 
In the present study, we have shown that the tumor size and negative horizontal margin 
rate are superior in ESD than EMRC. ESD is same complication risk as EMRC, however, did 
not suggest to be able to resect deeper lesions. Our results suggest that ESD is reliable 
technique for early superficial esophageal tumors.  
In the previous study, Ishihara reported ESD using Hook knife has higher curative rate than 
EMRC or 2-channel EMR2. They had carried out ESD later than EMR or c-channel EMR, and 
they also suggested that continuous improvement of instruments and techniques as our 
study, however, regarding the limited size of the specimen of EMRC, more reliable resection 
is possible by ESD than EMRC. In addition, other studies suggests that piecemeal resection 
with EMR would be risk of local recurrence3, 4. Therefore, ESD is considered to be high 
curative rate for such lesions.  
In spite of higher rate of en-bloc, curative resection, low risk of local recurrence and better 
histopathological evaluation of resected specimen, ESD is time-consuming and technically 
challenging. In this study, we did not evaluate procedure time. Oka also reported that 
average operation time was significantly longer in the ESD group than conventional EMR 
(84.4 minutes versus 12.6 minutes in total average)5. Operation time is disadvantage of ESD, 
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      EMRC ESD   
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In spite of higher rate of en-bloc, curative resection, low risk of local recurrence and better 
histopathological evaluation of resected specimen, ESD is time-consuming and technically 
challenging. In this study, we did not evaluate procedure time. Oka also reported that 
average operation time was significantly longer in the ESD group than conventional EMR 
(84.4 minutes versus 12.6 minutes in total average)5. Operation time is disadvantage of ESD, 
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therefore, a various technique are improving to overcome this disadvantage. Neuhas 
indicated that procedure time could be shorten based on the learning curve, especially in 
ESD rather than EMR6, and this could be also affect endoscopist’s experience, which related 
to early gastric lesions before esophageal lesions, since esophagus is more limited space and 
high risk for life-threating complications.  
Several different technique using different knives has been reported to overcome the known 
difficulty of ESD7-10. And recently, some comparison study has also reported with various 
methods10-12. Takahashi compared ESD and EMR for early squamous cell carcinoma of the 
esophagus (SCCE) and reported higher cure rate and safer than conventional EMR, based on 
the hook-knife ESD method13. Oyama also emphasized the advantage of hook-knife ESD for 
esophageal lesions9, however, this device is still available only in the limited countries and 
also require special training because of the uniqueness of its shapes as well as insulated-tip 
diathermic knife (IT-knife)14.  On the other hand, needle knife is available all over the world 
because it is approved as papillotome knife for ERCP already, and has been used without 
specialized training. Some authors had reported the feasibility and advantage of needle-
knife ESD15, 16, however, many endoscopist still consider that needle knife has higher 
complication risk for esophageal ESD. Therefore, we conducted the control study using 
needle-knife, and this is the first large scale, long-term study comparing ESD with 
conventional EMR of early esophageal neoplasm using needle knife. However, still there is 
no prospective randomized comparison study between these knives for esophageal ESD, 
therefore further multicenter study are needed.    
The other concern is the risk of complications. Oka also reported that for bleeding and 
perforation, ESD was higher than conventional EMR (22.6% versus 7.6%, and 6.2 % versus 
3.9%, respectively)5. Our data also suggests that ESD has high complication risk of 
perforation; however, all these complications could be managed conservatively in most of 
the cases because of smaller size of perforation than conventional EMR. More than two of 
third of the circumferential resection in esophageal ESD is well known to develop delayed 
stenosis, which could be also safely managed using the balloon type dilator17. 
5. Conclusion 
In summery ESD was able to accomplish en-bloc resection and achieved larger resection 
than conventional EMR for early superficial tumors in the esophagus as well as other GI 
tract. There are some residual problems of operation time and complication, however, ESD 
has large advantage to cure the esophageal lesions and indispensable for superficial 
esophageal neoplasms. Further experiences and multi-center study are needed for compare 
the various devises.  
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1. Introduction 
The term gastric adenoma means a benign lesion of the glandular epithelium having 
variable degrees of cellular atypia and showing papillary or tubular structures. Because 
long-term follow-up studies of gastric adenomas reveal malignant transformations, it is well 
known they are premalignant. Since these lesions lie histologically and clinically on the 
borderline of between whether they are benign or malignant, it is extremely important for 
clinicians to determine whether they are to be treated or not (Morson, 1980; Kamiya, 1982; 
Rugge, 1994).   
For a long time, there was no specific treatment policy of gastric adenomas and treatment 
varied from close endoscopic follow-ups to endoscopic resection, considering its 
heterogeneous clinical consequences (Di Gregorio, 1993; Saraga, 1987). When gastric 
epithelial dysplasia is classified using the two or three tier system, each group shows a 
different clinical course. For gastric adenoma with high grade dysplasia (HGD), endoscopic 
resection has become the standard treatment because of risk of malignant progression and 
synchronous carcinomas (Lansdown, 1990; Farinati, 1993). Many western publications have 
recommended close endoscopic follow-up of patients with moderate/low grade gastric 
epithelial dysplasia (Rugge, 1991, Fertitta, 1993; Rugge, 1991). The frequency of the follow-
up has been recommended to be every three to 12 months at least during the first year, but it 
is still unknown of how long the follow-up should be maintained for when no progression 
has been detected (Bearzi, 1994; Fertitta, 1993). The disadvantages of endoscopic follow-ups 
are patient anxiety, risk of disease progression, and low patient compliance for an undefined 
period (Lansdown, 1990; Rugge, 1991). Though endoscopic resection has become frequently 
applied for gastric adenoma with low grade dysplasia (LGD), there is ongoing controversy 
considering its relatively benign natural course and clinical significance. Although 
endoscopic resection is a less invasive procedure than surgical resection, it still carries the 
risk of complications and requires hospitalization of several days (Ono 2001, O'Mahony, 
2001; Miyata 2000).  
Argon plasma coagulation (APC) is a kind of non-contact technique for tissue coagulation, 
which transfers high-frequency electric current through ionized argon gas to targeted 
lesions (Grund, 1994; Grunde, 1997). Because APC has an advantage of confining the 
thermal effect to the superficial layer of the gastrointestinal wall, APC has been used for 
the treatment of bleeding ulcers, hemorrhagic telangiectasias, and tumors (Chau, 2003; 
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Cipolletta, 1998; Iacopini, 2007). For the treatment of early gastric cancer, APC has been 
used on a limited number of patients due to it being impossible to get a pathologic 
evaluation and to predict the depth of invasion (Sagawa, 2003; Kitamura, 2006). 
Considering that gastric adenomas are confined to the mucosa and the thermal effect of 
APC is extended to both the mucosa and submucosa, theoretically the gastric adenoma 
lesion can be eradicated with APC. APC has the advantage of preventing excessive tissue 
damage and perforation, due to the coagulation damage of tissue increasing the electrical 
impedance, in turn decreasing the electrical current and automatically stopping 
irradiation (Goulet Watson, 2000; Morson, 1980). Based on the above characteristics of 
APC, it can most probably be the safer and most effective therapeutic option of treating 
gastric adenomas. However, it has been reported that some endoscopists have 
experienced an unexpected extension of tissue destruction and even perforation, which 
could have been due to host and technical factors. Therefore, APC has been proven not to 
be completely free from the risk of perforation (Hoyer, 1998; Prost, 2004). In this chapter, 
we will give a brief introduction about the APC procedure after the submucosal saline 
injection for the treatment of gastric adenomas at the out-patient clinic without any need 
for hospitalization. 
2. Gastric adenoma and its natural course 
Most adenomas present a pale surface, and few cases reveal redness on the surface. The 
frequency of gastric adenomas in different age groups reveals a tendency to increase 
markedly with aging, especially above the fifth decade. This tendency may have some 
relation to atrophic changes and especially intestinal metaplasia of the gastric mucosa 
among the aged (Morson, 1980; Kamiya, 1982; Rugge,1994). In some report, co-existent 
gastric carcinomas were more frequently found (8%) in the same stomach and meticulous 
endoscopic evaluation was required. Epidemiological and histopathological studies have 
shown that intestinal type gastric cancers frequently develop through a sequence of 
histological events: namely diffuse chronic gastritis, often mucosal atrophy, intestinal 
metaplasia (complete and/or incomplete), gastric adenoma, and finally invasive carcinoma 
(Rugge, 1994; Saraga, 1987). Several prospective and retrospective serological studies have 
now linked Helicobacter pylori infection to gastric cancer (Talley, 1991; Parsonnet, 1991; 
Nomura, 1991). Helicobacter pylori infection is clearly associated with the induction of chronic 
inflammation of the gastric mucosa and the progressive development of metaplastic changes 
(Asaka, 2006).  
Gastric adenoma is known to be a precancerous lesion of intestinal type adenocarcinoma 
and has diverse outcomes depending on the degree of dysplasia. According to the 
histological abnormality, gastric dysplasia has been graded using a two or three tier system- 
high/low or high/moderate/low grade dysplasia. Gastric adenoma with HGD was known 
to regress in about 5%, to persist in 14%, and to progress in 81–85% of cases (Miyata, 2000; 
Giovannini 1993). In chronological studies of malignant progression, the time period 
between diagnosis of HGD and gastric cancer varied and was between less than 1 month to 
39 months (Farinati, 1993; Fertitta, 1993). It is suggested the possibility that some of these 
lesions already contained carcinomatous lesions but the invasive element was not included 
in the original biopsy sample (Lansdown, 1990; Farinati 1993). Endoscopic resection 
methods such as endoscopic mucosal resection (EMR) or endoscopic submucosal dissection 
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(ESD) confirmed this possibility (Miyata, 2000; Giovannini, 1999; Watanabe, 2006). 
Therefore, gastric adenomas with HGD have to be treated as if it were an early gastric 
cancer, because of the risk of synchronous carcinoma and high risk of malignant progression 
(Farinati, 1993; Rugge, 1991).  
Gastric adenomas with LGD show a different natural course. Gastric adenomas with LGD 
have been reported to regress in 38–49%, to be persistent in 19–28%, to progress in 5–21%, 
and eventually to be diagnosed as gastric adenocarcinoma in 0–5% of cases (Fertitta, 1993; 
Rugge, 1991). Although many cases of gastric adenomas with LGD do not progress, a 
number of cases were reported to have done so, progressing to HGD or carcinoma after a 
median follow-up period ranging from 34.5 to 41.5 months (Fertitta, 1993; Rugge, 1991). This 
long interval time suggests that gastric adenomas with LGD rarely contain carcinoma at the 
time of diagnosis (Fertitta, 1993; Rugge, 1991).  
Many western publications recommended close endoscopic follow-up of gastric adenomas 
with LGD, every 3–12 months until no progression is detected (Bearzi, 1994; Fertitta 1993). 
However, this approach has many problems; patient anxiety, risk of disease progression, and 
low compliance with frequent and expensive follow-up for an undefined period. Provided that 
HGD has been confirmed with endoscopic biopsy, many authors suggest surgical or 
endoscopic resection. Endoscopic resection can offer a non-surgical solution for intramucosal 
adenocarcinoma with advances in endoscopic localization method (chromoscopy, NBI) and 
staging techniques (endoscopic ultrasound)(Ono, 2001; O’Mahony, 2001).  
3. Endoscopic resection of gastric adenoma  
Endoscopic resection methods such as EMR and ESD are already recognized as standard 
treatments of premalignant lesions and small intramucosal cancerous lesions (Giovannini, 
1999; Watanabe, 2006; Takenaka, 2008). Because a lesion is resected by means of 
electrocautery snaring using the EMR method, EMR is typically used for removal of lesions 
smaller than 2 cm or piecemeal removal of larger lesions. ESD has been developed for en 
bloc removal of large lesions (usually more than 2 cm) (Ono, 2001; O’Mahony, 2001). Using 
the ESD method, a circumferential mucosal incision and submucosal dissection is done with 
specialized endoscopic electrocautery knives after marking the lesion and then injecting 
saline into the submucosal layer (Oka, 2006; Takeuchi, 2007, Oka, 2006).  
Although EMR and ESD are less invasive procedures than surgical operations, they still 
carry some risk of complications such as bleeding and perforation, and require hospital 
admission for a few days (Oka 2006; Takeuchi, 2007). ESD requires the use of expensive 
specialized knives and a longer procedure time, and runs a higher risk of bleeding or 
perforation, as compared to EMR (Ono, 2001). Considering the risk of synchronous 
carcinoma and malignant progression, endoscopic resection is the best therapeutic option of 
gastric adenomas with HGD (Lansdown, 1990; Farinati, 1993). However, because gastric 
adenomas with LGD have a relatively benign natural course, endoscopic resection might be 
an excessive and expensive procedure (Rugge, 1995; Fertitta, 1993). From this point of view, 
the treatment of gastric adenomas with LGD should be different from the therapeutic option 
for gastric adenomas with HGD or intramucosal adenocarcinoma. In gastric adenomas with 
LGD, it can be recommended that therapeutic modalities between the frequent endoscopic 
follow-up and endoscopic resection be done, because a number of cases were reported to 
have progressed.  
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Cipolletta, 1998; Iacopini, 2007). For the treatment of early gastric cancer, APC has been 
used on a limited number of patients due to it being impossible to get a pathologic 
evaluation and to predict the depth of invasion (Sagawa, 2003; Kitamura, 2006). 
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lesion can be eradicated with APC. APC has the advantage of preventing excessive tissue 
damage and perforation, due to the coagulation damage of tissue increasing the electrical 
impedance, in turn decreasing the electrical current and automatically stopping 
irradiation (Goulet Watson, 2000; Morson, 1980). Based on the above characteristics of 
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in the original biopsy sample (Lansdown, 1990; Farinati 1993). Endoscopic resection 
methods such as endoscopic mucosal resection (EMR) or endoscopic submucosal dissection 
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(ESD) confirmed this possibility (Miyata, 2000; Giovannini, 1999; Watanabe, 2006). 
Therefore, gastric adenomas with HGD have to be treated as if it were an early gastric 
cancer, because of the risk of synchronous carcinoma and high risk of malignant progression 
(Farinati, 1993; Rugge, 1991).  
Gastric adenomas with LGD show a different natural course. Gastric adenomas with LGD 
have been reported to regress in 38–49%, to be persistent in 19–28%, to progress in 5–21%, 
and eventually to be diagnosed as gastric adenocarcinoma in 0–5% of cases (Fertitta, 1993; 
Rugge, 1991). Although many cases of gastric adenomas with LGD do not progress, a 
number of cases were reported to have done so, progressing to HGD or carcinoma after a 
median follow-up period ranging from 34.5 to 41.5 months (Fertitta, 1993; Rugge, 1991). This 
long interval time suggests that gastric adenomas with LGD rarely contain carcinoma at the 
time of diagnosis (Fertitta, 1993; Rugge, 1991).  
Many western publications recommended close endoscopic follow-up of gastric adenomas 
with LGD, every 3–12 months until no progression is detected (Bearzi, 1994; Fertitta 1993). 
However, this approach has many problems; patient anxiety, risk of disease progression, and 
low compliance with frequent and expensive follow-up for an undefined period. Provided that 
HGD has been confirmed with endoscopic biopsy, many authors suggest surgical or 
endoscopic resection. Endoscopic resection can offer a non-surgical solution for intramucosal 
adenocarcinoma with advances in endoscopic localization method (chromoscopy, NBI) and 
staging techniques (endoscopic ultrasound)(Ono, 2001; O’Mahony, 2001).  
3. Endoscopic resection of gastric adenoma  
Endoscopic resection methods such as EMR and ESD are already recognized as standard 
treatments of premalignant lesions and small intramucosal cancerous lesions (Giovannini, 
1999; Watanabe, 2006; Takenaka, 2008). Because a lesion is resected by means of 
electrocautery snaring using the EMR method, EMR is typically used for removal of lesions 
smaller than 2 cm or piecemeal removal of larger lesions. ESD has been developed for en 
bloc removal of large lesions (usually more than 2 cm) (Ono, 2001; O’Mahony, 2001). Using 
the ESD method, a circumferential mucosal incision and submucosal dissection is done with 
specialized endoscopic electrocautery knives after marking the lesion and then injecting 
saline into the submucosal layer (Oka, 2006; Takeuchi, 2007, Oka, 2006).  
Although EMR and ESD are less invasive procedures than surgical operations, they still 
carry some risk of complications such as bleeding and perforation, and require hospital 
admission for a few days (Oka 2006; Takeuchi, 2007). ESD requires the use of expensive 
specialized knives and a longer procedure time, and runs a higher risk of bleeding or 
perforation, as compared to EMR (Ono, 2001). Considering the risk of synchronous 
carcinoma and malignant progression, endoscopic resection is the best therapeutic option of 
gastric adenomas with HGD (Lansdown, 1990; Farinati, 1993). However, because gastric 
adenomas with LGD have a relatively benign natural course, endoscopic resection might be 
an excessive and expensive procedure (Rugge, 1995; Fertitta, 1993). From this point of view, 
the treatment of gastric adenomas with LGD should be different from the therapeutic option 
for gastric adenomas with HGD or intramucosal adenocarcinoma. In gastric adenomas with 
LGD, it can be recommended that therapeutic modalities between the frequent endoscopic 
follow-up and endoscopic resection be done, because a number of cases were reported to 
have progressed.  
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4. Argon plasma coagulation 
Argon plasma coagulation (APC) is a non-contact technique for tissue coagulation in 
which a high-frequency electrical current is transferred to the target tissue by means  
of ionized argon gas. An APC applicator for endoscopic use was developed in 1994, 
making it possible to provide tangential irradiation to coagulate a target lesion uniformly 
(Grund, 1994). APC has been introduced to treat a broad range of gastrointestinal 
problems, including bleeding ulcers (Chau, 2003; Cipolletta, 1998), Dieulafoy’s lesions 
(Iacopini, 2007), hemorrhagic telangiectasias (Olmos, 2006; Sato, 2005; Rolachon, 2000; 
Kwan, 2006; Nakamura, 2001), radiation proctitis (Kaassis, 2000; Postgate, 2007) and 
tumors (Sagawa, 2003; Kitamura, 2006). As the lesion becomes coagulated with APC 
irradiation, tissue electrical impedance sharply increases and electrical current abruptly 
decreases and is automatically transferred to surrounding tissue sites with low impedance 
(Grund 1994; Grund, 1997; Wahab, 1997). Therefore, APC irradiation can safely coagulate 
large areas of tissue within a short time and the excessive tissue damage can 
automatically be prevented (Wahab, 1997). This characteristic of APC confines the thermal 
effect to the superficial portion and is an advantage over conventional endoscopic 
cauterization. Therefore, APC seems to be the most popular non-contact technique for 
tissue coagulation in the gastrointestinal field.  
5. Argon plasma coagulation and early gastric cancer  
As economic development and medical advancement lengthen the life expectancy rate, the 
number of elderly patients with early gastric cancers who have a serious morbidity of being 
physically unable to withstand either surgical or endoscopic resection is increasing. Local 
ethanol injection (Imaoka, 1987), microwave coagulation (Tabuse, 1985), Nd:YAG laser 
treatment (Yasuda, 1993; Hiki, 1989; Sibille, 1995), and photodynamic therapy(Nakamura, 
1990; Ell, 1998; Mimura, 1996) have been applied in such cases. Nd:YAG laser treatment is 
widely used in treating patients with gastric cancers as a curative or palliative therapy but has 
the drawback of being impossible of being tangentially irradiated (Tajiri, 1991; Hiki, 1989). 
Sagawa et al (Sagawa, 2003) performed ex vivo experiments with swine gastric mucosal 
tissue in order to set the irradiation conditions of APC for the treatment of early gastric 
cancers based on histological analysis (Fig. 1). Under all output settings tested from 20  
to 100 W, the coagulation front became deeper as the duration of irradiation was 
prolonged, reaching a plateau after irradiation for 15 seconds with each power setting 
(Fig. 2). The ex vivo experiment demonstrated that the depth of coagulation could easily 
be adjusted by changing the irradiation time and current output. They recommended  
that irradiation at 60 W for 15 seconds (900 J/cm2) is the ideal setting for intramucosal 
cancer because this setting could cauterize the whole mucosal layer but would not affect 
the deep submucosal layer. However, there is a concern that the effect of APC observed in 
the ex vivo experiment would be somehow attenuated in vivo because there is blood flow 
that may act as a heat sink in living tissue. In addition, there was a concern of 
chronological changes of coagulation depth within a few days after APC irradiation. They 
applied the APC technique for the treatment of 27 patients with intramucosal gastric 
cancers who had no lymph node metastases (T1N0M0). APC showed a very high efficacy 
(no recurrence in 26/27 patients) after a follow-up period of 18–49 months (median 30 
months). High treatment efficacy was obtained in 12 of the 27 patients whose cancers 
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were located at difficult locations for the endoscope to access, the cardia or posterior wall 
of the gastric body, probably by virtue of tangential irradiation and uniform cauterization 
over a wide area. With regard to complications, some patients experienced a sense of 





Fig. 1. Macroscopic findings of swine gastric mucosa irradiated by argon plasma coagulation 
(APC) under various conditions. The effect of APC was macroscopically studied on swine 
gastric samples at 20, 40, 60, 80, and 100 W, with pulse durations of 5, 10, 15, and 20 seconds. 
The mucosa exposed to a greater output power of high frequency current and/or for a 
longer pulse duration underwent a more conspicuous color change from white to brown. 
(Quotation from Gut 2003;52:334–339 Sagawa T et al) 
Kitamura et al (Kitamura , 2006) applied APC for the treatment of early gastric cancers in 
40 patients who could not withstand surgical operation and endoscopic resection. There 
was no residual cancer or recurrence in 35 patients with intramucosal cancer after either a 
single session or multiple sessions of APC. In contrast, 3 patients (60%), who had large 
tumors and were treated with a single session of APC, had residual cancers or recurrence 
among the 5 patients with submucosal cancers after APC treatment. All residual cancers 
were eradicated after retreatment with additional APC. They also suggested that  
small early gastric cancers could be successfully treated with only a single session of APC, 
while large protruding-type tumors or submucosal cancers required two sessions of  
APC.   
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Fig. 2. Coagulation depth under various irradiation conditions based on histological analysis. 
The experiment was repeated twice using stomach specimens from two separate swine  
(Exp 1 and Exp 2). The coagulation front became deeper as the duration of irradiation was 
prolonged, reaching a plateau after irradiation for 15 seconds with each power setting. It was 
determined that the optimum treatment conditions of APC for clinical studies was a current of 
60 W and a maximum irradiation time of 15 s/cm2, which would not be expected to cause 
perforation. (Quotation from Gut 2003;52:334–339 Sagawa T et al)  
6. Argon plasma coagulation and gastric adenoma 
Although APC has been proven to be efficient for the treatment of mucosal and even 
submucosal cancers, it was only applied to the limited patients who were not suitable for 
surgical resection or EMR/ESD, because of drawbacks of APC including the inability to be 
histologically evaluated for the response to treatment immediately after the procedure, 
because it is impossible for a pathological specimen to be obtained with APC treatment 
(Sagawa, 2003; Kitamura, 2006).  Therefore, either surgical or endoscopic resection is usually 
preferred to APC treatment for patients whose physical condition is tolerable.  
The biologic behavior of adenomas is quite different from that of carcinomas. Because 
adenomas are limited and confined to the mucosal layer, gastric adenomas with LGD have 
no capacity to invade or infiltrate into deeper layers of the gastric wall (Di Gregorio, 1993; 
Saraga, 1987). As APC at optimal setting can totally cauterize the mucosal layer and 
superficial portion of submucosal layer, theoretically gastric adenomas can be clearly 
eradicated with APC. Different from gastric adenomas with HGD which should be treated 
as an early gastric cancer because of the risk of synchronous carcinoma and high risk of 
malignant progression, gastric adenomas with LGD rarely contain carcinomatous lesions at 
the time of diagnosis (Farinati, 1993; Fertitta, 1993). Based on these characteristics, APC 
treatment has many merits over endoscopic resection and frequent endoscopic follow-up; 
short procedure time, low risk of bleeding and perforation, low procedure cost, and no 
requirement of hospitalization. Therefore, it could be a reasonable treatment of gastric 
adenomas with LGD.  
APC treatment is characterized by non-contact coagulation, making it possible to provide 
tangential irradiation to coagulate a target site uniformly (Wahab, 1997; Wahab, 1997, Chau, 
2003). This feature is an advantage over other endoscopic cauterization such as local ethanol 
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injection, Nd:YAG laser treatment, photodynamic therapy, and microwave coagulation 
(Tajiri, 1991; Ell, 1998). APC treatment method of gastric adenomas is similar to that of early 
gastric cancers. After a circumferential area around the lesion is marked with sufficient 
distance, irradiation is performed in the manner at 60-90 W for 15 seconds (900-1200 J/cm2), 
which makes the mucosa surface dry and the tissue to change from white to brown. 
Different from early gastric cancers in which one or two sessions of cauterization is usually 
required for eradication, one session of APC irradiation is sufficient for gastric adenomas 
because the depth of the lesion is limited. Inaccurate identification of boundary and the 
insufficient distance from the lesion to marking may be a more important factor of residual 
tumor after APC of gastric adenomas, as opposed to early gastric cancers. 
7. Argon plasma coagulation and thermal injury 
The thermal injury of APC is known to be confined to the mucosa and superficial 
submucosa layer and APC can theoretically prevent perforation. However, Kitamura et al 
(Kitamura, 2006) reported one case of perforation in 40 patients whose early gastric cancers 
were treated with APC. Fujishiro et al (Fujishiro, 2006; Fujishiro, 2008) investigated thermal 
tissue damage on the stomach of living minipigs to confirm the safety of APC, including a 
follow-up case. A minipig was sacrificed without delay after APC application, and a 
stomach specimen revealed that tissue damage was limited to the shallower submucosal 
layer regardless of the applied time (Fig. 1 and 2). The other was sacrificed after a one week 
follow-up, and its stomach specimen showed that granulomatous and fibrotic changes 
existed in the submucosal layer of the artificial ulcers at the pulse durations of 5 seconds and 
10 seconds. However, APC with pulse duration of 20 seconds created the deep ulceration 
with destruction of the proper muscle layer when examined after one week, which was not 
detected in the minipig sacrificed soon after APC application (Fig. 3).  
The thermal effects of APC have been studied in vitro with resected specimens of the 
stomach and other organs. Such models are limited to being evaluated to its biologic and 
healing response to thermal injury and the influence of digestive juices. Exposure of tissue 
directly to high temperatures causes an inflammatory response, coagulation necrosis, 
followed by desquamative necrosis. Immediately after exposure to thermal injury, histologic 
examinations of tissue specimens appeared normal, but necrosis occurred secondarily after 
formation of a nonvital layer (Fujishiro, 2006; Fujishiro, 2008). The electrical resistance of 
resected specimens is basically similar to that of the gastric mucosa in vivo. APC was 
reported to have tissue reaction of shrinkage, desiccation, coagulation, and devitalization 
from the applied surface to deep portion in order. Histological investigation may not detect 
the zone of devitalization, which means that tissue damage may be underestimated after 
APC treatment. APC is not completely safe from the risk of perforation, than we previously 
thought. This result suggests that we have to be aware of the risk of late perforation, which 
may occur a few days to a few weeks after APC application.  
8. Argon plasma coagulation and submucosal saline injection 
Previous experimental studies showed that thermal injury induced by APC was confined to 
the superficial area and deep tissue destruction caused by perforation was rare (Sagawa, 
2003; Watson, 2000). Clinical experiences with endoscopic evaluation also supported the 
rarity of perforation and safety of APC treatment. However, there is still the possibility of 
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the severe complication of perforation caused by APC as published in some reports 
(Yoshida, 2005; Fujishiro, 2008). And some studies indicated that APC-induced tissue 
damage could be extended to the proper muscle layer, which might lead to stricture or 
deformity of the gastrointestinal tract and also functional disturbance of the sphincter and 
peristaltic movement.  
 
 
Fig. 3. Correlation between the depth of tissue damage and pulse duration.  
The mean depth of the 4 observations is indicated as bars with a standard deviation  
in each condition. *m, the mucosal layer; ep, the epithelial layer; lpm, the lamina  
propria mucosae layer; mm, the muscularis mucosae layer; sm, the submucosal layer; 
 mp, proper muscle layer. A, Esophagus. B, Gastric upper third. C, Gastric middle third.  
D, Gastric lower third. E, Colon.  
(Quotation from Surg Laparosc Endosc Percutan Tech. 2006;16:307-11. Fujishiro et al) 
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Because the risk of deep tissue injury cannot be predicted, meticulous setting of electrical 
current, flow rate of argon gas, and irradiation duration need to be carefully monitored 
for a successful APC treatment, taking into consideration anatomical characteristics and 
patient condition. Differences in the extent of tissue damage due to APC may originate 
mainly from differences in the wall thickness and in the proportions of the wall 
components. In an experimental study using porcine tissue, the deepest tissue damage 
was observed in the colon after APC irradiation at the same setting conditions, probably 
because the colonic wall is much thinner than that of the other organs. From the parts of 
the stomach, the deepest tissue damage was observed in the upper third of the stomach at 
a 2-second pulse duration, which may also be because of the thinness of the mucosal wall 
(Fujishiro, 2006; Fujishiro, 2008).  
Submucosal injection of normal saline is an essential step for polypectomy and EMR for 
the prevention of bleeding and perforation (Fujishiro, 2004; Yoshida, 2005). The efficacy of 
submucosal injection of normal saline for the protection from thermal injury during APC 
was evaluated with animal studies (Norton, 2002; Fujishiro, 2006; Fujishiro, 2008).  
A minipig was sacrificed immediately after APC application, and its stomach specimen 
revealed that tissue damage deepened more as the applied time increased, but stayed 
confined to the mucosa and submucosa whether or not submucosal saline injections were 
done. The difference of depth of tissue injury was subtle between the two animal models, 
and the efficacy of submucosal saline injection was inconclusive in the immediate 
histopathologic evaluation of the specimen (Fujishiro, 2006; Fujishiro, 2008) (Fig. 4). An 
animal sacrificed one week after APC treatment revealed chronic inflammatory and 
fibrotic changes in the submucosal layer of the artificial ulcers and no injury of the proper 
muscle layer regardless of submucosal injection in the case of 5 and 10 seconds of 
irradiation time. APC irradiation without submucosal saline injections of a longer 
duration of 20 seconds only deepened the ulceration into the deep proper muscle layer. 
However, thermal injury after APC treatment of 20 seconds did not extend to the proper 
muscle layer in the animal with submucosal saline injection (Fig. 5). Therefore, 
submucosal saline injections are more likely to prevent the occasional deep tissue injury 
and the significant complication of perforation after long time irradiation of APC 
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The reason of this discrepancy of tissue damage with and without follow-up may be the 
limitations of histology to evaluate thermal damage, especially the devitalization zone. 
Histological investigations may not be able to detect the zone of devitalization 
immediately after tissue damage with APC and it can underestimate the range of damage 
than the true one. These results have two important clinical meanings. First, there is a risk 
of deep tissue destruction after APC treatment and follow-up studies are needed to 
evaluate the damaged lesion. Second, submucosal injection of normal saline before APC 
may be useful to decrease deep tissue destruction and to prevent perforation in a living 
body. Other studies using a resected stomach specimen showed the usefulness of 
submucosal injection before APC. The study of Fujishiro et al (Fujishiro, 2006; Fujishiro, 
2008) using a living minipig showed that APC irradiation after submucosal injection can 
limit thermal injury and prevent perforation not only immediately after procedure but 
also during the follow-up period.  
In practice, some endoscopists’ experienced an unexpected extension of tissue destruction 
and even perforation, which may be affected by various factors; host factors (mucosal and 
submucosa thickness, blood flow, inflammation, etc), technical factors (the extension of 
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the severe complication of perforation caused by APC as published in some reports 
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peristaltic movement.  
 
 
Fig. 3. Correlation between the depth of tissue damage and pulse duration.  
The mean depth of the 4 observations is indicated as bars with a standard deviation  
in each condition. *m, the mucosal layer; ep, the epithelial layer; lpm, the lamina  
propria mucosae layer; mm, the muscularis mucosae layer; sm, the submucosal layer; 
 mp, proper muscle layer. A, Esophagus. B, Gastric upper third. C, Gastric middle third.  
D, Gastric lower third. E, Colon.  
(Quotation from Surg Laparosc Endosc Percutan Tech. 2006;16:307-11. Fujishiro et al) 
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the gastric wall by inflated air, the irradiation angle, the distance between an applicator 
and tissue, irradiation duration, etc) (Postgate, 2007; Sagawa, 2003). Therefore, 
submucosal injection of normal saline may be the effective and practical method to 




Fig. 4. Tissue injury in a minipig sacrificed immediately after APC. A) APC (5 seconds) 
without prior submucosal injection. B) APC (5 seconds) after submucosal injection. C) APC 
(10 seconds) without prior submucosal injection. D) APC (10 seconds) after submucosal 
injection. E) APC (20 seconds) without prior submucosal injection. F) APC (20 seconds) after 
submucosal injection. Tissue coagulation was limited to the deeper submucosal layer under 
all the conditions. The thermal effects tended to deepen with a longer pulse duration and no 
prior saline injection. With prior saline injection, the increased thickness of the submucosal 
layer might prevent injury to the deeper submucosal layer. (Quotation from Gut Liver. 
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Since tissue damage up to the submucosal layer is considered sufficient for the treatment of 
gastric adenoma and intramucosal carcinoma, submucosal injections of saline has a high 






Fig. 5. Tissue damage in a minipig sacrificed 1 week after APC. A) APC (5 seconds)  
without prior submucosal injection. B) APC (5 seconds) after submucosal injection.  
C) APC (10 seconds) without prior submucosal injection. D) APC (10 seconds) after 
submucosal injection. E) APC (20 seconds) without prior submucosal injection.  
F) APC (20 seconds) after submucosal injection. Under all the conditions except for 20 
seconds of APC without prior submucosal injection, granulomatous and fibrotic changes 
were evident in the submucosal layer of the artificial ulcer, although the actual muscle layer 
appeared intact. Deep ulceration that destroyed the muscle layer was evident for 20 seconds 
of APC without submucosal injection.   
(Quotation from Gut Liver. 2008;2:95-8. Fujishiro M et al) 
9. Gastric adenoma treatment with APC and submucosal saline injection 
Gastric adenoma is a precursor lesion of gastric cancer and is usually classified using a 
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adenoma with HGD has a significant risk of disease progression and containing cancerous 
lesions, and it should be removed using an endoscopic resection procedure (Lansdown, 
1990, Farinati, 1993). Although endoscopic resection is a less invasive procedure than 
surgical resection, it carries the risk of various complications and requires hospitalization 
of several days (Watanabe, 2006; Fujishiro, 2004, Yoshida, 2005). Gastric adenoma with 
LGD is a less progressive disease than HGD; nevertheless, it carries some risk of disease 
progression (Rugge, 1995; Fertitta, 1993). The risk factors of developing gastric adenoma 
are chronic atrophic gastritis, intestinal metaplasia, Helicobacter pylori infection, old age, 
cigarette smoking, and alcohol drinking (Talley, 1991; Parsonnet, 1991; Nomura, 1991). 
These risk factors induce irreversible mucosal changes and can provide an environment 
for gastric tumors to occur at multiple sites (Talley, 1991; Parsonnet, 1991; Nomura, 1991). 
Patients at risk also have an increased chance of developing metachronous lesions, and  
a meticulous endoscopic follow-up should be done after treatment of gastric adenoma.  
Considering the less progressive nature of gastric adenomas with LGD, new less invasive 
and feasible treatment methods as opposed to endoscopic resection are needed, because it 
has a higher risk of procedure-related complications, need for hospitalization and high 
medical expenses. 
Gastric adenomas are confined to the mucosa of the gastric wall but are also located in reach 
of thermal effect of APC (Morson, 1980; Kamiya, 1982). Although APC is known to be an 
effective and safe procedure for early gastric cancers, bleeding control, and eradication of 
vascular lesions, they carry some risk of perforation due to the deep thermal effect. Based on 
the results of the animal study of Fujishiro et al (Fujishiro, 2006; Fujishiro, 2008), we have 
opted to use APC with submucosal saline injections (APC–SSI) to treat gastric adenomas 
with LGD. We have included submucosal saline injections as part of the routine procedure 
of APC for raising the mucosa and prevention of bleeding and perforation. It can be applied 
prior to APC to form an insulating fluid cushion in the submucosal layer to limit the thermal 
effect within the mucosa and superficial submucosal layer. The reduced risk of perforation 
and bleeding has lead to APC-SSI being available on an outpatient department (OPD) basis 
without requirement of hospitalization.  
We have evaluated the effectiveness of APC–SSI for gastric adenomas with LGD on  
OPD basis. We conducted a study of 57 patients with a combined total of 64 lesions of 
gastric adenomas with LGD, including patients who were not suitable for EMR/ESD due 
to bleeding tendency, serious concomitant disease, poor general condition, and advanced 
age (Table 1) (Lee, 2009). Gastric adenomas larger than 20 mm, accompanied with surface 
depression or nodularity, or containing HGD were excluded because of the possibility of 
co-existing cancerous tissue.  
The argon gas flow rate was 2.0 L/min, and the electrical current was set at 60 W. APC 
treatment was performed under sedation with midazolam and propofol. After spraying 
indigocarmine solution onto the lesion, the area around the lesion was marked using an 
APC probe. Normal saline solution was injected into the submucosal layer under the 
lesion with a standard disposable 25-G injection needle. Sometimes, indigocarmine 
solution would be mixed with normal saline for better identification of the submucosal 
layer. Normal saline-mixed solution was injected until sufficient submucosal swelling was 
achieved. The lesion and neighboring mucosa inside the marked sites were evenly treated 
with APC until the lesion was completely coagulated and appeared dry under endoscopic 
examination (Fig. 6).  
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Fig. 6. Endoscopic view of APC-SSI. A) Whitish discolored, flat surfaced, and slightly elevated 
lesion is noted at the greater curvature side of the distal antrum. B) After indigocarmine 
solution spraying, the boundary of the lesion is clearly distinct and a granular surface is 
visible. C) Surrounding markings were done with an APC probe with sufficient distance from 
the lesion. D) The size of lesion was measured by comparative ratio with 6 mm sized round 
piece of vinyl. E) Normal saline or sometimes normal saline-indigocarmine mixture solution 
was injected to the submucosal layer under the lesion with a standard 25-G injection needle. F) 
Normal saline solution was injected until sufficient submucosal swelling was achieved. G, H) 
The lesion and neighboring mucosa inside the marked sites were evenly coagulated with APC 
until the lesion was completely coagulated and appeared dry under endoscopic examination.  
After APC–SSI treatment, patients were closely observed. If there was no specific complaint, 
patients were discharged from hospital with proton pump inhibitor. On the occasion of severe 
pain or discomfort, patients were admitted to hospital. After discharge, follow- up endoscopic 
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months. Lesions found at the same site as the previous lesion were defined as being residual. 
On the other hand, lesions found at a different site were considered to be metachronous. The 
treatment outcomes of all patients are shown in Table 1 and 93.7% of gastric adenomas were 
eradicated with APC–SSI. Four residual lesions (6.3%) were found at previous treated sites and 
they were gastric adenomas with LGD during mean follow-up time of 5.8 ± 3.2 months (range 
3–9 months) (Table 2). Three of these were located at the posterior wall of the upper and mid 
body. One lesion was located in the prepylorus. The initial lesions were incompletely 
coagulated probably because their locations were difficult to be accessed with an endoscope.  
For instance, the prepyloric lesion extending through the pyloric channel into the mucosa of 
the duodenal side was incompletely treated with APC probably due to the limitation of 
endoscopic visual field (Fig. 7). All of the residual adenomas were eradicated with additional 
APC–SSI treatment and did not reappear during follow-up. 
 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
Gender (men-women)    45/12 
 
Mean age, yr    59.5 ± 10.9 (34-81) 
 
Macroscopic type    Flat elevated type    58 
 
     Central depressed type     6 
 
Patients with concomitant diseases   32 (56.1%) (COPD, 8; liver cirrhosis, 6;  
     heart failure, 5; renal failure on hemodialysis 
     or peritoneal dialysis, 4; others, 9) 
 
Patients who refused hospitalization 25 (43.8%) 
for EMR and with a risk of perforation  
or bleeding 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
EMR, Endoscopic mucosal resection 
Table 1. Characteristics of 57 patients with a combined total of 64 lesions of gastric adenoma 
treated with APC-SSI 
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    No.          yr                                                                            type                 treatment 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
 1                  66           M        P/W of Upper body     Adenoma c LGD        APC-SSI 
 2                  56           M        P/W of Upper body     Adenoma c LGD        APC-SSI 
 3                  70           M        P/W of Mid body         Adenoma c LGD        APC-SSI 
 4                  59           M        G/C of Prepylorus       Adenoma c LGD        APC-SSI 
 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
P/W, Posterior wall; G/C, Greater curvature; LGD, Low grade dysplasia;  
APC-SSI, Argon plasma coagulation with submucosal saline injection 
Table 2. Characteristics of 4 patients with residual adenoma 
 




Fig. 7. A case of treatment failure. Residual tumor was found 6 months after APC-SSI for 
prepyloric lesion. A) Round flat elevated lesion was located at greater curvature side of 
the distal antrum and prepylorus and has relatively clear margin. B, C) After marking 
with APC and submucosal saline injection, the lesion and surrounding mucosa was 
evenly coagulated. D) Follow-up endoscopy at 6 months after APC-SSI, a nodular 
surfaced elevated mass lesion with fold change was noted. Pathologic examination of 
biopsy specimen revealed gastric adenoma with LGD. E, F) After marking procedure and 
submucosal saline injection, the remnant lesion on the antrum was eradicated with APC 
treatment. G, H) With retroflexion of the endoscope, the lesion had extended into the 
duodenal bulb. After marking procedure and submucosal saline injection, the remnant 
lesion on the duodenal side was eradicated with additional APC treatment with 
retroflexion in the bulb. I) Follow-up endoscopy 1yr after additional treatment revealed 
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Fig. 8. The case of metachronous intramucosal adenocarcinoma and gastric adenoma after 
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curvature side of the mid antrum. Endoscopic biopsy revealed Helicobacter gastritis.  
B) Whitish discolored, flat elevated lesion with clear margin was noted at the lesser 
curvature side of the gastric angle. C) After indigocarmine spraying, its surface revealed a 
lobular appearance. D) About 25 x 24 mm sized APC-induced round ulceration was noted 
at the lesser curvature side of the gastric angle. The ulcer base was blue-colored due to the 
submucosa injection of indigocarmine mixed saline. E) Endoscopic finding at 6 months 
after APC-SSI showed scarring ulceration with reddish regenerative epithelium.  
F) Endoscopic findings at 12 months showed a small elevated lesion with nodular  
surface at the greater curvature side of the antrum. Forceps biopsy results revealed 
intramucosal adenocarcinoma.G) For the treatment of the lesion, ESD was done.  
H) A large ESD-induced ulcer was seen without bleeding or perforation.  
I) A metachronous flat elevated round lesion was found at the lesser curvature side  
of the cardia during a follow-up endoscopy 2 years later. Forceps biopsy results  
revealed it was a gastric adenoma with LGD. J) Based on patient age and tumor location, 
APC-SSI was successfully done to treat the lesion. K) Endoscopic finding at 6 months  
after the second APC-SSI showed an ulcer scar. There was no evidence of residual  
tumor with endoscopic biopsy. 
Fourteen metachronous lesions were found in eight patients (14.0%) during follow-up 
(Table 3). Twelve lesions of gastric adenomas with LGD were treated with additional 
APC–SSI. One lesion of gastric adenoma with HGD was treated with ESD and it was 
proven to be intramucosal adenocarcinoma (Fig. 8). The other one with intramucosal 
adenocarcinoma was treated with APC–SSI because of poor general condition and 
bleeding tendency. Mean interval from treatment to detection of metachronous lesion was 
18.1 ± 11.6 months.  
Mean procedure time for APC-SSI was 15.0±5.0 (8–30) min. Transient abdominal discomfort 
occurred in 11 patients. Three complications (4.7%), including Mallory-Weiss tearing, 
pneumoperitoneum, and delayed bleeding, were noted (Table 4). Mallory–Weiss tearing 
was successfully controlled using endoscopic hemoclippings. Pneumoperitoneum occurred 
in a patient with two broad lesions at the lesser curvature side of the mid and upper body 
after a longer duration of APC-SSI. Endoscopy the next day showed broad ulcerative lesions 
with a coagulated base without evidence of perforation. The patient was hospitalized and 
discharged after 2 days of conservative care. Several authors reported one case each of APC-
induced pneumoperitoneum after treatment of acute hemorrhagic radiation proctitis 
(Chung, 2005; Hoyer, 1998; Manes, 2007). Pneumoperitoneum, however, does not 
necessarily mean perforation. It can be caused by air leakage through a partially coagulated 
wall by elevated intraluminal pressure. In our study, argon gas flow rate was 2 L/min. The 
long procedure time of APC inevitably induced marked stomach distention and increased 
intragastric pressure, probably resulting in air leaking into the peritoneal cavity without a 
visible perforation site of the gastric wall. Delayed bleeding from the regenerative vessels on 
the APC-induced ulcer occurred in one patient 2 weeks after the procedure and it was 
successfully managed with additional APC. APC is an effective noncontact technique for 
bleeding control (Islam, 2009; Grund, 1994; Grund, 1997) and there was no procedure-
related bleeding during and immediately after APC–SSI. This delayed bleeding was not 
caused by the APC procedure itself but by the healing and regenerative process, indicating 
that APC may be a safe treatment of gastric adenoma in patients with bleeding risk. This can 
also bring about stressful retching and Mallory–Weiss tearing. Therefore, frequent suction of 
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curvature side of the mid antrum. Endoscopic biopsy revealed Helicobacter gastritis.  
B) Whitish discolored, flat elevated lesion with clear margin was noted at the lesser 
curvature side of the gastric angle. C) After indigocarmine spraying, its surface revealed a 
lobular appearance. D) About 25 x 24 mm sized APC-induced round ulceration was noted 
at the lesser curvature side of the gastric angle. The ulcer base was blue-colored due to the 
submucosa injection of indigocarmine mixed saline. E) Endoscopic finding at 6 months 
after APC-SSI showed scarring ulceration with reddish regenerative epithelium.  
F) Endoscopic findings at 12 months showed a small elevated lesion with nodular  
surface at the greater curvature side of the antrum. Forceps biopsy results revealed 
intramucosal adenocarcinoma.G) For the treatment of the lesion, ESD was done.  
H) A large ESD-induced ulcer was seen without bleeding or perforation.  
I) A metachronous flat elevated round lesion was found at the lesser curvature side  
of the cardia during a follow-up endoscopy 2 years later. Forceps biopsy results  
revealed it was a gastric adenoma with LGD. J) Based on patient age and tumor location, 
APC-SSI was successfully done to treat the lesion. K) Endoscopic finding at 6 months  
after the second APC-SSI showed an ulcer scar. There was no evidence of residual  
tumor with endoscopic biopsy. 
Fourteen metachronous lesions were found in eight patients (14.0%) during follow-up 
(Table 3). Twelve lesions of gastric adenomas with LGD were treated with additional 
APC–SSI. One lesion of gastric adenoma with HGD was treated with ESD and it was 
proven to be intramucosal adenocarcinoma (Fig. 8). The other one with intramucosal 
adenocarcinoma was treated with APC–SSI because of poor general condition and 
bleeding tendency. Mean interval from treatment to detection of metachronous lesion was 
18.1 ± 11.6 months.  
Mean procedure time for APC-SSI was 15.0±5.0 (8–30) min. Transient abdominal discomfort 
occurred in 11 patients. Three complications (4.7%), including Mallory-Weiss tearing, 
pneumoperitoneum, and delayed bleeding, were noted (Table 4). Mallory–Weiss tearing 
was successfully controlled using endoscopic hemoclippings. Pneumoperitoneum occurred 
in a patient with two broad lesions at the lesser curvature side of the mid and upper body 
after a longer duration of APC-SSI. Endoscopy the next day showed broad ulcerative lesions 
with a coagulated base without evidence of perforation. The patient was hospitalized and 
discharged after 2 days of conservative care. Several authors reported one case each of APC-
induced pneumoperitoneum after treatment of acute hemorrhagic radiation proctitis 
(Chung, 2005; Hoyer, 1998; Manes, 2007). Pneumoperitoneum, however, does not 
necessarily mean perforation. It can be caused by air leakage through a partially coagulated 
wall by elevated intraluminal pressure. In our study, argon gas flow rate was 2 L/min. The 
long procedure time of APC inevitably induced marked stomach distention and increased 
intragastric pressure, probably resulting in air leaking into the peritoneal cavity without a 
visible perforation site of the gastric wall. Delayed bleeding from the regenerative vessels on 
the APC-induced ulcer occurred in one patient 2 weeks after the procedure and it was 
successfully managed with additional APC. APC is an effective noncontact technique for 
bleeding control (Islam, 2009; Grund, 1994; Grund, 1997) and there was no procedure-
related bleeding during and immediately after APC–SSI. This delayed bleeding was not 
caused by the APC procedure itself but by the healing and regenerative process, indicating 
that APC may be a safe treatment of gastric adenoma in patients with bleeding risk. This can 
also bring about stressful retching and Mallory–Weiss tearing. Therefore, frequent suction of 
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 Patient Age Gender     Time(mon) Pathologic type  Further treatment 
 No 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
 1 51 M  9 Adenoma c LGD  APC-SSI 
 2 78 M  6 Adenoma c LGD   APC-SSI 
 3 49 M  12 Adenoma c LGD   APC-SSI 
 4 66 M  30 Intramucosal cancer  APC-SSI 
 5 59 F  5 Adenoma c LGD   APC-SSI 
    19 Adenoma c LGD   APC-SSI 
 6 50 M  6 Adenoma c LGD   APC-SSI 
    20 Adenoma c LGD   APC-SSI 
 7 51 M  12 Intramucosal cancer  ESD 
 8 49 M  43 Adenoma c LGD   APC-SSI 
    12 Adenoma c LGD   APC-SSI 
    19 Adenoma c LGD   APC-SSI 
    28 Adenoma c LGD   APC-SSI 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
P/W, Posterior wall; G/C, Greater curvature; LGD. Low grade dysplasia; 
APC-SSI, Argon plasma coagulation with submucosal saline injection;  
ESD, Endoscopic submucosal dissection 
Table 3. Characteristics of 14 metachronous lesions of 8 patients 
 
 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━              
 Mean duration of follow-up (mo)    19.5 ± 15.1 (6-49) 
 
 Mean time required for treatment (min)    15.0 ± 5.0 
 
 Patients with complications    3 (4.7%) 
 
 Mallory Weiss tearing                                         1 
 
 Pneumoperitoneum                                           1 
 
 Delayed bleeding                                             1 
 
 Patients with residual adenoma                               4 (7.0%) 
  
 Patients with metachronous adenoma                8 (14.0%) 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
Table 4. Outcomes of endoscopic argon plasma coagulation with submucosal saline injection 
treatment (n=64) 
There are two important viewpoints in this study. One is the importance of the accurate 
identification of the lateral margin of the lesion. Because gastric adenomas are confined to 
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the mucosal layer and the entire lesion can be ablated with APC, residual lesions may be left 
near the lateral margin but away from the deep layer (Morson, 1980, Rugge, 1995). Lesion 
marking should include a sufficient amount of normal tissue around the lesion to ensure a 
successful APC-SSI, preventing treatment failure, as seen in EMR or ESD. Unlike colorectal 
or esophageal lesions whose margins are rather easy to delineate with indigocarmine or 
Lugol spraying, the margins of gastric tumors are sometimes difficult to diagnose, because 
the background mucosa is affected by acute or chronic inflammation or intestinal 
metaplasia. Because indigocarmine accumulates in the grooves and emphasizes the surface 
structural changes of the mucosa, it is difficult to identify the margin of the lesion which 
surface change is not distinct. Therefore, it could result in incomplete resection with positive 
lateral margin in EMR or ESD, and also leave residual tissue in those who receive APC 
treatment for adenomas. Inability to perform histopathologic evaluation of resected 
specimen is a shortcoming of APC treatment of gastric adenomas and we recommend 
sufficient margin to be obtained before APC-SSI for the prevention of residual tissue. 
Therefore, endoscopists should pay more attention to the lesions at difficult sites for 
endoscopic approach, such as the posterior wall of the upper and mid body, making sure 
there is sufficient margin from the lesions.  
The other viewpoint is the high prevalence of metachronous lesions after APC-SSI for 
gastric adenomas. We found 14 metachronous lesions in eight patients, and their locations 
were different from their original lesions during a mean of 19.5 months of follow-up. 
Those who have risk factors of gastric adenomas, including chronic atrophic gastritis, 
intestinal metaplasia, Helicobacter pylori infection, old age, cigarette smoking, and alcohol 
drinking, are more likely to develop metachronous lesions even after APC treatment. 
Chronic atrophic gastritis and intestinal metaplasia are known to be irreversible and may 
work as a continuous background of gastric cancer to recur at other sites (Talley, 1991; 
Parsonnet, 1991; Nomura, 1991). Because patients who have risk factors of gastric 
adenomas have an increased risk of metachronous lesions, meticulous endoscopic follow-
up should be done after the treatment of gastric adenomas (Talley, 1991; Parsonnet, 1991; 
Nomura, 1991).  
10. Conclusion 
Gastric adenomas are well-known as premalignant lesions of gastric cancer. Gastric 
adenomas with LGD show a relatively benign natural course and low risk of progression, 
compared with gastric adenomas with HGD. Though endoscopic resection has become the 
standard treatment of intramucosal carcinomas and adenomas with HGD, there is 
controversy about the therapeutic option of gastric adenomas with LGD. APC-SSI is the 
most reasonable and feasible treatment being safe and effective, which can be done in place 
of endoscopic resection and repeated endoscopic follow-up.  
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the mucosal layer and the entire lesion can be ablated with APC, residual lesions may be left 
near the lateral margin but away from the deep layer (Morson, 1980, Rugge, 1995). Lesion 
marking should include a sufficient amount of normal tissue around the lesion to ensure a 
successful APC-SSI, preventing treatment failure, as seen in EMR or ESD. Unlike colorectal 
or esophageal lesions whose margins are rather easy to delineate with indigocarmine or 
Lugol spraying, the margins of gastric tumors are sometimes difficult to diagnose, because 
the background mucosa is affected by acute or chronic inflammation or intestinal 
metaplasia. Because indigocarmine accumulates in the grooves and emphasizes the surface 
structural changes of the mucosa, it is difficult to identify the margin of the lesion which 
surface change is not distinct. Therefore, it could result in incomplete resection with positive 
lateral margin in EMR or ESD, and also leave residual tissue in those who receive APC 
treatment for adenomas. Inability to perform histopathologic evaluation of resected 
specimen is a shortcoming of APC treatment of gastric adenomas and we recommend 
sufficient margin to be obtained before APC-SSI for the prevention of residual tissue. 
Therefore, endoscopists should pay more attention to the lesions at difficult sites for 
endoscopic approach, such as the posterior wall of the upper and mid body, making sure 
there is sufficient margin from the lesions.  
The other viewpoint is the high prevalence of metachronous lesions after APC-SSI for 
gastric adenomas. We found 14 metachronous lesions in eight patients, and their locations 
were different from their original lesions during a mean of 19.5 months of follow-up. 
Those who have risk factors of gastric adenomas, including chronic atrophic gastritis, 
intestinal metaplasia, Helicobacter pylori infection, old age, cigarette smoking, and alcohol 
drinking, are more likely to develop metachronous lesions even after APC treatment. 
Chronic atrophic gastritis and intestinal metaplasia are known to be irreversible and may 
work as a continuous background of gastric cancer to recur at other sites (Talley, 1991; 
Parsonnet, 1991; Nomura, 1991). Because patients who have risk factors of gastric 
adenomas have an increased risk of metachronous lesions, meticulous endoscopic follow-
up should be done after the treatment of gastric adenomas (Talley, 1991; Parsonnet, 1991; 
Nomura, 1991).  
10. Conclusion 
Gastric adenomas are well-known as premalignant lesions of gastric cancer. Gastric 
adenomas with LGD show a relatively benign natural course and low risk of progression, 
compared with gastric adenomas with HGD. Though endoscopic resection has become the 
standard treatment of intramucosal carcinomas and adenomas with HGD, there is 
controversy about the therapeutic option of gastric adenomas with LGD. APC-SSI is the 
most reasonable and feasible treatment being safe and effective, which can be done in place 
of endoscopic resection and repeated endoscopic follow-up.  
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The first description of surgery for rectal cancer was reported by the French surgeon 
Lisfranc who described a total of nine patients operated trough a perineal-transanal 
approach (Lisfranc, 1830). Although more recently gaining popularity, transanal techniques 
have long been used for the treatment of rectal diseases and were promoted by the work of 
Sir Alan Parks at St. Marks Hospital in London in the 1950s (Parks, 1970). This conventional 
surgical approach is well suited for the management of selected low rectal lesions; on the 
contrary, removal of lesions in the middle and upper rectum are less feasible due to the 
limited accessibility and inadequate exposure afforded by standard instrumentation. For 
these reasons, those more proximal lesions have historically been tackled by more radical 
surgical approaches, like abdominal low anterior, abdominoperineal, transsacral, and 
transsphincteric resections.  
 
 
Fig. 1. J. Lisfranc’s description of surgery for rectal cancer. 
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Transanal endoscopic microsurgery (TEM) came into practice in Germany, in the early 1980s 
through the collaboration of the German surgeon Gerhard Buess and the Medical Company 
Richard Wolf (Buess et al., 1984). Its initial indication was to remove large rectal polyps 
beyond the reach of standard transanal excision. TEM is a technique for the performance of 
local excision, by the way of a binocular, magnified operating system. This equipment 
involves an operating proctoscope, insufflation, and magnified stereoscopic vision. In fact, 
the three-dimensional amplification, magnified stereoscopic view and lighting within the 
rectal lumen, allow excellent vision of the operative field, enabling the surgeon to perform 
an extremely precise excision of rectal lesions, including a full-thickness excision. It has 
evolved into a valuable, state-of-the-art technology equaling any other technique in terms of 
reliably positive patient outcome. Its application has expanded beyond the excision of 
colonoscopically unresectable polyps to the removal of select, early rectal cancers, 
independent of prior adjuvant chemoradiation therapy. Further fields of use include the 
treatment of anastomotic strictures, and repair of proximal, complex rectal fistulae. TEM 
allows greater flexibility and options for the operating surgeon. In addition to extending the 
surgeon’s reach up to the distal sigmoid colon, the four ports of access allow for 
concomitant use of an illuminated camera, forceps, cautery, suction as well as the freedom 
to apply common laparoscopic techniques such as suturing and different energy sources.  
TEM has been found useful in the treatment of a broad variety of disease processes, both 
benign and malignant. Though many indications have been described, including excision of 
carcinoids or even retrorectal tumors, the most common use of TEM remains the resection of 
colonoscopically unresectable rectal adenomas and carefully selected rectal cancers. It 
should be stressed that even though TEM extends the reach of conventional transanal 
resections, it should not lead to any deviation from the established stringent indications for 
resection, especially in regard to rectal cancer (Palma et al, 2004). 
Due to the limited visibility and access inherent to traditional transanal retractors, use of the 
latter has been restricted to the resection of low rectal polyps and suitably located early 
cancers. The TEM technique grants access to the entire rectal cavity, facilitating the reach of 
lesions with their proximal margin located as far as 20 cm from the anal verge. Some of the 
limitations of TEM are due to the surgeon’s personal skills and experience. The conditions 
treated by TEM, namely, colonoscopically unresectable rectal polyps and early cancers, are 
far less common in terms of incidence and epidemiology, than those treated by abdominal 
laparoscopic operations, thus limiting any single surgeon’s or institution’s volume and 
operative experience.  
Contemporarily several factors have induced a new interest for TEM among practitioners, 
predominantly due to surging controversy about increased local recurrence rates following 
standard transanal resection of favorable early stage rectal cancers. TEM bears some 
advantage over standard transanal excision of neoplasms, including better visualisation of 
the surgical field and tumor margins. Inflicting fewer traumas, the probability of tumor 
fragmentation and dissemination diminishes, while additionally enabling resection of the 
potentially infiltrated mesorectum. As a matter of fact, more and more surgeons are being 
trained with advanced endoscopic skills. Synergistically these skills make handling the TEM 
equipment more feasible and surgeons face a less steep learning curve, generally promoting 
the use of the procedure. 
Also, the use of TEM may not be restricted to the anal cavity, but serve as a gateway to the 
peritoneum for natural orifice transluminal endoscopic surgery (NOTES). Transrectal access 
to the peritoneum via TEM has the future potential to facilitate the removal of larger organs, 
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maintenance of pneumoperitoneum, endoscopical visualisation of upper abdominal organs 
and secure suture closure of the proctotomy, by the application of larger, more versatile 
instruments.  
2. TEM Equipment 
2.1 Articulated stabilising arm 
The proctoscope is aligned using an articulated arm, also known as the Martin arm, which is 
firmly attached to the operating table (figure 2). There are two ball joints which fully 
articulate and are locked into place with a single set screw. A bar at the one end of the 
articulated arm attaches to the rail on the operating table. At the opposite end the articulated 
arm attaches to the operating proctoscope. 
 
 
Fig. 2. Martin articulated arm. 
2.2 Operative proctoscopes 
The diameter of the operating proctoscope is 4 cm, it is available in two different lengths, 
10 and 20 cm and allows access throughout the rectum. A rotating collar on the handle 
locks the scope shaft, creating an airtight seal. The handle comes with a port, allowing  
the attachment of a hand-bulb insufflator or a tube for monitoring the CO2 pressure 
(figure 3).  
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articulate and are locked into place with a single set screw. A bar at the one end of the 
articulated arm attaches to the rail on the operating table. At the opposite end the articulated 
arm attaches to the operating proctoscope. 
 
 
Fig. 2. Martin articulated arm. 
2.2 Operative proctoscopes 
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10 and 20 cm and allows access throughout the rectum. A rotating collar on the handle 
locks the scope shaft, creating an airtight seal. The handle comes with a port, allowing  
the attachment of a hand-bulb insufflator or a tube for monitoring the CO2 pressure 
(figure 3).  
 




Fig. 3. TEM operating proctoscope (20 cm) with hand-bulb insufflator. 
A faceplate is fitted to the handle and locked with an sealed lever. This faceplate has a port 
for the optics and three rubber caps for the long operating instruments (figure 4). These 
ports are able to maintain pneumorectum and are fitted with holes of varying size, to 
accommodate instruments of different diameters. The right-side operating port is slightly 
larger and thus requires a slightly larger cap. Flap valves in the snap-on multiport piece 
serve to help prevent gas leaks. 
 
 
Fig. 4. TEM faceplate with four ports. 
 




A 10-mm stereoscope which provides a high-definition, three-dimensional view is used. The 
stereoscope’s long, rigid shaft is inserted into the optic port on the faceplate and extends the 
entire length of the operating proctoscope.  
A 40o, 5-mm scope is inserted into the stereoscope and connected to a camera, allowing a 
live feed from the rectal cavity to be displayed on a video monitor. The stereoscope also has 
two ports serving for water irrigation and CO2 insufflation (figure 5). 
 
 
Fig. 5. TEM proctoscope (above) and 10 mm stereoscope (below), attached to a 5 mm scope 
for video viewing. 
2.4 TEM Instruments 
Long instruments are needed access the surgical field via the operating TEM proctoscopes 
(figure 6). The instruments include electrocautery, forceps, scissors, suction probe, clip 
applier, needle holder, and retractable needle. 
There are two variants of forceps, either straight or angled. Both types are provided on 
instruments with tips facing either left or right. Each instrument may be electrified 
individually. Also the scissors are provided with the tip facing either left or right, and are 
mainly used for cutting sutures. 
The suction probe is a, double-curved, rigid tube designed to be inserted through the 
proctoscope and sit on the side of the scope’s channel , not to obstruct vision during the 
procedure.   
The needle device has a retractable needle within the tip of the rigid tube and may be 
extended or retracted with a syringe type handle. The needle holders are available with 
either a straight or an angled tip. The angled tip provides a slightly wider arc when passing 
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a needle. In addition the jaws are ‘‘self-righting’’, when the needle is grasped it will rotate 
into the proper orientation by itself. The needle can be locked into position with a rotating 
ratchet controlled by the surgeon’s thumb. The lock is released by over-squeezing the 
handle, allowing the surgeon to safely handle the needle. 
The clip applier is a unique instrument which crimps a small silver clip onto the suture. 




Fig. 6. TEM distal proctoscope opening showing the stereoscope together with forceps and 
suction probe. 
2.5 Specific TEM devices 
The specific device providing CO2 insufflation, water injection, and suction is stacked on a 
suitable portable cart (figure 7) as well as the video monitor, recorder and light source 
(figure 8). An electrocoagulation unit may be placed in the stack or a separate standard 
operating room unit may be employed.  
 
 
Fig. 7. Specific device for CO2 insufflation, water injection and suction. 
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The insufflator injects CO2 via a port on the stereoscope’s optic shaft. Lighting is supplied 
via a fiberoptic cord leading to a connector on the optic probe. Water irrigation may be 
engaged using a pedal. The water for irrigation flows through the stereoscope’s shaft and is 
diverted across the optic tip, thus keeping the view clear.  
 
 
Fig. 8. The video monitor, recorder and light source are stacked on a portable cart. 
2.6 Surgical set-up 
Assembling the equipment can be time-consuming. The surgeon must position the patient 
in such way, that the tumor faces down directly towards the operating table; the choice of 
position is based upon prior examination in the office with a rigid proctoscope locating the 
tumor at both a specific level and a specific site on the circumference. 
The patient may be placed in the lithotomy position, prone, or laterally; for a tumor that is 
almost circumferential the patient may need to be turned during the procedure. In our 
experience, the patient must be secured to the table with a bean bag, as the table may need 
to be rotated to bring the tumor into the center of the field. After positioning the bean bag, 
the articulated arm is attached to the operating table. The four tubes leaving the 
insufflation/suction devices must be connected properly. 
Figure 9 shows the operation theatre setup with the patient in prone postion in order to 
reach the neoplasm, located on the anterior rectal wall. 
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Fig. 9. Surgical setup with the patient in prone position 
In conclusion, TEM requires specialized equipment and training. In addition to technical 
expertise, the dedicated TEM colorectal surgeon should be familiar with the necessary 
instruments and electronic devices. Expertise in troubleshooting is particularly helpful. 
There is, however, no substitute for a dedicated operating room team to ensure an efficient 
and successful TEM procedure.  
3. Surgical technique 
Preceding the procedure, bowel cleansing and prophylactic antibiosis have to be performed. 
In the actual procedure, two different operation techniques can be employed. Mucosectomy 
involves removing the mucosa, including the polyp from the inner circular layer of the 
muscularis; it represents a suitable technique for sessile adenomas located in the 
intraperitoneal portion of the rectum. 
Full-thickness excision requires removal of all layers of the rectal wall, in the plane located 
just slightly superficial of the perirectal fatty tissue. This excision is performed for the 
majority of malignant lesions. 
 
 
Fig. 10. Surgical dissection of an adenoma with two large TEM instruments. 
 
Transanal Endoscopic Microsurgery - State of the Art 
 
65 
In cases of malignancy, it is imperative that the procedure includes not only a full-thickness 
excision but also a 1 cm safety margin of normal mucosa surrounding the lesion. 
 
 
Fig. 11. TEM full-thickness dissection of rectal adenoma, showing the perirectal fatty tissue. 
It is of crucial importance to correctly align the specimen on the cork board immediately 
after resection, to evaluate the safety margins before fixation with formalin. The proximal 
and distal margins of resection have to be identified to ensure correct histologic 
examination.  
The rectal defect is closed by a running suture with a polydioxanone (3/0) monofilament 
and has to be performed transversely to prevent stenosis. The application of a silver clip at 
each end of the suture avoids the need for intraluminal knotting.  
Alternatively, recent reports indicate the possibility to leave the defect open for secondary 
wound repair, especially in cases of partial-thickness excision. 
 
 
Fig. 12. Rectal wall defect closed by a running suture. Please note the peritoneal opening. 
Patient in the prone position.  
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Following the excision of large masses, mobilization of the proximal and distal rectal wall 
will minimize tension on the suture line (figure 13). Approximating large defects with a 
single suture at the midpoint, facilitates the closure.  Following this, the defect is closed from 
the peripheral margins to the center in running fashion. In our experience, modern 
instruments like the endo-stitch™ (Covidien) are well suited to perform the running suture. 
 
   
Fig. 13. Large rectal mass excision resulting in a ¾ defect to be closed. 
4. Patient selection and staging 
Resection of rectal and distal sigmoid adenomas is the most prominent indication for TEM. 
These benign lesions do not require mesorectal dissection, thus patients can be spared the 
morbidity of an unnecessary radical intervention. Smaller adenomas without evidence of 
high-grade dysplasia may be removed by partial-thickness (submucosal) excision. Larger 
adenomas or those with high-grade dysplasia are at high risk of containing invasive 
adenocarcinoma loci and should be excised full-thickness with a 10 mm resection margin. 
 
 
Fig. 14. Adenoma specimen after TEM excision. 
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Resection of anterior rectal lesions requires special care. Full-thickness excision of the 
anterior and even lateral rectum carries the risk of unnoticed dissection into the vagina, 
urethra, or bladder. In this case, failure of adequate closure may lead to a rectourethral or 
rectovaginal fistula. 
Intraperitoneal entry carries a risk of injuring intraabdominal structures, bacterial and 
potential cytologic contamination, as well as anastomotic leakage. Initially regarded as a 
complication, intraperitoneal excision with secure closure of the rectal defect has been 
performed with growing experience, without increased short-term morbidity (figure 12). 
In case of a suspicious rectal polyp with unconfirmed malignancy in a patient unfit for or 
unwilling to undergo major abdominal surgery, TEM can be useful in resecting the entire 
lesion in one piece for complete histologic assessment. Salvage radical surgery, if indicated, 
can be performed thereafter without significantly increasing morbidity. TEM may also be 
useful as a palliative tool in patients with extensive metastatic disease or those medically 
unfit to withstand radical surgery. Neoadjuvant radiation therapy, when used in 
conjunction with resection, either aiming for cure or palliation, does not appear to increase 
complications following TEM. 
Accuracy in the preoperative staging is mandatory to correctly select patients eligible for 
local excision. The routine use of endorectal ultrasound (figure 15), in combination with 
magnetic resonance imaging (MRI) has revolutionized our ability to perform accurate 
preoperative staging with respect to rectal wall penetration (T stage) and regional lymph 
nodes (N stage) (figure 16). 
 
 
Fig. 15. 3D endorectal ultrsound showing a rectal mass without disruption of any of the 
rectal wall’s layers. 
Only patients with negative lymph nodes, a tumor limited to the wall of the rectum, 
presenting a diameter not exceeding 3 cm (in cases of malignancy), should be considered 
eligible for local excision. 
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Fig. 17. Histopathological specimen obtained from the patient mentioned above, showing 
both the rectal mass and the mesorectal lymph node in contact with the mesorectal fascia.  
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Preoperative staging workup includes: 
 Digital rectal examination 
 Colonoscopy 
 Rectoscopy, to:  
1. Perform biopsies 
2. Measure the distance from the anal verge to the lesion 
3. Evaluate the circumferential position of the tumor 
4. Select an appropriate patient positioning for TEM approach 
 Endorectal ultrasound 
 Pelvic-MRI 
 18F-FDG PET-CT, specifically in our institution (figure 18). 
 
 
Fig. 18. 18F-FDG PET-CT showing pathologic intense glucose uptake due to rectal cancer. 
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Each biopsy is examined by a dedicated pathologist to assess the tumor grade, as well as the 
lymphatic, neural, and blood vessel infiltration. 
5. Current indications and results 
Results from our experience and others are evaluated in the following chapter 
5.1 TEM for benign lesions 
Benign rectal tumors that are not suitable for snare diathermy excision are often amenable to 
removal via the transanal route, employing anal retractors and Parks’s method (Parks, 1970). 
However, this method is limited to the lower third of the rectum. In addition, it may be 
difficult to visualize the margins of flat adenomas.  
Conventional management of higher rectal lesions usually involves transabdominal 
procedures, posterior trans-sacral (Kraske), or sphincter-splitting (York-Mason) approaches. 
However, these are major surgical procedures with associated complications and may be 
unsuitable and unnecessary if the purpose of the intervention is to resect benign lesions or 
low risk carcinomas. 
With the development of TEM by G. Buess (Buess et al., 1984), it is now possible to carry out 
formal transanal resection by means of a rectoscope, which affords excellent access and 
vision in the entire rectum.  
According to our experience, we recomend a full-thickness resection, to ensure an 
appropriate margin of safety. In addition, we found that this standard procedure is 
technically easier to perform than mucosectomy and that it decreases the risk of missing a 
small rectal cancer which may be located within the villous adenoma. Such ‘intraephitelial 
neoplasia  dysplasia’ or ‘early invasion’ has been reported in up to 31% of cases. 
Although it is often difficult to ascertain the precise techniques (full-thickness or 
submucosal) used, the rates of complete excision at the time of operation and the exact 
follow up, large published series report a rate of recurrences in up to 27.3% after transanal 
excision of rectal adenomas (Sakamoto et al., 1991). In contrast the results reported using 
TEM show a recurrence rate between 3 and 7% with the 5.6% for the adenoma cases of our 
series pubished in 2004, being well in accordance with previous studies (Palma et al., 2004). 
The overall morbidity rate for conventional transanal surgery in reported series varies from 
0 to 14.5%, compared with 6% reported in the largest series of a total of 318 adenomas 
treated by Mentges (Mentges et al., 1996). These results are in accordance with others TEM-
series reporting morbidity of up to 4.5% in more than seven hundred patients and with our 
own experience (7%).  
It is of interest that postoperative bleeding is unusual with TEM, whereas it accounts for 
over half of the complications reported in other series (Sakamoto et al., 1991). Peritoneal 
entry, on the other hand, as assessed intra-operatively in 8 patient of our published 
experience (two of them with postoperative pneumoperitoneum), can be a significant source 
of morbidity with TEM. Presumably the excellent vision afforded by TEM allows more 
precise haemostasis, whereas the ability to excise high rectal lesions increases the likelihood 
of peritoneal entry, especially when the tumour is anterior, and thus more likely to be above 
the peritoneal reflection. In our experience, all perforations were recognized and managed 
by immediate endorectal suture (fig. 12). 
Our results after initial 100 cases with TEM indicate that this technique is reproducible with 
suitable surgical training.  
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Interestingly all three protective ileostomies in our series occurred within the first 20 cases 
indicating a learning curve, despite the fact that all surgeons received a special TEM 
training. 
Regarding the effect of a prolonged anal dilatation with the 40 mm diameter TEM operative 
rectoscope, manometric studies indicate a decrease in anal sphincter tone ranging from 25% 
to 37% of pre-operative sphincter pressure, with recovery to clinical continence within 6–16 
weeks (Herman et al., 2001). We observed postoperative transitory grade II incontinence in 
65 of the 100 patients, with full recovery in 98% of the cases after 12 weeks. There is also 
evidence indicating a significantly increased risk of diminishing the anal resting pressure by 
procedures lasting more than two hours. Others found 21% disturbances of rectoanal 
coordination and rectal perception, depending on the extent and type of resection of the 
tumor. However, when making continence judgement, it would be necessary to consider the 
risk of incontinence by using the Parks retractor in conventional surgery, or after a low 
restorative rectal excision, if those were to be the alternative procedures. 
In conclusion, TEM as a minimally invasive technique might be expected not only to benefit 
a small, specific population of patients in terms of morbidity but also to improve results in 
terms of completeness of excision and recurrence rates when compared to conventional 
transanal resection. 
5.2 TEM for early rectal cancer 
The standard treatment for early rectal cancer has been major surgery by anterior or 
abdominoperineal resection. After the introduction of total mesorectal excision, results 
regarding recurrence and survival rates have improved dramatically (figure 19). However, 
mortality, morbidity, and functional disturbances after major surgery are considerable. 
Perioperative mortality rates are usually 2 to 3 percent and overall morbidity 20 to 30 
percent. Furthermore, anorectal, bladder, and sexual function may be compromised. 
 
 
Fig. 19. Total mesorectal excision specimen 
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Fig. 19. Total mesorectal excision specimen 
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Given these side effects, there has been an increasing interest in the locoregional treatment 
of early rectal cancer. Nowadays local excision for selected rectal neoplasms is an accepted 
treatment worldwide (Bretagnol et al., 2007). Compared to the gold standard of radical 
surgery, local procedures of strictly selected early rectal cancers should lead to identical 
oncological results and even better outcomes regarding morbidity, mortality, and quality of 
life. 
Regardless of this trend, conventional transanal excision of rectal cancer has recently come 
under close scrutiny because of relatively high rates of local recurrence (Bentrem et al., 2005). 
In fact, scepticism has been expressed that such treatment may not be in the patient’s best 
interest. Despite all these concerns transanal endoscopic microsurgery has become the current 
standard procedure for the treatment of large rectal adenomas and early low risk carcinomas 
with curative intent, mostly in Europe (Demartines et al., 2001, Palma et al., 2004).  
As already assessed and in contrast to conventional transanal excisions using anal retractors, 
TEM offers an exceptionally good overview of the whole rectal cavity, allowing the precise 
removal of lesions not only in the lower and middle rectum but also in the upper region or 
even the retrorectal space, and obviates the need for major surgery. 
Despite the limitations and the lack of power of clinical studies to detect differences in 
outcome such as survival and complication rates, TEM does appear to result in less local 
recurrence than other usual methods of local excision.  
Furthermore, after local excision of early rectal cancer by TEM, recurrence and survival rates 
are comparable to those seen after major surgery, and complication rates and functional 
results are even superior when put into contrast with those seen after major surgery 
(Middleton et al., 2005). 
Since the introduction of TEM in our Division of Colon & Rectal Surgery a majority of 
patients with adenomas and T1 low-risk rectal cancer have been treated with local excision 
by this technique (Palma et al., 2004).  
In 2009 we ran a single center report to evaluate the safety and oncological outcomes of TEM 
excision compared to radical surgery (RS) in the treatment of T1 low-risk rectal cancer. We 
found no statistical differences between RS and TEM in terms of local recurrence and 
disease free survival rates (Palma et al., 2009). 
Today, various surgical techniques are still under discussion for the treatment of early rectal 
carcinomas. The historical gold standard procedures, such as anterior and 
abdominoperineal resection, show excellent results regarding local recurrence and survival 
rates, but are dearly paid for by a high incidence of complications and impaired quality of 
life (anorectal, sexual, and urinary dysfunction). Additionally, some of the patients require 
temporary diverting enterostomies. On the other hand, there are conventional, sphincter-
preserving techniques, such as conventional transanal resection with Park’s retractor (Parks, 
1970), which are associated with an almost unacceptably high local recurrence rate of up to 
29% (Madbouly et al., 2005).  
The primary factor limiting the effectiveness of local treatment for early rectal cancer is 
lymph node invasion. Depths of invasion into the rectal wall, grade or degree of 
differentiation, vascular, lymphatic and neural invasion are independent predictors of the 
risk of nodal metastasis. 
Since initial studies by Morson (Morson, 1985) and Hermanek (Hermanek & Marzoli, 1994) 
large series of resected rectal cancers have shown that well-differentiated tumors confined to 
the submucosa (T1) without vascular, lymphatic or neural invasion carry a 4% risk of nodal 
metastasis. 
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Although the reported rate of recurrence for early rectal cancers (pT1) resected by TEM is 
between 4- and 14%, follow-up and differentiation between low- and high-risk features are 
variable among series reported. In fact, the only published prospective study comparing 
TEM with radical resection for T1 low risk rectal cancer showed no statistical difference 
between local excision and radical resection regarding local recurrence and metastasis rate 
(Winde et al., 1996). These results are in accordance with our observations. We assessed two 
recurrences in the TEM group compared to none in the RS group. Local control is therefore 
undoubtedly better assessed after RS, but on the other hand it is interesting to underline that 
there was no statistically significant difference in overall survival and disease-free survival 
depending on the operation performed. 
In an outstanding systematic review published recently, both comparative and case-series 
studies were examined to assess evidence related to the safety and efficacy of TEM 
compared with radical resections and conventional local excisions ((Middleton et al., 2005). 
Despite limited evidence the authors pointed out the unequivocal tendency of TEM to 
achieve better results in well-selected cases than conventional local excision, without being 
less effective than radical resection. The question arising is, whether TEM represents the 
only adequate alternative to radical resection for early rectal cancer. 
The reason for the superiority of TEM over other transanal conventional techniques is the 
use of an optical system with 3D-view, 6-fold magnification, and human eye resolution; the 
creation of a stable pneumorectum, and specially designed instruments that allow full-
thickness excision under excellent view conditions not only in the lower but also in the 
middle and upper parts of the rectum. Furthermore, full-thickness excision allows proper 
histological examination. 
Recently we showed the ability and advantages of this technique to approach tumors 
located in the retrorectal space (Zoller et al., 2007). 
The advantage of TEM has already been observed in the lower rate of recurrences for 
adenoma excision (up to 7%) when compared to recurrence rate after transanal conventional 
excision (up to 27.3%). Even for adenomas, completeness of excision is an important 
predictor for early recurrence. Furthermore, the literature reported a lower morbidity rate 
when using TEM for adenoma excision (7% complication rate compared to 14.5% for 
conventional transanal surgery) (Ganai et al., 2006). 
Surprisingly many publications still advocate for caution in the local excision of rectal 
cancer. However, these studies are questionable regarding selection criteria, use of 
endorectal ultrasounds preoperatively, proper “in toto” excision, and histological 
examination (R-Status, differentiation, and lymphovascular invasion).  
In addition, some data is compromised by mainly retrospective analyses over extended time 
periods, and by a lack of standardized pathology reports. 
The main argument explaining the high rate of local recurrences after conventional local 
excision could be a technically inadequate operation in which margins are insuficcient, 
inadequate depth of resection, or shedding and implantation of tumor cells into the surgical 
field (Cataldo, 2006). 
Moore (Moore et al., 2008) compared 82 patients after TEM with another 89 after 
conventional transanal excision for rectal neoplasms. He found clear margins in 71 percent 
of specimens in the conventional group compared with 90% in the TEM group. 
Furthermore, non fragmented specimens were more likely to be found after TEM than after 
conventional surgery (94 vs. 65 percent). In our hands the rate of Rx and R1 after local 
excision was 5.88 and 2.94%, respectively. 
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We believe that strict patient selection criteria, together with full-thickness and margin-free 
excision is crucial for patient outcome. The strong correlation between incomplete tumor 
resection and poor outcome is widely accepted. In our experience, positive excision margins 
should not be regarded as a risk factor for recurrence but should be viewed as insufficient 
therapy requiring further treatment.  
Therefore, accurate pathological examination after corkboard fixation of the specimen, and 
intensive, close cooperation between surgeon and pathologist cannot be overemphasized. 
Although local recurrence was only observed after local excision, patients treated with TEM 
in our hands showed no significant differences in terms of overall survival and disease-free 
survival, as compared to patients who underwent RS. As local excision represents a 
minimally invasive technique in terms of morbidity, mortality and functional outcome, TEM 
should be offered as a valid option for well-selected patients with early rectal cancer. 
Despite the difficulty to perform further studies in the future, comparing different methods 
of local excision with more radical procedures and the possible combination of neoadjuvant 
chemoradiation for better local and distant control even for high risk tumors (Borschitz et 
al., 2008), we can conclude following our published experience, that TEM should be 
considered as best practice to perform a local excision of well selected cases of early rectal 
carcinoma. 
5.3 TEM in rectal cancer after chemoradiation 
Although adjuvant or neoadjuvant chemoradiotherapy seems to improve the prognosis 
after local excision, the indications for any kind of therapy following local resection of rectal 
cancer by TEM remain controversial. In fact, local treatment of rectal cancer is limited by the 
impossibility of removing the potentially positive lymph nodes, supporting the concept of 
adjuvant radiotherapy, chemotherapy, or both to achieve local control of the lymph nodes.  
Borschitz (Borschitz et al., 2008) published a review of the findings of neoadjuvant 
chemoradiation (nCRT) and local excision (LE) for T2–3 rectal carcinoma. He found a total of 
237 patients in seven different studies available for analysis, which did in fact permit an 
assessment of the recurrence rates in relation to histopathological tumor response.  
Patients with systemic metastases were excluded, and lymph node status was provided by 
only a few authors.  
In most studies analysed, clinical staging before nCRT identified a T2/3 rectal carcinoma (T1 
2%; T1–2 14%; T2 34%; T3 50%).  
The studies reported different therapeutic concepts, tumor locations, and intervals from 
completion of nCRT to surgery. Nevertheless, the analysis by Borschitz identified a number 
of similarities among them. These were predominance of cT2–3 carcinomas and the 
occurrences of local recurrence (LR). Patients with response at the submucosa level (ypT1) 
consistently showed low LR rates of 2% (0%–6%).  
Less clearly defined were the results of ypT2 findings, which ranged from 6% to 20% LR 
rates. Clearly unfavorable were the findings in patients, whose disease did not respond to 
therapy (ypT3), for whom a mean LR rate of 21% was calculated. The widely divergent LR 
rates of ypT2 findings may be increased as a result of to nonuniform time intervals from 
nCRT to surgery.  
The study by Borschitz confirms prior findings observed after nCRT and conventional 
resection. Almost no LR were reported for CR after nCRT of advanced (T3/4) tumors. 
Critical prognostic parameters are tumor response and tumor- free lymph nodes. LR and 
systemic recurrence rates ranging 0% to 23% and 8% to 22% were determined for this 
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constellation. For lesions that did not respond to therapy and for persistent nodal disease, 
far higher LR rates ranging from 16% to 58%, and metastases ranging from 35% to 58% were 
reported. 
Neoadjuvant CRT followed by LE may represent a viable alternative to rectum extirpation 
in patients with low T2–3 rectal carcinoma. Despite an optimized surgical technique made 




Fig. 20. Rectal cancer after neoadjuvant chemoradiation showing areas of fibrosis indicating 
good response 
The distal mesorectum, described by Morson (Morson et al., 1963) as a ‘‘bare area,’’ 
attenuates distally and is characterized by a circumferential decrease in healthy tissue 
surrounding the tumor, leading to a loss of tissue layers and a restricted field of view. For 
this region, incomplete mesorectal excision has been suggested as the cause of higher LR 
rates. 
Local full-thickness excision may be performed as an adequate therapeutic measure for 
complete response (CR) after nCRT. 
The described concept has been taken one step further by Habr-Gama (Habr-Gama et al., 
2004) who did not find a need for subsequent surgery in patients with clinically complete 
responses. In her retrospective, long-term, follow-up study which so far has remained 
unique, she reports a LR rate of only 3% in 100 patients.  
The question whether radical surgery, LE, or close-meshed follow-up alone may be 
appropriate in these patients, still remains largely unanswered. Furtherly it needs to be 
clarified, whether after nCRT with clinical confirmation of complete response, possibly 
remaining but vital tumor cells require surgical removal. These cells may have been 
damaged by irradiation and thus rendered unable to proliferate. Alternatively, some tumor 
cells surviving nCRT may represent resistant hypoxic clones that build the basis for 
development of recurrence later on. 
In summary, the findings of the revision made by Borschitz support the proposition, that the 
indication for LE after nCRT may be extended to distal cT2–3 rectal carcinoma. The 
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strongest prognostic parameter for favorable oncological outcomes is an effective tumor 
response without residual tumor (ypT0) or with response to at least the submucosa level 
(ypT1) in the excised specimen. For ypT2 tumors, the interpretation of the heterogeneous 
results should be performed with caution. But an extrapolation may be possible from LE 
alone, without nCRT. LE is not adequate in patients whose tumors exhibit no response or 




Fig. 21. Rectal cancer after neoadjuvant chemoradiation showing complete response (ypT0) 
6. Conclusion 
Transanal Endoscopic Microsurgery is a fairly new variant of transanally performed surgery 
of the rectal cavity, developed in Germany during the 1980’s. In comparison to preceding 
techniques, it has largely expanded the spatial range and resolution of transanal procedures 
by employing state-of-the-art optics and endoscopic instruments, enabling the surgeon to 
reach parts of the rectum that were previously unaccessible by transanal approach. 
Repassing the findings throughout the manuscript, it is evidence based to conclude that 
TEM currently is and prospectively will be playing an important role in the management of 
lower rectal neoformations.   
When used in select cases of adenoma or low-grade adenocarcinoma and in accordance with 
the stringent indications governing more radical interventions, already in place, patients are 
due to benefit from less morbidity and mortality, including shorter recovery times.  
Within its constraints, TEM has also shown a more favorable incidence of local recurrences 
compared to standard transanal surgery, while being able to parallel local recurrence rates 
of more extended invasive interventions, like anterior resection and abdominoperineal 
approaches, outlining its qualities in curative treatment of rectal cancer. 
It has to be stressed, that the suitability of TEM must be determined in a meticulous 
preoperative staging and grading process, including MRI imaging and endorectal 
ultrasound, to tackle the thin red line separating availible approaches case by case. 
Apart from that, TEM may also serve as a last line measure for patients unfit or unwilling to 
undergo laparotomy, adding to its value in managing palliative instances.  
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Aditionally, in multimodal therapy schemes, including neoadjuvant chemoradiotherapy, the 
indication of TEM could expand, in the near future, to those patients showing a complete 
response. 
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Aditionally, in multimodal therapy schemes, including neoadjuvant chemoradiotherapy, the 
indication of TEM could expand, in the near future, to those patients showing a complete 
response. 
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1. Introduction 
The development of fiberoptic endoscopes between 1960 and 1970 was an important event 
in the evolution of the specialty of gastroenterology. Several of these endoscopes had side-
viewing or oblique-viewing lenses that provided reasonable views of the ampulla of Vater. 
Cannulation of the ampulla and retrograde pancreatography was first reported in 1968 
(McCune et al., 1968). Subsequent developments largely occurred in Japan and led to a more 
detailed description of endoscopic retrograde cholangiopancreatography (ERCP) in 1970 
(Takagi et al., 1970). This was soon followed by a description of endoscopic sphincterotomy 
by independent groups in Germany and Japan in 1974 (Classen & Demling, 1974; Kawai et 
al., 1974).  
By the mid-1970’s, ERCP had been adopted by several major centers but was not widely 
accepted because it was perceived as either “too difficult” or “too prone to complications”. 
The major complication was that of pancreatitis. This occurred in up to 10% of patients and 
was associated with significant morbidity and at least some mortality. Even today, risks for 
pancreatitis remain significant despite a large number of studies that have attempted to 
reduce the risk using procedural modifications or various drugs.  
The next milestone in therapeutic ERCP was a description of endoscopic stents for 
malignant biliary obstruction (Soehendra and Reynders-Frederix, 1979). This was followed 
by a description of therapeutic procedures in the pancreas including stents for strictures in 
the main pancreatic duct, endoscopic extraction of pancreatic stones, endoscopic drainage of 
pancreatic pseudocysts and endoscopic stents for pancreatic fistulae and pancreatic ascites. 
By the mid-1980’s, ERCP had been widely adopted and was recognized as the therapeutic 
procedure of choice for bile duct stones, particularly after cholecystectomy.  
Developments since 1990 include the use of self-expanding metal (metallic) stents for 
malignant biliary obstruction and the development of ultrathin endoscopes for direct 
cholangioscopy and pancreatoscopy. Although endoscopic ultrasound (EUS) was first 
described in 1976 (Lutz and Rosch, 1976), it has only recently been widely applied to 
pancreatic and biliary disorders, largely because of technical developments including the 
opportunity for tissue sampling using fine-needle aspiration.  
The purpose of this report is to provide an outline of diagnostic and therapeutic procedures 
in the biliary tract and pancreas. We will also include endoscopic procedures currently 
under evaluation that might have a role in future therapy.  
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2. Diagnostic procedures 
2.1 Historical and technical aspects 
Prior to 1970, options for cholangiography included intravenous cholangiography and 
percutaneous transhepatic cholangiography. The former was unhelpful in the presence of 
jaundice and, in the absence of jaundice, had a relatively high frequency of false positive 
and false negative results. Percutaneous cholangiography was largely restricted to patients 
with jaundice and was usually performed as a pre-operative procedure because of the risk 
of a bile leak. Although ultrasound (US) and computed tomography (CT) scans were 
introduced in the late 1970’s and early 1980’s, respectively, these investigations did not have 
a major impact on the frequency of diagnostic procedures until the late 1980’s. Magnetic 
resonance imaging (MRI) scans were introduced in the late 1990’s but have only become 
widely available in the past decade.  
Surprisingly, the endoscopes and ancillary equipment necessary for ERCP were largely 
developed in the 1970’s. The principle was placement of a catheter in the orifice of the ampulla 
followed by the injection of contrast into the desired duct. The procedure was performed using 
intermittent fluoroscopy and radiographs were taken of appropriate images. In most patients, 
the desired duct is the bile duct but, unfortunately, it is often easier to outline the main 
pancreatic duct. Because of this, various techniques have been used to promote biliary 
cannulation including the use of a partly-opened papillotome, use of appropriately placed 
guide-wires and, under some circumstances, use of small endoscopic incisions (pre-cuts) to 
facilitate bile duct cannulation. The latter technique should probably be restricted to experts 
because of higher risks for pancreatitis (Hochberger et al., 2003). Endoscopic and radiologic 
images of selected biliary and pancreatic disorders are shown in figures 1 and 2. 
 
 
Fig. 1. Miscellaneous cholangiograms. (a) Multiple bile duct stones. (b) Carcinoma of the head 
of pancreas with strictures in the lower bile duct and main pancreatic duct. (c)  Bile duct cancer 
involving the common hepatic duct. (d) Typical features of sclerosing cholangitis.  
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2.2 Bile duct stones 
The preferred diagnosis for both patient and endoscopist is that of choledocholithiasis. In 
this setting, cannulation of the ampulla is often relatively easy and stones are outlined as 
mobile filling-defects within the bile duct. The cystic duct and gallbladder can also be 
outlined. For most of these patients, the sequence of investigations is an upper abdominal 
ultrasound study followed by ERCP. For patients with a probability of bile duct stones of 
80% or less, additional useful information may be obtained by magnetic resonance 
cholangiopancreatography (MRCP) or EUS.  
2.3 Ampullary, biliary and pancreatic neoplasms 
Duodenal endoscopy is helpful for at least some neoplasms. In particular, most ampullary 
neoplasms can be diagnosed at duodenal endoscopy and confirmed by biopsy. 
Furthermore, approximately 5% of biliary and pancreatic cancers infiltrate or ulcerate into 
the second part of the duodenum and can also be confirmed by biopsy. Typical pancreatic 
cancer with obstructive jaundice (but without duodenal infiltration) results in strictures in 
both the main pancreatic duct and bile duct.  This is usually associated with proximal 
dilatation of both ducts. In the absence of jaundice, the typical appearance is a stricture in 
the main pancreatic duct with proximal dilatation or complete obstruction of the duct. 
Similarly, in bile duct cancer, the typical appearance is an irregular biliary stricture that is 
normally associated with proximal dilatation including dilatation of intrahepatic ducts.  
 
 
Fig. 2. Neoplasms of the ampulla of Vater. (a) Tiny adenomas of the ampulla associated  
with familial adenomatous polyposis. (b)  Neuroendocrine neoplasm (carcinoid tumor) of 
the ampulla. (c)  Large polypoid carcinoma of the ampulla. (d)  Small ulcerated carcinoma of 
the ampulla.  
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At a clinical level, it may be difficult to differentiate pancreatic cancer from autoimmune 
pancreatitis and some cases of chronic pancreatitis. Although malignant biliary strictures 
without pancreatic duct strictures are usually caused by bile duct cancer (60%-70%), 
alternative possibilities include gallbladder cancer that spreads to the bile duct and 
metastatic cancer or lymphoma in subhepatic lymph nodes. Rarely, the differential 
diagnosis can also include benign biliary strictures such as post-operative strictures and 
sclerosing cholangitis.  
2.4 Pancreatitis and its complications 
Prior to the mid-1980’s, ERCP was widely used for the diagnosis of non-calcific chronic 
pancreatitis and for the diagnosis of complications of pancreatitis such as pseudocysts and 
biliary obstruction. The diagnosis of chronic pancreatitis largely rested on radiological 
changes in the main pancreatic duct and side-branches. In relation to pseudocysts, at least 
70% could be outlined at pancreatography although there was a small risk of conversion of a 
pseudocyst into a pancreatic abscess. Today, modern imaging techniques have largely 
replaced pancreatography for the diagnosis of most pancreatic disorders. However, 
pancreatography may still have a role in uncommon disorders such as idiopathic relapsing 
pancreatitis and pancreatic ascites (Petersen, 2002).  
2.5 Role of endoscopic ultrasound 
EUS is being increasingly used to enhance the diagnostic accuracy of traditional ERCP. 
Arguably, the most important development is the contribution of fine-needle aspiration to 
the histological or cytological diagnosis of various neoplasms. However, it is also being used 
to confirm the diagnosis of bile duct stones, to diagnose non-calcific chronic pancreatitis and 
to delineate the size and spread of various neoplasms (Figure 3a-e). In relation to bile duct 
stones, endoscopic ultrasound may be more sensitive than ERCP and MRCP for the 
detection of small stones, <5 mm in diameter (Kondo et al., 2005). It may also have a role in 
acute biliary pancreatitis where bile duct stones can pass spontaneously into the duodenum 
after induction of pancreatitis.  
Endoscopic ultrasound is also being used for the diagnosis of mild chronic pancreatitis that 
is not associated with ductal dilatation, calcification or cysts. Various EUS criteria have been 
developed to reflect changes in pancreatic parenchyma that may be more sensitive than 
ductal changes at ERCP (Gleeson and Topazian, 2007). For pancreatic neoplasms, EUS 
provides high-resolution images of the pancreas that can detect lesions as small as 2-3 mm 
in diameter. Similar results have been obtained for bile duct cancer although the quality of 
images for distal tumors is superior to that for proximal tumors.  
2.6 Tissue sampling 
Although radiologic appearances are highly associated with various cancers, some surgeons 
and most oncologists are reluctant to embark on major therapies without histologic 
confirmation. As noted above, a minority of tumors can be identified at duodenal 
endoscopy and confirmed by duodenal biopsy. For the majority, options include 
percutaneous fine-needle aspiration with cytology and the histologic or cytologic evaluation 
of tissue taken at endoscopy. One endoscopic option is the cytologic evaluation of fluid 
aspirated from the main pancreatic duct or bile duct (Tanaka and Kida, 2009). In general, 
results from these studies have been disappointing. A variation is that of brushing cytology 
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of these strictures. This has been helpful in some studies but results in bile duct cancer have 
been disappointing, perhaps because many cancers are sclerotic with only a minority of 
malignant cells (Tanaka and Kida, 2009). Another endoscopic approach is to take biopsies of 
the stricture using routine or modified biopsy forceps. This can be technically demanding 
but, when biopsies are obtained, confirmation of cancer has been reported in approximately 








Thick wall cystic NET
 
Fig. 3. EUS images demonstrating the presence of (a) a CBD stone, (b) a possible mass in a 
patient with pancreatic parenchymal changes consistent with chronic pancreatitis, (c) a 
cystic neuroendocrine tumor (NET), (d) a locally advanced pancreatic cancer invading the 
portal vein and (e & f) biopsy of a pancreatic lesion using EUS with fine-needle aspiration.  
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Currently, the procedure with the highest sensitivity for cancer is cytologic evaluation of 
fine-needle aspirates taken during endoscopic ultrasound (Figure 3f). In one randomized 
study in patients with suspected pancreatic cancer, rates for the detection of cancer in fine-
needle aspirates were higher for specimens taken by endoscopic ultrasound (84%) than for 
specimens taken percutaneously under ultrasound or CT control (62%) (Horwhat et al., 
2006). Similar results have been obtained for confirmation of bile duct cancer although the 
yield was significantly higher in distal cancer (81%) than in proximal cancer (59%) 
(Mohamadnejad et al., 2011).  
2.7 Diagnostic cholangiopancreatoscopy 
Although the first cholangioscope was developed over three decades ago, use of this 
technology was limited because of cost, endoscope fragility and the need for two 
experienced endoscopists to operate the “mother” and “daughter” scopes. However, interest 
in this technology has been reawakened by recent developments that include single-
operator cholangiopancreatoscopy with facilities for forcep biopsy, the development of 
video endoscopes for cholangiopancreatoscopy and the development of balloon-facilitated 





Fig. 4. Video (a & b)  and  SpyGlass (c & d) cholangiopancreatoscopy  images showing (a) an 
early superficial papillary bile duct lesion, (b) the typical fish-egg like lesions of intraductal 
papillary mucinous neoplasia carpeting the bile duct, (c) an obstructing polypoid 
cholangiocarcinoma of the right hepatic duct and (d) occult malignancy in a patient with 
primary sclerosing cholangitis.  
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The aim of cholangiopancreatoscopy is the direct visualization of ductal strictures, 
particularly in the bile duct. The appearance of these strictures often facilitates the 
differentiation of benign from malignant disorders (Figure 4). Video ductal endoscopes 
provide images of high quality but, at present, do not permit endoscopic biopsy. In contrast, 
the SpyGlass system incorporates a fiberoptic probe with somewhat inferior images but, 
importantly, provides access for endoscopic biopsy. Histological confirmation of cancer can 
be achieved in 70-80% of patients (Nguyen et al., 2009).  
3. Endoscopic interventions 
3.1 Sphincterotomy and stone extraction 
The contemporary technique of endoscopic sphincterotomy is remarkably similar to that 
described by Classen and Demling in 1974. The principles include selective cannulation of 
the bile duct with the papillotome, retraction of a diathermy wire to create a bow and 
passage of a current across the diathermy wire to make an endoscopic incision. This 
increases the diameter of the bile duct orifice from a pinhole to 2-5 mm. Prior to 1975, bile 
duct stones were initially left to pass spontaneously into the duodenum. However, within 2 
years, stone extraction techniques had been described including the use of wire (Dormia) 
baskets and catheters with peripheral balloons (Figure 5, a-c).  
 
 
Fig. 5. Endoscopic features relevant to therapeutic endoscopy. (a)  Impacted pigmented 
calculus in the orifice of the ampulla. (b)  Bulbous papilla caused by an impacted calculus. 
(c)  Extraction of a calculus after endoscopic sphincterotomy. (d)  Metallic stent projecting 
into the duodenum in a patient with pancreatic cancer.  
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specimens taken percutaneously under ultrasound or CT control (62%) (Horwhat et al., 
2006). Similar results have been obtained for confirmation of bile duct cancer although the 
yield was significantly higher in distal cancer (81%) than in proximal cancer (59%) 
(Mohamadnejad et al., 2011).  
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Although the first cholangioscope was developed over three decades ago, use of this 
technology was limited because of cost, endoscope fragility and the need for two 
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in this technology has been reawakened by recent developments that include single-
operator cholangiopancreatoscopy with facilities for forcep biopsy, the development of 
video endoscopes for cholangiopancreatoscopy and the development of balloon-facilitated 





Fig. 4. Video (a & b)  and  SpyGlass (c & d) cholangiopancreatoscopy  images showing (a) an 
early superficial papillary bile duct lesion, (b) the typical fish-egg like lesions of intraductal 
papillary mucinous neoplasia carpeting the bile duct, (c) an obstructing polypoid 
cholangiocarcinoma of the right hepatic duct and (d) occult malignancy in a patient with 
primary sclerosing cholangitis.  
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The aim of cholangiopancreatoscopy is the direct visualization of ductal strictures, 
particularly in the bile duct. The appearance of these strictures often facilitates the 
differentiation of benign from malignant disorders (Figure 4). Video ductal endoscopes 
provide images of high quality but, at present, do not permit endoscopic biopsy. In contrast, 
the SpyGlass system incorporates a fiberoptic probe with somewhat inferior images but, 
importantly, provides access for endoscopic biopsy. Histological confirmation of cancer can 
be achieved in 70-80% of patients (Nguyen et al., 2009).  
3. Endoscopic interventions 
3.1 Sphincterotomy and stone extraction 
The contemporary technique of endoscopic sphincterotomy is remarkably similar to that 
described by Classen and Demling in 1974. The principles include selective cannulation of 
the bile duct with the papillotome, retraction of a diathermy wire to create a bow and 
passage of a current across the diathermy wire to make an endoscopic incision. This 
increases the diameter of the bile duct orifice from a pinhole to 2-5 mm. Prior to 1975, bile 
duct stones were initially left to pass spontaneously into the duodenum. However, within 2 
years, stone extraction techniques had been described including the use of wire (Dormia) 
baskets and catheters with peripheral balloons (Figure 5, a-c).  
 
 
Fig. 5. Endoscopic features relevant to therapeutic endoscopy. (a)  Impacted pigmented 
calculus in the orifice of the ampulla. (b)  Bulbous papilla caused by an impacted calculus. 
(c)  Extraction of a calculus after endoscopic sphincterotomy. (d)  Metallic stent projecting 
into the duodenum in a patient with pancreatic cancer.  
 
Therapeutic Gastrointestinal Endoscopy 
 
86
The above techniques have been remarkably successful when performed by experienced 
endoscopists. For example, most endoscopists now claim rates for successful extraction of 
stones of between 90 and 95% (Safrany, 1978; Roberts-Thomson, 1984). However, difficulties 
may arise with large stones, impacted stones, ampullary orifices located within duodenal 
diverticula and bile duct stones in patients who have previously been treated with a Billroth 
II gastrectomy. The management of large stones often includes fragmentation using 
reinforced crushing baskets. If endoscopic extraction of stones fails during the first attempt, 
one option is placement of a plastic stent around the stone (to minimize the risk of 
cholangitis) and a second attempt at stone extraction after 2-4 weeks. Another option is 
direct cholangioscopy with visualization of the stone and fragmentation with intraductal 
shockwave (electrohydraulic or laser) lithotripsy. In patients who have previously had a 
Billroth II gastrectomy, difficulties may arise with negotiation of the afferent loop, selective 
cannulation of the bile duct and appropriate orientation of the papillotome.  
The complications of endoscopic sphincterotomy have been widely discussed and include 
pancreatitis (5%), significant bleeding from the margins of the incision (2%) and duodenal 
perforation (<1%). Mortality rates within 30 days are approximately 0.2% but only a 
minority of deaths are directly related to the procedure (Freeman et al., 1996; Cooper and 
Slivka, 2007).  
3.2 Endoscopic stents 
Options for patients with malignant strictures of the bile duct include radical surgery with 
the potential for cure, palliative surgery with a biliary bypass procedure and the endoscopic 
placement of a biliary stent. In patients scheduled for curative surgery, stents are sometimes 
used to relieve jaundice prior to the operation although this appears to be unnecessary in 
patients with a serum bilirubin of <250 mol/l (van der Gaag et al., 2009). In patients who 
require palliative procedures, the choice of stent versus biliary bypass is often determined 
by factors such as age and perceived operative risk. For example, older patients with more 
complex medical problems are more likely to be treated with stents while younger patients 
with fewer operative risks are more likely to be treated by biliary bypass. An additional 
issue is the presence of malignant infiltration of the duodenum that may result in duodenal 
obstruction. In this setting, options include biliary and duodenal stents or a biliary bypass 
procedure with a gastroenterostomy.  
The first endoscopic stents were composed of plastic and were 7F-8F in diameter. 
Subsequently, endoscopes with larger working-channels were introduced that permitted the 
insertion of larger stents (10F). Most patients treated with conventional 10F stents show 
improvement or resolution of jaundice but stents become obstructed by biofilms after 2-5 
months. Attempts to prolong stent patency have included use of different plastic materials, 
changes in stent design and longer-term treatment with drugs such as antibiotics and 
ursodeoxycholic acid. These measures have been largely ineffective in clinical trials. Because 
of this, stents are usually changed electively at intervals of about 3 months in those patients 
who require stenting for prolonged periods.  
Self-expanding metal stents (Figure 5d) are now widely used for palliation in patients with 
malignant obstructive jaundice (Chun et al., 2010). These stents expand to a diameter of 
approximately 30F (10 mm) and usually remain patent for 6-9 months. However, metal 
stents can still obstruct because of biofilms, the accumulation of biliary debris, tumor 
growth through the wire mesh or tumor growth above the stent. Additional issues are the 
higher cost of metallic stents and an inability to remove the stent if there are complications 
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such as obstruction or cholangitis. However, these complications can usually be managed by 
insertion of a second metal stent or by the insertion of a plastic stent within the metal stent. 
Another approach that may delay tumor ingrowth is use of a “covered” metal stent 
although a potential problem is greater formation of biofilms. One practical approach is to 
use plastic stents in patients whose survival seems likely to be short and metal stents in 
patients with a predicted survival of more than 3-6 months.  
3.3 EUS assisted therapeutic endoscopy 
Access to the biliary system at ERCP can fail in 1-5% of patients. Reasons include large 
duodenal diverticula and a sphincter of Oddi that is either thickened or deformed. In this 
setting, one option is percutaneous cholangiography with passage of a guidewire into the 
duodenum. Another option is to use EUS to direct a 19F needle into the bile duct and then 
pass a guidewire into the duodenum. EUS with passage of a guidewire into the duodenum 
has also been used to facilitate cannulation of an obstructed main pancreatic duct. Success 
rates with these techniques are higher if ducts are dilated (Kim et al., 2010).  
3.4 Cholangioscopy assisted therapeutic endoscopy 
If difficulty is encountered with passage of a guidewire through a tight biliary stricture, it 
may be helpful to perform cholangioscopy with passage of a guidewire under direct vision. 
There are also reports of the use of cholangioscopes for the ablation of biliary tumors using 
either lasers or argon plasma coagulation (Nguyen et al., 2009).  
3.5 Endoscopic ampullectomy  
Neoplasms of the ampulla of Vater have traditionally been managed by laparotomy with 
local or more radical resections (Whipple’s procedure). However, at least some neoplasms 
are now being managed by endoscopic resection, usually after staging by EUS. The 
technique of ampullectomy is similar to that for removal of larger polyps and includes 
elevation of the base with saline (with or without adrenaline) and resection using a 
polypectomy snare (Figure 6). In expert hands, successful eradication of adenomas has been 
reported in up to 85% of patients (Nguyen and Binmoeller, 2010). However, it may be 
inappropriate to attempt endoscopic resection for adenomas >4-5 cm in diameter because of 
higher risks for complications and higher rates of incomplete resection. 
3.6 Endoscopic therapy for pancreatic pseudocysts, pancreatic necrosis and 
pancreatic ascites 
Pancreatic pseudocysts can complicate both acute and chronic pancreatitis. The majority 
of pseudocysts are asymptomatic and resolve spontaneously. A drainage procedure is 
only indicated for pseudocysts that are symptomatic, infected, rapidly enlarging or 
causing obstruction of the gastrointestinal tract or neighbouring structures such as the 
biliary tract. An additional indication is the presence of cysts >10 cm in diameter because 
of the risk of spontaneous rupture or hemorrhage. Options for the drainage of 
pseudocysts include open or laparoscopic surgery, percutaneous drainage under US or 
CT guidance and endoscopic drainage with help from EUS. Unfortunately, these 
approaches have not been compared in randomized trials. Because of this, the choice of 
procedure is often determined by the availability of EUS and local expertise (Nguyen and 
Binmoeller, 2009). Percutaneous or endoscopic drainage is usually contraindicated for 
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cysts that are multi-loculated or for cysts with solid components or other features 
suspicious of neoplasia.  
 
 
Fig. 6. En bloc endoscopic ampullectomy showing (a) an ampullary adenoma, (b & c) snaring 
of the adenoma in its entirety, (d) appearance of the area after resection.  
Endoscopic approaches have also been used for the drainage of pancreatic fluid collections. 
These may develop because of severe pancreatitis or because of the development of 
pancreatic ascites. The latter is usually due to spontaneous rupture of a pseudocyst but, in a 
minority of cases, duct disruption can occur because of pancreatic necrosis. The endoscopic 
management of these patients needs to be individualized but may involve transpapillary 
drainage, transmural drainage or combined approaches. In this heterogeneous group, 
successful outcomes can be achieved in approximately 80% of patients although there are 
several potential complications including bleeding, perforation, infection and stent 
migration (Mergener and Kozarek, 2003).  
3.7 Endoscopic therapy for chronic pancreatitis 
Some patients with chronic pancreatitis have chronic pain or frequent episodes of pain that 
result in recurrent admissions to hospital or the use of escalating doses of narcotic 
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analgesics. In this setting, management options include pancreatic surgery, endoscopic 
therapy and various measures for pain including a celiac plexus nerve block. At least one 
mechanism for pain is a degree of obstruction of the main pancreatic duct with elevated 
intraductal pressures. Because of this, some surgical and endoscopic approaches have 
endeavoured to relieve duct obstruction by removing stones or dilating or bypassing duct 
strictures. In calcific chronic pancreatitis, endoscopic removal of stones is difficult and many 
patients are treated by extracorporeal shockwave lithotripsy prior to endoscopic therapy. 
The latter usually involves biliary and pancreatic sphincterotomy, dilatation of strictures 
and extraction of stones in the main pancreatic duct. Responses to endoscopic therapy have 
been variable but most studies report improvement in pain in 30-70% of patients. Although 
these endoscopic results may be inferior to results from pancreatic surgery (Díte et al., 2003; 
Cahen et al., 2007), endoscopic therapy can be repeated with a relatively low risk for 
complications.  
4. Future developments 
Preliminary studies are evaluating the possibility of endoscopic therapy for solid and 
cystic neoplasms of the pancreas. One promising approach is EUS-guided ethanol lavage 
(with or without paclitaxel injections) for the treatment of cystic tumors of the pancreas 
(DeWitt et al., 2011; Oh et al., 2011). This appears to result in resolution of cysts in up to 
70-80% of patients. Innovative approaches have also been taken for the treatment of 
locally advanced pancreatic cancer. These include EUS-guided injections of 
chemotherapeutic drugs and various immunomodulatory preparations including 
allogenic mixed lymphocyte cultures (Cytoimplants), adenovirus vectors carrying the 
tumor necrosis factor-alpha gene and attenuated adenoviruses that preferentially replicate 
in malignant cells. There are also on-going studies to evaluate local ablative therapies for 
cancer including therapies guided by EUS and therapies applied during direct 
visualization of ducts. Some of these therapies include radiofrequency ablation, 
photodynamic therapy and brachytherapy.  
Other developments are likely to include endoscopes with multimodal features and 
endoscopic platforms that permit even more precise localization of lesions by combining 
information from radiological procedures in addition to EUS (Roberts-Thomson et al., 2010). 
It would also be helpful to have better endoscopic therapy for calcific chronic pancreatitis. 
One option is fragmentation of stones under direct vision using electrohydraulic lithotripsy 
or various lasers including the yttrium-aluminium-garnet (YAG) laser. There is also a need 
for more sensitive techniques for the diagnosis of biliary and pancreatic neoplasms that 
might include larger tissue samples or the identification of novel proteins or novel gene 
mutations.  
5. Conclusion 
The biliary tract and pancreas have now been explored with flexible endoscopes for 40 
years. The era of diagnostic procedures using an injection of radiological contrast and 
fluoroscopy was soon followed by the therapeutic procedure of endoscopic 
sphincterotomy for bile duct stones. Subsequent developments included plastic and 
metallic stents for biliary obstruction and endoscopic therapy for chronic pancreatitis and 
pancreatic pseudocysts. More recently, direct visualization of biliary and pancreatic ducts 
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has become possible using ultrathin endoscopes passed down the channel of conventional 
endoscopes. A complementary procedure is that of endoscopic ultrasound that facilitates 
biliary and pancreatic diagnoses, particularly when combined with fine-needle aspiration 
and tissue cytology. Future developments are likely to include various endoscopic 
therapies for cancer and the wider use of endoscopic procedures for complications of 
pancreatitis .  
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1. Introduction 
Biliary reconstruction has been described 35 years ago by Sir Roy Calne as the technical 
‘Achilles heel’ of orthotopic liver transplantation (OLT). The name “Achilles' heel” comes 
from Greek mythology, which is a metaphor of a single vulnerable spot. This is because the 
potential detrimental effects of biliary complications on graft and patient survival. Biliary 
complications, which “plagued” the early experience of liver transplantation occurring in 
nearly one of every three transplant recipients (Moser & Wall, 2001), have been reduced 
dramatically due to  the improvements in organ selection, retrieval, preservation, and 
implantation techniques. However, biliary complications still remain a common source of 
morbidity and mortality (Greif et al., 1994). Additionally, they significantly affect the 
recipients’ quality of life because they entail frequent readmissions, repeated imaging, 
invasive procedures, and even reoperation. All of them added to the financial and emotional 
toll suffer the patients (Sharma et al., 2008). Biliary leaks and strictures, either anastomotic or 
non-anastomotic, are the most frequent complications. Cystic duct obstruction due to 
mucocele, stones, sludge or casts, hemobilia and sphincter of Oddi dysfunction have also 
been recorded (Colonna et al., 1992; Greif et al., 1994). The surgical management used to be 
the standard of care for these conditions in earlier practice. However, the revolutionary 
progress in minimally invasive armamentarium, namely endoscopy and percutaneous 
radiologic interventional modalities, made it the current alternative first line of management 
displacing surgical intervention to be a second backup option (Sharma et al., 2008; Williams 
& Draganov, 2009). A living donor liver transplantation (LDLT) was first reported in 1988 
by Raia in Brazil, followed by Nagasue in Japan in 1989. After the leading successful 
experience of right lobe living related liver transplantation (RL-LDLT) that has been 
reported by Hong Kong team in 1996, it rapidly evolved as a well-established practice in 
Asian countries. World wide organ shortage and promising results were alluring to other 
centers to consider (RL-LDLT) as a practical option. In this review we will shed more light 
on biliary complications related to right lobe living donor liver transplantation and their 
endoscopic management. 
1.1 Incidence of biliary complications 
Apparently, patients who were transplanted more recently are at increased risk of biliary 
complications. This could be explained by the awareness of this major problem, evolution of 
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both invasive and non invasive diagnostic modalities, and more importantly, the marked 
increase in graft survival in the last decade since biliary problems such as strictures need 
some time to develop and become evident (Verdonk et al., 2006). The incidence of biliary 
complications is greatest in the first few months after transplantation. The frequency 
becomes very low after the first post transplantation year; however, occasionally appear 
after several years (Moser & Wall, 2001). The reported incidence of such complications 
differs considerably among centers which can be attributed to the wide variety of research 
methodologies as well as the different surgical techniques adopted. In a review article which 
included six studies over several years from various countries, the overall biliary 
complication rate in deceased donor liver transplantation (DDLT) averaged 17.3% (range, 
9%–30%) with 6.8% (range, 0.3%–17%) bile leaks and 7.5% (range, 3%–13%) strictures 
(Dualilibi et al., 2010). While, overall biliary complication incidence in living donor liver 
transplantation (LDLT) was found to be 28.7% (range, 16.1%–33.3%) with 17.1% (range, 
9.3%–23%) bile leaks and 15.2% (range, 9.3%–27%) strictures. These results were higher 
compared to those in other reviews. For instance, in a review article (Pascher & Neuhaus, 
2005), 18.3% (8%–26.6%) was the reported incidence of biliary complications after right 
hepatic lobe grafting with 10.5% (range, 0%–26.6%) leakages and 9.1% (range, 3.3%–20%) 
strictures. Finally our results in right lobe LDLT show that rate of leakage and stricture were 
14.4% and 18.9%, respectively (Lee et al., 2008). From the above figures, overall rate of 
biliary complications was lower in DDLT compared with LDLT; however, variables were 
poorly linked. Perhaps standardization of methodologies and large scale research could 
help us to discover correlations between complications and modalities of transplantation. 
Taken together, higher rates of biliary complications may suggest that the inherently 
sensitive nature of the biliary epithelium is more vulnerable to ischemic damage in 
comparison with hepatocytes and vascular endothelium (Sharma et al., 2008). 
1.2 Etiology and classification of biliary complications after liver transplantation 
The etiology of biliary complications is multifactorial. Risk factors implicated include elderly 
donor (Shah et al., 2007), gender mismatch with a female donor/male recipient (Verdonk et al., 
2006), female recipient, age of recipient, severity of original disease, variations in the biliary 
tract anatomy, number and size of reconstructed bile dust(s), techniques in graft procurement 
and diseased liver removal, ischemic damage to bile duct (hepatic artery complication, warm 
and cold ischemia time, bile duct blood supply), method of biliary reconstruction (type, suture 
methods, suture material, stent, or T-tube use), immunological issues (ABO incompatibility, 
preformed antibody), infection (biliary sepsis, cytomegalovirus) (Todo et al., 2005). Moreover, 
Bile leakage after transplantation has been considered as a significant risk factor for the 
development of strictures (Lee et al., 2008; Shah et al., 2007; Verdonk et al., 2006). Other 
uncommon etiological factors that may present with biliary obstruction are post-
transplantation lymphoproliferative disease and recurrent or de novo cancer (Wojcicki et al., 
2008). In a review article published in 2005 (Todo et al., 2005), authors broadly classified the 
factors that must be considered while contemplating biliary complications, namely, biliary 
strictures after LDLT into two categories: anatomical and technical. 
2. Anatomical factors 
2.1 Bile duct anatomy 
Clear understanding of biliary anatomy is crucial in living donor liver transplantation to 
ensure donor safety and to minimize complications in recipients. According to Couinaud’s 
 
Endoscopic Management of Biliary Complications After Liver Transplantation 
 
95 
classification, patterns of the hepatic duct confluence fall into six groups: (A) typical 
anatomy (57%), (B) triple confluence (12%),  (C) ectopic drainage of a right duct (anterior or 
posterior) into the common hepatic duct (20%), (D) ectopic drainage of a right duct (anterior 
or posterior) into the left hepatic duct (6%), (E) absence of the hepatic duct confluence (3%), 
and (F) absence of the right hepatic duct and ectopic drainage of the right posterior duct into 
the cystic duct (2%). These findings are comparable to those observed during hepatic 
resection and LDLT donor surgeries. Thanks to recent imaging modalities, particularly 
multiphase three-dimensional studies, that allowed us to identify invaluable preoperative 
information on the graft volume and the vascular structures. However, imaging studies of 
the biliary tree are still significantly less reliable. Therefore, it has been suggested to perform 
intraoperative cholangiography at every donor hepatpectomy in LDLT to confirm bile duct 
anatomy and the point of bile duct transection (Todo et al., 2005). 
2.2 Blood supply of bile duct 
Bile duct receives 60% its blood supply from axial branches arising from the posterior 
superior pancreaticoduodenal artery and the gastro-duodenal artery at 3 O’clock and 9 
O’clock positions; while right and left hepatic arteries provides 38% of blood supply via a 
fine arterial plexus at the inferior aspect of the hilar plate nourishing the confluence and 
bilateral hepatic ducts. The remaining 2% of blood supply comes from the proper hepatic 
artery via transversal branches. Therefore, injury of the hilar plexus during donor or 
recipient hepatectomy may lead to leakage, stricture, or even necrosis due to bile duct 
ischemia (Todo et al., 2005). 
3. Technical considerations 
3.1 Donor hepatectomy (Graft harvesting) 
Standard techniques and refinements in graft preparation have been described thoroughly 
in literature. Technical safeguards have been stressed upon based on biliary and arterial 
anatomical considerations including intraoperative cholangiography which has been 
advocated for safer intrahepatic bile duct division, leaving at least 2 mm stump from the 
confluence to secure safe closure, avoidance of dissection between hepatic duct and the 
hepatic artery beyond level of  transection to maintain uninterrupted  blood supply to bile 
ducts, avoidance of  ischemic damage to the graft bile duct by excessive use of diathermy, 
and using fine suture ligation alternatively to control minor bleeding (Todo et al., 2005). 
3.2 Recipient hepatectomy (Liver explantation) 
By the same token, we should bear in mind biliary and arterial anatomical considerations in 
recipient hepatectomy. Preservation of uninterrupted blood supply to the biliary tract as 
high as possible in the hilum and leaving enough length for a tension-free biliary 
anastomosis are paramount. This has been fulfilled by a high hilar dissection method or 
intrahepatic Glissonian approach that proposed by Lee et al. and they showed good results 
in their series of adult duct to duct liver transplantation patients (Todo et al., 2005). 
3.3 Graft implantation (Biliary reconstruction) 
3.3.1 Type of biliary anastomosis 
Early practice of utilizing gallbladder as a pedicle graft biliary conduit had been abandoned 
due to associated bile stasis with stone formation, frequent episodes of cholangitis and 
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inferior outcomes. Roux-en-Y hepaticojejunostomy was the standard biliary reconstruction 
in living-donor liver transplantation and split liver transplantation. The growing evidence 
and experience in transplantation urged the surgeons to restore bilioenteric continuity 
through a duct-to-duct anastomosis which becomes the preferred choice of biliary 
reconstruction whenever possible and this for the following reasons: (i) technically faster, 
less number of anstomoses, (ii) preserved function of sphincter of Oddi as a defense against 
enteric reflux and ascending cholangitis, (iii) no need for intestinal manipulation, thus 
preventing possible intraoperative contamination and earlier oral feeding, (iv) the 
physiological bilio-enteric continuity enabling endoscopic access after right lobe-LDLT and 
(v) more treatment options for biliary complications including percutaneous approach, 
endoscopic approach, surgical revision, and surgical conversion to Roux-en-Y bilioenteric 
anastomosis (Yazumi & Chiba, 2005). Duct-to-duct anastomosis has been increasingly 
reported in right lobe living-donor transplants (Shah et al., 2007), in right lobe split 
transplants and also has been shown to be feasible in left lobe living-donor liver transplants. 
In earlier experience of living donor liver transplantation, duct-to-duct anastomosis has 
been only performed in presence of single biliary anastomosis. The use of the recipient right 
and left hepatic ducts as well as the cystic duct has been successfully utilized in later 
practice (Gondolesi et al., 2004). Having said that, Roux-en-Y reconstruction is still 
indispensable in pediatric LDLT, patients with bile duct diseases or prior biliary surgery, 
retransplantation (Todo et al., 2005), left lateral segment split liver grafts, left lateral segment 
and left lobe living donor grafts  in presence of separate segmental II and III ducts, segment 
IV duct draining into the confluence, and the presence of multiple small bile ducts in grafts 
harvested with caudate lobe; and still an option in right lobe graft with multiple small bile 
ducts (Cuinaud’s classification, types C-F). It is worth to mention that both duct-to-duct 
anastomosis and jujenal loop could be used in the same patient having a graft with multiple 
small ducts (Wojcicki et al., 2008). In an article published in 2005 (Yazumi & Chiba, 2005), 
the incidence of biliary complications has  been reviewed and it had been shown the 
incidence of anatomotic leakage in right lobe  living donor liver transplantation (RL-LDLT) 
with  Roux-en-Y hepatico-jujonostomy (RYHJ) was higher than that with duct-to-duct 
anastomosis (12.4%– 18.2% and 4.7%–7.3%, respectively), while on the other side, the 
incidence of anastomotic stricture in RL-LDLT with RYHJ was found to be less than that 
with duct-to-duct anastomosis (8.3%–16.3%  and 24.3%–31.7% , respectively) (Yazumi & 
Chiba, 2005). Although the superiority of either hepaticojejunostomy or duct-to-duct for 
biliary reconstruction in adult LDTT was debatable issue, it has been concluded that 
surgeons should follow the principle of tension-free, viable anastomosis, and be accustomed 
to both procedures at the forum of European Association for the Study of the Liver in 2005 
annual meeting (Todo et al., 2005).  
3.3.2 Stent or no stent 
There is an ongoing hot debate regarding the use of a T tube for duct-to-duct anastomosis. 
Traditionally, proponents of using biliary stents argue that T tube aids to access biliary tree, 
monitor the quality and quantity of bile output, decrease the incidence of late anastomotic 
strictures, and lower the pressure in the biliary system which may be elevated as a result of 
anastomotic stricture or to sphincter of Oddi dysfunction (Rabkin et al., 1998). On the other 
hand, biliary drains were considered by opponents to increase complication rates as shown 
by frequent reports of biliary leak following bile drain removal, dislodgement, cholangitis 
and/or biliary obstruction (Greif et al., 1994; Scatton et al., 2001). The incidence of biliary 
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drain related complications was found to range between 10 and 22% (Wojcicki et al., 2008), 
with bile leak after bile drain removal occurring in 5–15% of patients (Scatton et al., 2001; 
Vougas et al., 1996). The use of T tube in deceased-donor liver transplantation has been 
widely abandoned. This practice has been adopted after two prospective randomized trials 
(Scatton et al., 2001) showing that not using T tubes seems to be safe, efficacious, and cost-
effective. Some have suggested that using 6 F double J ureteric as internal stents 
theoretically could eliminate possible complications associated with T tubes and offers the 
potential benefits of a splint. Yet, this has not shown uniformly reproducible results (Sharma 
et al., 2008). Stenting or no stenting of biliary reconstruction in living donor liver 
transplantation is still a debate that is far from being settled (Wojcicki et al., 2008). 
3.3.3 Suturing technique and suture material 
Using continuous or interrupted sutures, conventional or microscopic biliary reconstruction, 
absorbable or non absorbable sutures material in biliary anastomsis, is also a technical issue 
that has not been standardized. However, some authors recently advocated the use of 
microsurgical technique and synthetic non-absorbable sutures (Lin et al., 2009) for their 
feasibility, easier handling, supposedly less induction of the tissue reaction (Sharma et al., 
2008) and theoretical durability in the early postoperative period especially with steroid 
based immunosuppressive regimen. 
3.3.4 Implantation (vascular reconstruction) 
Ischemic biliary problems are among the most troublesome complications both in early and 
late post transplantation periods. Two main broad categories are identified: hepatic artery 
thrombosis (HAT) and ischemic type biliary lesions (ITBL). 
3.3.4.1 Hepatic artery thrombosis (HAT) or macroangiopathy 
Hepatic artery thrombosis is generally divided into two categories: early and late hepatic 
artery thrombosis (eHAT and late HAT). Reports on eHAT are heterogeneous due to a lack 
of a commonly accepted definition. A systematic review by Bekker et al. from Netherlands 
that included all published work from 1990 to 2007 has provided us with valuable 
definitions. Early HAT is defined as a thromboembolic occlusion of the hepatic artery that 
occurrs within 2 months after liver transplantation (Bekker et al., 2009). The incidence of 
eHAT was found to be significantly higher in children (8.3%) than in adults (2.9%). eHAT 
presents with liver failure, hepatic necrosis, or bile duct necrosis in up to 58%of affected 
patients (Tzakis et al., 1985). Uncontrollable sepsis in the immunocompromised recipients 
and ultimately death are common scenarios after eHAT. Collaterals probably prevent 
similar ominous outcome in case of late HAT. Cholangiographic findings are characterized 
by confluent intraductal filling defects within irregular dilated or strictured bile ducts. These 
findings were reported in more than 80% of patients with hepatic artery thrombosis and 
were frequently associated with intrahepatic bile leak and biloma formation (Tzakis et al., 
1985). In comparison, hepatic artery stenosis has a wide spectrum of presentations. Many 
patients only present with nonspecific elevation in liver enzyme levels, however abnormal 
cholangiograms can be present in up to 67% of patients with hepatic artery stenosis even in 
absence of any evident abnormality by Ultrasonorgraphy (Orons et al., 1995a). Early 
diagnosis is critical to avoid permanent allograft damage. Orons and coworkers found that 
the treatment of hepatic artery stenosis with balloon angioplasty was of limited benefit once 
significant allograft dysfunction had occurred (Orons et al., 1995b). The reported risk factors 
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inferior outcomes. Roux-en-Y hepaticojejunostomy was the standard biliary reconstruction 
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for eHAT are cytomegalovirus mismatch (seropositive donor liver in seronegative 
recipient), retransplantation, arterial conduits, prolonged operation time, low recipient 
weight, variant arterial anatomy, and low volume transplantation centers. However, the 
exact cause of eHAT remains debatable. Incidence of eHAT was found to be higher in low 
volume centers, while no difference in incidence of eHAT was found between studies 
reporting only on living donor liver transplantation versus studies reporting only on 
deceased donor liver transplantation; also no difference in incidence of eHAT in the living 
donor liver transplantation (LDLT) subgroup was found in centers using the operation 
microscope for the arterial anastomosis versus centers using loupe magnification. It has 
been found that revascularization attempt was performed in approximately half of the cases 
with a reported success rate of about 50%, therefore, early detection and urgent 
revascularization are paramount especially in centers that lack a back up system for urgent 
retransplanation (Bekker et al., 2009). 
3.3.4.2 Ischemic type biliary lesions (ITBL) or microangiopathy 
The incidence of ITLB varies between 5% and 15%. The exact pathophysiological mechanism 
of ITBL is still unclear, however, several risk factors have been identified and strongly 
suggested a multifactorial origin. Ischemia-reperfusion and preservation injury related 
variables are well-described risk factors for non-anastomotic strictures including prolonged 
cold ischemia time (>12 hours) or warm ischemia time (>60 minutes) and variables related 
to the efficacy of preservation of the peribiliary plexus, such as viscosity and perfusion 
pressure of the preservation fluid (Guichelaar et al., 2003; Verdonk et al., 2007). Generally 
speaking, as suggested by Buis et al., risk factors for ITBL can be divided into three 
categories: ischemia-related injury to the biliary epithelium, immunologically mediated 
injury, and cytotoxic injury induced by bile salts (Buis et al., 2006).  
3.3.4.2.1 Cold ischemic and reperfusion injury 
It has been shown by many studies that prolonged cold ischemia time (CIT) predisposes to 
ITBL. In an experimental study using cell cultures, it has been shown that biliary epithelial 
cells are more susceptible to reperfusion/re-oxygenation injury than hepatocytes. Moreover, 
clinical evidence was provided in a clinical study as reflected by postoperative peaks in 
serum aspartate aminotransferase and alanine aminotransferase (Buis et al., 2006). 
3.3.4.2.2 Preservation injury 
Preservation injury was found to increase the arterial resistance, leading to circulatory 
disturbances in the small capillaries of the biliary plexus (Buis et al., 2006).  
3.3.4.2.3 Warm ischemic injury 
Bile ducts, that are solely dependent on arterial blood supply for their nourishment, are 
exposed to warm ischemia during initial reperfusion via the portal vein alone. However, 
favorable effect of simultaneous arterial and portal reperfusion on the incidence of ITBL 
could not be clearly demonstrated. Moreover, the higher incidence of non-anastomotic 
strictures in liver transplantation from donors after cardiac death also strongly suggests an 
ischemia-related factor in its pathogenesis. Several studies have provided evidence for an 
immunological injury in the pathogenesis of ITBL such as ABO-incompatible liver 
transplantation and pre-existing diseases with a presumed autoimmune component, such as 
primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), cytomegalovirus (CMV) 
infection, chronic rejection, and genetic polymorphism of chemokines (Buis et al., 2006). 
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4. Biliary complications in recipient 
4.1 Biliary leak 
Bile leaks are the second most common biliary tract complication in many series (Greif et al., 
1994; Rerknimitr et al., 2002a). As we mentioned before, the incidence of anastomotic biliary 
leakage in right lobe live donor living transplants with bilioenteric anastomosis and that 
with duct-to-duct reconstruction were 12.4%–18.2% and 4.7%–7.3%, respectively. 
Remarkably, refractory biliary leakage was found to be associated with significant mortality 
in bilioenteric reconstruction patients and 12%–19.1% of the patients died from sepsis 
(Yazumi & Chiba, 2005). However, the incidence of early bile leak appears to be equal in 
patients with duct-to-duct anastomosis with or without a T-tube (Rabkin et al., 1998; Scatton 
et al., 2001). Generally, bile leakage could be divided into anastomotic and non-anastomotic 
in site. Non-anastomotic leaks could occur from the T tube exit site or tract, cystic duct 
stump, duct of Lushka or damaged accessory bile ducts or from the cut surface of the graft 
in LDLT (Greif et al., 1994; Rabkin et al., 1998; Thuluvath et al., 2005; Wojcicki et al., 2008). 
The diagonosis of bile leak was primarily evidenced by extravasation of contrast medium in 
retrograde endoscopic cholangiogram or bile-stained fluid in percutaneous drainage. Leaks 
could be categorized as early and late postoperative leaks (Thuluvath et al., 2005). As a 
general rule, the majority of bile leaks occurs early in the postoperative period and 
mandates intervention to avoid sepsis (Greif et al., 1994). However, bile leakage could be 
successfully managed either by endoscopic therapy as a first option, percutaneous 
transhepatic cholangiography-guided drainage, or surgical reconstruction. Bile leakage 
remains as a risk factor for subsequent development of anastomotic stricture. Endoscopic 
management seems to be the treatment of choice in biliary leakage as it offers excellent 
diagnostic and therapeutic results. It can treat over 90% of biliary tract leaks with minimal 
morbidity (Greif et al., 1994; Ostroff et al., 1990; Pfau et al., 2000; Thuluvath et al., 2005). By 
the same notion followed in management of biliary complications, percutaneous 
transhepatic approach or surgery should be reserved for patients in whom the endoscopic 
approach failed (Thuluvath et al., 2005). 
4.1.1 Early postoperative leaks (within 4 weeks) 
Early leaks usually occur from the anastomotic site, and most probably due to technical 
problems and/or local ischemia (Thuluvath et al., 2005; Wojcicki et al., 2008). These risk 
factors may include insufficient arterial supply to the biliary anastomosis, active bleeding 
from cut ends of bile ducts, denuding the bile ducts during harvesting, excessive tension on 
ductal anastomosis or excessive use of diathermy to control bleeding on the bile ducts 
(Thuluvath et al., 2005). Therefore, high index of suspicion should be maintained to exclude 
any hepatic artery thrombosis or any vascular compromise. In one report, cut surface biliary 
leakage developed in 8.3% patients (Gondolesi et al., 2004), and this may be explained by 
increased pressure of the intrahepatic bile duct (Pascher & Neuhaus, 2005). Double or triple 
hepaticojejunostomies were found to be significant risk factor for biliary leakage in patients 
with bilioenteric anastomosis (Kasahara et al., 2006). Welling et al. showed that warm 
ischemia was the only independent risk factor for a leakage, however, direct correlation of 
warm ishchemia to biliary stictures did not reach statistical significance in their study 
(Welling et al., 2008). In presence of T tube, leaks are easily diagnosed with a T tube 
cholangiogram and can be managed conservatively as leaks frequently is resolved on their 
own after a short course of unclamping of the T tube (Thuluvath et al., 2005; Wojcicki et al., 
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2008). In the absence of a T tube, HIDA scanning or MRCP may be needed to diagnose bile 
leaks. However, if there is strong clinical suspicion or evidence like bile in drains, retrograde 
endoscopic stenting of the bile duct is preferable option, since endosocopy is both diagnostic 
and therapeutic and could identify the site of leaks in over 90% of patients (Pfau et al., 2000; 
Thuluvath et al., 2005). When leakage is suspected with a T−tube in situ and conservative 
management failed to control the leak, a 10 Fr biliary stent could be placed and then T tube 
should be removed. Although some reported success in sealing leaks within 6 weeks of 
stenting (Pfau et al., 2000), others recommended to leave the tube in place for approximately 
2-3 months as healing is delayed probably due to immunosuppressive drug treatment and 
this approach is supported by the occurrence of bile leaks through the T tube exit site even 
with 3-4 months of T tube placement (Thuluvath et al., 2005). 
Larger leaks, particularly those associated with bilioenteric anastomosis, tend to be less 
amenable to non-operative treatment. Immediate or early operative revision should be 
strongly considered as intestinal loop of the anastomosis increase the chance of 
intraabdominal abscess formation and sepsis. In case of bilioenteric anastomosis without a 
transanastomotic catheter in place, a bile leak could be diagnosed with ultrasound, 
computed tomography, magnetic resonance imaging, hepatobiliary scintigraphy and in 
selected cases with PTC, which was followed by non-surgical management of infection and 
leakage by systemic antibiotics. Percutaneous transhepatic biliary drainage and/or 
percutaneous transabdominal biloma and abscess drainage must be fully resolved before 
surgical reconstruction because regional sepsis and poor infection control can result in 
recurrent biliary leaks (Thuluvath et al., 2005). Non-surgical conservative treatment involves 
carrying out a PTC with placement of an internal-external drain that can be sequentially 
upsized for a total period of 3-6 months of stenting. However, surgical intervention may be 
required when conservative management fails or as a first line of treatment if there is 
evidence of HAT, or if the duct-to-duct anastomotic defect is too large. Traditionally, the 
duct-to-duct anastomosis is converted to a Roux-en-Y choledochojejunostomy which allows 
wide debridement of necrotic and infected tissue (Thuluvath et al., 2005).  
4.1.2 Late postoperative bile leaks 
Late postoperative bile duct leaks are nearly always related to elective or inadvertent 
removal of the T tube (Thuluvath et al., 2005). The incidence of late bile duct leakage is 7% 
(Scatton et al., 2001) with a mean time to presentation of 118 days after transplantation 
despite prolonged T tube placement (Thuluvath et al., 2005). Scatton et al. reported in their 
large randomized trial that the incidence of biliary fistula in DDLT was found to be 10% in 
the T-tube group and 2.2% in the group without a T tube (Scatton et al., 2001). Although the 
classical clinical picture of persistent abdominal discomfort or pain after T tube removal 
prompts the diagnosis of biliary leakage in most cases, the diagnosis is also suggested in a 
small subset of patients based on fluctuating cyclosporine levels, pneumoperitoneum or 
increased leakage through the T tube tract. Leaks resulting from T tubes are managed 
successfully by endoscopic placement of internal stents with resolution rate near to 100% 
(Pfau et al., 2000). In management of biliary leakage, several endoscopic strategies have also 
been described, such as biliary stents, nasobiliary drainage, sphincterotomy, or combination 
of the techniques. In the two large series, nasobiliary catheters were used successfully to 
treat post-transplant leaks (Ostroff et al., 1990). Other investigators have noted high closure 
rates with decompression by endoscopic sphincterotomy alone. It appears that any 
endoscopic technique significantly reduces or eliminates the pressure gradient between bile 
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duct and duodenum will seal a biliary fistula (Rerknimitr et al., 2002a). Some reported that 
majority of patients could be discharged within 48 hours after endoscopic stenting 
(Thuluvath et al., 2005). Nasobiliary tube has some advantages that it allows 
cholangiographic follow−up every 3-5 days and is easily removed without the need for 
another endoscopic intervention. Sherman et al. reported symptomatic relief of patients 
within 12 hours of nasobiliary stenting, and closure of fistula at a mean of 6.3 days (Sherman 
et al., 1993). However, inconvenience due to nasal tube, prolonged hospital stay, in addition 
to alteration of cyclosporine bioavailability due to biliary diversion is considered among the 
disadvantages of this approach (Thuluvath et al., 2005). 
4.2 Biliary strictures 
Generally, biliary strictures could be classified into anastomotic strictures (AS) and non-
anastomotic strictures (NAS). The former type is more frequent in living donor OLT as 
compared to recipients of deceased donor OLT (Tsujino et al., 2006; Yazumi et al., 2006). 
Strictures can present at any time after transplantation. The incidence is greatest in the first 5 
to 8 months (range, 1 to 36 months) (Gondolesi et al., 2004; Yazumi & Chiba, 2005; Kasahara 
et al., 2006). Recently, it has been suggested that prevalence continues to increase with time 
after transplantation (Verdonk et al., 2006), and that NAS presents earlier than AS, with 
mean time 3.3-5.9 months (Graziadei et al., 2006; Guichelaar et al., 2003). Moreover, NAS 
secondary to ischemic causes was shown to present within 1 year of the transplant, whereas 
the occurrence after 1 year was more often secondary to immunological causes (Verdonk et 
al., 2007). 
4.2.1 Diagnosis 
Timely management of biliary complications is paramount to avoid unnecessary diagnostic 
procedures, improves graft survival, reduces morbidity, mortality and decreases the 
financial and psychological toll that patients suffer. High index of suspicion must be 
maintained for early diagnosis, and therefore, it would be desirable to have an easy and 
non-invasive diagnostic tool for differentiation between different causes of cholestasis. 
However, the exact diagnosis and localization of post transplant biliary strictures prior to 
endoscopic cholangiography are unfortunately difficult for the following reasons (Shastri et 
al., 2007; Zoepf et al., 2005): (1) Pain, a feature of Charcot’s triad, may be absent in the 
transplant setting because of immunosuppression and hepatic denervation; (2) 
Derangements in biochemical profile may be misleading as it could be due to recurrence of 
the underlying pretransplant liver illnesses or graft rejection; (3) Clinical symptoms like 
fever, anorexia are non-specific; (4) Epithelial casts may fill the biliary system rendering it 
difficult to be visualized by indirect radiological imaging; and (5) Dilatation of the biliary 
system in allografts may develop slower (Thuluvath et al., 2005; Verdonk et al., 2006; 
Williams & Draganov, 2009). 
4.2.1.1 Value of biochemical and laboratory parameters 
There are diverse results about the value of biochemical parameters either in prediction or 
follow up of biliary complications. Some reported that they are not reliable enough 
(Thuluvath et al., 2005) or just could provide a hint to detect biliary complications post 
transplantation (Zoepf et al., 2005). While others concluded that Gamma glutamyl 
transferase (GGT) and serum alkaline phosphatase (AP) (Shastri et al., 2007), but not serum 
bilirubin, to be early, non-invasive and inexpensive diagnostic markers. Moreover, they 
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2008). In the absence of a T tube, HIDA scanning or MRCP may be needed to diagnose bile 
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despite prolonged T tube placement (Thuluvath et al., 2005). Scatton et al. reported in their 
large randomized trial that the incidence of biliary fistula in DDLT was found to be 10% in 
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prompts the diagnosis of biliary leakage in most cases, the diagnosis is also suggested in a 
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increased leakage through the T tube tract. Leaks resulting from T tubes are managed 
successfully by endoscopic placement of internal stents with resolution rate near to 100% 
(Pfau et al., 2000). In management of biliary leakage, several endoscopic strategies have also 
been described, such as biliary stents, nasobiliary drainage, sphincterotomy, or combination 
of the techniques. In the two large series, nasobiliary catheters were used successfully to 
treat post-transplant leaks (Ostroff et al., 1990). Other investigators have noted high closure 
rates with decompression by endoscopic sphincterotomy alone. It appears that any 
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Generally, biliary strictures could be classified into anastomotic strictures (AS) and non-
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secondary to ischemic causes was shown to present within 1 year of the transplant, whereas 
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financial and psychological toll that patients suffer. High index of suspicion must be 
maintained for early diagnosis, and therefore, it would be desirable to have an easy and 
non-invasive diagnostic tool for differentiation between different causes of cholestasis. 
However, the exact diagnosis and localization of post transplant biliary strictures prior to 
endoscopic cholangiography are unfortunately difficult for the following reasons (Shastri et 
al., 2007; Zoepf et al., 2005): (1) Pain, a feature of Charcot’s triad, may be absent in the 
transplant setting because of immunosuppression and hepatic denervation; (2) 
Derangements in biochemical profile may be misleading as it could be due to recurrence of 
the underlying pretransplant liver illnesses or graft rejection; (3) Clinical symptoms like 
fever, anorexia are non-specific; (4) Epithelial casts may fill the biliary system rendering it 
difficult to be visualized by indirect radiological imaging; and (5) Dilatation of the biliary 
system in allografts may develop slower (Thuluvath et al., 2005; Verdonk et al., 2006; 
Williams & Draganov, 2009). 
4.2.1.1 Value of biochemical and laboratory parameters 
There are diverse results about the value of biochemical parameters either in prediction or 
follow up of biliary complications. Some reported that they are not reliable enough 
(Thuluvath et al., 2005) or just could provide a hint to detect biliary complications post 
transplantation (Zoepf et al., 2005). While others concluded that Gamma glutamyl 
transferase (GGT) and serum alkaline phosphatase (AP) (Shastri et al., 2007), but not serum 
bilirubin, to be early, non-invasive and inexpensive diagnostic markers. Moreover, they 
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could be of great help during follow up and to correlate with adequacy of endoscopic 
therapy in patients presenting with early onset biliary complications after transplantation. 
However, others found that elevated serum bilirubin level >1.5 mg/dL is highly sensitive 
tool with negative predictive value of 100% and its decline is well correlated with clinical 
and radiographic improvement (Venu et al., 2007). 
4.2.1.2 Value of radiological modalities in diagnosis of biliary strictures 
Ultrasonography (US) with Doppler examination of hepatic vessels is usually the first 
imaging modality of choice when a biliary complication is suspected, followed by biliary 
imaging and may be biopsy depending on the pattern of liver test abnormalities. However, 
in post−transplant patients, the interpretation of histological findings due to ischemia, 
recurrence of liver disease or rejection can sometimes be misleading. Retrograde endoscopic 
cholangiography (ERC) can directly show the patency of biliary tree or the stenosis of biliary 
stree and show the site of stenosis/stricture. Definitely, ERC is the better diagnostic option 
than other modalities. Hepatic angiography may be indicated if hepatic vascular 
abnormality was suspected (Thuluvath et al., 2005). US may have low sensitivity (close to 
50%) to detect biliary dilatation in patients who received transplantation (Graziadei et al., 
2006; Zoepf et al., 2005) and not accurate enough to diagnose or localize biliary strictures 
either because the true diameter of cast filled bile ducts could not be properly determined, 
acute obstruction may not result in a prompt dilatation of the prestenotic bile ducts (Zoepf 
et al., 2005) or because dilatation of the biliary system in allografts may develop slower 
(Shastri et al., 2007). Different studies reported variable results for helical computed 
tomography and magnetic resonance imaging. However, exact data were not available, 
questionable or not applicable due to low accuracy in localizing stricture site (Zoepf et al., 
2005). While Scintigraphy of the hepatobiliary tract is rarely performed when biliary 
stricture is suspected but still remains an excellent test to detect biliary leaks. Magnetic 
resonance cholangiography (MRC) was shown to have a sensitivity of 95%, a positive 
predictive value of 98% and an overall accuracy of 95% compared to ERCP as the reference 
standard (Valls et al., 2005). Due to the progressive advancement in its computation modes, 
it is suggested that MRC becomes the most promising future diagnostic tool before referral 
to endoscopic intervention. Recently, a hepatocyte-specific contrast agent gadolinium 
ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)–enhanced MR 
cholangiography has been utilized in evaluation of biliary anatomy, differentiation of biliary 
from extrabiliary lesions, assessment of bile duct obstruction, detection of bile duct injury 
including leakage and stricture, evaluation of biliary-enteric anastomoses, post-procedure 
evaluation, differentiation of biloma from other pathologic conditions, and evaluation of 
sphincter of Oddi dysfunction, and was found to be effective. However, the clinical 
applications of this imaging technique have not yet been fully explored. Moreover, the chief 
disadvantage of MRC in general, beyond lack of availability, is the lack of its therapeutic 
ability (Williams & Draganov, 2009). Currently, cumulative results confirm that none of the 
indirect imaging modalities could replace direct cholangiography for diagnosis of post 
transplantation biliary strictures (Pascher & Neuhaus, 2006; Pfau et al., 2000; Rerknimitr et 
al., 2002; Thuluvath et al., 2005; Zoepf et al., 2005). 
4.2.2 Anastomotic strictures (AS) 
Incidence of anastomotic strictures reported is around 5%-10% of transplanted patients. AS 
is usually isolated, short in length, and resulted from fibrotic changes within the first year 
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after transplantation (Greif et al., 1994; Verdonk et al., 2006). Surgical technical issues seem 
to be the most important etiological factors in the early post transplant period, and may 
include improper techniques, small diameter of the bile ducts, size mismatch between the 
donor and recipient bile ducts, tension at the anastomosis, excessive use of 
electrocauterization for control of bile duct bleeding, infection and bile leakage which has 
been found to be an independent risk factor for AS (Lee et al., 2008; Welling et al. 2008). 
Later onset anastomotic stricture is most likely to indicate fibrotic changes due to ischemia 
either of donor or recipient bile duct (Verdonk et al., 2007; Pascher & Neuhaus, 2006). 
4.2.2.1 Management of AS 
The trend in management of AS has changed over the past 20 years from predominantly 
surgical to primarily endoscopic, namely endoscopic regtrograde cholangiography (ERC). 
ERC is considered as the gold standard, most physiological, least invasive diagnostic and 
therapeutic interventional option that carries good long term results in terms of graft and 
patient survival. ERC has an overall success rate in the range of 70%-100% in deceased 
donor liver transplantation (DDLT) (Graziadei et al., 2006; Morelli et al., 2003; Thuluvath et 
al., 2005; Williams & Draganov, 2009) and 60-75%  in living donor liver transplantation 
(LDLT) (Hisatsune et al., 2003; Tsujino et al., 2006; Yazumi & Chiba, 2006). Percutaneous 
transhepatic cholangiography (PTC), although it has high success rate (50%-75%),  is most 
often spared as a second line option for patients with Roux-en-Y bilioenteric reconstruction 
or failed ERC; and this is because the possible associated morbidities of PTC like 
hemorrhage and bile leak ((Sharma et al., 2008; Williams & Draganov, 2009). In high volume 
centers with experienced endoscopists, newer approaches of ERC have been described using 
the variable stiffness pediatric colonoscope, double balloon enteroscope, single balloon 
enteroscope, and spiral overtube. Moreover, both techniques could be combined by 
“rendezvous” endoscopy when endoscopic access to the anastomotic stricture can not be 
obtained. It is worth to mention that using ERCP or PTC is not only dependent on the type 
of biliary reconstruction, but also on the possibility of therapeutic intervention and the 
available expertise (Williams & Draganov, 2009). Therapeutic ERCP whether is successful or 
ultimately unsuccessful and necessitating surgical intervention does not negatively affect 
survival. Therefore, in the majority of patients with biliary complications, a trial of 
endoscopic therapy should be performed to delay or defer a post-OLT surgical procedure 
(Pfau et al., 2000). Surgical revision is now only reserved for patients who have failed the 
endoscopic and transhepatic percutaneous measures. Surgical revision in the form of Roux-
en-Y bilio-enteric reconstruction is usually the operation of choice in patients with duct-to-
duct anastomosis. In those who already have a Roux-en-Y bilioenteric anastomosis, 
repositioning the graft bile duct to a better vascularized area may be required (Verdonk et 
al., 2007), while retransplantation could be the last resort when all else fail (Graziadei et al., 
2006; Williams & Draganov, 2009). 
4.2.2.2 Deceased donor liver transplantation (DDLT) 
Factors found to be associated with poor outcome and/or higher recurrence following 
endoscopic treatment or stent removal include delayed initial presentation (more than 6 
months after transplantation), presence of tight strictures (Alazmi et al., 2006; Verdonk et al., 
2007), presence of bile leaks, and use of T tubes (Sharma et al., 2008; Alazmi et al., 2006). The 
conventional method of endoscopic treatment comprises of stricture localization followed 
by guidewire cannulation, balloon dilatation, and subsequent placement of plastic stents. It 
has been reported that success rate of balloon dilation is approximately 40% (Shwartz et al., 
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could be of great help during follow up and to correlate with adequacy of endoscopic 
therapy in patients presenting with early onset biliary complications after transplantation. 
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predictive value of 98% and an overall accuracy of 95% compared to ERCP as the reference 
standard (Valls et al., 2005). Due to the progressive advancement in its computation modes, 
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ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)–enhanced MR 
cholangiography has been utilized in evaluation of biliary anatomy, differentiation of biliary 
from extrabiliary lesions, assessment of bile duct obstruction, detection of bile duct injury 
including leakage and stricture, evaluation of biliary-enteric anastomoses, post-procedure 
evaluation, differentiation of biloma from other pathologic conditions, and evaluation of 
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applications of this imaging technique have not yet been fully explored. Moreover, the chief 
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after transplantation (Greif et al., 1994; Verdonk et al., 2006). Surgical technical issues seem 
to be the most important etiological factors in the early post transplant period, and may 
include improper techniques, small diameter of the bile ducts, size mismatch between the 
donor and recipient bile ducts, tension at the anastomosis, excessive use of 
electrocauterization for control of bile duct bleeding, infection and bile leakage which has 
been found to be an independent risk factor for AS (Lee et al., 2008; Welling et al. 2008). 
Later onset anastomotic stricture is most likely to indicate fibrotic changes due to ischemia 
either of donor or recipient bile duct (Verdonk et al., 2007; Pascher & Neuhaus, 2006). 
4.2.2.1 Management of AS 
The trend in management of AS has changed over the past 20 years from predominantly 
surgical to primarily endoscopic, namely endoscopic regtrograde cholangiography (ERC). 
ERC is considered as the gold standard, most physiological, least invasive diagnostic and 
therapeutic interventional option that carries good long term results in terms of graft and 
patient survival. ERC has an overall success rate in the range of 70%-100% in deceased 
donor liver transplantation (DDLT) (Graziadei et al., 2006; Morelli et al., 2003; Thuluvath et 
al., 2005; Williams & Draganov, 2009) and 60-75%  in living donor liver transplantation 
(LDLT) (Hisatsune et al., 2003; Tsujino et al., 2006; Yazumi & Chiba, 2006). Percutaneous 
transhepatic cholangiography (PTC), although it has high success rate (50%-75%),  is most 
often spared as a second line option for patients with Roux-en-Y bilioenteric reconstruction 
or failed ERC; and this is because the possible associated morbidities of PTC like 
hemorrhage and bile leak ((Sharma et al., 2008; Williams & Draganov, 2009). In high volume 
centers with experienced endoscopists, newer approaches of ERC have been described using 
the variable stiffness pediatric colonoscope, double balloon enteroscope, single balloon 
enteroscope, and spiral overtube. Moreover, both techniques could be combined by 
“rendezvous” endoscopy when endoscopic access to the anastomotic stricture can not be 
obtained. It is worth to mention that using ERCP or PTC is not only dependent on the type 
of biliary reconstruction, but also on the possibility of therapeutic intervention and the 
available expertise (Williams & Draganov, 2009). Therapeutic ERCP whether is successful or 
ultimately unsuccessful and necessitating surgical intervention does not negatively affect 
survival. Therefore, in the majority of patients with biliary complications, a trial of 
endoscopic therapy should be performed to delay or defer a post-OLT surgical procedure 
(Pfau et al., 2000). Surgical revision is now only reserved for patients who have failed the 
endoscopic and transhepatic percutaneous measures. Surgical revision in the form of Roux-
en-Y bilio-enteric reconstruction is usually the operation of choice in patients with duct-to-
duct anastomosis. In those who already have a Roux-en-Y bilioenteric anastomosis, 
repositioning the graft bile duct to a better vascularized area may be required (Verdonk et 
al., 2007), while retransplantation could be the last resort when all else fail (Graziadei et al., 
2006; Williams & Draganov, 2009). 
4.2.2.2 Deceased donor liver transplantation (DDLT) 
Factors found to be associated with poor outcome and/or higher recurrence following 
endoscopic treatment or stent removal include delayed initial presentation (more than 6 
months after transplantation), presence of tight strictures (Alazmi et al., 2006; Verdonk et al., 
2007), presence of bile leaks, and use of T tubes (Sharma et al., 2008; Alazmi et al., 2006). The 
conventional method of endoscopic treatment comprises of stricture localization followed 
by guidewire cannulation, balloon dilatation, and subsequent placement of plastic stents. It 
has been reported that success rate of balloon dilation is approximately 40% (Shwartz et al., 
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2000); however, additional stent placement seems to have more successful and durable 
outcomes in 75% of patients (Shwartz et al., 2000; Zoepf et al., 2005). Dual or multiple stents 
placed side by side further improves outcomes in up to 80-90% of patients (Morelli et al., 
2003; Graziadei et al., 2006). The stents are generally replaced by larger stents every 3 
months (Shwartz et al., 2000; Morelli et al., 2003) to prevent the complication of clogging, 
cholangitis, or stone formation (Sharma et al., 2008). The majority of  patients with 
anastomotic strictures will require several endoscopic interventions every 3 months with a 
mean of 3 to 5 sessions, using balloon dilation of 6-10 mm and multiple stents of 7 Fr to 10 Fr 
repeated for 12-24 months (Morelli et al., 2003; Thuluvath et al., 2005). The long-term success 
rates were in the range of 70%-100% (Alazmi et al., 2006; Morelli et al., 2003; Rerknimitr et 
al., 2002; Verdonk et al., 2006). A small group of patients, with transient anastomotic 
narrowing during the first 1-2 month post transplant, presumably due to postoperative 
edema, may respond with a single session of endoscopic balloon dilatation and plastic stent 
placement with no need for further intervention (Verdonk et al., 2006).  An “aggressive 
approach” has been advocated by Pasha et al., which they defined as combination of 
maximal dilation and placement of maximum number of stents. Temporary placement of 
covered self-expanding metal stents has been tried to reduce the need for repeated stent 
exchanges, however, the data are limited (Williams & Draganov, 2009).  Another protocol 
proposed an accelerated dilation every 2 weeks and a shortened stenting period of an 
average of 3.6 months. The results were encouraging with a high success rate 87%. 
Generally, it seems that shorter intervals in between treatments may ultimately reduce the 
time needed for successful long term outcomes (Williams & Draganov, 2009). 
Significantly, more recurrences were seen in the patients who developed AS after more than 
6 months after orthotopic liver transplantation compared to those with AS in the first 6 
months (Verdonk et al., 2006). Recurrence rate of post-anastomotic biliary strictures was 
reported by Alzami et al. to be relatively small (18%) over a follow-up period of almost 3 
years (Alazmi et al., 2006), while others reported to be around 10%–13% (Morelli et al., 
2003). They concluded that recurrence could be effectively diagnosed and treated by 
endosopic approach requiring between one and four additional sessions. However, they did 
not identify any clinical or endoscopic parameters that predicted recurrence of anastomotic 
biliary strictures in post-OLT patients. 
4.2.2.3 Living donor liver transplantation 
However, the results of endoscopic intervention for biliary strictures in DDLT is excellent, but 
cannot be extrapolated to right-lobe LDLT. Inability to cannulate the stricture (Yazumi & 
Chiba, 2006; Tashiro et al., 2007) and difficulty to place a stent (Tsujino et al., 2006) were found 
to be the most common reasons for the failure of endoscopic treatment in this group of 
patients. The difference in outcome might be explained by the presence of multiple ductal 
anastomosis, smaller size, peripheral location, and increased risk of devascularization (Sharma 
et al., 2008).  However, as in DDLT, the combination of balloon dilatation and stenting was 
superior to either modality alone (Tashiro et al., 2007). Kyoto group classified the strictures in 
living donor liver transplants into four types: unbranched, fork-shaped, trident-shaped, and 
multibranched (Hisatsune et al., 2003). Moreover, they were the first to describe the “crane 
neck deformity”, in which the biliary anastomosis was located at a point that was far below the 
highest portion of the recipient duct. This event was probably related to compensatory 
hypertrophy of the graft that resulted in sharp angulation of the bile duct rendering it 
extremely difficult to be managed endoscopically (Yazumi & Chiba, 2006). Generally, it is 
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recommended to start with endosocpic therapy as the first approach while percutaneous 
therapy should be spared for rescue therapy for following reasons (Chang et al., 2010). First, 
although the rates of successful interventions and patency do not differ for percutaneous or 
endoscopic therapy, the numbers of necessary interventions are higher for percutaneous 
therapy; second, the inconvenience of the percutaneous drain catheter cannot be ignored 
which significantly affects quality of life of those patients. Lastly but not the least, 
percutaneous drain related complications, such as leakage, pain, infection, and accidental 
removal of the drain are not uncommon. Other reported complications of percutatneous 
approach include portal vein injury, hepatic artery injury, and death (Yazumi & Chiba, 2005). 
In other studies, PTBD resulted in hemobilia, cholangitis, and a hemothorax (Schwartz et al., 
2000). The patients in whom the endoscopic treatment is unsuccessful are rescued with a 
percutaneous transhepatic biliary drainage. The procedure could be summarized as follows: 
under fluoroscopic guidance, the right intrahepatic duct is punctured with a 21G Chiba needle 
and then few ml of bile is aspirated. After insertion of 0.018-inch hairwire, a yellow sheath 
followed by a 0.035-inch guide wire is introduced. After confirmation of anastomotic stricture, 
dilatation of biliary stricture with balloon catheters is performed. An 8 F pigtail catheter is 
inserted over the wire with its tip placed within the common bile duct or duodenum, and 
tubogram is then obtained. The catheter is anchored to the skin with anchoring device (Chang 
et al., 2010). If primary or rescue percutaneous approach is successfully performed, subsequent 
insertion of endoscopic retrograde biliary stents is recommended. Consequently, percutaneous 
drain catheter could be removed earlier and its related complications can be reduced. If the 
insertion of stents is expected to be difficult because of sharp or twisted angle of the 
anastomosis or for other reasons, endoscopic approach can be successfully performed with the 
“rendezvous” method, which could be generally described as, insertion of 0.035-inch or (0.025-
inch) guidewire through the catheter into the intrahepatic bile duct proximal to the site of 
biliary stricture; then dilatation using a bougination catheter (7 F-11.5 F), a stent retriever (7 F-
11.5 F) or a balloon catheter (6 or 8 mm in diameter) according to the indications. After 
stricture dilatation and minor sphincterotomy, stents as many and as big as possible, are 
endoscopically placed. The proximal side of the stent is located sufficiently over the stricture 
and the distal side of the stent is passed 1-2 cm outside the major papilla (Chang et al., 2010).  
Sphincterotomy is usually required during endoscopic stenting to avoid acute pancreatitis as a 
result of compression of pancreatic duct orifice by the duodenal end of stents. However, this 
procedure could be associated with cholangitis. Other theoretically possible long term 
complications in patients who underwent endoscopic sphicterotomy for choledocholithiasis 
unrelated to transplantation might be reported in transplant patients. When longer term 
results are more available in the future, these complications include recurrent stones (12.3%), 
biliary carcinoma (2.0%), and liver abscess (1.2%) (Tanaka et al., 1998). There was a successful 
trial by Koyoto group (Hisatsune et al., 2003; Yazumi et al., 2006) with endoscopic stenting of 
biliary strictures without sphincterotomy. Placing the inside stent above the papilla of Vater 
apparently has two clinical benefits. First, the inside stents are not directly exposed to digested 
food and this may reduce the possibility of being occluded. The average patency of the inside 
stent was found to be 450 days, exceeding the median patency of the conventional endoscopic 
biliary stent (about 3 months); Secondly, more stents could be placed because the orifice of the 
pancreatic duct is not compressed by the distal ends of these stents. Magnetic compression 
anastomosis (MCA) is revolutionary method of performing choledochocholedochostomy in 
patients with biliary obstruction after LDLT (Itoi et al., 2010). Endoscopically, a samarium-
cobalt (Sm-Co) rare-earth magnet is placed at the superior site of obstruction via the 
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2000); however, additional stent placement seems to have more successful and durable 
outcomes in 75% of patients (Shwartz et al., 2000; Zoepf et al., 2005). Dual or multiple stents 
placed side by side further improves outcomes in up to 80-90% of patients (Morelli et al., 
2003; Graziadei et al., 2006). The stents are generally replaced by larger stents every 3 
months (Shwartz et al., 2000; Morelli et al., 2003) to prevent the complication of clogging, 
cholangitis, or stone formation (Sharma et al., 2008). The majority of  patients with 
anastomotic strictures will require several endoscopic interventions every 3 months with a 
mean of 3 to 5 sessions, using balloon dilation of 6-10 mm and multiple stents of 7 Fr to 10 Fr 
repeated for 12-24 months (Morelli et al., 2003; Thuluvath et al., 2005). The long-term success 
rates were in the range of 70%-100% (Alazmi et al., 2006; Morelli et al., 2003; Rerknimitr et 
al., 2002; Verdonk et al., 2006). A small group of patients, with transient anastomotic 
narrowing during the first 1-2 month post transplant, presumably due to postoperative 
edema, may respond with a single session of endoscopic balloon dilatation and plastic stent 
placement with no need for further intervention (Verdonk et al., 2006).  An “aggressive 
approach” has been advocated by Pasha et al., which they defined as combination of 
maximal dilation and placement of maximum number of stents. Temporary placement of 
covered self-expanding metal stents has been tried to reduce the need for repeated stent 
exchanges, however, the data are limited (Williams & Draganov, 2009).  Another protocol 
proposed an accelerated dilation every 2 weeks and a shortened stenting period of an 
average of 3.6 months. The results were encouraging with a high success rate 87%. 
Generally, it seems that shorter intervals in between treatments may ultimately reduce the 
time needed for successful long term outcomes (Williams & Draganov, 2009). 
Significantly, more recurrences were seen in the patients who developed AS after more than 
6 months after orthotopic liver transplantation compared to those with AS in the first 6 
months (Verdonk et al., 2006). Recurrence rate of post-anastomotic biliary strictures was 
reported by Alzami et al. to be relatively small (18%) over a follow-up period of almost 3 
years (Alazmi et al., 2006), while others reported to be around 10%–13% (Morelli et al., 
2003). They concluded that recurrence could be effectively diagnosed and treated by 
endosopic approach requiring between one and four additional sessions. However, they did 
not identify any clinical or endoscopic parameters that predicted recurrence of anastomotic 
biliary strictures in post-OLT patients. 
4.2.2.3 Living donor liver transplantation 
However, the results of endoscopic intervention for biliary strictures in DDLT is excellent, but 
cannot be extrapolated to right-lobe LDLT. Inability to cannulate the stricture (Yazumi & 
Chiba, 2006; Tashiro et al., 2007) and difficulty to place a stent (Tsujino et al., 2006) were found 
to be the most common reasons for the failure of endoscopic treatment in this group of 
patients. The difference in outcome might be explained by the presence of multiple ductal 
anastomosis, smaller size, peripheral location, and increased risk of devascularization (Sharma 
et al., 2008).  However, as in DDLT, the combination of balloon dilatation and stenting was 
superior to either modality alone (Tashiro et al., 2007). Kyoto group classified the strictures in 
living donor liver transplants into four types: unbranched, fork-shaped, trident-shaped, and 
multibranched (Hisatsune et al., 2003). Moreover, they were the first to describe the “crane 
neck deformity”, in which the biliary anastomosis was located at a point that was far below the 
highest portion of the recipient duct. This event was probably related to compensatory 
hypertrophy of the graft that resulted in sharp angulation of the bile duct rendering it 
extremely difficult to be managed endoscopically (Yazumi & Chiba, 2006). Generally, it is 
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recommended to start with endosocpic therapy as the first approach while percutaneous 
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2000). The patients in whom the endoscopic treatment is unsuccessful are rescued with a 
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and then few ml of bile is aspirated. After insertion of 0.018-inch hairwire, a yellow sheath 
followed by a 0.035-inch guide wire is introduced. After confirmation of anastomotic stricture, 
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inserted over the wire with its tip placed within the common bile duct or duodenum, and 
tubogram is then obtained. The catheter is anchored to the skin with anchoring device (Chang 
et al., 2010). If primary or rescue percutaneous approach is successfully performed, subsequent 
insertion of endoscopic retrograde biliary stents is recommended. Consequently, percutaneous 
drain catheter could be removed earlier and its related complications can be reduced. If the 
insertion of stents is expected to be difficult because of sharp or twisted angle of the 
anastomosis or for other reasons, endoscopic approach can be successfully performed with the 
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11.5 F) or a balloon catheter (6 or 8 mm in diameter) according to the indications. After 
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and the distal side of the stent is passed 1-2 cm outside the major papilla (Chang et al., 2010).  
Sphincterotomy is usually required during endoscopic stenting to avoid acute pancreatitis as a 
result of compression of pancreatic duct orifice by the duodenal end of stents. However, this 
procedure could be associated with cholangitis. Other theoretically possible long term 
complications in patients who underwent endoscopic sphicterotomy for choledocholithiasis 
unrelated to transplantation might be reported in transplant patients. When longer term 
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biliary strictures without sphincterotomy. Placing the inside stent above the papilla of Vater 
apparently has two clinical benefits. First, the inside stents are not directly exposed to digested 
food and this may reduce the possibility of being occluded. The average patency of the inside 
stent was found to be 450 days, exceeding the median patency of the conventional endoscopic 
biliary stent (about 3 months); Secondly, more stents could be placed because the orifice of the 
pancreatic duct is not compressed by the distal ends of these stents. Magnetic compression 
anastomosis (MCA) is revolutionary method of performing choledochocholedochostomy in 
patients with biliary obstruction after LDLT (Itoi et al., 2010). Endoscopically, a samarium-
cobalt (Sm-Co) rare-earth magnet is placed at the superior site of obstruction via the 
 
Therapeutic Gastrointestinal Endoscopy 
 
106 
percutaneous transhepatic biliary drainage route, and another Sm-Co magnet is also placed at 
the inferior site of obstruction with the aid of an endoscope. 
4.2.3 Non anastomotic stricutes (NAS) 
NAS after liver transplantation is not just single disease but rather an array of biliary 
abnormalities with different pathogenesis and variations in anatomical localization and 
severity, ranging from slight, localized mucosal irregularity to extensive and diffuse biliary 
strictures (Verdonk et al., 2007). Non-anastomotic strictures account for 10%-25% of all 
stricture complications after OLT with an incidence of 1%-19%. These strictures are often 
multiple, longer, proximal to the anastomosis in the extra- or intra-hepatic bile ducts and 
occur earlier than anastomotic strictures with a mean time to stricture development of 3-6 
months (Graziadei et al., 2006; Guichelaar et al., 2003; Williams & Draganov, 2009). Verdonk 
et al. reported that more than 50% of the cases presented within the first year post 
transplantation. However, long-term follow-up revealed gradual increase in incidence up to 
12 years after transplantation, resulting in steep initial rise of the cumulative incidence curve 
of NAS during the first year after OLT and followed by a smaller increment beyond the first 
year. The cumulative incidence was 14%, 15%, and 16% at 3, 5, and 10 years after OLT, 
respectively (Verdonk et al., 2007). As we discussed before, the risk factors could be broadly 
classified as macroangiopathic due to hepatic artery thrombosis (HAT) or microantiopathic 
which also known as ischemic type biliary lesions (ITBL). ITBL could be divided into three 
categories: ischemia-related injury to the biliary epithelium; imunologically mediated injury; 
and cytotoxic injury induced by bile salts. Groningen team reported that ischemia-related 
injury represented around 80% of NAS cases. Non-anastomotic strictures secondary to 
ischemic causes presented within 1 year of transplant and found around the bifurcation and 
the common bile duct had severer course and higher risk of progression. Whereas, the 
occurrence of NAS after 1 year was more often related to immunological causes as the risk 
factors identified more frequently in the periphery of the liver and represented around 20% 
of NAS cases. Groningen team also showed that cold and warm ischemia times were 
significantly longer for the group with early NAS compared to the group with late NAS. 
Anastomotic bile leak which is generally associated with local bile duct ischemia is observed 
in the group with early NAS. Moreover, higher incidence of NAS in liver transplantation 
from donors after cardiac death (non–heart-beating donors) also strongly suggests an 
ischemia-related factor in the pathogenesis of NAS. The critical relevance of arterial blood 
supply for the viability of the larger and extrahepatic bile ducts is well described. This part 
of the biliary tree in the graft becomes entirely dependent on arterial blood from the hepatic 
artery, making them more prone to hypoperfusion and ischemia. This may explain the 
central localization of NAS presenting early after transplantation (Buis et al., 2007; Verdonk 
et al., 2007). They also analyzed the risk factors in relation to the outcome and concluded 
that patients with following criteria:  hepaticojejunostomy as biliary reconstruction and 
early diagnosis of NAS, NAS presenting at the level of the peripheral branches of the biliary 
tree were at risk for the development of recurrent cholangitis, radiological progression, 
development of cirrhosis, and eventually retransplantation (Verdonk et al., 2007).  
4.2.3.1 Management of NAS 
NAS secondary to early HAT usually requires urgent revascularization or 
retransplantation, whereas NAS due to late HAT or any other etiological risk factor could 
be salvaged by endoscopic means (Sharma et al., 2008). Compared to AS, non-anastomotic 
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strictures are more difficult to treat with more complications and less favorable overall 
outcomes including increased graft loss and death (Williams & Draganov, 2009). It is 
reported that only 50%-75% of DDLT patients had a long term response to endoscopic 
therapy and the median time of response was 185 days; on the other hand, long term 
response in patients with anastomotic strictures was 70%-100% and the median time of 
response was 67 days (Graziadei et al., 2006; Pfau et al., 2000; Rerknimitr et al., 2002; 
Thuluvath et al., 2005). The results of endoscopic approaches in the context of NAS in 
LDLT are even more disappointing, as the average success rate varies from 25% to 
33%(Todo et al., 2005; Tsujino et al., 2006; Yazumi et al., 2006), which is way below the 
success rate seen with NAS in DDLT. Non-anastomotic strictures required an increased 
number of interventions, and also did not result in significant long term improvement 
(Graziadei et al., 2006) as it is  complicated by the  development of repeated episodes of 
cholangitis, biliary cirrhosis, atrophy of the involved lobe and graft failure (Sharma et al., 
2008). It did not appear that the poor response of non-anastomotic treatment varied with 
etiology (Guichelaar et al., 2003). In patients with changes located primarily in the 
extrahepatic bile duct and the duct bifurcation, complex surgical reconstruction with 
resection of the bifurcation and Roux-en-Y hepaticojejunostomy could be an option. 
Ultimately, up to 30-50% of the patients with NAS either required retransplantation or 
died as a consequence of these complications despite endoscopic or percutaneous therapy 
(Graziadei et al., 2006; Guichelaar et al., 2003; Pascher & Neuhaus, 2006; Shah et al., 2007; 
Thuluvath et al., 2005). Generally, endoscopic therapy of NAS is challenging and 
comprises of extraction of the biliary sludge and casts, balloon dilation of all accessible 
strictures and placement of plastic stents which are replaced every 3 months. However, 
dilatation of all strictures is not possible due to their multifocal distribution, involvement 
of the smaller and peripheral intrahepatic ducts, and rapid stent occlusion by biliary 
sludge and casts (Williams & Draganov, 2009). Although endoscopic therapy is 
considered as first line in management of  non-anastomotic strictures and may 
occasionally be a definite solution in selected patients, it requires lifelong surveillance 
since strictures are likely to recur, and more importantly, it seems to play a prominent 
role as a bridge to liver retransplantation. A stricture that is too tight precluding 
successful cannulation of biliary system by the guidewire is the commonest cause of 
endoscopic failure in management of biliary strictures after LDLT (Tashiro et al., 2007; 
Verdonk et al., 2007). However, once a stricture is cannulated, the reported success for 
this procedure is about 80%-90%, which highlights the importance of cannulation of the 
stricture as a critical event in predicting the success or failure of the endoscopic treatment. 
Sharma et al. used the Spyglass direct visualization system as the guidance system for the 
passage of the guidewire through very tight strictures in this subset of patients where 
conventional ERCP failed. However, definitive answers on the best treatment modality for 
NAS should come from multicenter, prospective, randomized studies (Sharma et al., 
2008). 
4.3 Other indications of endoscopy in recipients 
4.3.1 Sphincter of Oddi Dysfunction (SOD) 
Also termed ampullary dysfunction occurs in from 0-7% of liver transplant recipients with 
duct to duct anastomosis. Its pathophysiology in the post-transplant setting is poorly 
understood (Thuluvath et al., 2005), but it is probably related to denervation of the 
ampullary region of the native duct, resulting in abnormal ampullary relaxation and 
 
Therapeutic Gastrointestinal Endoscopy 
 
106 
percutaneous transhepatic biliary drainage route, and another Sm-Co magnet is also placed at 
the inferior site of obstruction with the aid of an endoscope. 
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strictures (Verdonk et al., 2007). Non-anastomotic strictures account for 10%-25% of all 
stricture complications after OLT with an incidence of 1%-19%. These strictures are often 
multiple, longer, proximal to the anastomosis in the extra- or intra-hepatic bile ducts and 
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et al. reported that more than 50% of the cases presented within the first year post 
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of NAS during the first year after OLT and followed by a smaller increment beyond the first 
year. The cumulative incidence was 14%, 15%, and 16% at 3, 5, and 10 years after OLT, 
respectively (Verdonk et al., 2007). As we discussed before, the risk factors could be broadly 
classified as macroangiopathic due to hepatic artery thrombosis (HAT) or microantiopathic 
which also known as ischemic type biliary lesions (ITBL). ITBL could be divided into three 
categories: ischemia-related injury to the biliary epithelium; imunologically mediated injury; 
and cytotoxic injury induced by bile salts. Groningen team reported that ischemia-related 
injury represented around 80% of NAS cases. Non-anastomotic strictures secondary to 
ischemic causes presented within 1 year of transplant and found around the bifurcation and 
the common bile duct had severer course and higher risk of progression. Whereas, the 
occurrence of NAS after 1 year was more often related to immunological causes as the risk 
factors identified more frequently in the periphery of the liver and represented around 20% 
of NAS cases. Groningen team also showed that cold and warm ischemia times were 
significantly longer for the group with early NAS compared to the group with late NAS. 
Anastomotic bile leak which is generally associated with local bile duct ischemia is observed 
in the group with early NAS. Moreover, higher incidence of NAS in liver transplantation 
from donors after cardiac death (non–heart-beating donors) also strongly suggests an 
ischemia-related factor in the pathogenesis of NAS. The critical relevance of arterial blood 
supply for the viability of the larger and extrahepatic bile ducts is well described. This part 
of the biliary tree in the graft becomes entirely dependent on arterial blood from the hepatic 
artery, making them more prone to hypoperfusion and ischemia. This may explain the 
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et al., 2007). They also analyzed the risk factors in relation to the outcome and concluded 
that patients with following criteria:  hepaticojejunostomy as biliary reconstruction and 
early diagnosis of NAS, NAS presenting at the level of the peripheral branches of the biliary 
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strictures are more difficult to treat with more complications and less favorable overall 
outcomes including increased graft loss and death (Williams & Draganov, 2009). It is 
reported that only 50%-75% of DDLT patients had a long term response to endoscopic 
therapy and the median time of response was 185 days; on the other hand, long term 
response in patients with anastomotic strictures was 70%-100% and the median time of 
response was 67 days (Graziadei et al., 2006; Pfau et al., 2000; Rerknimitr et al., 2002; 
Thuluvath et al., 2005). The results of endoscopic approaches in the context of NAS in 
LDLT are even more disappointing, as the average success rate varies from 25% to 
33%(Todo et al., 2005; Tsujino et al., 2006; Yazumi et al., 2006), which is way below the 
success rate seen with NAS in DDLT. Non-anastomotic strictures required an increased 
number of interventions, and also did not result in significant long term improvement 
(Graziadei et al., 2006) as it is  complicated by the  development of repeated episodes of 
cholangitis, biliary cirrhosis, atrophy of the involved lobe and graft failure (Sharma et al., 
2008). It did not appear that the poor response of non-anastomotic treatment varied with 
etiology (Guichelaar et al., 2003). In patients with changes located primarily in the 
extrahepatic bile duct and the duct bifurcation, complex surgical reconstruction with 
resection of the bifurcation and Roux-en-Y hepaticojejunostomy could be an option. 
Ultimately, up to 30-50% of the patients with NAS either required retransplantation or 
died as a consequence of these complications despite endoscopic or percutaneous therapy 
(Graziadei et al., 2006; Guichelaar et al., 2003; Pascher & Neuhaus, 2006; Shah et al., 2007; 
Thuluvath et al., 2005). Generally, endoscopic therapy of NAS is challenging and 
comprises of extraction of the biliary sludge and casts, balloon dilation of all accessible 
strictures and placement of plastic stents which are replaced every 3 months. However, 
dilatation of all strictures is not possible due to their multifocal distribution, involvement 
of the smaller and peripheral intrahepatic ducts, and rapid stent occlusion by biliary 
sludge and casts (Williams & Draganov, 2009). Although endoscopic therapy is 
considered as first line in management of  non-anastomotic strictures and may 
occasionally be a definite solution in selected patients, it requires lifelong surveillance 
since strictures are likely to recur, and more importantly, it seems to play a prominent 
role as a bridge to liver retransplantation. A stricture that is too tight precluding 
successful cannulation of biliary system by the guidewire is the commonest cause of 
endoscopic failure in management of biliary strictures after LDLT (Tashiro et al., 2007; 
Verdonk et al., 2007). However, once a stricture is cannulated, the reported success for 
this procedure is about 80%-90%, which highlights the importance of cannulation of the 
stricture as a critical event in predicting the success or failure of the endoscopic treatment. 
Sharma et al. used the Spyglass direct visualization system as the guidance system for the 
passage of the guidewire through very tight strictures in this subset of patients where 
conventional ERCP failed. However, definitive answers on the best treatment modality for 
NAS should come from multicenter, prospective, randomized studies (Sharma et al., 
2008). 
4.3 Other indications of endoscopy in recipients 
4.3.1 Sphincter of Oddi Dysfunction (SOD) 
Also termed ampullary dysfunction occurs in from 0-7% of liver transplant recipients with 
duct to duct anastomosis. Its pathophysiology in the post-transplant setting is poorly 
understood (Thuluvath et al., 2005), but it is probably related to denervation of the 
ampullary region of the native duct, resulting in abnormal ampullary relaxation and 
 
Therapeutic Gastrointestinal Endoscopy 
 
108 
increased intraductal biliary pressure ( Clavien et al., 1995). However, distal bile duct 
obstruction in the post transplant setting might be due to a combination of SOD, edema, or 
inflammatory stricturing due to long term stenting with a T tube or internal stent when the 
distal end protrudes into the sphincter. CMV and other opportunistic infections may also 
play a pathological role in post-transplant sphincter of Oddi dysfunction (Thuluvath et al., 
2005). It is usually suspected clinically by persistently elevated liver enzymes in an 
obstructive/cholestatic pattern, dilation of the native duct to a diameter greater than 10 mm 
(Pfau et al., 2000), improvements in liver tests with T tube unclamping, delayed drainage of 
contrast (> 15 min) in a cholangiography that fails to show any evident cause of obstruction 
(Greif et al., 1994). Hepatobiliary scintigraphy and sphincter or T tube manometry could 
also be diagnostic (Thuluvath et al., 2005). Endoscopic sphincterotomy and/or biliary 
stenting is usually a successful treatment. Some reported 100% response to sphincterotomy 
without stenting (Pfau et al., 2000; Thuluvath et al., 2005; Wojcicki et al., 2008). Therefore, 
manometric studies, although diagnostic, are not performed in most cases because evidence 
to support this approach has been largely anecdotal and remains controversial (Pfau et al., 
2000). A study reported that conversion to a hepaticojejunostomy may occasionally be 
required to resolve the dysfunction (Greif et al., 1994). 
4.3.2 Biliary stones 
The incidence of biliary stones after liver transplantation is quite variable in different 
reports. For instance, Riknimitir et al. reported the occurrence of biliary stones in 38% of 
their patients (Rerknimitr et al., 2002), while others reported an incidence of 4-18% of post 
liver transplant patients (de la Mora-Levy & Baron, 2005).The exact etiology is unclear, 
however, this could be explained theoretically by increased lithogenicity of the bile or as a 
result of cyclosporine inhibitory effect on bile acid production and bile flow. However, post 
transplant calculi formation is most likely the result of mechanical obstruction mainly 
strictures (de la Mora-Levy & Baron, 2005; Thuluvath et al., 2005), biliary tract infection, 
biliary reflux and biliary mucosal inflammation. The stones or debris can be removed 
successfully after sphincterotomy in almost all cases, and patients with strictures require 
dilation of the strictures before stone removal (de la Mora-Levy & Baron, 2005; Pfau et al., 
2000; Thuluvath et al., 2005).  
4.3.3 Biliary cast syndrome 
Biliary cast syndrome is an ill-defined entity that includes a number of pathophysiologies 
that share similar cholangiographic findings. Biliary casts, rare in nontransplant patients, are 
associated with morbidity, graft failure, need for retransplantation, and mortality. Biliary 
cast syndrome describes the cholangiographic findings of multiple fixed filling defects in the 
intrahepatic or extrahepatic biliary tree that conform to the luminal dimensions of the 
segment of bile duct. Cast material may be hard or soft, may adhere to the bile duct wall, 
and may have a “staghorn” configuration. Theories as to the etiology include sloughed 
biliary epithelium due to prolonged cold storage time or transient or ongoing ischemia, 
chronic rejection, infection, bile stasis, and alteration of the bile milieu (Pfau et al., 2000); and 
are often accompanied by strictures including diffuse stricturing of the hilum. Evidence 
suggests that endoscopic therapy will fail to treat multiple biliary casts and many patients 
may be better managed with the percutaneous approach. Ursodeoxycholic acid might delay 
new formation of sludge and stones. Although enough data are not available, most patients 
may require retransplantation (Pfau et al., 2000; Thuluvath et al., 2005). 
 




It is a very rare complication after liver transplantion. It can develop when the outflow end 
of the blind donor cystic duct remnant is incorporated into the suture line of a biliary 
anastomosis (Koneru et al., 1989). This creates the blind mucosa-lined sac which can later on 
become distended by accumulated mucus and leads to bile duct obstruction by extrinsic 
compression (Osroff et al., 1990; Wojcicki et al., 2008). Computed tomography and 
ultrasonography will reveal the mucocele as a fluid collection in the porta hepatis and 
should be differentiated from other conditions, including hepatic artery pseudoaneurysm, 
biloma, loculated ascites, abscess, liquefied hematoma, tumor, adenopathy, and a fluid filled 
Roux−en−Y loop of jejunum. Surgical excision or drainage of the cystic duct remnant by 
enteric anastomosis is curative (Koneru et al., 1989; Thuluvath et al., 2005).  
4.3.5 Posttransplant lymphoproliferative disease and opportunistic infection 
Posttransplant lymphoproliferative disease is generally associated with over-
mmunosuppression in the setting of Epstein-Barr virus infection and may respond to 
lowering of immunosuppression and antiviral therapy. Bile duct obstruction may occur at 
the hilum and can be relieved with temporary endoscopic biliary stent placement. However, 
if the disease progresses to lymphoma, long-term biliary stent placement may be necessary 
(de la Mora-Levy & Baron, 2005). Chronic CMV infection can cause chronic cholangitis and 
lead to multiple strictures mimicking PSC. 
4.3.6 Recurrence of the primary sclerosing cholangitis 
Primary sclerosing cholangitis recurs after OLT in 5–20% of patients, and the risk seems to 
be increased in males and in recipients who have not undergone colectomy before 
transplantation. The recurrence may be difficult to distinguish from ischemic-type biliary 
lesions (Wojcicki et al., 2008). The diagnosis is usually based on preoperative diagnosis of 
primary sclerosing cholangitis. Cholangiographic findings inculde non-anastomotic biliary 
strictures of the intrahepatic and/or extrahepatic biliary tree with beading and irregularity 
occurring more than 90 days after transplantation (Graziadei et al., 2006; Wojcicki et al., 
2008). Differential diagnosis includes wide spectrum of factors such as hepatic artery 
thrombosis or stenosis and ischemic-type biliary lesions of other etiology. However, it seems 
that patient and graft survival are not negatively affected in the intermediate term of follow-
up. An increased incidence of biliary strictures and reduced graft and patient survival are 
observed in patients with duct-to-duct anastomosis, as compared to those undergoing 
hepaticojejunostomy reconstructions. Therefore, Roux loop has been preferentially 
performed aiming at reducing the risk of disease recurrence. However, some authors 
reported that duct-to-duct anastomosis in these patients could be performed if the disease 
was not involving the distal duct, and the results in terms of the rates of biliary 
complications and patient and graft survival were comparable (Wojcicki et al., 2008). 
5. Biliary complications in donor 
The incidence of biliary complications in donors tends to be about 5% based on recent 
publications. Bile leakage and biliary strictures are the most common biliary complications. 
Most bile leakages occurred from cut surfaces, and others may originate from biliary 
radicles draining the caudate lobe (Yuan & Gotoh, 2010). When strictures develop, they tend 
to occur at the hilum. The same endoscopic treatments previously described are used. 
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manometric studies, although diagnostic, are not performed in most cases because evidence 
to support this approach has been largely anecdotal and remains controversial (Pfau et al., 
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may require retransplantation (Pfau et al., 2000; Thuluvath et al., 2005). 
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performed aiming at reducing the risk of disease recurrence. However, some authors 
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Specifically for the cut surface of the liver, endoscopic biliary drainage could be successfully 
used as demonstrated in patients undergoing liver resection for other causes (Hasegawa et 
al., 2003). 
6. Conclusion 
ERCP has become an established procedure in the management of post-transplantation 
biliary complications both in recipients and donors with a comprehensive body of literature 
published for more than 20 years to support its use. In addition to the formentioned 
indications, it also has diagnostic and/ therapeutic role in management of hemobilia, 
necrosis of the bile duct, bile duct redundancy/kinking, and retained surgical stents. In 
genereal, therapeutic ERC, whether successful or ultimately unsuccessful and necessitating 
surgical intervention, does not negatively affect survival. Therefore, in the majority of 
patients with biliary complications, a trial of endoscopic therapy should be performed to 
delay or defer a post-OLT surgical procedure. 
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Specifically for the cut surface of the liver, endoscopic biliary drainage could be successfully 
used as demonstrated in patients undergoing liver resection for other causes (Hasegawa et 
al., 2003). 
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indications, it also has diagnostic and/ therapeutic role in management of hemobilia, 
necrosis of the bile duct, bile duct redundancy/kinking, and retained surgical stents. In 
genereal, therapeutic ERC, whether successful or ultimately unsuccessful and necessitating 
surgical intervention, does not negatively affect survival. Therefore, in the majority of 
patients with biliary complications, a trial of endoscopic therapy should be performed to 
delay or defer a post-OLT surgical procedure. 
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1. Introduction 
Advanced endoscopy can be used to insert stents (hollow tubes) into various sites of the 
gastrointestinal tract and this has proved to be a major therapeutic advance. Stents can hold 
open strictured areas in the oesophagus, the biliary tree, the colon and the gastroduodenal 
region. Stents are usually positioned in order to overcome stricturing associated with 
cancerous tumours. They are used as definitive treatment, as a bridge to surgery, and for 
palliation of obstructive symptoms. In the setting of incurable gastrointestinal cancer, the 
endoscopic placement of such stents allows palliation of symptoms non-invasively, and is 
an attractive alternative to surgery. Stents can also be used in benign disease of the 
gastrointestinal tract. 
The basic principles of stent insertion involve the initial placement of a guidewire, (and 
sometimes an overrunning introducing catheter) across the region to be stented, using 
endoscopic vision and often fluoroscopic guidance too. The stent is advanced over the 
guidewire until it traverses the area to be stented. In the case of self-expanding stents, the 
restraining mechanism is then released to deploy the stent. 
Gastrointestinal stent insertion is not the sole domain of the endoscopist. Gastrointestinal 
stents are also placed non-endoscopically by radiologists. For example, interventional 
radiologists use fluoroscopic guidance to position oesophageal stents in the oesophagus, or 
can use a combination of sonography and percutaneous transhepatic cholangiography to 
place biliary stents in the biliary tree. The route of stent insertion may be influenced by local 
expertise, but the indications for stent insertion are usually those benefitting from a 
multidisciplinary approach involving endoscopists, surgeons, interventional radiologists 
and oncologists. Gastrointestinal stent insertion is an area of medicine where the territorial 
boundaries of interventional endoscopists, minimally invasive surgeons and interventional 
radiologists are increasingly blurred. 
2. Technology of stents 
2.1 Simple plastic stents 
Initially endoscopic stents were solely plastic. Up until the 1990s, rigid plastic stents were 
used to stent stricturing oesophageal cancers. However the development of safer Self-
Expanding Metal Stents (SEMS) has rendered these rigid plastic oesophageal stents obsolete. 
Today plastic stents are mainly confined to use in the biliary tree and pancreas. These plastic 
stents are usually composed of one of three polymers - polyethylene, polyurethane or 
Teflon. Plastic stents used in the biliary tree and pancreas may be straight with anchoring 
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Teflon. Plastic stents used in the biliary tree and pancreas may be straight with anchoring 
 
Therapeutic Gastrointestinal Endoscopy 
 
116 
side-flaps to prevent migration. Alternatively, pigtailed stents may be used in the biliary 
tree. The curled end of a pigtail stent is straightened over the guidewire during positioning 
and the pigtail resumes its shape once the guidewire has been removed. The pigtail anchors 
the stent in position. The diameter of a plastic stent is usually described in terms of the 
French scale, where 1 French (Fr) is 0.33 mm. Thus a 6 Fr stent has a diameter of 2 mm. The 
maximum diameter of a simple plastic stent is limited by the maximum size of an 
endoscope’s operating channel size at 12 Fr or 4 mm.  
 
 
Fig. 1. Straight plastic stents used for biliary and pancreatic stenting  
 
 
Fig. 2. Pigtail stent used for biliary stenting 
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2.2 Self-expanding stents 
Although simple plastic stents still have a role in biliary and pancreatic stenting, 
technological improvements have led to the development of smarter stents. Self-Expanding 
Metal Stents (SEMS) are positioned while collapsed, using a small calibre introducer. 
Insertion of SEMS is easier, safer, with a reduced risk of perforation, and much reduced 
need for prior stricture dilatation. 
Metals in SEMS need to be biocompatible i.e. biologically innocuous when functioning in 
patients. Shape memory alloys are ‘intelligent’, possessing the ability to recover a previously 
defined length or shape when deployed in the patient (Tarnita et al., 2009). There are several 
types and sizes of SEMS on the market. Each has its own characteristics in terms of radial 
forces exerted, foreshortening on deployment, and flexibility. SEMS can be made from 
stainless steel e.g. Z-stent® (Cook Medical, Bloomington, IN, USA) or from alloys. Nitinol is 
an alloy of nickel and titanium used in Ultraflex® stent (Boston Scientific, Natick, MA, USA) 
and Alimaxx E® stent (Alveolus, Charlotte, NC, USA). Elgiloy, a cobalt /chromium /nickel 
alloy, is used in Wallstent® (Boston Scientific). 
 
 
Fig. 3. Different sizes of Self-Expanding Metal Stents used in oesophageal stenting 
SEMs should be fluoroscopically opaque to aid positioning, and should be easily deployable 
via a small calibre introducer. They are introduced in a collapsed position, being run over a 
guidewire positioned through the region to be stented. Once in position the constraining 
mechanism is released and the stent expands, exerting radial forces on any stricturing lesion 
thus increasing the lumen of the area being stented. SEMS are designed to expand to a 
diameter of more than 20mm. The bare metal strands of an uncovered stent may embed in 
the underlying tumour and serve to anchor the stent in position. Through pressure necrosis, 
the struts of the stent migrate into the mucosa and submucosa of the gut wall. A fibrous 
reaction with chronic lymphocytic infiltration occurs, as the stent becomes embedded in 
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side-flaps to prevent migration. Alternatively, pigtailed stents may be used in the biliary 
tree. The curled end of a pigtail stent is straightened over the guidewire during positioning 
and the pigtail resumes its shape once the guidewire has been removed. The pigtail anchors 
the stent in position. The diameter of a plastic stent is usually described in terms of the 
French scale, where 1 French (Fr) is 0.33 mm. Thus a 6 Fr stent has a diameter of 2 mm. The 
maximum diameter of a simple plastic stent is limited by the maximum size of an 
endoscope’s operating channel size at 12 Fr or 4 mm.  
 
 
Fig. 1. Straight plastic stents used for biliary and pancreatic stenting  
 
 
Fig. 2. Pigtail stent used for biliary stenting 
 
Stents in Gastrointestinal Endoscopy 
 
117 
2.2 Self-expanding stents 
Although simple plastic stents still have a role in biliary and pancreatic stenting, 
technological improvements have led to the development of smarter stents. Self-Expanding 
Metal Stents (SEMS) are positioned while collapsed, using a small calibre introducer. 
Insertion of SEMS is easier, safer, with a reduced risk of perforation, and much reduced 
need for prior stricture dilatation. 
Metals in SEMS need to be biocompatible i.e. biologically innocuous when functioning in 
patients. Shape memory alloys are ‘intelligent’, possessing the ability to recover a previously 
defined length or shape when deployed in the patient (Tarnita et al., 2009). There are several 
types and sizes of SEMS on the market. Each has its own characteristics in terms of radial 
forces exerted, foreshortening on deployment, and flexibility. SEMS can be made from 
stainless steel e.g. Z-stent® (Cook Medical, Bloomington, IN, USA) or from alloys. Nitinol is 
an alloy of nickel and titanium used in Ultraflex® stent (Boston Scientific, Natick, MA, USA) 
and Alimaxx E® stent (Alveolus, Charlotte, NC, USA). Elgiloy, a cobalt /chromium /nickel 
alloy, is used in Wallstent® (Boston Scientific). 
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collagen and fibrous tissue. A chronic lymphocytic reaction occurs in the normal tissue 
underlying the proximal and distal ends of the stent (Bethge et al.,1996). Once in situ the 
stent should be MRI compatible. 
 
 
Fig. 4. Uncovered Self-Expanding Metal Stent used in biliary stenting 
SEMS may be covered with a silicone membrane to reduce the risk of tumour in-growth and 
to seal fistulas. However fully covered stents are less likely to embed in the underlying 
tissues, and have an increased risk of stent migration compared to uncovered stents. 
Therefore, partially covered stents have been developed with flared uncovered segments at 
both ends to anchor on to the tissue. Fully covered SEMS are also increasingly used in 
benign oesophageal disease, such as non-malignant strictures and anastomotic leaks. The 
Polyflex ® stent (Boston Scientific, Natick, MA, USA) is a removable self-expanding plastic 
stent for use in the management of benign and malignant oesophageal strictures. Such a 
removable self-expanding plastic stent allows temporary stent insertion for benign 
oesophageal disease and for patients undergoing neoadjuvant chemotherapy prior to 
oesophagectomy. Recently biodegradable stents have been developed which slowly break 
down over time, e.g. the SX-Ella Esophageal Degradable BD stent®, (ELLA-CS, Hradec-
Kralove, Czech Republic) made from the biodegradable polymer poly-dioxanon, and the 
Tanaka-Marui stent (Marui Textile Machinery Co., Osaka, Japan) composed of biodegradable 
poly-L-lactic acid monofilaments. 
Potential complications of SEMS insertion include perforation, tumour overgrowth or 
ingrowth, and stent migration. Newer stents are being developed with the aim of increasing 
technical and clinical success rates, while reducing complication rates. Other areas of 
development include radioactive or drug-eluting stents for malignant disease.  
3. Oesophageal stents for malignant oesophageal obstruction 
Patients with oesophageal cancer experience progressive dysphagia and weight loss. 
Radical surgery in the form of oesophagectomy offers the only chance of cure. 
Unfortunately, patients often present late with inoperable tumours, or are too frail to be 
considered for surgery which itself caries significant morbidity and mortality. Dysphagia 
is a distressing and unpleasant symptom. Relief of dysphagia, so that patients can 
swallow again, is very important in the treatment of oesophageal cancer. Oesophageal 
stents are an excellent option for the palliation of dysphagia. In contrast to other treatment 
modalities like endoscopic laser or brachytherapy, stents are widely available and are not 
restricted to specialised centres. They can be inserted under endoscopic or fluoroscopic 
guidance or a combination of both. They rapidly relieve dysphagia, and can be used in 
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patients with advanced inoperable disease or in patients too frail to have chemotherapy or 
radiotherapy. 
The first stents used in malignant dysphagia were rigid plastic stents. Placing such rigid 
stents, and the necessary prior stricture dilatation carried a substantial risk of perforation. 
SEMS were developed in the early 1990s. Their design allows them to be preloaded onto a 
delivery mechanism typically measuring 5-10mm in diameter. Consequently little or no 
dilatation is needed prior to stent insertion. Oesophageal SEMS are deployed over a 
guidewire after delineating the margins of the stricture endoscopically. Although the stents 
are usually deployed under fluoroscopic guidance, increasingly many endoscopists deploy 
them under direct endoscopic vision with the endoscope positioned alongside the 
guidewire–stent assembly. The diameter of most fully deployed oesophageal SEMS varies 
between 16 and 24 mm and their length varies between 7 and 15 cm. SEMS are usually 
partially or fully covered with a membrane to prevent tumour ingrowth through the metal 
mesh. 
Early studies comparing traditional rigid plastic stents and SEMS demonstrated the 
superiority of the latter in several domains. Knyrim et al (1993) compared the two types of 
stents and showed SEMS and rigid plastic stents to be equivalent in their improvement of 
dysphagia, 30 day mortality and re-intervention rates. However, metal stents were 
associated with fewer complications, shorter hospitalisation after stent placement and 
superior cost effectiveness (Knyrim et al., 1993). Subsequent randomised studies and a 
retrospective review produced similar results (De Palma et al., 1996; Roseveare et al., 1998; 
Eickhoff et al., 2005). Furthermore, the perforation rates and early mortality rates were lower 
in those patients receiving SEMS. Rigid plastic stents are no longer used in oesophageal 
cancer. 
Although the procedure-related complication rates are lower with SEMS, these devices are 
still subject to late complications including stent migration and stent occlusion due to food 
bolus or tumour overgrowth. One study has suggested that such late complications are 
more common with SEMS compared to rigid plastic stents (Kozarek et al., 1996). In a 
retrospective study of SEMS for malignant dysphagia, repeat endoscopy to address 
complications was needed in 46 of 97 patients, and in 10 of these a further stent had to be 
inserted (Ross et al., 2007). Acid reflux frequently occurs when stents are placed across, and 
thus hold open, the gastro-oesophageal junction. Patients with stents traversing the gastro-
oesophageal junction should experience fewer reflux symptoms if they take acid 
suppressive drugs to decrease gastric acid production, prokinetic drugs to hasten stomach 
emptying, avoid eating within 2-3 hours of bed-time, and elevate the head of the bed. 
Despite these measures patients can still experience significant reflux symptoms and 
consequently stents with inherent anti-reflux mechanisms have been developed e.g. the 
Oesophageal Z stent with Dua anti-reflux valve ®, (Cook Medical, Bloomington, USA), and the 
FerX-ELLA Esophageal Stent – Boubella ®, (ELLA-CS, Hradec-Kralove, Czech Republic). 
3.1 Types of expandable oesophageal stents used for oesophageal cancer 
The majority of commercially available oesophageal SEMS are made of nitinol or stainless 
steel. Covered stents are less prone to tumour ingrowth, but more prone to migration. 
Consequently partially covered stents have been developed. These have a central covered 
portion which is placed across the oesophageal tumour with the two ends left uncovered to 
allow embedding and anchoring into the adjacent tissue. Patients with partially covered stents 
have less tumour ingrowth and fewer interventions for recurrent dysphagia than patients with 
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collagen and fibrous tissue. A chronic lymphocytic reaction occurs in the normal tissue 
underlying the proximal and distal ends of the stent (Bethge et al.,1996). Once in situ the 
stent should be MRI compatible. 
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patients with advanced inoperable disease or in patients too frail to have chemotherapy or 
radiotherapy. 
The first stents used in malignant dysphagia were rigid plastic stents. Placing such rigid 
stents, and the necessary prior stricture dilatation carried a substantial risk of perforation. 
SEMS were developed in the early 1990s. Their design allows them to be preloaded onto a 
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partially or fully covered with a membrane to prevent tumour ingrowth through the metal 
mesh. 
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stents and showed SEMS and rigid plastic stents to be equivalent in their improvement of 
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retrospective review produced similar results (De Palma et al., 1996; Roseveare et al., 1998; 
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in those patients receiving SEMS. Rigid plastic stents are no longer used in oesophageal 
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still subject to late complications including stent migration and stent occlusion due to food 
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inserted (Ross et al., 2007). Acid reflux frequently occurs when stents are placed across, and 
thus hold open, the gastro-oesophageal junction. Patients with stents traversing the gastro-
oesophageal junction should experience fewer reflux symptoms if they take acid 
suppressive drugs to decrease gastric acid production, prokinetic drugs to hasten stomach 
emptying, avoid eating within 2-3 hours of bed-time, and elevate the head of the bed. 
Despite these measures patients can still experience significant reflux symptoms and 
consequently stents with inherent anti-reflux mechanisms have been developed e.g. the 
Oesophageal Z stent with Dua anti-reflux valve ®, (Cook Medical, Bloomington, USA), and the 
FerX-ELLA Esophageal Stent – Boubella ®, (ELLA-CS, Hradec-Kralove, Czech Republic). 
3.1 Types of expandable oesophageal stents used for oesophageal cancer 
The majority of commercially available oesophageal SEMS are made of nitinol or stainless 
steel. Covered stents are less prone to tumour ingrowth, but more prone to migration. 
Consequently partially covered stents have been developed. These have a central covered 
portion which is placed across the oesophageal tumour with the two ends left uncovered to 
allow embedding and anchoring into the adjacent tissue. Patients with partially covered stents 
have less tumour ingrowth and fewer interventions for recurrent dysphagia than patients with 
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bare metal stents (Vakil et al; 2001; Saranovic et al., 2005). Studies comparing different 
commercially available covered stents have shown all the studied stents to have similar 
efficacy and complication rates (May et al., 1996; Sabharawal et al., 2003; Siersema et al., 2001). 
 
 
Fig. 5. Endoscopic view immediately after deployment of a SEMS for oesophageal cancer 
In addition to SEMS, an self-expanding plastic stent made of polyester and covered with 
silicone (Polyflex®, Boston Scientific, Natick, MA, USA) has become available. Randomised 
controlled studies have shown that it can be successfully placed in the majority of cases and 
produces similar improvements in dysphagia when compared to SEMS (Conio et al., 2007; 
Verschuur et al., 2008). However, self-expanding plastic stents are associated with more 
complications, in particular stent migration (Conio et al., 2007), and for this reason are not 
routinely used for the treatment of malignant oesophageal obstruction. 
3.2 Effect of oesophageal stenting on symptom palliation and quality of life 
SEMS improve swallowing in malignant dysphagia. When formally studied, SEMS have 
consistently been shown to improve dysphagia scores (Knyrim et al., 1993). Oesophageal 
SEMS enable patients to ingest semi-solids but rarely improve dysphagia to the point of 
taking a completely normal diet. Patients with SEMS run the risk of causing food bolus 
obstruction if they attempt to take an unrestricted diet. Roast meats and crusty bread are 
particular culprits in blocking stents. In addition to the symptomatic improvement some 
studies have documented a benefit in the overall quality of life (Diamantis et al., 2011). 
Karnofsky scores were shown to significantly improve from a median of 40 before SEMS 
insertion to a median of 65 after SEMS insertion (Knyrim et al., 1993). Other advantages of 
SEMS include nutritional benefits, with patients receiving SEMS enjoying food more and 
maintaining their weight longer compared to patient receiving rigid plastic stents 
(Roseveare et al., 1998). 
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3.3 Comparison of stenting with other palliative treatments in malignant dysphagia 
Alternative treatments for malignant dysphagia include endoscopic laser and brachytherapy. 
A multi-centre randomised trial found that SEMS improved dysphagia quicker than single 
dose brachytherapy, but brachytherapy was associated with better long term improvements in 
dysphagia, fewer complications and better quality of life scores (Homs et al., 2004). A Belgian 
centre retrospectively compared 125 patients with malignant dysphagia treated with 
endoscopic laser, rigid plastic stents and SEMS. Dysphagia improved significantly in all 3 
groups but the rate of complications was significantly higher in both stent groups, compared 
to endoscopic laser (Gevers et al., 1998). In a prospective comparison, SEMS insertion was as 
safe and effective as laser combined with radiotherapy for inoperable oesophageal cancer 
(Königsrainer et al., 2000). SEMS insertion seems to be the preferred option for treating 
malignant dysphagia, since SEMS are widely available, relatively easy to place endoscopically 
or under fluoroscopic guidance, and provide rapid symptom relief. Brachytherapy, although 
efficacious remains a treatment that is not widely available. 
3.4 Stents for benign oesophageal peptic strictures  
Benign oesophageal strictures are most commonly caused by chronic reflux of gastric acid 
into the distal oesophagus. Such benign peptic strictures can lead to significant dysphagia. 
They are normally readily treated by endoscopic dilatation and acid suppression therapy. 
Rarely, the stricture repeatedly recurs within a few weeks. In these patients alternative 
treatments to repeated dilatation and acid suppressants may be needed. Although surgery is 
the mainstay of treatment in these refractory cases, oesophageal stenting should be 
considered in those less suitable for surgery. The ideal oesophageal stent for use in benign 
disease should, as with malignant disease, be easy to place, use a small calibre delivery 
mechanism and have a low rate of migration. However it should also be easy to retrieve, 
easy to reposition, and have low rates of insertion and removal related complications 
(Sharma & Kozarek, 2010). 
Data on the use of SEMS in benign oesophageal strictures come from case reports and case 
series. These reports show that SEMS are associated with high rates of complications. The 
most commonly reported are stent migration occurring in 12.5-31%, new stricture formation 
in 20-100% and fistula formation in 6-33% of patients (Sandha & Marcon, 1999; Fiorini et al., 
2000; Ackroyd et al., 2001; Wadhwa et al., 2003). Stent migration is more likely to occur with 
covered stents while uncovered stents or partially covered stents become embedded in the 
tissue making their removal difficult and traumatic. These complications rates are generally 
felt to be too high to justify in the treatment of benign disease. Therefore SEMS are best 
avoided in benign oesophageal strictures (Sharma & Kozarek, 2010). 
In distinction to metal stents, expandable plastic stents such as the removable Polyflex® stent 
have been increasingly studied in benign oesophageal strictures that do not respond to 
conventional treatments. A recent meta-analysis of fully covered self-expanding metal and 
plastic stents has shown that the improvement in dysphagia was significantly better in 
patients receiving a Polyflex® stent (55.3%) compared to those receiving a nitinol stent 
(21.8%) (Thomas et al., 2011). 
A more exciting prospect in the treatment of benign oesophageal conditions has been the 
recent development of biodegradable stents. Such stents are designed to stay in place for a 
few weeks before disintegrating. This avoids the need for further procedures to remove the 
stent. Some small series have now reported on their efficacy in benign strictures (Saito et al., 
2007; Repici et al., 2010).  
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3.5 Stents for malignant tracheo-oesophageal fistulas 
Malignant tracheo-oesophageal fistulas may arise from infiltration of oesophageal cancers into 
the respiratory tract, or cancers of the trachea and bronchi infiltrating into the oesophagus. 
These life-threatening connections between the digestive tract and the airways are usually 
difficult to treat and are associated with poor prognosis. Patients receiving best supportive 
treatment survive a median of 22 days (Burt et al., 1991).There are no randomised controlled 
data on the use of SEMS in these patients. However, several case series have demonstrated 
that covered SEMS can lead to fistula occlusion in 70-100% of patients (May & Ell, 1998). A 
retrospective study has shown covered SEMS to be more successful at fistula occlusion 
compared to rigid plastic stents, 92% vs. 77% (Low & Kozarek, 1998). Furthermore, successful 
occlusion of the fistula was associated with improved 30 day survival, 90% vs. 25% 
(Dumonceau et al., 1999) and overall survival, 15.1 vs. 6.2 weeks (Shin et al., 2004).  
3.6 Stents for oesophageal perforations and leaks 
Spontaneous and iatrogenic perforations of the oesophagus also carry a very high mortality 
and morbidity. Early diagnosis and prompt treatment are essential to achieve a good 
outcome. 
Spontaneous oesophageal perforation as a result of vomiting (Boerhaave’s syndrome) is a 
surgical emergency, requiring surgical intervention within hours of the perforation. Rarely, 
patients present late and there have been a handful of reports of oesophageal SEMS being 
used in the treatment of spontaneous oesophageal perforations if the patient has presented 
late (Eubanks et al., 1999; Chung et al., 2001).  
Iatrogenic perforations of the oesophagus are more common than spontaneous perforations. 
They usually occur at endoscopy, most frequently when malignant stricture dilatation is 
undertaken. The diagnosis of perforation is usually obvious and rapid. Although iatrogenic 
oesophageal perforation is life-threatening, contamination of the mediastinum and pleural 
space with stomach contents is less problematic compared to spontaneous perforation, since 
the patient is fasted. Small case series have shown that insertion of a covered SEMS, together 
with thoracostomy tube drainage of the pleural space and antibiotic administration is a 
successful strategy in sealing off iatrogenic perforations (Siersema et al., 2003). Prompt stent 
insertion (average delay 45 minutes) after iatrogenic oesophageal perforation leads to 
minimal morbidity compared to delayed treatment, and produces results similar to surgical 
treatment (Fischer et al., 2006). It has to be emphasised that the clinical state of patients may 
individualise therapy for oesophageal perforations; although most centres consider surgery 
as first-line therapy (Keeling et al., 2010; Kiernan et al., 2010), endoscopic stenting is an 
option in many patients (Johnsson et al., 2005; van Heel et al., 2010). 
3.7 Oesophageal stenting for anastomotic leaks 
Post-operative anastomotic leaks are another area where oesophageal stents are increasingly 
used. Case series of anastomotic leaks following upper gastrointestinal surgery have 
demonstrated high success and low complications rates, with patients returning to eating 2 
days after stent insertion. 
3.8 Stenting for bleeding oesophageal varices 
Oesophageal stents have recently been used to arrest bleeding from oesophageal varices in 
patients with portal hypertension. Bleeding from oesophageal varices has a high mortality, 
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especially in patients with advanced liver disease. Bleeding is usually controlled by 
endoscopic band ligation of the varices, and vasopressor medication to decrease portal 
pressure. If these measures fail, the bleeding can be controlled with the insertion of a 
Sengstaken-Blakemore tube which tamponades the varices. Balloon tamponade is a 
temporary measure often used as a bridge to treatment with a transjugular intrahepatic 
portosystemic stent shunt (TIPSS). 
A covered self-expanding oesophageal stent (SX-Ella Stent Danis®,ELLA-CS, Hradec-Kralove, 
Czech Republic) has recently been developed as another treatment option in variceal bleeding. 
It is an alternative to balloon tamponade in patients who are not suitable for TIPSS or in whom 
Sengstaken-Blakemore tube insertion is not possible, has failed or is complicated by 
oesophageal perforation. The SX-Ella Stent Danis® delivery mechanism is inserted over a 
guidewire that has been endoscopically placed in the stomach. The endoscope is then 
withdrawn and the delivery mechanism advanced through the oesophagus into the stomach. 
A balloon located at the stent’s distal end is then inflated, and the whole mechanism is 
withdrawn until the balloon reaches the cardia and resistance is felt. The stent, now positioned 
in the distal oesophagus can be deployed, followed by balloon deflation and removal of the 
delivery mechanism. The stent can also be placed without prior endoscopy in emergency 
situations. Once deployed, the tamponading stent permits ongoing oral nutrition, unlike 
balloon tamponade. Case series show that such stents are efficacious in bleeding oesophageal 
varices. They can be successfully placed in the majority of patients and are removed within 14 
days of insertion. The only complication that has been reported is of oesophageal ulceration 
(Hubmann et al., 2006; Zehetner et al., 2008; Wright et al., 2010). 
4. Gastroduodenal stents 
Recurrent and distressing vomiting due to gastric outlet obstruction occurs in some patients 
with pancreatic cancer, distal gastric cancer, duodenal cancer and some metastatic cancers. 
Most of these patients have advanced and inoperable disease, and only a few months of life 
remaining. Until recently the only treatment to prevent relentless vomiting and allow oral 
nutrition was the fashioning of a surgical gastroenterostomy to bypass the antro-pyloro-
duodenal region. Even though such surgery can now often be done laparoscopically, 
complications are not uncommon in such patients who are often malnourished and 
frequently have comorbidities. The development of gastroduodenal stent insertion offers a 
noninvasive means of palliating vomiting without surgery (Martin & Laasch, 2004; Lowe et 
al., 2007; Kim et al., 2007).  
Gastroduodenal stents are of the SEMS variety and are positioned under direct endoscopic 
vision, and with fluoroscopic guidance. Before stent placement is attempted, a period of 
gastric drainage using a wide-bore nasogastric tube is recommended. Drainage of gastric 
contents will improve endoscopic views and reduce the risk of vomiting and aspiration 
during the procedure. At endoscopy, the stricture’s proximal anatomy is assessed but 
usually the endoscope’s diameter is too large to allow safe negotiation through the stricture. 
The stricture can be outlined by fluoroscopy after the injection of a contrast agent. A 
guidewire is then passed down the operating channel of a therapeutic endoscope and 
advanced through the stricture. The stent assembly is then passed over the wire and 
positioned so that its ends overlap the ends of the stricture. Once fluoroscopy confirms a 
satisfactory position, the SEMS is deployed. An alternative method of gastroduodenal stent 
insertion involves a radiologist placing the stent via the oral route using fluoroscopy alone.  
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3.5 Stents for malignant tracheo-oesophageal fistulas 
Malignant tracheo-oesophageal fistulas may arise from infiltration of oesophageal cancers into 
the respiratory tract, or cancers of the trachea and bronchi infiltrating into the oesophagus. 
These life-threatening connections between the digestive tract and the airways are usually 
difficult to treat and are associated with poor prognosis. Patients receiving best supportive 
treatment survive a median of 22 days (Burt et al., 1991).There are no randomised controlled 
data on the use of SEMS in these patients. However, several case series have demonstrated 
that covered SEMS can lead to fistula occlusion in 70-100% of patients (May & Ell, 1998). A 
retrospective study has shown covered SEMS to be more successful at fistula occlusion 
compared to rigid plastic stents, 92% vs. 77% (Low & Kozarek, 1998). Furthermore, successful 
occlusion of the fistula was associated with improved 30 day survival, 90% vs. 25% 
(Dumonceau et al., 1999) and overall survival, 15.1 vs. 6.2 weeks (Shin et al., 2004).  
3.6 Stents for oesophageal perforations and leaks 
Spontaneous and iatrogenic perforations of the oesophagus also carry a very high mortality 
and morbidity. Early diagnosis and prompt treatment are essential to achieve a good 
outcome. 
Spontaneous oesophageal perforation as a result of vomiting (Boerhaave’s syndrome) is a 
surgical emergency, requiring surgical intervention within hours of the perforation. Rarely, 
patients present late and there have been a handful of reports of oesophageal SEMS being 
used in the treatment of spontaneous oesophageal perforations if the patient has presented 
late (Eubanks et al., 1999; Chung et al., 2001).  
Iatrogenic perforations of the oesophagus are more common than spontaneous perforations. 
They usually occur at endoscopy, most frequently when malignant stricture dilatation is 
undertaken. The diagnosis of perforation is usually obvious and rapid. Although iatrogenic 
oesophageal perforation is life-threatening, contamination of the mediastinum and pleural 
space with stomach contents is less problematic compared to spontaneous perforation, since 
the patient is fasted. Small case series have shown that insertion of a covered SEMS, together 
with thoracostomy tube drainage of the pleural space and antibiotic administration is a 
successful strategy in sealing off iatrogenic perforations (Siersema et al., 2003). Prompt stent 
insertion (average delay 45 minutes) after iatrogenic oesophageal perforation leads to 
minimal morbidity compared to delayed treatment, and produces results similar to surgical 
treatment (Fischer et al., 2006). It has to be emphasised that the clinical state of patients may 
individualise therapy for oesophageal perforations; although most centres consider surgery 
as first-line therapy (Keeling et al., 2010; Kiernan et al., 2010), endoscopic stenting is an 
option in many patients (Johnsson et al., 2005; van Heel et al., 2010). 
3.7 Oesophageal stenting for anastomotic leaks 
Post-operative anastomotic leaks are another area where oesophageal stents are increasingly 
used. Case series of anastomotic leaks following upper gastrointestinal surgery have 
demonstrated high success and low complications rates, with patients returning to eating 2 
days after stent insertion. 
3.8 Stenting for bleeding oesophageal varices 
Oesophageal stents have recently been used to arrest bleeding from oesophageal varices in 
patients with portal hypertension. Bleeding from oesophageal varices has a high mortality, 
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especially in patients with advanced liver disease. Bleeding is usually controlled by 
endoscopic band ligation of the varices, and vasopressor medication to decrease portal 
pressure. If these measures fail, the bleeding can be controlled with the insertion of a 
Sengstaken-Blakemore tube which tamponades the varices. Balloon tamponade is a 
temporary measure often used as a bridge to treatment with a transjugular intrahepatic 
portosystemic stent shunt (TIPSS). 
A covered self-expanding oesophageal stent (SX-Ella Stent Danis®,ELLA-CS, Hradec-Kralove, 
Czech Republic) has recently been developed as another treatment option in variceal bleeding. 
It is an alternative to balloon tamponade in patients who are not suitable for TIPSS or in whom 
Sengstaken-Blakemore tube insertion is not possible, has failed or is complicated by 
oesophageal perforation. The SX-Ella Stent Danis® delivery mechanism is inserted over a 
guidewire that has been endoscopically placed in the stomach. The endoscope is then 
withdrawn and the delivery mechanism advanced through the oesophagus into the stomach. 
A balloon located at the stent’s distal end is then inflated, and the whole mechanism is 
withdrawn until the balloon reaches the cardia and resistance is felt. The stent, now positioned 
in the distal oesophagus can be deployed, followed by balloon deflation and removal of the 
delivery mechanism. The stent can also be placed without prior endoscopy in emergency 
situations. Once deployed, the tamponading stent permits ongoing oral nutrition, unlike 
balloon tamponade. Case series show that such stents are efficacious in bleeding oesophageal 
varices. They can be successfully placed in the majority of patients and are removed within 14 
days of insertion. The only complication that has been reported is of oesophageal ulceration 
(Hubmann et al., 2006; Zehetner et al., 2008; Wright et al., 2010). 
4. Gastroduodenal stents 
Recurrent and distressing vomiting due to gastric outlet obstruction occurs in some patients 
with pancreatic cancer, distal gastric cancer, duodenal cancer and some metastatic cancers. 
Most of these patients have advanced and inoperable disease, and only a few months of life 
remaining. Until recently the only treatment to prevent relentless vomiting and allow oral 
nutrition was the fashioning of a surgical gastroenterostomy to bypass the antro-pyloro-
duodenal region. Even though such surgery can now often be done laparoscopically, 
complications are not uncommon in such patients who are often malnourished and 
frequently have comorbidities. The development of gastroduodenal stent insertion offers a 
noninvasive means of palliating vomiting without surgery (Martin & Laasch, 2004; Lowe et 
al., 2007; Kim et al., 2007).  
Gastroduodenal stents are of the SEMS variety and are positioned under direct endoscopic 
vision, and with fluoroscopic guidance. Before stent placement is attempted, a period of 
gastric drainage using a wide-bore nasogastric tube is recommended. Drainage of gastric 
contents will improve endoscopic views and reduce the risk of vomiting and aspiration 
during the procedure. At endoscopy, the stricture’s proximal anatomy is assessed but 
usually the endoscope’s diameter is too large to allow safe negotiation through the stricture. 
The stricture can be outlined by fluoroscopy after the injection of a contrast agent. A 
guidewire is then passed down the operating channel of a therapeutic endoscope and 
advanced through the stricture. The stent assembly is then passed over the wire and 
positioned so that its ends overlap the ends of the stricture. Once fluoroscopy confirms a 
satisfactory position, the SEMS is deployed. An alternative method of gastroduodenal stent 
insertion involves a radiologist placing the stent via the oral route using fluoroscopy alone.  
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Once a gastroduodenal stent has been sited, patients can resume oral intake without 
vomiting. Patients should be advised to chew all foods well, and initially a soft diet is 
recommended. Patients who remain on a semi-solid diet are less likely to experience food 
impaction in their stent, but many patients are able to tolerate all food consistencies. 
Following gastroduodenal stent insertion, potential early complications include bleeding 
and perforation. Late complications include distal stent migration, and stent obstruction by 
tumour ingrowth, reactive tissue hyperplasia, tumor overgrowth, and food impaction.  
4.1 Endoscopic stenting v. gastrojejunostomy in malignant gastric outlet obstruction 
Most comparisons of gastroduodenal stent insertion with surgical gastrojejunostomy in 
malignant outlet obstruction have been retrospective. There is little in the way of large 
randomised trial data prospectively comparing these two palliative procedures. Despite the 
limitations of studies to date, some conclusions can be drawn (Gaidos & Draganov, 2009; Ly 
et al., 2010). Compared to surgical gastrojejunostomy, gastroduodenal stent insertion is 
associated with a shorter hospital stay, fewer costs (Johnsson et al., 2004) and fewer 
complications at the time of intervention. Stent insertion also leads to faster resumption of 
oral food intake than surgical gastrojejunostomy (Maettani et al., 2004; Ly et al., 2010). 
However, in the longer term there may be stent migration or obstruction, and long term 
results are better with surgery (Jeurnink et al., 2010).  
4.2 Combined biliary and gastric outlet obstruction 
By the time an inoperable pancreatic cancer causes gastric outlet obstruction, there has often 
already been biliary obstruction. Endoscopic access to the duodenal papilla is important for 
biliary stenting and jaundice relief (see below). A gastroduodenal stent will cover the 
duodenal papilla, but with an uncovered stent some endoscopic access to the papilla can be 
achieved through the holes in the metal mesh. However it is technically very difficult to 
perform biliary stenting though the mesh of an uncovered metal duodenal stent, and biliary 
stent insertion or exchange is more readily achieved percutaneously via the transhepatic 
cholangiographic route once a gastroduodenal stent is present. Covered gastroduodenal 
stents will further confound endoscopic access to the duodenal papilla and impede 
percutaneous biliary stent placement, as well as being more likely to migrate. Consequently 
uncovered gastroduodenal stents are most frequently used in gastric outlet obstruction due 
to pancreatic head cancers.  
Simultaneous biliary and gastroduodenal metal stenting can be done in patients with 
inoperable pancreatic cancers causing obstructive jaundice and gastric outlet obstructive 
symptoms (Kaw et al., 2003; Mutignani et al., 2007). Whenever a gastroduodenal stent is to 
be inserted in a pancreatic cancer patient, consideration should be given to initially stenting 
the bile duct. A pre-existing plastic biliary stent can be changed for a wider biliary SEMS 
before the gastroduodenal stent is placed. If the duodenal obstruction does not allow 
passage of the duodenoscope to reach the ampullary region, then transhepatic insertion of a 
biliary SEMS should be considered prior to placing the gastroduodenal stent. 
5. Biliary stents  
5.1 Biliary strictures 
Biliary stents are inserted at Endoscopic Retrograde Cholangio-Pancreatography (ERCP) 
in the setting of malignant bile duct strictures (pancreatic head cancers and 
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cholangiocarcinomas). At ERCP, biliary stents are positioned through a side-viewing 
duodenoscope under direct endoscopic vision, and with fluoroscopic guidance. Despite 
advances in healthcare, most patients with malignant biliary strictures are not surgically 
curable. The obstructive jaundice and pruritus arising from blockage to the flow of bile 
into the duodenum can be very distressing. Endoscopic biliary stenting at ERCP provides 
relief from obstructive jaundice and pruritus, with associated improvement in quality of 
life (Ballinger et al., 1994). Stents used can be plastic or SEMS. Prior to the development of 
endoscopic stenting, relief of obstructive jaundice in unresectable malignant disease 
required a surgical biliary bypass operation. The first endoscopic transpapillary biliary 
stent insertion was performed in 1979 (Soehendra et al., 1980). 
 
  
Fig. 6. Diagram of a SEMS deployed in distal bile duct at ERCP (left panel), and endoscopic 
view of a plastic biliary stent protruding from the duodenal ampulla in a patient with 
pancreatic cancer (right panel) 
5.1.1 Role of stenting in obstructive jaundice due to operable pancreatic head 
carcinoma 
Approximately 20% of patients with pancreatic cancer have localised disease making a 
surgical resection technically possible. Surgical candidates for the required 
pancreaticoduodenectomy (Whipple’s procedure) may require preoperative biliary stenting 
to improve symptoms of obstructive jaundice while awaiting surgery. Furthermore, 
traditional surgical teaching has stated that operating in the presence of obstructive jaundice 
is linked to increased postoperative complications, and that the biochemical correction of 
jaundice preoperatively is linked to fewer surgical complications. However there are now 
increasing data indicating that preoperative biliary drainage using plastic stents may not 
actually be beneficial but may even be associated with more complications, particularly 
from cholangitis (van der Gaag et al., 2010). Therefore, if there is no time delay to surgical 
resection, preoperative biliary drainage using endoscopic stenting is best avoided.  
5.1.2 Biliary stenting v. surgery for jaundice in unresectable pancreatic head carcinoma 
Most (80%) patients with pancreatic head cancers and consequent biliary tract obstruction 
are not candidates for surgical resection. This is because of locally advanced disease 
(particularly infiltration of the major mesenteric vessels) or distant metastases, or patient 
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biliary SEMS should be considered prior to placing the gastroduodenal stent. 
5. Biliary stents  
5.1 Biliary strictures 
Biliary stents are inserted at Endoscopic Retrograde Cholangio-Pancreatography (ERCP) 
in the setting of malignant bile duct strictures (pancreatic head cancers and 
 
Stents in Gastrointestinal Endoscopy 
 
125 
cholangiocarcinomas). At ERCP, biliary stents are positioned through a side-viewing 
duodenoscope under direct endoscopic vision, and with fluoroscopic guidance. Despite 
advances in healthcare, most patients with malignant biliary strictures are not surgically 
curable. The obstructive jaundice and pruritus arising from blockage to the flow of bile 
into the duodenum can be very distressing. Endoscopic biliary stenting at ERCP provides 
relief from obstructive jaundice and pruritus, with associated improvement in quality of 
life (Ballinger et al., 1994). Stents used can be plastic or SEMS. Prior to the development of 
endoscopic stenting, relief of obstructive jaundice in unresectable malignant disease 
required a surgical biliary bypass operation. The first endoscopic transpapillary biliary 
stent insertion was performed in 1979 (Soehendra et al., 1980). 
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to improve symptoms of obstructive jaundice while awaiting surgery. Furthermore, 
traditional surgical teaching has stated that operating in the presence of obstructive jaundice 
is linked to increased postoperative complications, and that the biochemical correction of 
jaundice preoperatively is linked to fewer surgical complications. However there are now 
increasing data indicating that preoperative biliary drainage using plastic stents may not 
actually be beneficial but may even be associated with more complications, particularly 
from cholangitis (van der Gaag et al., 2010). Therefore, if there is no time delay to surgical 
resection, preoperative biliary drainage using endoscopic stenting is best avoided.  
5.1.2 Biliary stenting v. surgery for jaundice in unresectable pancreatic head carcinoma 
Most (80%) patients with pancreatic head cancers and consequent biliary tract obstruction 
are not candidates for surgical resection. This is because of locally advanced disease 
(particularly infiltration of the major mesenteric vessels) or distant metastases, or patient 
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frailty/comorbidities. Until the advent of biliary stenting, obstructive jaundice and 
pruritus could only be relieved by a palliative surgical biliary bypass procedure 
(cholecystojejunostomy or choledochojejunostomy). The introduction of plastic biliary 
stent placement at ERCP has allowed a non-invasive means of palliating jaundice and 
pruritus. Comparative trials of plastic stent placement with biliary bypass operations have 
shown similar survival outcomes, but stenting is associated with fewer complications, less 
use of resources and a shorter period of hospitalisation (Shepherd et al., 1988; Andersen et 
al., 1989; Smith et al., 1994; Moss et al., 2007). However plastic biliary stenting is 
associated with a higher risk of recurrent biliary obstruction than surgery. There have 
been no direct prospective trials comparing SEMS with biliary bypass surgery.  
5.1.3 Plastic stents v. SEMS in unresectable pancreatic head carcinoma 
Plastic stents tend to become blocked with biliary sludge and bacterial biofilm formation. A 
standard plastic 10 Fr stent may only last 3-5 months. A blocked stent will lead to a 
recurrence of jaundice and frequently cholangitis too. In the setting of inoperable pancreatic 
head cancer, the short life-span of the plastic stent is often greater than the life expectancy of 
the patient. Therefore although there is no doubt that modern biliary SEMS are less likely to 
become blocked (Davids et al., 1992; Moss et al., 2007; Weber et al., 2009), their superior 
patency over plastic stents will not become manifest in pancreatic head cancer patients with 
short life expectancy (Moss et al., 2006; Gronroos et al., 2010). 
 
  
Fig. 7. ERCP images in a patient with carcinoma of head of pancreas. A wire has been placed 
across a stricture of the distal common bile duct into the dilated obstructed biliary system 
above (left hand image). Following insertion of a plastic stent (right hand image).  
Wider plastic stents will remain patent for longer, but 12 Fr currently represents the maximum 
diameter of a plastic biliary stent since it is limited by the diameter of the duodenoscope’s 
operating channel. Biliary stents, whether plastic or metal, traverse the Sphincter of Oddi 
which is the physiological barrier preventing bacteria from the duodenum refluxing into the 
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biliary system. Since occlusion of biliary stents is in part due to bacterial biofilm formation, 
consideration has been given to prolonging stent patency by impregnating stents with 
antimicrobial agents or coating them with silver or hydrophilic polymer which reduce 
bacterial adhesion. However these approaches are based on in vitro observations and have not 
been translated into clinical advantage (Schilling et al., 2003; Donelli et al., 2007). Similarly 
administering oral antibiotics or using the choleretic agent ursodeoxycholic acid does not 
reliably lead to prolongation of plastic stent patency (Galandi et al., 2002). 
For patients with inoperable pancreatic head cancer whose survival is predicted to be 
several months or longer, and for patients who cannot undergo resective surgery for distal 
common bile duct cholangiocarcinomas or ampullary tumours (both slower growing than 
pancreatic cancers), SEMS placement is superior to plastic stent placement. Biliary SEMS 
remain patent for longer periods than plastic stents (Moss et al., 2006). At least in part this is 
due to the fact that the diameter of a biliary SEMS is three times that of plastic stent. Biliary 
SEMS are far more costly than plastic stents, but their use is justified in patients whose 
survival is predicted to be more than 6 months since a repeat endoscopic procedure to 
replace an occluded plastic stent is likely to be needed by then. Although SEMS 
undoubtedly have greater patency, tumour tissue may grow through the gaps in the metal 
mesh leading to subsequent occlusion. The stent can be unblocked by trawling a balloon 
through its lumen, by using diathermy devices or by placing another (metal or plastic) stent 
within it. Tumour ingrowth can be offset by using silicone-covered biliary stents, but as with 
all covered stents these are more likely to migrate, compared to uncovered bare metal stents. 
In the constant quest to improve stent design, a biliary SEMS incorporating a novel 
antireflux device has been developed with the hope that preventing reflux of duodenal 
contents into the biliary tract will aid stent patency (Hu et al., 2011). 
 
 
Fig. 8. SEMS being deployed across a malignant stricture of the common bile duct at 
transhepatic cholangiography 
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biliary system. Since occlusion of biliary stents is in part due to bacterial biofilm formation, 
consideration has been given to prolonging stent patency by impregnating stents with 
antimicrobial agents or coating them with silver or hydrophilic polymer which reduce 
bacterial adhesion. However these approaches are based on in vitro observations and have not 
been translated into clinical advantage (Schilling et al., 2003; Donelli et al., 2007). Similarly 
administering oral antibiotics or using the choleretic agent ursodeoxycholic acid does not 
reliably lead to prolongation of plastic stent patency (Galandi et al., 2002). 
For patients with inoperable pancreatic head cancer whose survival is predicted to be 
several months or longer, and for patients who cannot undergo resective surgery for distal 
common bile duct cholangiocarcinomas or ampullary tumours (both slower growing than 
pancreatic cancers), SEMS placement is superior to plastic stent placement. Biliary SEMS 
remain patent for longer periods than plastic stents (Moss et al., 2006). At least in part this is 
due to the fact that the diameter of a biliary SEMS is three times that of plastic stent. Biliary 
SEMS are far more costly than plastic stents, but their use is justified in patients whose 
survival is predicted to be more than 6 months since a repeat endoscopic procedure to 
replace an occluded plastic stent is likely to be needed by then. Although SEMS 
undoubtedly have greater patency, tumour tissue may grow through the gaps in the metal 
mesh leading to subsequent occlusion. The stent can be unblocked by trawling a balloon 
through its lumen, by using diathermy devices or by placing another (metal or plastic) stent 
within it. Tumour ingrowth can be offset by using silicone-covered biliary stents, but as with 
all covered stents these are more likely to migrate, compared to uncovered bare metal stents. 
In the constant quest to improve stent design, a biliary SEMS incorporating a novel 
antireflux device has been developed with the hope that preventing reflux of duodenal 
contents into the biliary tract will aid stent patency (Hu et al., 2011). 
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5.1.4 Biliary stenting in obstructive jaundice due to unresectable hilar malignancies 
Malignant biliary obstruction at the liver hilum is usually due to cholangiocarcinoma, a 
primary cancer originating from the biliary ductal system (Aljiffry et al., 2009). Metastatic 
cancer infiltrating lymph nodes at the liver hilum can also cause stricturing at this site. 
While the most proximal cholangiocarcinomas originate from either the right or the left 
intrahepatic ductal system, cholangiocarcinomas more commonly involve the confluence of 
the two ductal systems where they join to form the common hepatic duct and are then 
known as hilar tumours. These intrahepatic and hilar chlangiocarcinomas often cause 
obstructive jaundice and pruritus. The only chance of a cure is a hepatic resection, but for 
many patients this is not an option due to advanced disease or due to frailty/comorbidities. 
In unresectable disease, palliation of jaundice and pruritus may be achieved by biliary 
stenting.  
Stenting across malignant hilar strictures can be technically challenging at ERCP. Prior 
imaging of the biliary ductal system using Magnetic Resonance Cholangio-Pancreatography 
(MRCP) provides invaluable information before stenting is attempted. Strictures at the liver 
hilum may be complex and it may not be possible to drain obstructed liver segments at 
ERCP. There is a significant risk of causing cholangitis by injecting contrast medium into 
undrained ductal segments, therefore drainage of contrast-filled obstructed biliary branches 
is crucial. There has been much debate about the importance of establishing drainage of 
both liver lobes in malignant hilar obstruction. Although the right hepatic duct drains a 
greater volume of liver than the left hepatic duct, successful stenting of either side achieves a 
similar symptomatic and biochemical improvement (Polydoru et al., 1989). A randomised 
trial comparing the insertion of a single plastic stent to drain one side of the liver with 
placing two plastic stents to drain both sides, found that there was no advantage in placing 
two stents. Attempts to place two stents were associated with more complications, 
particularly cholangitis (de Palma et al., 2001). Extrapolating from this, it would seem that 
that if endoscopic stenting is to be performed for malignant hilar strictures, then a single 
SEMS is the best strategy. As with distal biliary strictures SEMS are less likely than plastic 
stents to occlude (Perdue at al., 2008).  
Satisfactory biliary drainage of hilar strictures may not be possible at ERCP. Percutaneous 
hepatic drainage and stenting can be performed by an interventional radiologist if initial 
ERCP is unsuccessful, or if following endoscopic stenting there are undrained hepatic 
segments requiring treatment. Percutaneous stenting is performed using local anaesthetic 
and with intravenous sedation. Initial percutaneous transhepatic cholangiography will 
delineate the strictured area at the hilum and, usually after a period of external biliary 
drainage, a stent can be positioned at a second percutaneous transhepatic biliary procedure. 
ERCP and percutaneous transhepatic biliary radiology are thus complimentary 
interventions in the approach to proximal obstructive biliary strictures. There are few data 
comparing endoscopic and percutaneous stenting for hilar strictures. One retrospective 
study concluded that biliary decompression using SEMS was more likely to be successful if 
the SEMS was inserted via the percutaneous transhepatic route than if inserted via the 
endoscopic route (Paik et al., 2009).  
5.2 Biliary stenting for common bile duct stones (choledocholithiasis) 
Choledocholithiasis can lead to pain, obstructive jaundice, acute pancreatitis and cholangitis. 
Endoscopic removal of stones at ERCP is safer than open surgical exploration of the common 
bile duct. Common bile duct stone extraction at ERCP is usually successful using balloon 
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catheters, baskets or lithotripsy after performing endoscopic sphincterotomy or 
sphincteroplasty (Williams et al., 2008). However it is not always possible to clear the common 
bile duct of stones, particularly large stones. The insertion of a stent to splint residual stone(s) 
is a reasonable temporary strategy, although it is preferable to clear the duct completely at a 
later procedure. Biliary stents used to splint common bile duct stone(s) are typically of the 
plastic pigtail variety. They are usually of smaller calibre, typically 7 Fr and inserted over a 
guidewire. The pigtail stent splints the stone within the bile duct, allowing bile to drain around 
it, and does not rely solely on the stent remaining patent. Stent placement for 
choledocholithiasis is a good temporising intervention in the setting of common bile duct 
stone(s) causing jaundice and/or cholangitis (Cairns et al., 1989; Maxton et al., 1995). 
Previously nasobiliary drainage was used as an emergency intervention in patients with life-
threatening supporative cholangitis but the placement of a plastic stent provides as effective 
biliary drainage in this acute emergency (Sharma et al., 2005; Park et al., 2008). 
If intervention at the index ERCP does not clear common bile duct stones and a stent is left 
in situ to provide drainage, then a follow up ERCP or surgical exploration of the common 
bile duct will be necessary (Williams et al., 2008). A second therapeutic ERCP after an 
interval is often successful at clearing the common bile duct (Maxton et al., 1995; Horiuchi et 
al., 2010). Clearing the bile duct is the preferred management course since the retention of 
common bile duct stones and ongoing presence of a plastic splinting stent makes a bout of 
future cholangitis more likely (Bergman et al., 1995; Chopra et al., 1996). Only patients who 
have limited life expectancy, or who have significant comorbidity should have plastic biliary 
stents left as sole therapy for their retained common bile duct stones (van Steenbergen et al., 
1992; Williams et al., 2008). 
5.3 Stenting for biliary leaks following cholecystectomy  
Biliary leaks are not uncommon after cholecystectomy (Lau et al., 2010), and the advent of the 
laparoscopic approach to cholecystectomy has, if anything, made this surgical complication 
more common. Biliary leaks usually become evident in the early post-operative period, and 
may arise from an inadvertent intraoperative bile duct injury, or from the clips on the 
transected cystic duct becoming displaced. Once it is evident that a biliary leak with 
consequent biliary peritonitis is occurring, endoscopic treatment at ERCP is the preferred 
intervention (Tzovaras et al., 2001; Sandha et al., 2004; Agarwal et al., 2006). Endoscopic 
sphincterotomy alone will reduce pressure in the biliary system by equating it with 
intraduodenal pressure. The elimination or reduction in pressure gradient promotes 
preferential flow of bile from the common bile duct into the duodenum instead of 
extravasation via the leak. This allows a more proximal bile duct leak or cystic duct stump leak 
to heal spontaneously. However many endoscopists prefer to insert a temporary plastic stent. 
This can be a short stent across the Sphincter of Oddi, again effectively reducing pressure in 
the biliary system, so that the defect can heal spontaneously (Bjorkman et al., 1995). 
Alternatively a longer stent can be placed to cover the leak. For example in the case of a 
leaking cystic duct stump, a long straight plastic stent might be positioned with the proximal 
end above the junction of the cystic duct and bile duct. Endoscopically-placed plastic stents 
can be removed after approximately 6 weeks, by which time the biliary leak will have healed. 
5.4 Stenting of biliary strictures caused by cholecystectomy or liver transplant 
Bile duct stricturing may complicate bile duct injury at cholecystectomy. Traditionally a 
hepaticojejunostomy has been the definitive treatment for such stricturing after 
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5.1.4 Biliary stenting in obstructive jaundice due to unresectable hilar malignancies 
Malignant biliary obstruction at the liver hilum is usually due to cholangiocarcinoma, a 
primary cancer originating from the biliary ductal system (Aljiffry et al., 2009). Metastatic 
cancer infiltrating lymph nodes at the liver hilum can also cause stricturing at this site. 
While the most proximal cholangiocarcinomas originate from either the right or the left 
intrahepatic ductal system, cholangiocarcinomas more commonly involve the confluence of 
the two ductal systems where they join to form the common hepatic duct and are then 
known as hilar tumours. These intrahepatic and hilar chlangiocarcinomas often cause 
obstructive jaundice and pruritus. The only chance of a cure is a hepatic resection, but for 
many patients this is not an option due to advanced disease or due to frailty/comorbidities. 
In unresectable disease, palliation of jaundice and pruritus may be achieved by biliary 
stenting.  
Stenting across malignant hilar strictures can be technically challenging at ERCP. Prior 
imaging of the biliary ductal system using Magnetic Resonance Cholangio-Pancreatography 
(MRCP) provides invaluable information before stenting is attempted. Strictures at the liver 
hilum may be complex and it may not be possible to drain obstructed liver segments at 
ERCP. There is a significant risk of causing cholangitis by injecting contrast medium into 
undrained ductal segments, therefore drainage of contrast-filled obstructed biliary branches 
is crucial. There has been much debate about the importance of establishing drainage of 
both liver lobes in malignant hilar obstruction. Although the right hepatic duct drains a 
greater volume of liver than the left hepatic duct, successful stenting of either side achieves a 
similar symptomatic and biochemical improvement (Polydoru et al., 1989). A randomised 
trial comparing the insertion of a single plastic stent to drain one side of the liver with 
placing two plastic stents to drain both sides, found that there was no advantage in placing 
two stents. Attempts to place two stents were associated with more complications, 
particularly cholangitis (de Palma et al., 2001). Extrapolating from this, it would seem that 
that if endoscopic stenting is to be performed for malignant hilar strictures, then a single 
SEMS is the best strategy. As with distal biliary strictures SEMS are less likely than plastic 
stents to occlude (Perdue at al., 2008).  
Satisfactory biliary drainage of hilar strictures may not be possible at ERCP. Percutaneous 
hepatic drainage and stenting can be performed by an interventional radiologist if initial 
ERCP is unsuccessful, or if following endoscopic stenting there are undrained hepatic 
segments requiring treatment. Percutaneous stenting is performed using local anaesthetic 
and with intravenous sedation. Initial percutaneous transhepatic cholangiography will 
delineate the strictured area at the hilum and, usually after a period of external biliary 
drainage, a stent can be positioned at a second percutaneous transhepatic biliary procedure. 
ERCP and percutaneous transhepatic biliary radiology are thus complimentary 
interventions in the approach to proximal obstructive biliary strictures. There are few data 
comparing endoscopic and percutaneous stenting for hilar strictures. One retrospective 
study concluded that biliary decompression using SEMS was more likely to be successful if 
the SEMS was inserted via the percutaneous transhepatic route than if inserted via the 
endoscopic route (Paik et al., 2009).  
5.2 Biliary stenting for common bile duct stones (choledocholithiasis) 
Choledocholithiasis can lead to pain, obstructive jaundice, acute pancreatitis and cholangitis. 
Endoscopic removal of stones at ERCP is safer than open surgical exploration of the common 
bile duct. Common bile duct stone extraction at ERCP is usually successful using balloon 
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catheters, baskets or lithotripsy after performing endoscopic sphincterotomy or 
sphincteroplasty (Williams et al., 2008). However it is not always possible to clear the common 
bile duct of stones, particularly large stones. The insertion of a stent to splint residual stone(s) 
is a reasonable temporary strategy, although it is preferable to clear the duct completely at a 
later procedure. Biliary stents used to splint common bile duct stone(s) are typically of the 
plastic pigtail variety. They are usually of smaller calibre, typically 7 Fr and inserted over a 
guidewire. The pigtail stent splints the stone within the bile duct, allowing bile to drain around 
it, and does not rely solely on the stent remaining patent. Stent placement for 
choledocholithiasis is a good temporising intervention in the setting of common bile duct 
stone(s) causing jaundice and/or cholangitis (Cairns et al., 1989; Maxton et al., 1995). 
Previously nasobiliary drainage was used as an emergency intervention in patients with life-
threatening supporative cholangitis but the placement of a plastic stent provides as effective 
biliary drainage in this acute emergency (Sharma et al., 2005; Park et al., 2008). 
If intervention at the index ERCP does not clear common bile duct stones and a stent is left 
in situ to provide drainage, then a follow up ERCP or surgical exploration of the common 
bile duct will be necessary (Williams et al., 2008). A second therapeutic ERCP after an 
interval is often successful at clearing the common bile duct (Maxton et al., 1995; Horiuchi et 
al., 2010). Clearing the bile duct is the preferred management course since the retention of 
common bile duct stones and ongoing presence of a plastic splinting stent makes a bout of 
future cholangitis more likely (Bergman et al., 1995; Chopra et al., 1996). Only patients who 
have limited life expectancy, or who have significant comorbidity should have plastic biliary 
stents left as sole therapy for their retained common bile duct stones (van Steenbergen et al., 
1992; Williams et al., 2008). 
5.3 Stenting for biliary leaks following cholecystectomy  
Biliary leaks are not uncommon after cholecystectomy (Lau et al., 2010), and the advent of the 
laparoscopic approach to cholecystectomy has, if anything, made this surgical complication 
more common. Biliary leaks usually become evident in the early post-operative period, and 
may arise from an inadvertent intraoperative bile duct injury, or from the clips on the 
transected cystic duct becoming displaced. Once it is evident that a biliary leak with 
consequent biliary peritonitis is occurring, endoscopic treatment at ERCP is the preferred 
intervention (Tzovaras et al., 2001; Sandha et al., 2004; Agarwal et al., 2006). Endoscopic 
sphincterotomy alone will reduce pressure in the biliary system by equating it with 
intraduodenal pressure. The elimination or reduction in pressure gradient promotes 
preferential flow of bile from the common bile duct into the duodenum instead of 
extravasation via the leak. This allows a more proximal bile duct leak or cystic duct stump leak 
to heal spontaneously. However many endoscopists prefer to insert a temporary plastic stent. 
This can be a short stent across the Sphincter of Oddi, again effectively reducing pressure in 
the biliary system, so that the defect can heal spontaneously (Bjorkman et al., 1995). 
Alternatively a longer stent can be placed to cover the leak. For example in the case of a 
leaking cystic duct stump, a long straight plastic stent might be positioned with the proximal 
end above the junction of the cystic duct and bile duct. Endoscopically-placed plastic stents 
can be removed after approximately 6 weeks, by which time the biliary leak will have healed. 
5.4 Stenting of biliary strictures caused by cholecystectomy or liver transplant 
Bile duct stricturing may complicate bile duct injury at cholecystectomy. Traditionally a 
hepaticojejunostomy has been the definitive treatment for such stricturing after 
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cholecystectomy. However endoscopic access to the common bile duct at ERCP allows 
balloon dilatation and the insertion of a plastic biliary stent across the stricture. If plastic 
stents are routinely changed (to avoid clogging) every 3 months, then after approximately 
one year, stents can then be removed and in most cases the stricturing will not recur (de 
Palma et al., 2003; Vitale et al., 2008). 
Biliary stricturing remains a common problem after orthotopic liver transplantation (Ayoub 
et al., 2010). The two usual types of bile duct reconstruction performed at the time of 
transplantation are duct-to-duct (choledocho-choledochostomy) and hepatico-jejunostomy. 
Duct-to-duct biliary reconstructions allow endoscopic access to the reconstructed bile duct. 
Strictures of the biliary anastomosis are characteristically localised and short. They respond 
well to endoscopic treatment with balloon dilatation and plastic biliary stenting (Seo et al., 
2009). However transplant recipients may also experience non-anastomotic strictures which 
are a consequence of ischaemia or immunological reaction. These non-anastomotic strictures 
may be more diffuse and longer. They respond less well to endoscopic therapy with 
repeated dilatations and stenting (Williams & Draganov, 2009). 
6. Pancreatic stents 
Stenting of the pancreatic duct at ERCP is used in chronic pancreatitis, pancreatic duct leaks 
and the prevention of ERCP-induced pancreatitis. Invariably plastic stents are used in these 
settings. The pancreatic duct is much narrower than the biliary ductal system, and stents in 
the pancreatic duct can induce fibrosis and stricturing.  
6.1 Chronic pancreatitis  
Refractory pain in chronic pancreatitis may be associated with an obstructed pancreatic 
duct. In patients suffering ongoing pain due to chronic pancreatitis, pancreatic stenting 
helps relieve pressure in a pancreatic duct obstructed by an inflammatory stricture or stone, 
often with subsequent pain relief (Wilcox & Varadarajulu, 2006, Weber et al., 2007, Nguyen-
Tang & Dumonceau, 2010). Patients with a dominant pancreatic duct stricture in the 
pancreatic head seem to derive most benefit from such transpapillary stent placement. 
However well-performed prospective controlled studies of pancreatic endoscopic therapy 
for chronic pancreatitis are lacking. Furthermore, pancreatic duct stenting is inferior to 
surgical drainage in relieving pain associated with an obstructed pancreatic duct (Cahen et 
al,, 2007). When pancreatic stents are used in chronic pancreatitis, endoscopists typically use 
stent calibres ranging from 7 Fr to 11.5 Fr, and elective stent changes are needed every 2-3 
months. Smaller calibre stents will occlude more easily and need more frequent changing.  
6.2 Pancreatic duct fistulae  
The pancreatic duct can be disrupted by an attack of acute pancreatitis or following surgery. 
Subsequent pancreatic duct leaks with/without pseudocyst formation can be treated by the 
insertion of a transpapillary pancreatic duct stent (Cicek et al,, 2006). Any discrete 
connection between the pancreatic duct and a pancreatic pseudocyst can be sealed off by the 
insertion of a pancreatic stent.  
6.3 Preventing ERCP-induced pancreatitis  
Acute pancreatitis is a recognised complication of ERCP, occurring in up to approximately 
5% of therapeutic ERCPs (Freeman et al., 1996; Arata et al., 2010). The risk of pancreatitis is 
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greater in some patient categories (Cheng et al., 2006), and may be as great as 20-30% in 
women with Sphincter of Oddi dysfunction. Pancreatic stent placement decreases the risk of 
post-ERCP pancreatitis in high-risk patients (Arata et al., 2010; Choudhary et al., 2011). 
Typically 5 Fr or 3 Fr gauge straight stents are used. Unflanged stents are advantageous in 
this setting since they are more likely to spontaneously dislodge, and a second endoscopic 
procedure to remove the stent is avoided. 
7. Colorectal stents 
Colorectal cancer is usually treated by planned surgery, but many patients present as an 
emergency with acute colonic obstruction. Colorectal SEMS can be used in the treatment of 
acute malignant colonic obstruction as a bridge to definitive surgery. Secondly, some 
patients with colonic cancers which are starting to produce obstructive symptoms may not 
be surgical candidates due to metastatic disease or frailty/comorbidities. These patients can 
be electively palliated using SEMS. 
Colonic SEMSs are usually uncovered and can be inserted with a combination of endoscopy 
and fluoroscopic guidance. Typically an endoscope is used to identify the obstructing cancer, 
and a wire is passed through the stricture and into the proximal bowel. The endoscope is then 
withdrawn and the stent delivery mechanism is fed over the wire. The endoscope can be 
reinserted alongside the stent delivery mechanism and together with fluoroscopy can be used 
to guide the deployment of the stent across the obstructing lesion. For obstructing cancers in 
the proximal colon, stent placement is best achieved using a “through the scope” delivery 
mechanism. The stent delivery mechanism is delivered over a guidewire through the working 
channel of a colonoscope and deployed without removing the colonoscope. 
7.1 Colorectal SEMS for acute colonic obstruction 
Up to 20% of patients with colon cancer initially present with symptoms of acute colonic 
obstruction. Obstruction is more common in the distal colon, which has a smaller calibre 
than the proximal colon. Emergency surgery plays a major role in the management of these 
patients. However, emergency decompressive surgery on the unprepared and obstructed 
bowel, in patients who are often very sick, carries a significant risk of morbidity (32%-64%) 
and mortality (15%-34%) (McLoughlin & Byrne, 2008).  
Emergency surgical decompression invariably involves colostomy formation, since primary 
anastomosis in the setting of an unprepared and obstructed bowel is likely to break down. 
Operations range from a loop colostomy, a Hartmann's procedure or sometimes a subtotal 
colectomy. Following such emergency surgery, a patient with a potentially resectable cancer 
will then require a planned second operation at a later stage. However, in up to 40% patients 
the colostomy becomes permanent and will not be closed because of metastatic disease or 
frailty. 
Placement of a colonic SEMS to relieve the malignant obstruction in the emergency setting 
will spare the patient emergency surgery and colostomy formation. Stenting allows time for 
the patient to recover from acute symptoms, and undergo appropriate cancer staging 
investigations. In patients whose staging investigations confirm operable cancer, stenting as 
a bridge to a definitive resection allows better preparation for the surgery which is less 
likely to then involve stoma formation. In these situations the stent is removed together with 
the resected tumour. In patients whose staging investigations reveal inoperable cancer, the 
stent provides palliation. 
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cholecystectomy. However endoscopic access to the common bile duct at ERCP allows 
balloon dilatation and the insertion of a plastic biliary stent across the stricture. If plastic 
stents are routinely changed (to avoid clogging) every 3 months, then after approximately 
one year, stents can then be removed and in most cases the stricturing will not recur (de 
Palma et al., 2003; Vitale et al., 2008). 
Biliary stricturing remains a common problem after orthotopic liver transplantation (Ayoub 
et al., 2010). The two usual types of bile duct reconstruction performed at the time of 
transplantation are duct-to-duct (choledocho-choledochostomy) and hepatico-jejunostomy. 
Duct-to-duct biliary reconstructions allow endoscopic access to the reconstructed bile duct. 
Strictures of the biliary anastomosis are characteristically localised and short. They respond 
well to endoscopic treatment with balloon dilatation and plastic biliary stenting (Seo et al., 
2009). However transplant recipients may also experience non-anastomotic strictures which 
are a consequence of ischaemia or immunological reaction. These non-anastomotic strictures 
may be more diffuse and longer. They respond less well to endoscopic therapy with 
repeated dilatations and stenting (Williams & Draganov, 2009). 
6. Pancreatic stents 
Stenting of the pancreatic duct at ERCP is used in chronic pancreatitis, pancreatic duct leaks 
and the prevention of ERCP-induced pancreatitis. Invariably plastic stents are used in these 
settings. The pancreatic duct is much narrower than the biliary ductal system, and stents in 
the pancreatic duct can induce fibrosis and stricturing.  
6.1 Chronic pancreatitis  
Refractory pain in chronic pancreatitis may be associated with an obstructed pancreatic 
duct. In patients suffering ongoing pain due to chronic pancreatitis, pancreatic stenting 
helps relieve pressure in a pancreatic duct obstructed by an inflammatory stricture or stone, 
often with subsequent pain relief (Wilcox & Varadarajulu, 2006, Weber et al., 2007, Nguyen-
Tang & Dumonceau, 2010). Patients with a dominant pancreatic duct stricture in the 
pancreatic head seem to derive most benefit from such transpapillary stent placement. 
However well-performed prospective controlled studies of pancreatic endoscopic therapy 
for chronic pancreatitis are lacking. Furthermore, pancreatic duct stenting is inferior to 
surgical drainage in relieving pain associated with an obstructed pancreatic duct (Cahen et 
al,, 2007). When pancreatic stents are used in chronic pancreatitis, endoscopists typically use 
stent calibres ranging from 7 Fr to 11.5 Fr, and elective stent changes are needed every 2-3 
months. Smaller calibre stents will occlude more easily and need more frequent changing.  
6.2 Pancreatic duct fistulae  
The pancreatic duct can be disrupted by an attack of acute pancreatitis or following surgery. 
Subsequent pancreatic duct leaks with/without pseudocyst formation can be treated by the 
insertion of a transpapillary pancreatic duct stent (Cicek et al,, 2006). Any discrete 
connection between the pancreatic duct and a pancreatic pseudocyst can be sealed off by the 
insertion of a pancreatic stent.  
6.3 Preventing ERCP-induced pancreatitis  
Acute pancreatitis is a recognised complication of ERCP, occurring in up to approximately 
5% of therapeutic ERCPs (Freeman et al., 1996; Arata et al., 2010). The risk of pancreatitis is 
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greater in some patient categories (Cheng et al., 2006), and may be as great as 20-30% in 
women with Sphincter of Oddi dysfunction. Pancreatic stent placement decreases the risk of 
post-ERCP pancreatitis in high-risk patients (Arata et al., 2010; Choudhary et al., 2011). 
Typically 5 Fr or 3 Fr gauge straight stents are used. Unflanged stents are advantageous in 
this setting since they are more likely to spontaneously dislodge, and a second endoscopic 
procedure to remove the stent is avoided. 
7. Colorectal stents 
Colorectal cancer is usually treated by planned surgery, but many patients present as an 
emergency with acute colonic obstruction. Colorectal SEMS can be used in the treatment of 
acute malignant colonic obstruction as a bridge to definitive surgery. Secondly, some 
patients with colonic cancers which are starting to produce obstructive symptoms may not 
be surgical candidates due to metastatic disease or frailty/comorbidities. These patients can 
be electively palliated using SEMS. 
Colonic SEMSs are usually uncovered and can be inserted with a combination of endoscopy 
and fluoroscopic guidance. Typically an endoscope is used to identify the obstructing cancer, 
and a wire is passed through the stricture and into the proximal bowel. The endoscope is then 
withdrawn and the stent delivery mechanism is fed over the wire. The endoscope can be 
reinserted alongside the stent delivery mechanism and together with fluoroscopy can be used 
to guide the deployment of the stent across the obstructing lesion. For obstructing cancers in 
the proximal colon, stent placement is best achieved using a “through the scope” delivery 
mechanism. The stent delivery mechanism is delivered over a guidewire through the working 
channel of a colonoscope and deployed without removing the colonoscope. 
7.1 Colorectal SEMS for acute colonic obstruction 
Up to 20% of patients with colon cancer initially present with symptoms of acute colonic 
obstruction. Obstruction is more common in the distal colon, which has a smaller calibre 
than the proximal colon. Emergency surgery plays a major role in the management of these 
patients. However, emergency decompressive surgery on the unprepared and obstructed 
bowel, in patients who are often very sick, carries a significant risk of morbidity (32%-64%) 
and mortality (15%-34%) (McLoughlin & Byrne, 2008).  
Emergency surgical decompression invariably involves colostomy formation, since primary 
anastomosis in the setting of an unprepared and obstructed bowel is likely to break down. 
Operations range from a loop colostomy, a Hartmann's procedure or sometimes a subtotal 
colectomy. Following such emergency surgery, a patient with a potentially resectable cancer 
will then require a planned second operation at a later stage. However, in up to 40% patients 
the colostomy becomes permanent and will not be closed because of metastatic disease or 
frailty. 
Placement of a colonic SEMS to relieve the malignant obstruction in the emergency setting 
will spare the patient emergency surgery and colostomy formation. Stenting allows time for 
the patient to recover from acute symptoms, and undergo appropriate cancer staging 
investigations. In patients whose staging investigations confirm operable cancer, stenting as 
a bridge to a definitive resection allows better preparation for the surgery which is less 
likely to then involve stoma formation. In these situations the stent is removed together with 
the resected tumour. In patients whose staging investigations reveal inoperable cancer, the 
stent provides palliation. 
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Early studies showed that colorectal stents inserted under a combination of endoscopic and 
fluoroscopic (Baron et al., 1998) or fluoroscopic guidance alone (Mainar et al., 1996) are safe 
and effective in the treatment of acute malignant colonic obstruction. A randomised study of 
48 patients with obstructing left distal colonic cancers compared SEMS placement followed 
by definitive laparoscopic-assisted colonic resection and conventional emergency open 
surgery. Patients in the SEMS / laparoscopic surgery group were more likely to have a 
successful single stage operation (67% vs 38%), less likely to have a permanent stoma (0% vs 
25%), and less likely to have complications than the emergency surgery group (Cheung et 
al., 2009). In another prospective randomised study, obstructed patients who were stented 
prior to surgery were also more likely to have a primary anastomosis compared to those 
who had emergency surgery (85% vs 41%). They also had fewer complications, re-
interventions and a reduced total hospital and ITU stay (Martinez-Santos et al., 2002). In a 
meta-analysis that included non randomised and somewhat heterogeneous studies 
comparing SEMS and open surgery for malignant large bowel obstruction, mortality was 
5.7% in those undergoing SEMS compared to 12.1% in those having emergency surgery 
(Tilney et al., 2007). 
7.2 Colorectal SEMS for palliation of incurable colonic cancer 
SEMS are also used electively for palliation of symptoms in patients who are frail and not fit 
for surgery, or in cases of advanced cancer. Two small randomised controlled trials have 
compared SEMS to colostomy for the palliation of malignant obstruction (Fiori et al., 2004; 
Xinopoulos et al., 2004). They found that patients who were treated with SEMS spent less 
time in hospital and had a shorter time to oral intake and restoration of bowel function. A 
recent retrospective study from a single centre also showed a high technical and clinical 
success rate for SEMS insertion, with few complications up to 30 days after stent insertion. 
However complications (mainly stent re-obstruction and stent migration necessitating the 
placement of a second stent) after 30 days were higher in patients treated with SEMS than in 
those treated with surgery (Lee et al., 2011).  
7.3 Technical success and complications associated with colorectal SEMS 
Colonic stents have now been used in malignant colorectal obstruction for two decades. 
Two systematic reviews of non randomised studies (Khot et al., 2002; Sebastian et al., 2004) 
conclude that colonic stents can be successfully placed in the majority of cases (92% and 
94%) with a good clinical result (88% and 91%). Complications in these reviews included 
perforation in about 4%, stent migration in 10% and re-obstruction in 10% of patients. Stent 
related mortality is approximately 1%. Based on the available data, the World Society of 
Emergency Surgery and the Peritoneum and Surgery Society advocate the use of colorectal 
stents in preference to colostomy in cases where palliation is needed, and endorse their use 
as a bridge to surgery in cases of acute malignant colonic obstruction (Ansaloni et al., 2010)  
SEMS insertion for benign diseases of the colon is somewhat controversial. The role for 
SEMS in treating benign colonic strictures has yet to be established. 
8. Summary 
Advances in endoscopy and in stent technology in the past 20 years have allowed non-
invasive palliation of obstructive symptoms within the gastrointestinal tract using stents. In 
many clinical scenarios, stent placement has proved advantageous over surgery. 
 




Figures of in vitro stents are reproduced with permission from Cook Medical and Olympus. 
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Early studies showed that colorectal stents inserted under a combination of endoscopic and 
fluoroscopic (Baron et al., 1998) or fluoroscopic guidance alone (Mainar et al., 1996) are safe 
and effective in the treatment of acute malignant colonic obstruction. A randomised study of 
48 patients with obstructing left distal colonic cancers compared SEMS placement followed 
by definitive laparoscopic-assisted colonic resection and conventional emergency open 
surgery. Patients in the SEMS / laparoscopic surgery group were more likely to have a 
successful single stage operation (67% vs 38%), less likely to have a permanent stoma (0% vs 
25%), and less likely to have complications than the emergency surgery group (Cheung et 
al., 2009). In another prospective randomised study, obstructed patients who were stented 
prior to surgery were also more likely to have a primary anastomosis compared to those 
who had emergency surgery (85% vs 41%). They also had fewer complications, re-
interventions and a reduced total hospital and ITU stay (Martinez-Santos et al., 2002). In a 
meta-analysis that included non randomised and somewhat heterogeneous studies 
comparing SEMS and open surgery for malignant large bowel obstruction, mortality was 
5.7% in those undergoing SEMS compared to 12.1% in those having emergency surgery 
(Tilney et al., 2007). 
7.2 Colorectal SEMS for palliation of incurable colonic cancer 
SEMS are also used electively for palliation of symptoms in patients who are frail and not fit 
for surgery, or in cases of advanced cancer. Two small randomised controlled trials have 
compared SEMS to colostomy for the palliation of malignant obstruction (Fiori et al., 2004; 
Xinopoulos et al., 2004). They found that patients who were treated with SEMS spent less 
time in hospital and had a shorter time to oral intake and restoration of bowel function. A 
recent retrospective study from a single centre also showed a high technical and clinical 
success rate for SEMS insertion, with few complications up to 30 days after stent insertion. 
However complications (mainly stent re-obstruction and stent migration necessitating the 
placement of a second stent) after 30 days were higher in patients treated with SEMS than in 
those treated with surgery (Lee et al., 2011).  
7.3 Technical success and complications associated with colorectal SEMS 
Colonic stents have now been used in malignant colorectal obstruction for two decades. 
Two systematic reviews of non randomised studies (Khot et al., 2002; Sebastian et al., 2004) 
conclude that colonic stents can be successfully placed in the majority of cases (92% and 
94%) with a good clinical result (88% and 91%). Complications in these reviews included 
perforation in about 4%, stent migration in 10% and re-obstruction in 10% of patients. Stent 
related mortality is approximately 1%. Based on the available data, the World Society of 
Emergency Surgery and the Peritoneum and Surgery Society advocate the use of colorectal 
stents in preference to colostomy in cases where palliation is needed, and endorse their use 
as a bridge to surgery in cases of acute malignant colonic obstruction (Ansaloni et al., 2010)  
SEMS insertion for benign diseases of the colon is somewhat controversial. The role for 
SEMS in treating benign colonic strictures has yet to be established. 
8. Summary 
Advances in endoscopy and in stent technology in the past 20 years have allowed non-
invasive palliation of obstructive symptoms within the gastrointestinal tract using stents. In 
many clinical scenarios, stent placement has proved advantageous over surgery. 
 




Figures of in vitro stents are reproduced with permission from Cook Medical and Olympus. 
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1. Introduction   
Flexible endoscopy is a widely used diagnostic and therapeutic procedure. In The Netherlands, 
a 26% increase in the number of endoscopies from 325.000 in 1999 to almost 410.000 in 2004 was 
found. The total number of endoscopic retrograde cholangiopancreatographies (ERCP) was 
estimated at 14.596 in 2004 (Terhaar sive Droste et al., 2006). 
Contaminated endoscopes have been linked to more outbreaks of healthcare-associated 
infections than any other medical device. During the period 1974–2004, 70 outbreaks 
following endoscopy procedures were reported in the USA in 64 scientific articles (Seoane-
Vazquez et al., 2006). A total of 10637 patients were exposed to contamination agents during 
28 outbreaks. Inadequate decontamination procedures were the leading cause of 
contamination; equipment malfunction became the second cause of contamination during 
the period 1990–2004. More than 91% of the infections identified could be prevented if 
quality control systems are improved. However, the true transmission during endoscopy 
may go unrecognized because of inadequate surveillance or no surveillance at all, low 
frequency and absence of clinical symptoms (Srinivasan, 2003). 
Endoscopes become heavily contaminated with blood, secretions and microorganisms 
during use, and because each endoscope may be used for different patients in a single day, it 
is essential to clean and disinfect them effectively between every endoscopic procedure in 
patients. Accurate reprocessing of flexible endoscopes must involve cleaning, followed by 
high level disinfection with further rinsing and drying before storage. Most contemporary 
flexible endoscopes cannot be heat-sterilized and are designed with multiple channels and 
ports which are exposed to body fluids and are difficult to clean and disinfect (Nelson et al., 
2001). Growth of biofilms inside endoscope channels can result in failure of the endoscope 
reprocessing and is an important factor in the pathogenesis of endoscopy-related infections 
(Buss et al., 2008; Kovaleva et al., 2009). Such events should be prevented by well instructed 
personnel, well functioning washing, disinfection and drying equipment and observance of 
general hygiene guidelines in the endoscopy center. 
Bacterial transmission from endoscopes to patients tends to be incidentally identified when 
an unusual species or a microorganism with an uncommon resistance profile is involved. 
The microorganisms most frequently associated with iatrogenic transmission during 
endoscopy are gram-negative bacteria (Pseudomonas aeruginosa, Serratia marcescens and 
Salmonella species), mycobacteria and yeasts (Buss et al., 2008; Kovaleva et al., 2009; Spach et 
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1. Introduction   
Flexible endoscopy is a widely used diagnostic and therapeutic procedure. In The Netherlands, 
a 26% increase in the number of endoscopies from 325.000 in 1999 to almost 410.000 in 2004 was 
found. The total number of endoscopic retrograde cholangiopancreatographies (ERCP) was 
estimated at 14.596 in 2004 (Terhaar sive Droste et al., 2006). 
Contaminated endoscopes have been linked to more outbreaks of healthcare-associated 
infections than any other medical device. During the period 1974–2004, 70 outbreaks 
following endoscopy procedures were reported in the USA in 64 scientific articles (Seoane-
Vazquez et al., 2006). A total of 10637 patients were exposed to contamination agents during 
28 outbreaks. Inadequate decontamination procedures were the leading cause of 
contamination; equipment malfunction became the second cause of contamination during 
the period 1990–2004. More than 91% of the infections identified could be prevented if 
quality control systems are improved. However, the true transmission during endoscopy 
may go unrecognized because of inadequate surveillance or no surveillance at all, low 
frequency and absence of clinical symptoms (Srinivasan, 2003). 
Endoscopes become heavily contaminated with blood, secretions and microorganisms 
during use, and because each endoscope may be used for different patients in a single day, it 
is essential to clean and disinfect them effectively between every endoscopic procedure in 
patients. Accurate reprocessing of flexible endoscopes must involve cleaning, followed by 
high level disinfection with further rinsing and drying before storage. Most contemporary 
flexible endoscopes cannot be heat-sterilized and are designed with multiple channels and 
ports which are exposed to body fluids and are difficult to clean and disinfect (Nelson et al., 
2001). Growth of biofilms inside endoscope channels can result in failure of the endoscope 
reprocessing and is an important factor in the pathogenesis of endoscopy-related infections 
(Buss et al., 2008; Kovaleva et al., 2009). Such events should be prevented by well instructed 
personnel, well functioning washing, disinfection and drying equipment and observance of 
general hygiene guidelines in the endoscopy center. 
Bacterial transmission from endoscopes to patients tends to be incidentally identified when 
an unusual species or a microorganism with an uncommon resistance profile is involved. 
The microorganisms most frequently associated with iatrogenic transmission during 
endoscopy are gram-negative bacteria (Pseudomonas aeruginosa, Serratia marcescens and 
Salmonella species), mycobacteria and yeasts (Buss et al., 2008; Kovaleva et al., 2009; Spach et 
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al., 1993). These microorganisms can be transferred from previous patients or contaminated 
cleaning sources (reprocessing equipment, water supply lines) by contaminated endoscopes 
or accessories (Srinivasan, 2003).  
Endoscopy-related outbreaks are associated with high costs including the costs of the 
epidemiological investigation of the outbreak, the diagnosis and treatment of the affected 
patients, and the use of resources cost associated with endoscope unit inactivity (Seoane-
Vazquez et al., 2006). 
Microbiological surveillance of endoscope reprocessing is appropriate to trace 
contamination of endoscopes and to prevent contamination and infection in patients after 
endoscopic procedures. Routine microbiological monitoring of endoscope reprocessing has 
been recommended by several organizations (Beilenhoff et al., 2008; Systchenko et al., 2000). 
The repeated detection of an infection with the same microorganism in patients after 
endoscopic procedures in the University Medical Center Groningen (UMCG), The 
Netherlands, led to the implementation of the surveillance system for evaluation of the 
efficacy of the endoscope reprocessing (Buss et al., 2008; Kovaleva et al., 2009).  
2. Endoscopy-related infections 
Flexible endoscopes belong to semi-critical devices which come in contact with mucus 
membranes or non intact skin during endoscopic procedures. Endoscopes for therapeutic 
procedures (bronchoscopy, ERCP) are used in sterile body cavities. They are frequently 
designed with small lumina and multiple channels which are difficult to clean and disinfect. 
Such endoscopes should be sterilized or receive an intensive disinfection procedure 
(Alvarado & Reichelderfer, 2000). 
Infections related to endoscopes can be divided into two types: endogenous and exogenous. 
Endoscopic procedures most often result in endogenous infections (i.e., infections resulting 
from the patient’s own microbial flora) and Escherichia coli, Klebsiella, Enterobacter species and 
enterococci are generally isolated (Spach et al., 1993). Endogenous infections are associated 
with endoscopy but can not be prevented by well controlled disinfection procedures. The 
exogenous microorganisms most frequently associated with transmission during 
bronchoscopy are P. aeruginosa and Mycobacterium tuberculosis, atypical Mycobacterium 
species, and P. aeruginosa the most common in gastrointestinal endoscopy (Nelson & 
Muscarella, 2006). These microorganisms can be transmitted from previous patients or 
contaminated reprocessing equipment by contaminated endoscopes or its accessory 
equipment. Exogenous infection should be prevented by strict endoscope disinfection 
procedures (Srinivasan, 2003). 
2.1 Endoscopy-related infection associated with gastrointestinal endoscopy 
Bacteraemia occurs in any situation where there is damage of the mucosal membrane (for 
example, during teeth cleaning). The presence of bacteraemia after an endoscopic procedure 
does not indicate that serious clinical infection is present. Microscopic tissue trauma 
occurring during endoscope insertion can result in the passage of microflora into the 
bloodstream. The microorganisms isolated from the blood cultures belong to the 
oropharyngeal commensal microflora and are general of low pathogenicity (O'Connor et al., 
1983). 
The important risk factors of endoscopy-related infections in gastrointestinal endoscopy are 
the number of microorganisms present inside the endoscope or its accessories or the growth 
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of a biofilm, invasive endoscopic procedures resulting in tissue damage, compromised 
immune status of the patient and the presence of infective foci (abscess, cholangitis) during 
an endoscopic procedure (Gastroenterological Society of Australia, 2006).  
The role of antibiotic prophylaxis in gastrointestinal endoscopy is controversial. 
Prophylactic antibiotic administration is not recommended for any gastrointestinal 
endoscopic procedure (Hirota et al., 2003). Only patients with bile duct obstruction, 
immunosuppression or previous endocarditis may need the prophylaxis during ERCP or 
other therapeutic gastrointestinal endoscopic procedure (Cotton et al., 2008). Recent studies 
examining antibiotic prophylaxis prior to ERCP concluded that it may reduce the incidence 
of bacteraemia, but did not reduce the incidence of clinical sepsis or cholangitis. Optimum 
benefit of antibiotics is obtained if therapeutic levels are present in the tissues at the time of 
endoscopic procedure. Antibiotic prophylaxis should be started intravenously at least one to 
two hours before the procedure (Cotton et al., 2008; Harris et al., 1999; Gastroenterological 
Society of Australia, 2006).  
Despite the large number of annually performed procedures, iatrogenic infections due to 
flexible gastrointestinal endoscopy are apparently rare. ERCP is the only endoscopic 
procedure which has been associated with a significant rate of procedure-induced infection 
(Christensen et al., 2004). The common pathogenic microorganisms encountered in the 
biliary tree are P. aeruginosa, E. coli, Klebsiella, Bacteroides species and enterococci. 
A complication of ERCP can be defined as any event occurring during the 30-day period 
after the procedure that changed the health status of a patient negatively. Post-ERCP 
complications can be divided into mild (required up to 3 days in hospital), moderate 
(required 4 to 10 days of hospitalization) and severe complications (required more than 10 
days of hospitalization, surgical intervention and/or resulted in the death of the patient) 
(Cotton et al., 1991).  
Cholangitis and bacteraemia following ERCP can occur due to exogenous source 
(contaminated endoscope or accessories) or endogenous bacterial flora. Bloodstream 
infection is one of the most serious complications of this procedure, with the actual 
incidence varied from 0% to 27% in different populations and with the 8% - 20% mortality 
rate (Anderson et al., 2008; Kullman et al., 1992). Cholangitis, the most frequent infective 
complication of ERCP, most commonly results from inadequate drainage of infected and 
obstructive biliary duct system (Low et al., 1980). Post-ERCP cholangitis is defined by a 
typical clinical picture (temperature >38°C, upper abdominal colicky pain, 
cholestasis/jaundice) without evidence of other concomitant infections with/without 
positive gall cultures obtained during the biliary drainage (Masci et al., 2001). 
2.1.1 Role of Pseudomonas aeruginosa in endoscopy-related infections   
P. aeruginosa, a gram-negative opportunistic pathogen, is the most commonly reported 
organism responsible for transmission of infection during gastrointestinal endoscopy. It is 
known by its preference for a moist environment (wet endoscope channels after 
reprocessing, hospital water supply) (Nelson & Muscarella, 2006). Pseudomonas is well 
known to be able to form biofilms, and these biofilms are extremely difficult to remove 
from plumbing, automatic endoscope reprocessors and endoscope channels (Pajkos et al., 
2004).  
Pseudomonas contamination of endoscopes was first reported in the mid-70s (Bilbao et al., 
1976) and is adequately documented as a serious clinical cause of ERCP-associated infection 
by 1980 (Low et al., 1980). Outbreaks of P. aeruginosa sepsis and cholangitis following ERCP 
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continue to be reported. Frequently, the infection has not been recognized because of 
inadequate surveillance, low frequency and absence of clinical symptoms. It comes to light 
only as a result of infection control procedures.  
According to the recent reports, P. aeruginosa transmission during gastrointestinal 
endoscopy has been attributed to (1) inadequate high-level disinfection of the endoscope 
channels after endoscope reprocessing prior to storage (Allen et al., 1987; Fraser et al., 2004), 
(2) colonization of the water supply to the endoscope (Bass et al., 1990) and (3) defective 
disinfecting machines, failure in design or defects in endoscope channels and accessories 
(Alvarado et al., 1991; Nelson & Muscarella, 2006). Serotype 10 of P. aeruginosa was 
predominating in the published reports of Pseudomonas transmission (Allen et al., 1987; 
Alvarado et al., 1991). This serotype persisted in the outbreaks despite the intensive 
disinfection procedures. This phenomenon was linked to biofilm formation but no 
explanation was found as to why this serotype was isolated. 
Inadequate drying of the endoscope channels prior to storage was responsible for the 
outbreaks of Pseudomonas bacteraemia after ERCP (Allen et al., 1987; Classen et al., 1988). P. 
aeruginosa remaining in the endoscope moist channels after reprocessing can colonize and 
multiply to high numbers during storage. This situation can result in an increased risk of 
transmission to the first patient of the day during an ERCP procedure. 
2.1.2 Example of an outbreak of Pseudomonas sepsis after ERCP   
We have recently been confronted with an outbreak of multidrug-resistant P. aeruginosa 
sepsis affecting six patients after ERCP. Our registration system enabled us to retrieve one of 
three endoscopes daily in use as the possible source of infection. Epidemiologic 
investigation including microbiological sampling of the implicated endoscope, the washer 
disinfectors and the tubes connecting the washer disinfectors and the endoscopes was 
performed. The results of recent surveillance cultures from diagnostic and therapeutic 
endoscopes were reviewed. Environmental investigations to determine potential reservoirs 
or sources of contamination included wash tables, sinks, drying cabinets, hand soap and 
detergent soap for endoscopes. The medical records of all patients who underwent ERCP 
with this endoscope from introduction in service until it was removed from service were 
reviewed. 
All of the cultures from the washer disinfectors, the connecting tubes, other endoscopes, and 
from the environmental surfaces in the endoscopy center were negative for P. aeruginosa. 
Epidemiologic investigation found that the implicated ERCP endoscope had contamination 
with P. aeruginosa in microbiological surveillances before the outbreak, despite intensive 
high level disinfection procedures. The endoscope was removed from service and 
underwent sterilization with ethylene oxide. Following gas sterilization, the implicated 
endoscope was found to have P. aeruginosa-negative cultures and was re-introduced into 
service. However, 4 months later, it was again contaminated with P. aeruginosa. The 
endoscope was sent to the manufacturer for repair. Structures suggesting the presence of 
biofilm were found on the inner surface of the undamaged endoscope channels. The 
endoscope channels were changed. 
The available P. aeruginosa strains were subjected to molecular typing by repetitive DNA 
sequence-based polymerase chain reaction (rep-PCR) using the DiversiLab System for DNA 
fingerprinting (BioMérieux, France). The isolates from the six patients and from the 
endoscope channels, obtained before gas sterilization, showed matching patterns (similarity 
above 95%) (Kovaleva et al., 2009).  
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2.2 Endoscopy-related infection associated with bronchoscopy 
During the period 1974-2004, bronchoscopy procedures accounted for 47.5% of the 
endoscopy-related infections in the USA and 21.1% of the infections in other countries 
(Seoane-Vazquez et al., 2007). Several studies have found bronchoscopy procedures to be 
relatively more prone to infection transmission than gastrointestinal endoscopic procedures 
(Seoane-Vazquez et al., 2007; Spach et al., 1993). 
The microorganisms most frequently associated with transmission during bronchoscopy are 
gram-negative bacilli, particularly P. aeruginosa or Enterobacteriaceae or infection with M. 
tuberculosis or other mycobacteria (Cêtre et al., 2005; Nelson & Muscarella, 2006). While 
isolation of various Enterobacteriaceae from the lungs is not rare, severe nosocomial 
pneumonia is not frequently diagnosed in patients during infection outbreaks. It is possible 
that the incidence of pneumonia related to bronchoscopy is underestimated (Shimonom et 
al., 2008). The pathogens of nosocomial pneumonia are related to the timing of onset. 
Microorganisms responsible for early-onset nosocomial pneumonia are generally 
endogenous. In late-onset nosocomial pneumonia, the causative microorganisms include 
potentially multidrug-resistant nosocomial organisms such as P. aeruginosa.  
Three large outbreaks of P. aeruginosa infections following flexible bronchoscopy 
associated with a loose port of the biopsy channel of the bronchoscope were reported in 
the literature (Cêtre et al., 2005; Kirschke et al., 2003; Srinivasan et al., 2003). Another two 
Pseudomonas outbreaks were associated with a damaged internal channel caused by 
defective biopsy forceps (Corne et al., 2005). A contaminated bronchoscope washer 
disinfector was the source of the several Pseudomonas outbreaks (Schelenz & French, 2000; 
Shimonom et al., 2008). 
Numerous reports of mycobacterial transmission by flexible bronchoscopy have been 
reported. Mycobacterial infections during bronchoscopy have been related to contaminated 
suction valves (Wheeler et al., 1989), cracked biopsy channels (Pappas et al., 1982), 
contaminated topical anaesthetic solutions (Leers et al., 1980) and contaminated disinfecting 
machines (Bryce et al., 1993; Fraser et al., 1992). 
The last two years we were confronted with repeated contaminations of flexible 
bronchoscopes with fastidiously growing Methylobacterium. Methylobacterium was also 
isolated from the broncho-alveolair lavages of the patients after bronchoscopy with the 
contaminated bronchoscopes. We consider Methylobacterium as a contaminant being the 
cause of pseudo-infections because no patient manifested true infection with this bacterium. 
Methylobacterium is a fastidious, slowly growing gram-negative rod that forms pink colonies 
on agar plates and is a common contaminant in water (Sanders et al., 2000). Nevertheless it 
has been described as opportunistic human pathogen and has been shown to be able to 
cause colonization and infections in immunocompromised patients (Kaye et al., 1992; Liu et 
al., 1997). Two publications of Methylobacterium contamination related to endoscopic 
procedures were found in the literature. One patient developed Methylobacterium 
bacteraemia following ERCP with the contaminated endoscope (Imbert et al., 2005). A 
pseudo-outbreak of Methylobacterium mesophilicum and Mycobacterium chelonae was described 
in patients who underwent bronchoscopy. M. mesophilicum was isolated from broncho-
alveolar lavages obtained from ventilated patients. Methylobacterium grew from the 
bronchoscopes and automated washers which were revealed as the source of the 
contamination. The presence of biofilm was demonstrated on tubing from the manifold 
block to the top of the reservoir (Kressel & Kid, 2001). 
 
Therapeutic Gastrointestinal Endoscopy 
 
144 
continue to be reported. Frequently, the infection has not been recognized because of 
inadequate surveillance, low frequency and absence of clinical symptoms. It comes to light 
only as a result of infection control procedures.  
According to the recent reports, P. aeruginosa transmission during gastrointestinal 
endoscopy has been attributed to (1) inadequate high-level disinfection of the endoscope 
channels after endoscope reprocessing prior to storage (Allen et al., 1987; Fraser et al., 2004), 
(2) colonization of the water supply to the endoscope (Bass et al., 1990) and (3) defective 
disinfecting machines, failure in design or defects in endoscope channels and accessories 
(Alvarado et al., 1991; Nelson & Muscarella, 2006). Serotype 10 of P. aeruginosa was 
predominating in the published reports of Pseudomonas transmission (Allen et al., 1987; 
Alvarado et al., 1991). This serotype persisted in the outbreaks despite the intensive 
disinfection procedures. This phenomenon was linked to biofilm formation but no 
explanation was found as to why this serotype was isolated. 
Inadequate drying of the endoscope channels prior to storage was responsible for the 
outbreaks of Pseudomonas bacteraemia after ERCP (Allen et al., 1987; Classen et al., 1988). P. 
aeruginosa remaining in the endoscope moist channels after reprocessing can colonize and 
multiply to high numbers during storage. This situation can result in an increased risk of 
transmission to the first patient of the day during an ERCP procedure. 
2.1.2 Example of an outbreak of Pseudomonas sepsis after ERCP   
We have recently been confronted with an outbreak of multidrug-resistant P. aeruginosa 
sepsis affecting six patients after ERCP. Our registration system enabled us to retrieve one of 
three endoscopes daily in use as the possible source of infection. Epidemiologic 
investigation including microbiological sampling of the implicated endoscope, the washer 
disinfectors and the tubes connecting the washer disinfectors and the endoscopes was 
performed. The results of recent surveillance cultures from diagnostic and therapeutic 
endoscopes were reviewed. Environmental investigations to determine potential reservoirs 
or sources of contamination included wash tables, sinks, drying cabinets, hand soap and 
detergent soap for endoscopes. The medical records of all patients who underwent ERCP 
with this endoscope from introduction in service until it was removed from service were 
reviewed. 
All of the cultures from the washer disinfectors, the connecting tubes, other endoscopes, and 
from the environmental surfaces in the endoscopy center were negative for P. aeruginosa. 
Epidemiologic investigation found that the implicated ERCP endoscope had contamination 
with P. aeruginosa in microbiological surveillances before the outbreak, despite intensive 
high level disinfection procedures. The endoscope was removed from service and 
underwent sterilization with ethylene oxide. Following gas sterilization, the implicated 
endoscope was found to have P. aeruginosa-negative cultures and was re-introduced into 
service. However, 4 months later, it was again contaminated with P. aeruginosa. The 
endoscope was sent to the manufacturer for repair. Structures suggesting the presence of 
biofilm were found on the inner surface of the undamaged endoscope channels. The 
endoscope channels were changed. 
The available P. aeruginosa strains were subjected to molecular typing by repetitive DNA 
sequence-based polymerase chain reaction (rep-PCR) using the DiversiLab System for DNA 
fingerprinting (BioMérieux, France). The isolates from the six patients and from the 
endoscope channels, obtained before gas sterilization, showed matching patterns (similarity 
above 95%) (Kovaleva et al., 2009).  
 
Usefulness of Bacteriological Monitoring of Endoscope Reprocessing 
 
145 
2.2 Endoscopy-related infection associated with bronchoscopy 
During the period 1974-2004, bronchoscopy procedures accounted for 47.5% of the 
endoscopy-related infections in the USA and 21.1% of the infections in other countries 
(Seoane-Vazquez et al., 2007). Several studies have found bronchoscopy procedures to be 
relatively more prone to infection transmission than gastrointestinal endoscopic procedures 
(Seoane-Vazquez et al., 2007; Spach et al., 1993). 
The microorganisms most frequently associated with transmission during bronchoscopy are 
gram-negative bacilli, particularly P. aeruginosa or Enterobacteriaceae or infection with M. 
tuberculosis or other mycobacteria (Cêtre et al., 2005; Nelson & Muscarella, 2006). While 
isolation of various Enterobacteriaceae from the lungs is not rare, severe nosocomial 
pneumonia is not frequently diagnosed in patients during infection outbreaks. It is possible 
that the incidence of pneumonia related to bronchoscopy is underestimated (Shimonom et 
al., 2008). The pathogens of nosocomial pneumonia are related to the timing of onset. 
Microorganisms responsible for early-onset nosocomial pneumonia are generally 
endogenous. In late-onset nosocomial pneumonia, the causative microorganisms include 
potentially multidrug-resistant nosocomial organisms such as P. aeruginosa.  
Three large outbreaks of P. aeruginosa infections following flexible bronchoscopy 
associated with a loose port of the biopsy channel of the bronchoscope were reported in 
the literature (Cêtre et al., 2005; Kirschke et al., 2003; Srinivasan et al., 2003). Another two 
Pseudomonas outbreaks were associated with a damaged internal channel caused by 
defective biopsy forceps (Corne et al., 2005). A contaminated bronchoscope washer 
disinfector was the source of the several Pseudomonas outbreaks (Schelenz & French, 2000; 
Shimonom et al., 2008). 
Numerous reports of mycobacterial transmission by flexible bronchoscopy have been 
reported. Mycobacterial infections during bronchoscopy have been related to contaminated 
suction valves (Wheeler et al., 1989), cracked biopsy channels (Pappas et al., 1982), 
contaminated topical anaesthetic solutions (Leers et al., 1980) and contaminated disinfecting 
machines (Bryce et al., 1993; Fraser et al., 1992). 
The last two years we were confronted with repeated contaminations of flexible 
bronchoscopes with fastidiously growing Methylobacterium. Methylobacterium was also 
isolated from the broncho-alveolair lavages of the patients after bronchoscopy with the 
contaminated bronchoscopes. We consider Methylobacterium as a contaminant being the 
cause of pseudo-infections because no patient manifested true infection with this bacterium. 
Methylobacterium is a fastidious, slowly growing gram-negative rod that forms pink colonies 
on agar plates and is a common contaminant in water (Sanders et al., 2000). Nevertheless it 
has been described as opportunistic human pathogen and has been shown to be able to 
cause colonization and infections in immunocompromised patients (Kaye et al., 1992; Liu et 
al., 1997). Two publications of Methylobacterium contamination related to endoscopic 
procedures were found in the literature. One patient developed Methylobacterium 
bacteraemia following ERCP with the contaminated endoscope (Imbert et al., 2005). A 
pseudo-outbreak of Methylobacterium mesophilicum and Mycobacterium chelonae was described 
in patients who underwent bronchoscopy. M. mesophilicum was isolated from broncho-
alveolar lavages obtained from ventilated patients. Methylobacterium grew from the 
bronchoscopes and automated washers which were revealed as the source of the 
contamination. The presence of biofilm was demonstrated on tubing from the manifold 
block to the top of the reservoir (Kressel & Kid, 2001). 
 
Therapeutic Gastrointestinal Endoscopy 
 
146 
3. Microbiological surveillance of endoscope reprocessing 
Endoscopes, especially the instruments with highly refined technical properties, can be 
cleaned and disinfected but not sterilized after use. This implies the risk of settlement of 
biofilm producing species, which can not be removed with current cleaning and disinfection 
procedures. A currently applied surveillance protocol for endoscopes demonstrates 
recurrent colonization of these instruments. Occasionally this leads to series of infections in 
patients, who become severely ill with pathogenic species being part of the biofilm which 
has settled in the interior of the endoscope.  
In The Netherlands the current guidelines advise no routine microbiological surveillance 
of endoscopes, only under special circumstances like a defect of the endoscope or in the 
disinfection process and also in case of an outbreak (Dutch Infection Prevention Working 
Party, 2004). In our opinion is a good working disinfection process no guarantee on 
“clean” endoscopes, because damage of the endoscope itself occurs during use, e.g. due to 
through scratches in the working channel by the biopsy forceps, and forms a niche for 
rising microbiological biofilm. Outbreaks can easily be overlooked and are often only 
recognized if special microorganisms are involved, like outbreaks caused by a multi-
resistant E. coli in 2002 and by a multi-resistant P. aeruginosa in 2008 in patients after ERCP 
in the UMCG (Kovaleva et al., 2009). Recently in France hospitals duodenoscopes-related 
nosocomial infections due to Klebsiella pneumoniae producing extended-spectrum beta-
lactamase (ESBL) occurred (Aumeran et al., 2010) and also of even more multidrug-
resistant K. pneumoniae carbapenemase (KPC)-producing K. pneumoniae type 2 (Carbonne 
et al., 2010).  
3.1 Endoscope reprocessing 
Accurate reprocessing of flexible endoscopes must involve cleaning, followed by high level 
disinfection with further rinsing and drying before storage. If the programme does not 
include an adequate drying phase, like after manual disinfection, the instrument must be 
disinfected again if it has not been in use for longer than 4 hours (Dutch Infection 
Prevention Working Party, 2004). Because almost all outbreaks are related to breaches in 
reprocessing techniques, it is crucial that endoscope cleaning and disinfection are performed 
carefully. However, process control of the endoscope reprocessing does not guarantee 
prevention of settlement of biofilm and consequent shedding of bacteria during endoscopy. 
Disinfection and drying procedures may fail in the endoscope with a manufacturing defect 
or damaged internal channels when the decontamination process cannot reach all internal 
parts of the instrument, and biofilm formation will occur within the endoscope channels 
(Kovaleva et al., 2009; Srinivasan, 2003). 
At the UMCG endoscope reprocessing is performed according to the recommendations of 
the Dutch national guideline (Dutch Infection Prevention Working Party, 2004) and to the 
manufacture’s recommendations. After manual pre-cleaning and cleaning with detergent 
(Neodisher Mediclean, Dr. Weigert, Hamburg, Germany) and rinsing with water, 
endoscopes are disinfected 10 minutes at the temperature of 25 ºC in one of the automatic 
washer disinfectors (WD 440, Wassenburg Medical Devices B.V., The Netherlands) with 1 % 
Neodisher Septo PAC (Dr. Weigert, Hamburg, Germany). This disinfectant contains a blend 
of peracetic acid (1 %), acetic acid (< 20%) and hydrogen peroxide (15-30%). After 
disinfection endoscopes are dried for 2 hours at 50 ºC using sterile compressed air and 
hereafter are stored in drying cabinets with continuous flow of dry compressed air at room 
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temperature. If a flexible endoscope is used for different patients in a single day, the 
disinfection and drying procedures will be performed between patients. 
3.2 Surveillance algorithm 
In the UMCG the surveillance system for evaluation of the efficacy of the endoscope 
reprocessing was implemented. According to our surveillance protocol, therapeutic 
gastro- and duodenoscopes are microbiologically tested monthly and diagnostic 
endoscopes once every 3 months (Buss et al., 2008; Kovaleva et al., 2009). A decision 




Fig. 1. Decision algorithm for endoscope surveillance. 
If, in terms of the decision algorithm, a contamination problem occurs or clinical data 
suggest transmission, additional samples are taken from the washer disinfectors and also 
from the tubes connecting the washer disinfectors and the endoscopes and other endoscope 
accessories. Culturing of special microorganism (e.g. mycobacteria) might be indicated. 
After a single contamination with a relevant microorganisms (e.g., Enterobacteriaceae, Candida 
species, gram-negative nonfermenters, Staphylococcus aureus), the endoscope is taken out of 
service in patients and the results of repeat sampling are awaited. Such endoscopes undergo 
an intensive high level disinfection procedure. Endoscopes with positive cultures for the 
same clinically relevant microbial species in two consecutive tests after high level 
disinfection procedures stay out of use and undergo an additional reprocessing step using 
sterilization with ethylene oxide followed by microbiological testing before use.  
A contaminated endoscope should be inspected for potential defects. Unfortunately, it is not 
possible to adequately check all internal endoscope channels. Cracking, splitting, channel 
wall holes can all be the source of bacterial contamination within the endoscope which can 
be difficult to impossible to detect by routine inspection and testing.  
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In the literature there are no standards about frequency of the testing intervals of surveillance 
cultures. The Gastroenterological Society of Australia  guideline (2006) recommends the 
microbiologic monitoring of ERCP endoscopes and bronchoscopes every 4 weeks and all other 
gastrointestinal endoscopes every 4 months. According to the European Society of 
Gastrointestinal Endoscopy guideline, routine microbiological testing of endoscopes is advised 
to perform at intervals no longer than 3 months (Beilenhoff  et al., 2007).  
Every microbiological surveillance system has one important limitation. If there is a clinical 
demand for reuse of an endoscope in the mean time, surveillance culture results will likely 
not be obtained until after the endoscope is used on the next patient because cultures take a 
minimum of 24 to 48 hours to incubate (Beilenhoff  et al., 2007). 
3.3 Sampling technique 
Sampling of patient-ready endoscopes can be performed with two different techniques. For 
anterograde sampling, the last rinse water from the endoscope is collected inside the washer 
disinfector at the distal end of the endoscope. At the endoscopy center in the UMCG, we use 
a retrograde technique to obtain surveillance specimens for culture from the biopsy/suction 
and the water/air endoscope channels (Buss et al., 2008; Kovaleva et al., 2009).  
For retrograde sampling, the biopsy/suction channel and the water/air channel of the 
endoscope are each flushed with 20 ml sterile demineralised water manually outside the 
washer disinfector from the distal to the proximal end. To allow the water to enter the small 
distal openings of the channels, we connect the syringe with an adapter taken from a 
gastrointestinal dilator (Savary-Gilliard Dilators; Cook Medical, Bloomington, IN, USA). For 
sampling under sterile conditions this work has to be done by two persons. The water is 
collected at the proximal ends of the channels. The biopsy/suction channel is flushed a 
second time after collecting the water at the suction port and the endoscope is then turned 
upside-down in order to collect the fluid at the biopsy port. Sampling options can differ 
depending on the design of the endoscope and the washer disinfector. Samples should be 
processed shortly after collecting. All samples from endoscopes are sent for culturing. In 
case of positive results all isolated strains are stored. 
If sampling of washer disinfectors is indicated samples from all water channels, the water 
inlet and the water reservoir and from the tubes connecting the washer disinfectors and the 
endoscopes should be taken. To enhance the sensitivity of culturing, the washer disinfector 
can be taken out of use at the end of a normal working day and samples should be taken 
several days later or at least after one overnight storage period. Following this procedure an 
auto-disinfection cycle can be run and one to several days later a second sampling can be 
performed.  
The endoscopes have to be sampled in a retrograde manner, because anterograde sampling 
is not sensitive enough, as shown by our own data (Buss et al., 2008) and those of another 
study (Srinivasan et al., 2003). Srinivasan et al. (2003) and Cêtre et al. (2005) sampled the 
biopsy suction channel retrogradely using the suction button of bronchoscopes to suck back 
the sample fluid, used for flushing, to the proximal channel opening. In our approach the 
water and air channels of gastrointestinal endoscopes were sampled retrogradely. 
Alternatively, flushing through combined with brushing may be used (Rejchrt et al., 2004). 
During the endoscopy-related outbreak caused by ESBL-positive K. pneumoniae in France the 
epidemic strain was finally isolated from one duodenoscope by flushing and brushing the 
channels (Aumeran et al., 2010). We know no comparison of the sensitivities of these 
variants with that of our way of retrograde sampling. The mechanisms underlying the 
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higher sensitivity of retrograde sampling need to be further investigated. Probably, 
changing the direction of the water flow leads to easier removal of organic material and 
biofilm that have grown with the anterograde flow of the disinfection procedure. Niches 
inside the endoscopes that are not reached by the anterograde sampling flow may become 
more accessible. 
3.4 Laboratory protocol   
One hundred mL of each sample are inoculated on agar plates for aerobic culturing as 
follows: blood agar (BA; 5% blood sheep agar; Oxoid Ltd., Cambridge, UK), chocolate blood 
agar (CHOC; Oxoid), Sabouraud dextrose agar with 0.02 g/L aztreonam and 0.02 g/L 
vancomycin (SABav; Oxoid), and tryptone glucose extract agar (TGE; Oxoid). The cultures 
are incubated for 4 days at 35 C (BA, CHOC, SABav) or 7 days at room temperature (TGE). 
In addition, 1 mL of each sample are added to an aerobic blood culture bottle and incubated 
for 4 days in the BacT/ALERT system (bioMérieux SA, Marcy l’Etoile, France). Alternatively 
to the use of a broth medium, samples can be filtrated to concentrate the microorganisms 
and the filters cultured.  
Bacterial isolates and yeasts are identified according to standard determination schemes.  
If indicated, culturing of mycobacteria can be done following standard sampling 
procedures. We do not culture for anaerobic microorganisms nor do we carry out virus 
detection. 
3.5 Culture results and interpretation 
In 2008 208 retrograde samples from endoscopes were taken. With retrograde sampling, 
20% (42/208) of all endoscope cultures were found to be contaminated with a 
microorganism; 5.3% (11/208) of the tests resulted in withdrawal of the contaminated 
endoscopes, followed by repeated intensified disinfection procedures and gas 
sterilization. Previous surveillance data from September 2002 until January 2005 
demonstrate the much higher sensitivity of retrograde versus anterograde taken samples. 
The percentage of positive cultures of anterograde versus retrograde samples were 7.9% 
respectively 31% for all microorganisms and for yeasts alone 2.8% respectively 25% (Buss 
et al., 2008).  
Various groups of bacteria were found in the surveillance cultures. The following 
microorganisms were frequently found: aerobic gram-positive cocci, Enterobacteriaceae, 
gram-negative nonfermenters (Pseudomonas, Acinetobacter species). Repeated endoscope 
contamination with Stenotrophomonas maltophilia and Methylobacterium is regularly 
demonstrated, after which intervention conform the protocol is implemented. Frequently 
more than one species was found in one culture; in many cases this was a mix of Candida 
species with gram-negative rods or nonfermenters.  
In the course of time we found an increasing number of endoscopes positive for non-
albicans Candida species, in particular Candida parapsilosis (77% of all further identified 
non-albicans Candida species). The persistent culturing of C. parapsilosis was generally an 
indicator of a disinfection problem and may be caused by a low disinfection temperature. 
3.6 Economic burden of endoscope reprocessing and endoscopy-related infection  
The literature related to the costs associated with endoscope reprocessing and the economic 
consequences of endoscope contamination is very limited. The economic evaluation of 
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exogenous endoscopy-related outbreaks should include the analysis of outcomes (the 
number of prevented exogenous endoscopy-related infections) and the estimation of the 
health care, non-health care and indirect costs (Seoane-Vazquez et al., 2006). The health care 
costs include the costs of the epidemiological investigation of the outbreak, the diagnosis 
and treatment of the affected patients, and the use of resources cost associated with 
endoscope unit inactivity. A study of post-arthroscopy infections estimated the cost 
approximately at $9,155 per case (Babcock et al., 2003).  
The economic evaluation of the microbiological surveillance should include a calculation of 
the costs for the microbiological tests, costs in time for nursing staff to collect the samples, 
costs of endoscope recall and extra disinfection procedures or service of the endoscopes. 
Recent articles pointed to the high cost of periodic monitoring of endoscopes, washer 
disinfectors and the environment. A recently published study analysed the cost of 4-weekly 
surveillance microbiological tests of bronchoscopes, duodenoscopes and automated washer 
disinfectors during a 5-year period. The overall cost of performed tests and cost in time for 
nursing staff to collect the samples was estimated at $AUD 100.400 (Gillespie et al., 2008). 
The costs of an outbreak with a number of clinical complications as described in our cases 
are usually a multiple of this amount. Microbiological surveillance of endoscope 
reprocessing and intervention protocol can save the high costs associated with incidental 
cases and outbreaks of endoscopy-related infections. 
In the economic analyses performed in 2008 in the UMCG, the costs of the surveillance of 
the endoscope reprocessing (cost of tests and cost in time for staff) were estimated at € 
25.967. Not calculated were the costs for reprocessing and/or revision of endoscopes by the 
manufacturer. It was estimated that the costs of the recent Pseudomonas outbreak, i.e. the 
direct health-care costs for the diagnosis, treatment and hospitalization of the six affecting 
patients, approximated € 157.729. 
3.7 Summary and future prospects 
The UMCG has 9 years of experience with the microbiological monitoring of flexible 
endoscopes, biofilm detection and intervention. Positive results of microbiological surveillance 
have been leading to withdrawal, additional disinfection and incidental gas sterilization of the 
contaminated endoscopes. The risk of contamination and infection were reduced for large 
groups of patients, and the expected costs of the post-endoscopic infectious complications 
were saved (Buss et al, 2008;  Kovaleva et al., 2009). However, our surveillance and 
intervention did not prevent six serious infections by the genotypic similar strain of P. 
aeruginosa, due to the window period in between the surveillance procedures (1 month). 
Our protocol is able to detect a structural problem in the endoscope disinfection process. 
Retrograde sampling is crucial for this purpose, because it has much higher sensitivity than 
anterograde sampling (Buss et al., 2008; Srinivasan et al., 2003). Endoscopes with damaged 
working channels often are the source of the contamination problems.  
Our monitoring and decision algorithm is a product of a learning-by-doing process when 
we were confronted with contamination problems. If we had not done retrograde sampling 
we would not have recognized the structural disinfection problems of individual 
endoscopes. Ideally, an easily performed daily microbiological surveillance method will be 
developed in the future, which can replace culturing and give faster results. This technique 
might be based on adenosine triphosphate measuring or polymerase chain reaction 
detection (Obee et al., 2005; Sciortino et al., 2004).  
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Some investigators have begun exploring sterile-sheathed endoscopes with new technology 
to reduce the risk for infectious complications. The EndoSheath is an endoscope system in 
which all parts of the endoscope that come into contact with the patient are fully disposable 
(Colt et al., 2000; Srinivasan, 2003). The endoscope does not come in contact with the patient 
and does not require disinfection. The disposable sheath, which is in contact with the 
patient, includes the air/water, suction, and working channels. The main purposes of the 
sheath are to prevent the transmission of pathogens, and to reduce the need for high-level 
sterilization. 
4. Impact of biofilms on endoscope reprocessing  
4.1 Definition and properties of biofilm  
Microorganisms in nature do not generally grow in nutrient-rich suspensions as in the 
laboratory, but prefer to grow in surface-associated communities, called biofilms (Bar-Or, 
1990). The phenomenon of biofilm formation by microorganisms on inert surfaces has been 
extensively studied and there appears to be a direct relationship between the ability of the 
organism to form a biofilm and its pathogenicity (Shin et al., 2002).  
A biofilm is an assemblage of microbial cells that is irreversibly attached to a surface and 
enclosed in an exopolysaccharide matrix (Donlan, 2002). Biofilms consist of a substratum to 
which the microorganism adheres, a conditioning film, the matrix and the liquid phase 
(Costerton et al., 1995). A typical biofilm will contain around 85% polysaccharide matrix and 
only 15% bacterial mass. Biofilms may form on different surfaces, including living or dead 
tissues, indwelling medical devices, water supply systems, or endoscope channels (Donlan, 
2002; Pajkos et al., 2004).  
Bacteria growing within biofilms have a number of characteristics that distinguish them 
from planktonic populations. Ability to form biofilms allows microorganisms to survive 
under conditions of drying, chemical and antibiotic exposure. Cells growing within biofilms 
are protected from host immune system and are frequently 1000 times more resistant to 
antibiotics than the non-attached planktonic cells. The increased resistance to antimicrobial 
agents can be explained by poor penetration of an antibiotic into a biofilm, slow growth rate 
and formation of resistant phenotypes of microorganisms within biofilms (Costerton et al., 
1995; Patel, 2005).  
Under adverse conditions, biofilms are capable to release their bacterial population into a 
planktonic state. This ability can be explained by intercellular communication within a 
biofilm (Davies et al., 2008). Signalling systems include quorum sensing (the release of 
signal chemicals in response to increasing population density), biosignal blockers, 
pheromones and butyrylhomoserine lactone. These signalling systems are important in 
regulation of a number of physiological processes, including antibiotic synthesis, plasmid 
transfer and the expression of virulence factors (van Delden & Iglewski, 1998). 
With the increasing use of invasive medical procedures, infections involving biofilms form an 
important risk factor for infectious complications. It has been reported that bacterial biofilm 
causes about 65% of bacterial infections in the clinic (Chicurel, 2000). These infections often 
develop in immunocompromised patients and can be caused by a variety of different 
microorganisms. Biofilm infections show poor manifestation and recurring symptoms after 
antibiotic therapy (Costerton et al., 1995). Bacteria within biofilms are able to evade the host 
immune system. Antibodies are not effective against microorganisms within biofilms, and 
immune complex can damage the surrounding tissues (Cochrane et al., 1985).   
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4.2 Removal of biofilms  
During endoscopy, the environment provides optimal conditions for the growth of biofilms. 
Modern endoscopes contain multiple channels and ports which allow for the collection of 
organic material. The presence of biofilms on the inner surface of endoscope channels has 
been reported in many publications (Buss et al., 2008; Kovaleva et al., 2009; Pajkos et al., 
2004). Even if valid endoscope reprocessing protocols are applied, microbial accumulation 
can lead to the development of a mature biofilm inside narrow endoscope channels in time 
(Pajkos et al., 2004). Biofilm formation on the inner surface of the endoscope channels, 
especially, when these become scratched or damaged, can result in failure of the 
decontamination process. It can create a vicious circle of growth, disinfection, partial killing 
or inhibition and regrowth, resulting in outbreaks of endoscopy-related infections in 
patients who underwent an endoscopy with the biofilm-containing endoscope (Buss et al., 
2008; Kovaleva et al., 2009). 
Scanning electron microscopy is able to reveal incomplete removal of debris from the 
interior part of a dismantled endoscope after reprocessing. Figure 2 shows a bacterial 
biofilm inside an endoscope channel. This endoscope was contaminated not only the inside 




Fig. 2. Scanning electron microscopy picture of bacterial biofilm in an endoscope channel. 
Oxidising agents are the most effective chemicals currently available for killing and 
removing biofilms. Peracetic acid is an oxidising agent usually used for high-level 
disinfection of flexible endoscopes. It is effective against bacteria, fungi, spores and 
viruses, minimally toxic and not corrosive at the concentration recommended for 
disinfection. The biocidal effect of peracetic acid on sessile microorganisms is well known 
(Henoun Loukili et al., 2004). However, the effect of this disinfectant on biological 
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deposits, particularly its ability to fix or to remove biofilms from materials, is not 
completely studied.  
To have potential action on biofilms, relatively high concentrations of the disinfecting 
agent are necessary. Current peracetic acid disinfectants are not used in high 
concentrations for endoscope reprocessing because of corrosive properties 
(Gastroenterological Society of Australia, 2006). According to Marion-Ferey et al. (2003), 
peracetic acid had a limited efficacy in biofilm removal from the silicone tubing in 
haemodialysis systems. Other studies demonstrated the ability of peracetic acid 
disinfectants to fix the E. coli biofilm and blood on to artificial materials (Henoun Loukili 
et al., 2004; Kampf et al., 2004) 
Glutaraldehyde is also an effective agent in endoscope disinfection. It requires a much 
greater time to kill the biofilm and is less effective in causing shedding of the biofilm from 
the surface. However, glutaraldehyde is irritating to the skin, can cause allergic contact 
dermatitis, and may result in irritation of the eyes and nasal mucosa (Alvarado & 
Reichelderfer, 2000). Recently, resistance to glutaraldehyde against some M. chelonae strains 
has been described in the literature (van Klingeren & Pullen, 1993). Kovacs et al. (1998) 
reported a strain of P. aeruginosa responsible for three separate clinical episodes of ERCP-
associated cholangitis and concluded that the organism developed adaptive chemical 
resistance to glutaraldehyde.  
The use of anti-biofilm oxidising agents and disinfectants with antimicrobial coating inside 
washer disinfectors could reduce biofilm build-up inside endoscopes and endoscope 
washers and decrease the risk of transmitting infections (Marion et al., 2006; Rutala & 
Weber, 2001).  
Sterilization can be helpful to destroy microorganisms within biofilms. However, flexible 
endoscopes cannot be heat-sterilized because of vulnerable elements. Low temperature 
hydrogen peroxide plasma and ethylene oxide gas sterilization can be used during 
endoscope reprocessing. Recent studies indicate problems with gas and plasma sterilization 
of long, narrow lumina in the presence of organic soil and salts (Gastroenterological Society 
of Australia, 2006).  
4.3 Role of drying in biofilm removal  
Accurate drying and storage are important factors in the maintenance of bacteria-free 
endoscopes. The potential for microbial growth inside endoscope channels after disinfection 
mainly depends on the conditions within the endoscope channels during drying and 
storage. Wet channels after reprocessing facilitate growth of such microorganisms as 
Pseudomonas and Acinetobacter species during storage (Alfa & Sitter, 1991). The drying 
procedure of the endoscopes after cleaning at 50 C, followed by drying with a constant flow 
of compressed ambient air is applied in the UMCG. 
According to the literature, endoscopes stay bacteria-free after prolonged storage if an 
adequate drying procedure was applied. When stored in the drying cabinet with a laminar 
air flow, no growth of bacteria and Candida species was found in endoscopes channels 5 
days after reprocessing (Rejchrt et al., 2004). Allen et al. (1987) pointed the high efficiency of  
a drying procedure with suctioning 70% alcohol through endoscope channels, followed by 
compressed air in prevention of the further contaminations during the P. aeruginosa infection 
outbreak. 
We recently demonstrated that routine cleaning procedures can not always remove biofilm 
reliably from endoscope channels if the accurate drying procedure is not applied. We 
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We recently demonstrated that routine cleaning procedures can not always remove biofilm 
reliably from endoscope channels if the accurate drying procedure is not applied. We 
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studied the ability for biofilm formation and the effects of the peracetic acid-based 
disinfectant, currently in use for endoscope reprocessing in the UMCG, with, and without 
additional drying on Candida albicans, C.  parapsilosis, P. aeruginosa and S. maltophilia biofilms 
(Kovaleva et al., 2010).   
The biofilms were prepared in sterile tissue culture polystyrene 96-well microtiter plates. 
After 72 h incubation, single- and dual-species biofilms were treated for 10 min with the 
disinfectant at concentrations conform the minimal bactericidal concentration of the 
strains tested and at 1% concentration, recommended for disinfection of flexible 
endoscopes by the company. In order to mimic the biofilm formation and to establish a 
possible regrowth of biofilms inside the endoscope channels after reprocessing, we 
developed an in vitro biofilm model which underwent the different steps of the 
disinfection and drying procedures applied for reprocessing of flexible endoscopes 
(Figure 3). The viability of the biofilm was quantified by using the tetrazolium salt (MTT) 
reduction assay and by counting colony-forming yeasts and bacteria of the 10-fold serial 




Fig. 3. In vitro biofilm model mimicking the different steps of the disinfection procedure 
without and with the drying process in a flexible endoscope. CFU, colony-forming units; 
MTT, tetrazolium salt reduction assay; MBC, minimal bactericidal concentration;  
TSA, trypticase soy agar; PBS, phosphate buffered saline. 
A low MTT formazan signal was demonstrated in all biofilms directly after 10 min 
treatment with the minimal bactericidal concentration and 1% disinfectant (Figure 4a). A 
total inhibition of microbial growth in all biofilms on agar plates occurred after treatment 
with 1% disinfectant. Minimal bactericidal concentration caused a marked inhibition of 
microbial growth of all biofilms but not a 100% bactericidal and fungicidal efficacy. 
Regrowth of all biofilms occurred following 48 h incubation with trypticase soy broth 
directly after treatment with the minimal bactericidal concentration and 1% disinfectant if 
the drying procedure was skipped. No biofilm regrowth occurred in wells after a drying 
procedure for 1, 3 and 5 days in all biofilms (Figure 4b). 
 





Fig. 4. Regrowth of the single- and dual-species C. albicans (CA), C. parapsilosis (CAPP), P. 
aeruginosa (PSAE) and S. maltophilia (STMA) biofilms expressed in vitality by measuring the 
MTT signal and expressed in viability in CFU per well after the disinfection procedure with 
MBC and 1% disinfectant (a) without additional drying and (b) with additional drying for 1, 
3 and 5 days.   
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This study demonstrated the high efficacy of the drying procedure after the disinfection step 
against yeasts and bacteria in all single- and dual-species biofilms. Failure of 
decontamination endoscopes can be explained by an invalid drying procedure. 
5. Conclusion 
Contaminated endoscopes have been linked to many outbreaks of device-related 
nosocomial infections. The true incidence of endoscopy-related infections is unknown 
because of inadequate surveillance or no surveillance at all. Endoscopy-related infections 
can cause serious harm and can give rise to concerns over these procedures by physicians 
and patients in. 
Flexible endoscopes can be cleaned and disinfected but not sterilized after use. This implies 
the risk of settlement of biofilm producing species. Routine cleaning and disinfection 
procedures do not remove biofilm reliably from endoscope channels if the accurate drying 
procedure is not applied. This may explain the failure of decontamination during endoscope 
reprocessing. 
Process control of the washing and disinfection procedure is requested and implemented 
but does not guarantee prevention of settlement of biofilm and consequent shedding of 
bacteria during endoscopy. Implementation of a microbiological surveillance of endoscope 
reprocessing is appropriate to detect early colonization and biofilm formation in the 
endoscope and to prevent contamination and infection in patients after endoscopic 
procedures. However, the returns of prevention of endoscopy-related infections should be 
reasonably in balance with the costs of the technical and laboratory procedures resulting 
from surveillance and the costs of reprocessing or servicing of the contaminated endoscope. 
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After Percutaneous Endoscopic Gastrostomy 
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1Department of Internal Medicine, Nishimino Kosei Hospital,  
2Department of Gastroenterology, Graduate School of Medicine, Gifu University,  
Japan 
1. Introduction  
Recent developments have made ultrathin endoscopes available for routine 
esophagogastroduodenoscopy and also for unsedated transnasal observation (Shaker, 1994). 
Transnasal endoscopy is known to be less of a burden for patients (more tolerable) than 
transoral endoscopy and has benefits including fewer effects on respiratory and 
cardiovascular status and reduced recovery time after the procedure (Campo et al., 1998; 
Dumortier et al., 1999; Mori et al., 2008). Transnasal ultrathin endoscopy has also been 
applied for biliary drainage, insertion of a nasoenteral feeding tube or a long intestinal tube, 
and percutaneous endoscopic gastrostomy (PEG) (Fang et al., 2005; Itoi et al., 2008; Sato et 
al., 2008; Vitale et al., 2005). PEG has become the primary access for long term enteral 
feeding since its introduction in 1980 (Gauderer et al., 1980; Ponsky & Gauderer, 1981), 
being a very easy and rapid method compared with the previous surgical technique to place 
a gastrostomy tube. 
The endoscopic approach from the gastrocutaneous tract was first described by Chaurasia , 
et al. for the insertion of a jejunal feeding tube through the PEG (PEG-J) tract (Chaurasia & 
Chang, 1995). Although they used a pediatric bronchoscope at that time, an ultrathin 
endoscope later took its place for this purpose (Adler et al., 2002). We have been employing 
an ultrathin endoscope through the gastrostomy tract for observation, diagnosis, and 
treatment of various digestive diseases from April 2003. We also investigated the usefulness 
of such transgastrostomal endoscopy (TGE) for management of patients who had 
undergone percutaneous endoscopic gastrostomy (PEG). 
2. Procedure of transgastrostomal endoscopy (TGE) 
Patients with a mature gastrocutaneous tract are candidates for this procedure. Patients 
before the maturation of the fistula (2 to 4 weeks after the PEG) have higher risk of fistula 
disruption. If it is necessary to perform TGE in an earlier phase or at the PEG, tight 
affixation of the stomach to the abdominal wall using a gastropexy device (Rogers, 1989) 
allows TGE to be performed. 
 
Therapeutic Gastrointestinal Endoscopy 
 
162 
Van Delden, C. & Iglewski, B. Cell-to-cell Signalling and Pseudomonas Aeruginosa 
Infections. Emerging Infectious Diseases, Vol.4, No.4, (October - December 1998), pp. 
551-560, ISSN 1080-6059 
Van Klingeren, B. & Pullen, P. Glutaraldehyde Resistant Mycobacteria from Endoscope 
Washers. Journal of Hospital Infection, Vol.25, No.2, (October 1993), pp. 147-149, ISSN 
0195-6701 
Wheeler, P.; Lancaster, D. & Kaiser, A. Bronchopulmonary Cross-colonization and Infection 
Related to Mycobacterial Contamination of Suction Valves of Bronchoscopes. The 
Journal of Infectious Diseases, Vol.159, No.5, (May 1989), pp. 954-958, ISSN 0022-1899 
10 
Transgastrostomal Observation and 
Management Using an Ultrathin Endoscope 
After Percutaneous Endoscopic Gastrostomy 
Shinji Nishiwaki1, Hiroo Hatakeyama1,  
Masahide Iwashita1 and Hiroshi Araki2 
1Department of Internal Medicine, Nishimino Kosei Hospital,  
2Department of Gastroenterology, Graduate School of Medicine, Gifu University,  
Japan 
1. Introduction  
Recent developments have made ultrathin endoscopes available for routine 
esophagogastroduodenoscopy and also for unsedated transnasal observation (Shaker, 1994). 
Transnasal endoscopy is known to be less of a burden for patients (more tolerable) than 
transoral endoscopy and has benefits including fewer effects on respiratory and 
cardiovascular status and reduced recovery time after the procedure (Campo et al., 1998; 
Dumortier et al., 1999; Mori et al., 2008). Transnasal ultrathin endoscopy has also been 
applied for biliary drainage, insertion of a nasoenteral feeding tube or a long intestinal tube, 
and percutaneous endoscopic gastrostomy (PEG) (Fang et al., 2005; Itoi et al., 2008; Sato et 
al., 2008; Vitale et al., 2005). PEG has become the primary access for long term enteral 
feeding since its introduction in 1980 (Gauderer et al., 1980; Ponsky & Gauderer, 1981), 
being a very easy and rapid method compared with the previous surgical technique to place 
a gastrostomy tube. 
The endoscopic approach from the gastrocutaneous tract was first described by Chaurasia , 
et al. for the insertion of a jejunal feeding tube through the PEG (PEG-J) tract (Chaurasia & 
Chang, 1995). Although they used a pediatric bronchoscope at that time, an ultrathin 
endoscope later took its place for this purpose (Adler et al., 2002). We have been employing 
an ultrathin endoscope through the gastrostomy tract for observation, diagnosis, and 
treatment of various digestive diseases from April 2003. We also investigated the usefulness 
of such transgastrostomal endoscopy (TGE) for management of patients who had 
undergone percutaneous endoscopic gastrostomy (PEG). 
2. Procedure of transgastrostomal endoscopy (TGE) 
Patients with a mature gastrocutaneous tract are candidates for this procedure. Patients 
before the maturation of the fistula (2 to 4 weeks after the PEG) have higher risk of fistula 
disruption. If it is necessary to perform TGE in an earlier phase or at the PEG, tight 
affixation of the stomach to the abdominal wall using a gastropexy device (Rogers, 1989) 
allows TGE to be performed. 
 




The endoscopes we used were GIF-XP240, GIF-XP260 and GIF-XP260N (Olympus Optical 
Co., Ltd., Tokyo, Japan) (Fig. 1). The diameters of these endoscopes were 7.7, 6.5, and 5.2 
mm, respectively. The diameter of the working channel of these endoscopes was 2.0 mm. 
GIF-XP240, GIF-XP260, and GIF-XP260N allow insertion through more than 24, 20 and 18 F 
fistula tracts, respectively. 
 
 
Fig. 1. Photograph of ultrathin endoscopes and gastrostomy tubes. a: GIF-XP260N, b: GIF-XP260, 
c: GIF-XP240 (Olympus Optical Co., Ltd., Tokyo, Japan), d: Ponsky NBR, 20F (Bard Access 
Systems, Inc., Salt Lake City, UT, USA ), e: Securi-T, 24F (Boston Scientific, Natick, MA, USA) 
2.2 Routine observation by TGE 
The patient is usually infused with 500 ml of water instead of liquid feeds for several hours 
before the endoscopic examination to remove the gastric mucus. The patient is laid in the 
supine position and then the gastrostomy tube is removed. After applying lidocaine jelly 
around the stoma, an ultrathin endoscope is inserted through the fistural tract and 
proceeded into the gastric lumen (Fig. 2A). The endoscope is directed to the oral side and 
advanced to the esophagogastric junction (Fig. 2B). The junction can be observed in detail 
without disturbance, free from the shade of the endoscope. The endoscope is retrogradely 
inserted through the esophagus, and we can observe oral cavity as well as pharyngeal cavity 
if necessary. The endoscope is then withdrawn to the stomach and directed to the anal side. 
The endoscope is easily inserted up to the upper jejunum from the stoma (Fig. 2C). The 
endoscope is pulled back to the stomach and turned back to see around the stoma (Fig. 2D). 
 
 
Fig. 2. A: Insertion of an ultrathin endoscope through the gastrostomy tract. B: Endoscopic 
view of esophagogastric junction (arrow) which is retrogradely observed from the stomach. 
C: Endoscopic view of upper jejunum. D: Endoscopic view of the stoma from the stomach. 
Arrow indicates the endoscope inserted through the stoma. 
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After the observation of the upper gastrointestinal tract, the endoscope is withdrawn from 
the stoma and a new gastrostomy tube is replaced via the skin incision. 
3. Diagnostic application of TGE 
Since most of patients who undergo PEG are of advanced age and also have comorbid 
diseases, they usually do not undergo esophagogastroduodenoscopy after PEG. As TGE is a 
less invasive procedure to perform even for critically ill patients, we have routinely 
conducted TGE at the periodical replacement of gastrostomy tubes. We have found variety 
of newly developed lesions in the upper gastrointestinal tracts and were able to treat them 
at an early stage without symptoms. 
3.1 Cardiopulmonary tolerance during the procedure of TGE 
TGE is a less invasive examination compared to transoral and transnasal endoscopy, 
because TGE does not pass through the pharynx. It requires neither local anesthesia of the 
pharynx or nasal tract nor conscious sedation before the procedure of TGE. We monitored 
blood pressure, heart rate, and percutaneous oxygen saturation concentration measurement 
of the arterial blood (SPO2) during TGE procedures in 20 consecutive patients. The values 
were compared to those for patients with the same clinical background during the 
examination of transoral endoscopy in routine esophagogastroduodenoscopy. Table 1 
shows the comparison of cardiopulmonary effects during the procedures of TGE and 
transoral endoscopy. None of the TGE examinations required sedation, while the transoral 
examinations required 1 to 4 mg of intravenous administration of midazolam. There were 
no significant differences in the fluctuation of blood pressure and heart rate between TGE 
and transoral endoscopy. TGE displayed no effects on SPO2 during the procedure, while 






endoscopy (n=13) P value 
Fluctuation of blood pressure  
(more than 20%) 5% (1/20) 23% (3/13) P = 0.157 
Fluctuation of heart rate 
(more than 20%) 15% (3/20) 15% (2/13) P > 0.5 
Decrease of SPO2 
(more than 3%) 0% (0/20) 46% (6/13) P < 0.01 
Table 1. The effects of TGE and transoral endoscopy on blood pressure, heart rate, and SPO2. 
3.2 Newly developed lesions in upper gastrointestinal tract after PEG 
We have been conducting TGE for screening the upper gastrointestinal tract since April 
2003. TGE was carried out 805 times in 245 PEG patients (Table 2) during routine 
replacement of gastrostomy tubes until November 2010. The demographic data are shown 
in Table 2. The mean age of the subjects was 80.8 years old, and the most frequent 
underlying disease was cerebrovascular disease. The endoscopic findings of TGE were 
compared to those at PEG placement. There were a variety of newly developed lesions after 
PEG. 
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Age (mean + SD) 80.8 + 8.9
















Table 2. Demographic data of patients who underwent TGE after PEG. 
Reflux esophagitis was found in 35 patients (14.2%), which was the most frequent lesion 
after PEG. Among the 35 patients, reflux esophagitis was absent at the PEG tube placement 
in the 30 patients. There were 5 severe cases with symptoms of hematemesis and this had 
subsequently led to stricture of the lower esophagus in 3 patients (Fig. 3A). Although in 
these 3 patients, we were unable to insert a transoral endoscope into the stomach, we were 
able to conduct endoscopic observation of the stomach by TGE (Fig. 3B). 
 
   
Fig. 3. Endoscopic view of severe reflux esophagitis after PEG. A: Circumferential ulcer was 
observed by emergency transoral esophagoscopy after the symptom of hematemesis. B: The 
stricture of the lower esophagus after administration of proton pump inhibitor was 
observed from the stomach by TGE. 
The next most frequent lesion after PEG was polypoid lesion around the stoma. We 
classified polypoid lesions into 3 types according to their location e.g.; basal bumper type, 
peri-bumper type and opposite-bumper type. The basal-bumper type polyp was 
communicated with the fistural tract and the pathology was inflammatory granulation (Fig. 
4A). The peri-bumper type polyp was located around the stoma and often observed in cases 
with decompression by a mushroom type gastrostomy tube (Fig. 4B). Pathological 
examination revealed hyperplasia of the gastric mucosa. The opposite-bumper type polyp 
was located on the contra lateral wall of the stoma, probably caused by the contact of the top 
of the bumper or tube (Fig. 4C). The pathology was hyperplasia. Most of the polypoid lesion 
was not significantly changed in the subsequent observation by TGE. One case with 
haemorrhage from the basal-bumper type granuloma was resected by polypectomy using 
TGE. 
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Fig. 4. Endoscopic views of polypoid lesions around the stoma. A: basal-bumper type, B: 
peri-bumper type, C: opposite-bumper type. 
Gastric ulcer was observed in 6 patients. All of their lesions were accidentally found at TGE, 
because they did not complain of symptoms due to their comorbid diseases. Among the 6 
patients, the lesions of 3 patients were supposed to have been caused by direct contact with 
the bumper. These ulcers were characterized by their location on the contralateral side of the 
bumper (Fig. 5A). The remaining 3 patients were sporadic cases (Fig. 5B). We have also 
experienced additional 2 cases of symptomatic gastric ulcer which were detected by 
transoral endoscopy. For their initial symptoms of hematemesis and tarry stool, emergent 
esophagogastroduodenoscopy was performed (Nishiwaki et al., 2010b). Hemostasis was 
obtained by endoscopic hemoclips and coagulation, respectively. TGE was not available for 
such therapy, because the working channel of the ultrathin endoscope was too narrow to 




Fig. 5. A: Gastric ulcer was observed on the posterior wall of the lower body of the stomach, 
contralateral to the stoma. B: Peptic ulcer was observed on the lesser curvature of the upper 
body in the stomach. 
Neoplastic lesions were also detected by TGE. We have experienced 3 cases of early gastric 
cancer and one case of carcinoid tumor that developed after PEG. One case was recurrence 
of early gastric cancer after endoscopic mucosal resection before the PEG. One case of early 
gastric cancer underwent coagulation therapy with argon plasma (Fig. 6A). The remaining 
two cancer (Fig. 6B) and one carcinoid tumor lesions were resected by endoscopic 
submucosal dissection assisted by TGE, the technique of which is described in section 4.2.1. 
The primary duodenal cancer was accidentally found by TGE at the first endoscopic 
examination 5 years after PEG. 
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Candida esophagitis was observed in 4 patients. All of the patients were administered 




Fig. 6. A: Indigocarmine sprayed endoscopic view of early gastric cancer. Superficial 
depressed lesion (IIc) was observed on the greater curvature of the antrum. The biopsy 
specimen of the lesion was well-differentiated tubular adenocarcinoma. B: Superficial 
elevated lesion (IIa) was observed on the lesser curvature of the upper body of the stomach. 
Pathological finding of the biopsy specimen was well-differentiated tubular 
adenocarcinoma. 
Table 3 summarizes newly developed lesions after PEG. TGE was useful for the early 
detection and follow up of these lesions. 
 
Pathological conditions Number of patients 
Reflux esophagitis 30 
Polypoid lesion around the stoma 28 
Gastric ulcer 6 
Neoplastic lesions  
 Early gastric cancer 3 
 Gastric carcinoid tumor 1 
 Primary duodenal cancer 1 
Candida esophagitis 4 
Total 73 
Table 3. Newly developed upper gastrointestinal lesions which were detected by TGE after 
PEG. 
4. Therapeutic application of TGE 
TGE also offers several advantages for endoscopic treatments compared with a transoral 
endoscope. TGE can easily access up to the upper jejunum with less patient discomfort. TGE 
covers treatments for lesions from the upper esophagus to upper jejunum. Table 4 shows the 
list of TGE we have conducted for therapeutic purposes. . 
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 No. of trial No. of success 
Establishement of direct jejunal feeding access   
    Placement of jejunal feeding thorough the PEG (PEG-J) 27 27 
    Direct percutaneous endoscopic jejunostomy (DPEJ) 36 33 
Resection of upper gastrointestinal tumors   
    TGE assisted endoscopic submucosal dissection (ESD) 5 5 
    Endoscopic mucosal resection 1 1 
    Polypectomy 1 1 
Palliative therapy for gastrointestinal obstruction   
    Transgastrostomal gastroduodenal stenting  5 4 
    Placement of long intestinal decompression tube 2 2 
Other usage for endoscopic treatments   
    Recovery of disrupted gastrocutaneous tract 5 5 
    Transgastrostomic biliary drainage 1 1 
Table 4. Reference chart of TGE for therapeutic purposes and their outcomes.  
4.1 Establishment of direct jejunal feeding access 
Since the introduction of endoscopic placement of a gastrostomy tube, PEG has been the 
primary choice for long-term enteral access. However, there are some situations which 
postpyloric or jejunal feeding is preferable to gastric feeding. The indications for jejunal 
feeding include a high risk of aspiration, previous gastric resection, gastric pull-up, gastric 
outlet obstruction, an obstructed or nonfunctioning gastrojejunostomy, and gastric 
dysmotility (Shike & Latkany, 1998). The access for jejunal feeding was initially established 
as two methods, i.e.; transnasal insertion of a feeding tube and surgical placement of a 
jejunostomy tube. Alternative accesses methods for jejunal feeding have been developed; 
placement of a jejunal feeding tube through the PEG (PEG-J) and direct percutaneous 
endoscopic jejunostomy (DPEJ). We utilized TGE for the establishment of the two access 
methods. 
4.1.1 Placement of a jejunal feeding tube through the PEG (PEG-J) 
PEG-J was first described in 1984 (Ponsky & Aszodi, 1984). This technique was usually 
conducted for patients with high risk of aspiration due to gastroesophageal reflux of food 
after PEG (Nishiwaki et al., 2006).  The tube is usually placed under fluoroscopic guidance. 
However, it is sometimes difficult to pass the feeding tube through the pyloric ring and 
duodenum using only fluoroscopy. A technique to assist the tube passage into the 
duodenum by transoral endoscopy has been reported (Duckworth et al., 1994; Leichus L et 
al., 1997). A transgastric technique using a pediatric bronchoscope or an ultrathin endoscope 
was described first in 1995 (Adler et al., 2002; Chaurasia & Chang, 1995). 
We treated 27 patients using this technique with the following procedures: 1. Remove the 
gastrostomy tube. 2. Insert an endoscope through the gastrostomy and proceed up to the 
jejunum (Fig. 7A). 3. Insert a guidewire through the working channel of the endoscope. 4. 
Remove the endoscope retaining the guidewire (Fig. 7B). 5. Place a jejunal feeding tube over 
the guidewire through the PEG under fluoroscopic guidance (Figs. 7 C & D). 
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Fig. 7. Schematic procedure of PEG-J using TGE. 
The jejunal feeding tubes (J-tube, Boston Scientific, Natick, MA, USA, or Jejunal Feeding 
Tube, Bard Access Systems, Inc., Salt Lake City, UT, USA) were successfully placed in all 27 
patients. The duration of the procedure ranged from 4 to 20 minutes, which was remarkably 
quick compared with the procedure using only fluoroscopic guidance. 
4.1.2 Direct percutaneous endoscopic jejunostomy (DPEJ) 
Direct percutaneous placement of the jejunostomy tube was first described in 1987 (Shike et 
al., 1987). The first case series were for patients with previous gastric resection, and the 
technique was subsequently applied for patients with intact stomach. Becuase the length of 
the endoscope for the performance of DPEJ in the transoral route is 160 cm or longer, it 
requires the use of a long colonoscope or a small intestinal scope (Shike et al., 1991). 
However, the transgastrostomal approach facilitates access to the upper jejunum without 
difficulty. DPEJ using TGE was first described in 2002 (Baron, 2002). Although they 
successfully placed a jejunostomy tube through the mature gastrostomy tract, the 
gastrocutaneous tract was disrupted by passing through the bumper of the jejunostomy 
tube. We modified the procedure (Fig. 8) so that the jejunostomy tube does not pass the 
gastrostomy tract (Nishiwaki et al., 2009b). 
After conscious sedation with intravenous administration of midazolam (1 to 2 mg) in most 
patients, an ultrathin endoscope was inserted through the gastrocutaneous tract 
immediately after the removal of the gastrostomy tube. The endoscope was inserted up to 
the jejunum and the site for placement was determined by transillumination to the 
abdominal wall and finger pressure against the jejunum (Fig. 8A). The abdominal skin 
surface of the placement area was cleansed with povidone-iodine, and local anesthesia was 
done administering 1% lidocaine. After test-puncturing with a 21-gauge needle, one or two 
point sutures were made using gastropexy devices (Create Medic Co., Ltd., Yokohama, 
Japan, or Easy Tie, Boston Scientific Japan K.K., Tokyo, Japan) to fix the jejunum against the 
abdominal wall. A 16- or 18-gauge Seldinger needle was inserted through the abdomen 
toward an open snare inserted through the TGE and a loop wire was passed through the 
outer sheath of the needle. The loop wire was grasped by the snare and pulled out through 
the gastrocutaneous tract with the endoscope (Fig. 8B). In most cases, the loop wire was then 
grasped in the stomach by biopsy forceps of an orally inserted endoscope (Fig. 8C) and 
pulled out via the mouth (Fig. 8D). In a few cases, the loop wire was directly brought out 
from the mouth by transgastrostomic endoscopy. Next, an jejunostomy tube was connected 
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to the loop wire and the tube was placed in the jejunum by the pull-through technique (Fig. 
8E). The systems to place the jejunostomy tube were One Step Button (Boston Scientific Co., 




Fig. 8. Schematic procedure of DPEJ using TGE. 
Thirty six DPEJ procedures were attempted in 35 patients, with 33 (92%) successful 
placements. One unsuccessful placement was due to jejunum migration away from the 
abdominal wall during the puncture; this patient was maintained by feeding via the PEG-J. 
The other two failures were due to the lack of transillumination. The average + SD of 
duration of procedure, from insertion of the endoscope to the placement of the jejunostomy 
tube, was 29.6 + 13.1 (15 to 70) min. 
Procedure-related complications consisted of 1 case each of pneumonia, colocutaneous 
fistula, and pneumoperitoneum. Of these, pneumonia and colocutaneous fistula were 
considered major complications. In the former case, placement of the jejunostomy tube took 
50 min, and pneumonia occurred before administration of nutrients. The patient died 4 days 
after DPEJ due to respiratory failure. In the latter case, the fact that the jejunostomy tube had 
been placed penetrating through the colon was revealed at the second replacement of the 
jejunostomy tube. The colocutaneous fistula was naturally closed after removal of the 
replaced tube and DPEJ was successfully completed 28 days after the removal. 
Pneumoperitoneum, a minor complication, was observed in a severely obese patient. 
4.2 Resection of upper gastrointestinal tumors 
Endoscopic techniques to remove gastrointestinal tumors have been established as snare 
polypectomy and endoscopic mucosal resection (EMR). EMR allows the removal of flat 
lesions by injection with saline into the submucosal layer, but it is difficult to remove larger 
tumors. Recent development of the technique of endoscopic submucosal dissection (ESD) 
facilitates the removal of widely-spread neoplastic lesions compared to the EMR. We 
utilized TGE for these resection techniques of the upper gastrointestinal tumors. 
4.2.1 TGE assisted endoscopic submucosal dissection (ESD) 
ESD is a new technique for the resection of early gastric cancer (Ono et al., 2001). This 
technique allows en bloc resection even for larger lesions and allows for precise histological 
analyses. However, this method has a high incidence of complications such as bleeding and 
perforation, and the technique requires skill and a longer time for resection compared to 
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to the loop wire and the tube was placed in the jejunum by the pull-through technique (Fig. 
8E). The systems to place the jejunostomy tube were One Step Button (Boston Scientific Co., 
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conventional EMR (Gotoda 2006). One of the technical problems of ESD is the difficulty of 
maintaining a clear view of the submucosal layer of the gastric wall during submucosal 
dissection. We developed the technique of ESD assisted by TGE to dissolve the problem 
(Nishiwaki et al., 2009a). 
Five patients previously established with PEG underwent TGE-assisted ESD (Table 5). ESD 
was carried out by a single-channel videoendoscope, GIF H260 (Olympus Optical Co., Ltd, 
Tokyo), attached with a short hood. The high-frequency electrosurgical unit was the 
Erbotom ICC 200 in Cases 1-3, and the VIO 300D in Cases 4 and 5 (ERBE Elektromedizin 
GmbH, Tubingen, Germany). After circumferential markings around the lesion, submucosal 
injection was carried out using a mixture of hyaluronic acid and glycerol containing 
indigocarmine, according to the method described by Fujishiro, et al (Fujishiro et al., 2006). 
Circumferential mucosal cutting and submucosal dissection were carried out using a needle 
knife, a Flex knife, an insulation-tipped (IT) knife, or a combination of the three. TGE was 
inserted through the mature gastrocutaneous tract and grasped the edge of the resecting 
specimen to achieve appropriate counter-traction during submucosal dissection (Figs. 9A-
C). Hemostatic forceps were used when active bleeding took place during the procedure or 
to prevent bleeding from large vessels before cutting in soft coagulation mode. TGE also 
worked for additional submucosal injection, washing with water, aspiration of gastric fluid. 
 
Case I.D. 1 2 3 4 5 
Age/Gender 83/M 82/F 72/M 79/F 82/F 
Pathology tub 1 tub 1 adenoma tub 1 carcinoid tumor 
Location a.w. antrum l.c. body p.w. antrum g.c. body a.w. body 
Dissection size (mm) 24 X 22 20 X 20 60 X 30 30 X 22 15 X 10 
Operative duration 
(min) 21 18 105 55 80 
tub 1: well differentiated tubular adenocarcinoma, a.w.: anterior wall, l.c.: lesser curvature,  
p.w.: posterior wall, g.c.: greater curvature 
Table 5. Summary of the patients who underwent TGE-assisted ESD. 
A laparoscopic port with a trocar is inserted into the gastric lumen percutaneously and 
assists in the ESD using an IT knife (Kondo et al., 2004). However these methods are thought 
to be limited for some tumor locations, as the assisting devices are not flexible. EMR assisted 
by a magnetic anchor has also been reported to create strong counter traction (Kobayashi et 
al., 2004). In our methods, an ultrathin endoscope is inserted through the gastrocutaneous 
tract after PEG, and assisted ESD is performed with an orally inserted videoendoscope. TGE 
can cover the whole stomach and esophagus and create appropriate counter traction for 
dissection of the lesion. Furthermore, TGE not only can provide traction control but can also 
support diverse procedures of ESD, such as marking, submucosal injection, washing out or 
aspiration of the intragastric contents. TGE facilitates ESD by this type of assistance, and the 
operation duration of TGE-assisted ESD has been found to be relatively short compared to 
the single-scope ESD in our hospital. 
One of the problems of this method is light interference between the two endoscopes (Fig. 
9D). When the two endoscopes faced each other, the position of the TGE had to be changed 
to eliminate the light interference. The other problem of this method is that it might be 
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difficult to perform TGE before maturation of the gastrocutaneous tract. In the present case 
series, gastric tumors were found after PEG in three cases, but two tumors were found at the 
placement of PEG catheter. In general, it takes 3-4 weeks to complete the stoma. ESD was 
conducted in the two cases 3-4 weeks after PEG, after waiting for maturation of the 
gastrocutaneous tract. Pneumoperitoneum occurred after ESD in Case 3, although it 
recovered spontaneously. The use of gastropexy devices enabled us to fix the abdominal 
and gastric walls more tightly, such that pneumoperitoneum might be prevented even with 
prolonged endoscopic treatment. Narrowing of the ultrathin endoscope would be helpful 
for this method. Therefore, simultaneous PEG and TGE-assisted ESD using a gastropexy 
device and an ultrathin endoscope might be possible for large, difficult lesions. 
 
 
Fig. 9. TGE-assisted ESD. A. Schematic illustration of ESD assisted by TGE. B. Endoscopic 
view from transoral endoscope in Case 4. A grasping forceps was inserted through the TGE 
and grasped the edge of the gastric tumor (arrow). C. Endoscopic view from transoral 
endoscope in Case 4. Counter traction of the exfoliating lesion by TGE facilitated the 
submucosal dissection by a Flex knife. D. Endoscopic view from transoral endoscope in 
Case 1. Light from the TGE impeded the procedure of ESD when the endoscope faces each 
other. The position of TGE should be changed so as not to disturb the procedure. 
4.2.2 Endoscopic mucosal resection (EMR) and polypectomy 
The performance of ESD by TGE alone is quite difficult because the working channel of the 
ultrathin endoscope is too narrow to insert the devices for ESD. However, TGE itself can be 
used for polypectomy and EMR by using an appropriate injection needle and snare for the 
ultrathin endoscope. We carried out resection of two benign polyps by TGE. One case was a 
hyperplastic polyp on the prepylorus, and the other was inflammatory granuloma on the 
gastric stoma (Fig. 4A). Both polyps showed a tendency to develop during the periodical 
observation by TGE. Transgastric resections were successfully conducted without conscious 
sedation. 
4.3 Palliative therapy for gastrointestinal obstruction using TGE 
One of the indications of PEG is decompression of gastrointestinal content in cases of 
obstruction of gastrointestinal tract. On the other hand, some cases develop gastrointestinal 
obstruction after PEG. TGE also facilitates the palliative therapy in such cases. 
4.3.1 Transgastrostomal stenting on gastroduodenal outlet obstruction 
Endoscopic deployment of stents for malignant gastroduodenal outlet obstruction has been 
reported as a less invasive palliative therapy compared to a surgical bypass operation (Yim 
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conventional EMR (Gotoda 2006). One of the technical problems of ESD is the difficulty of 
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Table 5. Summary of the patients who underwent TGE-assisted ESD. 
A laparoscopic port with a trocar is inserted into the gastric lumen percutaneously and 
assists in the ESD using an IT knife (Kondo et al., 2004). However these methods are thought 
to be limited for some tumor locations, as the assisting devices are not flexible. EMR assisted 
by a magnetic anchor has also been reported to create strong counter traction (Kobayashi et 
al., 2004). In our methods, an ultrathin endoscope is inserted through the gastrocutaneous 
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One of the problems of this method is light interference between the two endoscopes (Fig. 
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difficult to perform TGE before maturation of the gastrocutaneous tract. In the present case 
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conducted in the two cases 3-4 weeks after PEG, after waiting for maturation of the 
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for this method. Therefore, simultaneous PEG and TGE-assisted ESD using a gastropexy 
device and an ultrathin endoscope might be possible for large, difficult lesions. 
 
 
Fig. 9. TGE-assisted ESD. A. Schematic illustration of ESD assisted by TGE. B. Endoscopic 
view from transoral endoscope in Case 4. A grasping forceps was inserted through the TGE 
and grasped the edge of the gastric tumor (arrow). C. Endoscopic view from transoral 
endoscope in Case 4. Counter traction of the exfoliating lesion by TGE facilitated the 
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Case 1. Light from the TGE impeded the procedure of ESD when the endoscope faces each 
other. The position of TGE should be changed so as not to disturb the procedure. 
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The performance of ESD by TGE alone is quite difficult because the working channel of the 
ultrathin endoscope is too narrow to insert the devices for ESD. However, TGE itself can be 
used for polypectomy and EMR by using an appropriate injection needle and snare for the 
ultrathin endoscope. We carried out resection of two benign polyps by TGE. One case was a 
hyperplastic polyp on the prepylorus, and the other was inflammatory granuloma on the 
gastric stoma (Fig. 4A). Both polyps showed a tendency to develop during the periodical 
observation by TGE. Transgastric resections were successfully conducted without conscious 
sedation. 
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One of the indications of PEG is decompression of gastrointestinal content in cases of 
obstruction of gastrointestinal tract. On the other hand, some cases develop gastrointestinal 
obstruction after PEG. TGE also facilitates the palliative therapy in such cases. 
4.3.1 Transgastrostomal stenting on gastroduodenal outlet obstruction 
Endoscopic deployment of stents for malignant gastroduodenal outlet obstruction has been 
reported as a less invasive palliative therapy compared to a surgical bypass operation (Yim 
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et al., 2001). It is more difficult to place the stent across the postpyloric lesion compared to 
the esophagus, because the delivery system often forms a loop in the stomach before passing 
through the obstruction. When the gastrostomy site is adjacent to the obstructed lesion, a 
transgastric approach for stenting is easier than a transoral approach. Transgastrostomic 
stenting for malignant duodenal obstruction was first described in 1993 (Keymling et al., 
1993). 
The schematic procedure of transgastrostomal stenting is shown in Fig. 10. An ultrathin 
endoscope is inserted through the mature gastrocutaneous tract followed by removal of the 
gastrostomy tube. A guidewire is advanced through the stenosis (Fig. 10A). The endoscope 
is once removed from the gastrostomy keeping the position of the guidewire. A balloon 
catheter is inserted over the guidewire and the stenosis is dilated with the balloon catheter 
(Fig. 10B). The ultrathin endoscope is inserted after the removal of the balloon catheter and 
advanced to the upper jejunum (Fig. 10C). A guidewire is inserted deeply in the jejunum 
through the endoscope and the endoscope is removed again, retaining the guidewire. A 
stent is finally deployed over the guidewire across the obstructed lesion using a delivery 
device (Figs. 10D & E). 
 
 
Fig. 10. Schematic procedure of the placement of an expandable metallic stent on the pyloric 
stenosis. 
We tried this procedure for 5 patients in whom we had failed to place a stent by the 
transoral approach (Table 6). In 4 out of 5 patients, a non-covered expandable metallic stent 
was successfully deployed (Ultraflex, Boston Scientific Co., Natick, MA, USA). The one case 
(#5) of failure was changed to the placement of a jejunal feeding tube through the 
obstruction. The duodenal obstruction of this case was too severe to pass the delivery device 
but a 12F jejunal feeding tube was successfully inserted through the obstruction. All of the 
patients could successfully feed again after the procedure. 
 
Case I.D. 1 2 3 4 5 
Age/Gender 88/F 82/F 84/M 75/M 72/F 
Tumors Stomach CBD Stomach CBD Gall bladder 
Obstruction Pylorus Duodenum Pylorus Duodenum Duodenum 
Operative 
duration (min) 20 27 15 45  
Outcome Success Success Success Success Failure 
CBD: common bile duct 
Table 6. Summary of the cases with transgastrostomal stenting. 
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4.3.2 Placement of long intestinal decompression tube 
Placement of a long intestinal decompression tube was carried out for malignant lower 
intestinal obstructions. A series of radiographs of the procedure in the case with ascending 
colon cancer is shown in Fig. 11. The procedure was the same as for the placement of a PEG-
J tube as described in 4.1.1. The benefit of this procedure is that it is more comfortable for the 




Fig. 11. Radiographs of the placement of a long intestinal decompression tube. A. An 
ultrathin endoscope was inserted into the stomach after removal of the gastrostomy tube. B. 
The endoscope was advanced to the upper jejunum. C. A guidewire was passed through the 
endoscope. D. A long intestinal decompression tube (CLINY Ileus Tube, Create Medic Co. 
Ltd., Yokohama, Japan) was placed over the guidewire. 
4.4 Other usage for endoscopic treatments 
We utilized TGE to treat other pathological conditions. The applications for 
pancreaticobiliary and esophageal diseases have been reported. Alternative possibilities for 
the usage of TGE are discussed in this section. 
 
 
Fig. 12. Schematic illustrations of the recanalization of a disrupted fistula using TGE. A. 
Misplacement of a gastrostomy tube into the peritoneal cavity. B. Insertion of ultrathin 
endoscopy from the skin incision and looking for the gastric lumen. C. Successful insertion 
into the stomach. D. Passing the endoscope through the esophagus to the oral cavity. E. 
Insertion of a loop wire from the stoma out of mouth. F. A new gastrostomy tube is replaced 
by the pull-thorough technique. 
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stent is finally deployed over the guidewire across the obstructed lesion using a delivery 
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Fig. 11. Radiographs of the placement of a long intestinal decompression tube. A. An 
ultrathin endoscope was inserted into the stomach after removal of the gastrostomy tube. B. 
The endoscope was advanced to the upper jejunum. C. A guidewire was passed through the 
endoscope. D. A long intestinal decompression tube (CLINY Ileus Tube, Create Medic Co. 
Ltd., Yokohama, Japan) was placed over the guidewire. 
4.4 Other usage for endoscopic treatments 
We utilized TGE to treat other pathological conditions. The applications for 
pancreaticobiliary and esophageal diseases have been reported. Alternative possibilities for 
the usage of TGE are discussed in this section. 
 
 
Fig. 12. Schematic illustrations of the recanalization of a disrupted fistula using TGE. A. 
Misplacement of a gastrostomy tube into the peritoneal cavity. B. Insertion of ultrathin 
endoscopy from the skin incision and looking for the gastric lumen. C. Successful insertion 
into the stomach. D. Passing the endoscope through the esophagus to the oral cavity. E. 
Insertion of a loop wire from the stoma out of mouth. F. A new gastrostomy tube is replaced 
by the pull-thorough technique. 
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4.4.1 Recovery of disrupted gastrocutaneous tract 
Fistula disruption usually occurs upon early dislodgement of the gastrostomy tube or upon 
replacement of the tube. It might cause the serious complication of peritonitis due to leaking 
of gastric contents or feeding materials into the peritoneal cavity (Fang, 2007; McQuaid & 
Little, 1992; Romero et al., 1996). In order to place a new gastrostomy tube, a PEG procedure 
is often performed adjacent to the disrupted fistula (Galat et al., 1990). We employed TGE 
for recanalization of the disrupted fistula at the tube replacement (Nishiwaki et al., 2009 c). 
Schematic illustrations of the procedure are shown in Fig. 12. 
We tried this technique for 5 patients with fistula disruption and in all of the patients, the 
disrupted fistula tract was successfully recovered. Before the introduction of this procedure, 
we inserted a guidewire to search for the gastric lumen from the skin incision under 
fluoroscopic guidance. However, in 2 out of 5 trials, we failed to reestablish a 
gastrocutaneous tract. The endoscopic view of TGE is helpful to locate the intragastric route 
from the skin incision. 
4.4.2 Transgastrostomic biliary drainage 
Endoscopic retrograde cholangiopancreatography from the gastrostomy have been reported 
(Baron & Vickers, 1998; Mori et al., 2007). Since all ultrathin endoscopes are forward-
viewing, it is more difficult to insert a canula into a pancreatic or bile duct. Moreover, 
endoscopic treatment has limitations because of the limited availability of therapeutic 
devices. However, there is a benefit of direct access into the bile duct after sphincterotomy 
and the ability to conduct direct endoscopic observation of the bile tract (Larghi & Waxman, 
2006). 
We only experienced one case with transgastrostomal biliary drainage for obstructive 
jaundice in a patient with primary sclerosing cholangitis (Fig. 13). Placement of a 
transgastrostomal drain tube is more comfortable than that of a transnasal drain tube. 
 
 
Fig. 13. Establishment of transgastrostomal biliary drainage. A. Endoscopically placed 
retrograde biliary drainage tube (FLEXIMA Single-Use Biliary Stent System, 6F, Boston 
Scientific, Maple Grove, MN, USA) was retrieved from the gastric stoma by TGE. B. The 
tube was passed through a 12F Jejunal Feeding Tube (Bard Access Systems, Inc., Salt Lake 
City, UT, USA). This procedure allowed the patient to continue to feed through the gastric 
decompression port of the tube. 
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4.4.3 Transstomal endoscopy other than gastrostomy 
Transstomal endoscopy is also available via other routes than the gastrostomy tract. We 
experienced two cases of endoscopic placement of a jejunal extension tube through direct 
endoscopic jejunostomy. The first case had undergone DPEJ and showed repeated 
aspiration due to jejunoesophageal reflux of the feeding materials. We inserted the top of a 
feeding tube to 40 cm anal direction from the jejunostomy site using a transjejunostomal 
endoscope (Fig. 14). Another case was jejunal obstruction caused by inflammatory 
granuloma of the jejunostomy site (Nishiwaki et al., 2007). We could successfully place a 
feeding tube on the anal side of the obstruction by transjejunostomal endoscope. Although a 
similar procedure has previously reported under fluoroscopic guidance (Luttman et al., 
2005), it might be easier to place a feeding tube using the transjejunostomal endoscope. 
 
 
Fig. 14. Placement of an extension feeding tube through the DPEJ. A. An ultrathin 
endoscope was inserted through the jejunostomy site (arrow) and advanced to the anal side. 
B. A guidewire was placed through the endoscope. C. J-tube (Boston Scientific, Natick, MA, 
USA) was placed over the guidewire. 
 
 
Fig. 15. Placement of an expandable metallic stent (Ultraflex, Boston Scientific, Natric MA, 
USA) across the obstructed ascending cancer. A. Insertion of an ultrathin endoscope 
through the cecostomy (arrow). Arrow heads indicate the location of the tumor. B. A 
guidewire was passed through the obstruction and inserted deeply along the anal side of 
the bowel under the guidance of fluoroscopy. C. Delivery system of the Ultraflex was 
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4.4.1 Recovery of disrupted gastrocutaneous tract 
Fistula disruption usually occurs upon early dislodgement of the gastrostomy tube or upon 
replacement of the tube. It might cause the serious complication of peritonitis due to leaking 
of gastric contents or feeding materials into the peritoneal cavity (Fang, 2007; McQuaid & 
Little, 1992; Romero et al., 1996). In order to place a new gastrostomy tube, a PEG procedure 
is often performed adjacent to the disrupted fistula (Galat et al., 1990). We employed TGE 
for recanalization of the disrupted fistula at the tube replacement (Nishiwaki et al., 2009 c). 
Schematic illustrations of the procedure are shown in Fig. 12. 
We tried this technique for 5 patients with fistula disruption and in all of the patients, the 
disrupted fistula tract was successfully recovered. Before the introduction of this procedure, 
we inserted a guidewire to search for the gastric lumen from the skin incision under 
fluoroscopic guidance. However, in 2 out of 5 trials, we failed to reestablish a 
gastrocutaneous tract. The endoscopic view of TGE is helpful to locate the intragastric route 
from the skin incision. 
4.4.2 Transgastrostomic biliary drainage 
Endoscopic retrograde cholangiopancreatography from the gastrostomy have been reported 
(Baron & Vickers, 1998; Mori et al., 2007). Since all ultrathin endoscopes are forward-
viewing, it is more difficult to insert a canula into a pancreatic or bile duct. Moreover, 
endoscopic treatment has limitations because of the limited availability of therapeutic 
devices. However, there is a benefit of direct access into the bile duct after sphincterotomy 
and the ability to conduct direct endoscopic observation of the bile tract (Larghi & Waxman, 
2006). 
We only experienced one case with transgastrostomal biliary drainage for obstructive 
jaundice in a patient with primary sclerosing cholangitis (Fig. 13). Placement of a 
transgastrostomal drain tube is more comfortable than that of a transnasal drain tube. 
 
 
Fig. 13. Establishment of transgastrostomal biliary drainage. A. Endoscopically placed 
retrograde biliary drainage tube (FLEXIMA Single-Use Biliary Stent System, 6F, Boston 
Scientific, Maple Grove, MN, USA) was retrieved from the gastric stoma by TGE. B. The 
tube was passed through a 12F Jejunal Feeding Tube (Bard Access Systems, Inc., Salt Lake 
City, UT, USA). This procedure allowed the patient to continue to feed through the gastric 
decompression port of the tube. 
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endoscope (Fig. 14). Another case was jejunal obstruction caused by inflammatory 
granuloma of the jejunostomy site (Nishiwaki et al., 2007). We could successfully place a 
feeding tube on the anal side of the obstruction by transjejunostomal endoscope. Although a 
similar procedure has previously reported under fluoroscopic guidance (Luttman et al., 
2005), it might be easier to place a feeding tube using the transjejunostomal endoscope. 
 
 
Fig. 14. Placement of an extension feeding tube through the DPEJ. A. An ultrathin 
endoscope was inserted through the jejunostomy site (arrow) and advanced to the anal side. 
B. A guidewire was placed through the endoscope. C. J-tube (Boston Scientific, Natick, MA, 
USA) was placed over the guidewire. 
 
 
Fig. 15. Placement of an expandable metallic stent (Ultraflex, Boston Scientific, Natric MA, 
USA) across the obstructed ascending cancer. A. Insertion of an ultrathin endoscope 
through the cecostomy (arrow). Arrow heads indicate the location of the tumor. B. A 
guidewire was passed through the obstruction and inserted deeply along the anal side of 
the bowel under the guidance of fluoroscopy. C. Delivery system of the Ultraflex was 
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inserted through the obstruction over the guidewire. D. Ultraflex was deployed across the 
tumor.  
We additionally experienced one case of transcecostomal endoscopy for stent placement 
across the ascending colon cancer (Nishiwaki et al., 2010b). The patient was too critically ill 
to undergo surgical treatment, and we were also unable to place a colonic stent by 
colonoscopy. After establishment of ultrasonography-guided percutaneous cecostomy, 
transcecostomal endoscopy facilitated the passing of a guidewire thorough the obstruction. 
The procedure of the stent deployment is shown in Fig. 15. 
4.4.4 Other applications 
TGE was reported to be useful for the dilatation of radiation-induced complete esophageal 
obstruction (Maple et al., 2006). The rendezvous technique for the dilatation of esophageal 
stricture was conducted by cooperative use of transoral endoscope and TGE. The use of TGE 
made the procedure more safe and effective. 
Recent developments in super ultrathin endoscopes allow for insertion through the 
gastrostomy tube. The endoscope is then utilized for verification of a replaced gastrostomy 
tube into the stomach. 
5. Conclusions 
TGE offers a less invasive way to observe the upper gastrointestinal tract and allows for the 
detection of early stage gastrointestinal lesions. TGE also facilitates endoscopic treatments 
which might be more difficult by transoral endoscope. However, the narrow working 
channel of the ultrathin endoscope is a limitation of therapeutic TGE. Further improvements 
to the endoscope and applicable devices will be expected in the future. 
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to undergo surgical treatment, and we were also unable to place a colonic stent by 
colonoscopy. After establishment of ultrasonography-guided percutaneous cecostomy, 
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The procedure of the stent deployment is shown in Fig. 15. 
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TGE was reported to be useful for the dilatation of radiation-induced complete esophageal 
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made the procedure more safe and effective. 
Recent developments in super ultrathin endoscopes allow for insertion through the 
gastrostomy tube. The endoscope is then utilized for verification of a replaced gastrostomy 
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TGE offers a less invasive way to observe the upper gastrointestinal tract and allows for the 
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1. Introduction 
Not long ago, the small intestine was an unexplored frontier in gastrointestinal endoscopy. 
New developments in enteroscopes have opened up this region of the gastro-intestinal tract 
but it remains a difficult organ to access. Until recently, it was not possible to access most of 
the small bowel using endoscopic techniques without concomitant surgery. 
Capsule endoscopy and balloon-assisted enteroscopy thus represent decisive breakthroughs 
in this field. Small bowel enteroscopy was considered a technically challenging procedure 
often requiring much time. In the past diagnostic and therapeutic options for small bowel 
conditions have traditionally been limited and frustrating for endoscopists. 
With the development of balloon-assisted enteroscopy and most recently, spiral 
enteroscopy, endoscopic diagnosis and treatment of the entire small intestine are now 
feasible without operative intervention. 
As indications expand and caseloads grow, it is important for gastroenterologists to know 
how these procedures are done and to be familiar with their potential complications. 
2. Indication for deep enteroscopy 
The indications for enteroscopy of the small intestine are rising so small bowel endoscopy is 
enjoying a significant renaissance.  
Deep enteroscopy offers the potential advantages of biopsy, treatment of bleeding lesions, 
and other therapeutic maneuvers including stricture dilation, and stent placement. 
Lesions located within the proximal two thirds of the small bowel transit time on capsule 
endoscopy are thought to be amenable to deep enteroscopy performed via the 
anterograde approach. Table 1 summarizes reported indications, relating to spiral 
enteroscopy 1 2 3 4 5 6 7. 
The majority of the outcomes literature on deep enteroscopy pertains to double ballon 
enteroscopy (DBE), because publications on single ballon enteroscopy and spiral 
enteroscopy remain limited. A summary of the published DBE literature has 
demonstrated similar diagnostic yields to capsule endoscopy. In a summary of 16 
published studies to date, the overall mean diagnostic yield was 67% with a treatment 
success rate of 64%.8. Double balloon enteroscopy has been reported to be diagnostic in a 
small percentage of patients with normal capsule examinations, particularly in the 
situation of ongoing acute obscure hemorrhage9 
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 Abnormal capsule endoscopy 
 Abnormal radiologic imaging 
 Anastamotic stricture 
 Celiac disease 
 Chronic abdominal pain 
 Chronic diarrhea 
 Fistula plug placement for enterocutaneous fistula 
 Push enteroscopy (PE) 
 Hepatojejunostomy stricture 
 History of intestinal polyps (familial adenomatous polyposis, Gardner’s 
syndrome) 
 Iron deficiency anemia 
 Obscure-occult gastrointestinal bleeding 
 Obscure-overt gastrointestinal bleeding 
 Small bowel fistula 
 Small bowel obstruction 
 Suspected small bowel Crohn’s disease 
 Therapeutic ERCP after Roux-en-Y gastric bypass 
 
Table 1. Indication for spiral enteroscopy 
Approximately 5% of patients presenting with acute or chronic gastrointestinal (GI) 
hemorrhage will have a responsible source located in the small intestine10. For patients 
residing in the United States or Europe, lesions most responsible for small bowel 
hemorrhage include arteriovenous malformations in 30%–40%11, ulcerations, other vascular 
disorders including Dieulafoy lesions, and small bowel neoplasms in 1%–3% of patients.12. 
Small bowel follow-through radiographs have demonstrated a low yield (3%–20%) for 
pathologic findings in patients with obscure bleeding, and the findings are dependent upon 
the skill and time allotted by the radiologist for fluoroscopy13. 
Other indications for deep enteroscopy other gastrointestinal hemmorhage are similar to 
capsule endoscopy and include evaluation of patients with polyposis syndromes, refractory 
celiac sprue, and other ulcerative small bowel disorders. Similar to capsule endoscopy, the 
yield of DBE in patients with chronic abdominal pain is very low 
3. Evolution of enteroscopy  
Intraoperative enteroscopy  was initially performed in the 1950s with a rigid sigmoidoscope 
passed through an operative laparotomy. By the 1970s fiberoptic endoscopes were used for 
intraoperative enteroscopy .14 Intraoperative enteroscopy  has a high diagnostic yield but 
has largely been replaced because of its high complication rate, need for a surgeon as well as 
an endoscopist, and postprocedural hospital stay.  
Sonde enteroscopy was introduced in 1986 as an alternative to intraoperative enteroscopy, 
but it was eventually abandoned because it was labor intensive for the endoscopist and 
uncomfortable for the patient. 
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Push enteroscopy was the most widely used endoscopic procedure, but only about 60 to 120 
cm of small bowel can be visualized 15. Further advancement is generally limited by 
intragastric or small-bowel looping. Advanced skill or training is not typically required to 
perform this procedure. The procedure is performed under conscious sedation and takes 
between 15 and 45 minutes. The overall complication rate from PE is approximately 1%16. 
Care must be taken to avoid trauma to the thin-walled duodenum and jejunum during 
advancement of the relatively stiff enteroscope. 
Device-assisted enteroscopy techniques, including double balloon endoscopy (DBE), single-
balloonenteroscopy (SBE), and spiral enteroscopy (SE), have both diagnostic and therapeutic 
capabilities. Double-balloon enteroscopy (DBE) emerged as an option for small bowel 
imaging in the United States in 2004; single-balloon enteroscopy (SBE) and spiral 
enteroscopy were introduced into the US market in 2007 
4. Device assisted enteroscopy 
Device-assisted enteroscopy is the modality of choice for evaluating disorders of the mid-
gut whenever tissue acquisition or therapeutic intent is cogent. This new term, mid-gut, 
refers to the small bowel between the ampulla and the ileocecal valve.17. 
Although capsule endoscopy can visualize the entire small intestine, a main disadvantage is 
the inability to obtain biopsy specimens, navigate altered anatomy, or perform therapeutic 
maneuvers via this procedure.  
4.1 Ballon assisted enteroscopy 
New techniques such as DBE and SBE  use techniques designed to pleat the small bowel on 
the endoscope and overtube. They work on the principle of push-pull advancement through 
the small bowel by alternately inflating and deflating the balloons on the overtube and the 
enteroscope (in DBE) 18 
4.1.1 Double ballon enteroscopy 
The concept of DBE was introduced in 199719 and was subsequently introduced into the 
United States in 2004 (Fujinon Inc, Saitama, Japan). The development of DBE was based on 
the concept that “stretching” of the small intestinal wall prevents further endoscopic 
advancement, and that the usage of a balloon would grip the intestinal wall and prevent 
subsequent loop formation20.  
The diagnostic enteroscope (EN450P5) has a 200-cm working length, an endoscope diameter 
of 8.5 mm, and an accessory channel of 2.2 mm. The therapeutic enteroscope (EN450T5) has 
a diameter of 9.4 mm and an accessory channel of 2.8 mm. 
4.1.2 Single ballon enteroscopy 
The SBE system (Olympus Corporation, Tokyo, Japan) was developed in 2006 and 
introduced subsequently into the commercial market in 2007.21  
The rationale behind development of the SBE system was to reduce the learning curve for 
balloon-assisted enteroscopy, avoid the difficulty of attaching the enteroscope balloon to the 
distal tip of the scope encountered in DBE, and eliminate the requirement of inflating and 
deflating 2 balloons in multiple steps with the current DBE insertion technique. 
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4.2 Spiral enteroscopy 
In addition to balloon assisted enteroscopy using double or single balloons, the novel 
technique of spiral enteroscopy (SE) has recently been reported.  
This technique uses a flexible over-tube threaded with a pliable plastic spiral to grip the 






Fig. 1. Spiral overtube 
Although the earlier prototypes were placed over a pediatric colonoscope, the newer 
devices are used with enteroscopes. 
Rotational torque applied by the operator is converted into plication of the small bowel over 
the over-tube as the enteroscope advances.  
Anterograde enteroscopic introduction with the spirus overtube helps to advance 
compatible enteroscopes beyond to Ligament of Treitz, the fixed portion of small bowel 
within the abdominal cavity. Rotation of the overtube beyond the Ligament of Treitz, allows 
a spiral to pleat the segment of the small bowel where disease is most commonly found 
(Figure 2). 
The first case utilizing rotate to advance was performed in 2006 by Drs. Akerman and 
Cantero22. 
Spiral enteroscopy can also be performed in post-gastric surgery patients, and can be used 
in Roux-en-Y patients requiring endoscopic retrograde cholangiopancreatography. 
The Endo-Ease Discovery SB system is an overtube with an outer spiral, which was cleared 
for enteroscopy by the FDA in 2008. The device is 118 cm long with a hollow spiral 5.5 mm 
high and 22 cm long with a locking device on the proximal end. The Discovery SB has an 
outer diameter of 16 mm and an internal diameter of 9.8 mm. The tube lightly connects to 
the existing enteroscopes by a ‘‘gentle lock’’ and rotates independently from the 
enteroscope. The lock can be disengaged and reengaged, allowing the option of advancing 
the enteroscope through the overtube when unlocked or performing spiral enteroscopy with 
the spiral overtube when locked.  
 





Fig. 2. Concept of “rotate to advance.” 
The Spirus overtube can be paired with existing enteroscopes measuring up to 9.4 mm . The 
product is a single use device sterilized. 
An in vitro porcine model was created to demonstrate spiral advancement and pleating 
tecniques. 
Spiral enteroscopy is possible also with retrograde approach. For this use exists a dedicated 
spiral tip overtube (Vista overtube, tube length 100 cm, tube outer diameter 1.85 cm, outer 
diameter includes spirals 3.33 cm). This overtube can be preloaded onto pediatric 
colonoscope or enteroscope.  Initaial experience with this device are reported.23 
While all three of these methods allow intubation of the deep small bowel, these techniques 
provide unique challenges involving patient sedation. Preliminary reports detailing the use 
of spiral enteroscopy have used anesthesiologist-guided monitored anesthesia care 
exclusively for sedation.24 When standard sedation is used, spiral enteroscopy is technically 
feasible, clinically useful, and safe. Deep small bowel enteroscopy using the spiral overtube 
can be successfully and safely accomplished with gastroenterologist- guided, nurse-
administered standard sedation also in a patient population with multiple comorbidities 
and a high prevalence of diagnostic findings requiring endoscopic therapy. 
Although some of them only published in abstract form, some studies have compared SE 
with DBE and shown that SE required significantly shorter time than DBE to insert to 
similar depths25 26. Initial studies of deep enteroscopy focused on presenting narrative 
experiences with the individual techniques. Comparative trials have been conducted to 
compare the utility of these various techniques in terms of their diagnostic yield, deep of 
maximal insertion allowed, efficacy, and complications27 
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In one prospective study on 35 patients DBE showed a clinically higher diagnostic yield 
than spiral enteroscopy but there was non difference in investigation performance, as 
assessed by time o insertion, duration of enteroscopy and amount of sedoanalgesia 
required.28 
Khashab et al.29 reported the first study comparing SE and SBE. Although SE yielded greater 
depth of maximal insertion than SBE, both techniques had similar diagnostic yields and 
procedure times. In addition, both techniques were safe and were particularly useful in 
evaluation and treatment of patients with obscure gasto-intestinal bleeding. 
As seen above, the strengths of SE are rapid advancement in the small bowel and better 
control of the endoscope, which makes it easy to conduct endoscopic interventions. 
4.2.1 Complications 
Serious complications of deep small bowel enteroscopy occur infrequently. In published 
series, severe complications occur in deep small bowel enteroscopy in 0.3 to 4% of cases.  
There are 2950 patients who have undergone spiral enteroscopy from August 2006 until 
May 2009. Cases have been performed in North America and Europe. Severe complications 
were defined as pancreatitis, nontransient intussusception, bleeding requiring transfusion or 
admission to the hospital, cardio-pulmonary arrest during a procedure and perforation. 
There were no reported complications of esophageal or gastric perforations, severe bleeding 
requiring transfusion, or cardio-pulmonary arrest during or resulting from the spiral 
enteroscopy procedures. There were 9 reported severe complications (0.3%) and no deaths 
reported as a result of the procedure. There were eight small bowel perforations (0.27%), all 
were recognized immediately. Four small bowel perforations occurred in the jejunum. Three 
duodenal perforations occurred while pushing to advance the scope through the 
duodenum. Two of four jejunal perforations occurred during therapeutic interventions. One 
perforation occurred in a Roux en Y patient. None of the perforations appeared to occur 
during rotation of the overtube to pleat the small bowel. Five perforations occurred when 
the experience of the physician was less than 10 cases. 
Perforations may be minimized by advancing the enteroscope only when the lumen is 
clearly visualized and maintaining the scope tip 25-30 cm from the end of the Discovery SB 
overtube.  
Also in a typical US patient population with multiple comorbidities and high prevalence of 
pathologic finding spiral enteroscopy is a technically feasible and safe way to perform 
diagnostic and therapeutic deep small bowel enteroscopy and in conclusion Spiral 
enteroscopy is a safe procedure with a low rate serious complications. 
4.2.2 Procedure 
Spiral enteroscopy applies the mechanical advantage of a screw to convert rotational force 
into linear force and pleat the small bowel on the enteroscope. 
The patients is placed in the left lateral decubitus position for the procedure and received 
monitored anesthesia with propofol/midazolam hydrochloride/fentanyl or general 
anesthesia, according to the anesthesiologist’s preference. Before performing the procedure, 
a proprietary lubricant is applied thoroughly to the overtube  channel and than the DSB 
device is placed over the enteroscope. The distal end of the DSB is positioned 25 cm from the 
tip of the enteroscope and locked into place with the DSB proximal collar. When locked 
tightly onto the coupler at the proximal end of the overtube at the 140 cm mark, the scope is 
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inserted into the esophagus. All subsequent movements of the scope must be done with 
gentle rotation of the overtube except when the overtube coupler has been unlocked. 
Engagement of the spiral in the duodenum may be difficult and it requires backing up of the 
scope and the overtube.  
To rotate the tube, the hands are placed on the 2 soft handles located just below the lock. A 
special curved mouthpiece with a bigger aperture to accommodate the DSB and the 
enteroscope is used. Once past the ligament of Treitz the mobile small bowel can be plated 
on the overtube using spiral technique (Figure 3). 
 
 
Fig. 3. Rotation pleats the small bowel. 
Two operators are required, one for spiralling and a second for steering and insufflation to 
maximize insertion. Minimal insufflation is used. Spiral advancement is continued as long 
as the overtube rotates easily and the small bowel continues to be pleated onto the overtube. 
When advancement slow or rotations become difficult the overtube may be straightened 
and pulled back to remove loops. This achives a stray scope that is optimal for spiral 
advancement. When working optimally the spiral advancement has a rapid one to one 
advancement whith a minimal slippage of the overtube.  
Fluoroscopic guidance can be helpful but not necessary to assist in advancing through the 
small bowel.  
The overtube let maneuver the enteroscope if needed while it remains in place indeed the 
endoscope can be withdrawn completely from the overtube and reinserted without loss of 
position.  
Withdrawal of the overtube and endoscope is accomplished by counter clockwise rotation of 
the overtube. The counter clockwise rotation unpleats the small bowel from the overtube By 
rotation of the DSB, advancement can be continued until the pleating of small bowel with 
rotation is no longer effective. The enteroscope is then unlocked from the DSB and pushed 
through the overtube for added depth of small bowel intubation. The DSB is then gradually 
withdrawn by anticlockwise rotation of the DSB, and the small-bowel mucosa examined. 
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Small-bowel pleating is accomplished without apparent twisting of the small bowel because 
the mesentery attachment to the small bowel resists the rotation of the small bowel. 
In a setting when prompt endoscope extubation may have become necessary, rapid 
anticlockwise rotation would have achieved rapid withdrawal of the DSB. 
The DSB has many features that make it a safe and easy device to use. 
The shaft is uniformly more flexible at the distal end and transitions gradually to a less 
flexible proximal end, resulting in optimal integration of torque transmission and flexibility. 
The locking device on the DSB allows spiral enteroscopy and standard push enteroscopy 
techniques to be used in conjunction to advance the enteroscope through the small bowel. 
During withdrawal of the enteroscope, the DSB is rotated anticlockwise, which results in the 
pleated small bowel gradually coming off the device, allowing for controlled, careful 
examination of the small-bowel mucosa. 
Spiral enteroscopy also has potential advantages over DBE and SBE, including speed of 
advancement through the small bowel, excellent controlled withdrawal especially useful for 
therapeutic maneuvers, and ability to completely withdraw the enteroscope and maintain 
position in the small bowel. 
SE allows similar insertion depths to be reached as with DBE but the positioning with SE for 
collecting samples and for therapy is more stable than with DBE.  
When using retrograde approach the endoscope is introduced in the usual fashion through 
the anus and advanced to where the colon lumen straightened out, usually in the 
descending or transverse colon. The overtube is disengaged and advanced over the 
endoscope using clockwise rotation; thus, the colonoscope served as a “guidewire” for the 
overtube. Since this maneuver usually resulted in simultaneous advancement of the tip of 
the colonoscope, it is important to always maintain good visibility of the lumen. When 
visualization of the lumen is not possible, overtube insertion is stopped, and water irrigation 
is performed to expose the lumen. Insufflation is kept to a minimum, and carbon dioxide 
can be used. If this failed, the scope can be gently pulled back while holding the overtube, 
and rarely spinning the overtube counter-clockwise, until the lumen is seen. The tip of the 
endoscope is usually advanced to the transverse colon or distal ascending colon in this 
fashion, where maximal overtube insertion usually occurred. The cecum is reached by 
disengaging the overtube and, while holding the handle at the anus, pushing the endoscope 
through the overtube. Once the ileum is intubated, the endoscope is exclusively advanced 
by pushing. 
Table 2 shows a list of reported diagnostic/therapeutic interventions with spiral enteroscopy. 
In particular management of patients with small-bowel obstruction distal to the third part of 
the duodenum can be challenging. These patients are often poor surgical candidates, and 
placement of a self-expanding metal stent  can be technically demanding. Deploying a stent 
distal to an endoscope is technically challenging, requiring a stable position to effectively 
traverse the stricture and deploy a self-expanding metal stent. The configuration of the 
spirals of the overtube is such that the bowel is held in a very secure position, providing 
stability at the distal tip, which greatly assists self-expanding metal stent placement and 
other interventions30. The accessory channel of commercially available enteroscopes is not 
large enough to admit an enteral stent. This problem is overcome by using the DSB overtube 
as a vehicle for deploying SEMS and conceivably other therapies. However, this is a 
relatively new technique, and, as such, larger numbers of cases and further experience are 
required to determine whether there are any significant side effects. 
 




- Balloon sphincteroplasty and sludge 
extraction 
- Cannulation/sphincterotomy 
- Pancreatic stent placement 
- Stent removal with stricture dilation 
- Stone extraction and biliary stent placement 
 
 Lumenal: 
- Argon plasma coagulation 
- Biopsy 
- Bipolar cauterization 
- Enteral stent placement (for malignant obstruction) 
- Fistula plug placement 
- Foreign body retrieval (percutaneous endoscopic gastrostomy tube bumper) 
- India ink tattoo 
- Polypectomy 
Table 2. Diagnostic/therapeutic interventions with spiral enteroscopy  
4.2.3 Spiral enteroscopy in surgically altered gastrointestinal anatomy 
Surgically altered gastrointestinal anatomy presents considerable impediments for accessing 
the pancreaticobiliary tree. Endoscopic methods for accessing the biliary and pancreatic 
ducts in patients with surgically altered anatomy can be difficult and patients with 
surgically altered upper gastro-intestestinal tract anatomy pose a challenge to endoscopic 
biliary  interventions. 
Endoscopic treatments are preferable because they are less invasive than either transhepatic 
or surgical options. 
Performance of ERCP's in cases of Roux-en-Y anastamosis has presented particular 
challenges with success rates at reaching the biliary and pancreatic orifices using standard 
endoscopic techniques up to a maximum of 50%. One of the most common causes of 
difficulty is the inability of the endoscope to reach the papilla of Vater or the bilio-enteric 
anastomosis, due to the length of the passage or the angle of the anastomosis. 
Cholelithiasis occurs in up to 38% of gastric bypass patients within 6 months of surgery. 
Cholecystectomy is not routinely performed in asymptomatic individuals with gallstones, 
leaving choledocolithiasis as a potential complication following gastric bypass. 
Because of the length of the Roux limb and the acute angle of the jejunal-jejunal anastomis, 
ERCP is especially challenging and may not be feasible with standard equipment. 
Wire guided passage of a duodenoscope has a demonstrated cannulation success rate of 
only 67%. Invasive techniques such as percutaneous gastrostomy tube placement and 
transhepatic access may carry additional risk and comorbidity.  
Recently, balloon enteroscopy (BE) techniques such as double-balloon enteroscopy (DBE) or 
single-balloon enteroscopy (SBE) have made it easier to perform ERCP in these patients31  
Although data on the use of SE are limited, the usefulness of SE for ERCP in patients  
with surgically altered anatomy is expected to be equal to or more than that of balloon 
enteroscopy.  
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Although only published in abstract form, some studies on SE-assisted ERCP have been 
reported.  
Chandrasekharaet al.32 reported a series of 5 patients undergoing ERCP with SE. Three 
patients had Roux-en-Y gastric bypass and 2 were status post-pancreaticoduodenectomy. 
All procedures were performed using the Olympus SIF-Q 180 enteroscope and DSB, and the 
success rate was 80%. 
Shah33 reported a series of 13 patients undergoing SE-assisted ERCP. Post-surgical anatomy 
included Roux-en-Y gastric bypass (n = 6), liver transplant (n = 6), and hepaticojejunostomy 
post liver resection (n = 1). Access to the papilla or anastomosis was achieved in 11/13 
patients (85%) and ERCP was successfully performed in 9/13 (62%). Complications were 
seen in 2 patients, including mild pancreatitis and self-limiting hypopharyngeal trauma. 
Sanjay et al.34 reported that SE-assisted ERCP was performed in 3 patients including 2 patients 
for whom DBE-assisted ERCP had failed once. Successful selective cannulation and 
therapeutic intervention were achieved in all 3 cases. Mean total procedure time was 117 min. 
In conclusion Spiral enteroscopy ERCP is a new technique that is a highly effective platform 
for reaching the pancreaticobiliary orifice in Roux-en-Y patients. Spiral enteroscopy ERCP 
also provides excellent stability for high success rates for completion of ERCP's.  
Spirus enteroscopy reaches the biliary-enteric anastomosis or papilla in most patients with 
altered surgical anatomy and is associated with technical success in the majority of patients 
in whom access to the afferent limb is achieved. Modification of enteroscope-length ERCP 
accessories may improve success.  
5. Clinical case 
Our patient is a 26 yrs old woman, with Peutz-Jeghers syndrome and history of multiple 
abdominal surgeries: ileal resection for occlusion and for polyps removal in distal ileum. 
 
 
Fig. 4. Jejunal polyp at videocapsule endoscopy 
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In May 2010 she was submitted on video capsule (that revealed many penducolated and 
sessile polyps in the distal jejunum and not in the ileum, Figure 4) and enteroscopy with 
single balloon (retrograde and anterograde approach) with the detection of large polyps in 
II-III part of duodenum (not seen by video capsule) and small polyps in distal jejunum. 
In July 2010 we performed spiral enteroscopy  in general anesthesia in surgical room with 
surgeon in stand-by for the high risk of complication. More than 15  polipectomies were 
done (figure 5). 
 
 
Fig. 5. Jejunal Polyp 
We found small and large polyps , from 5 mms to 5 centimeters , penduncolated and sessile, 
the resection was en bloc or piece meal, with taking every specimen for histological 
evaluation (all was amartomas). 
The time of endoscopy was 4 hours . 24 hours later, we recorded an elevation of 
transaminases (1.5 x) and total bilirubin (1.3 x) without abdominal symptom ; the patient 
was discharged 48 hour after the procedure, with normalization of blood tests.  
5.1 Conclusion 
Because of great number of large polyps,  the spiral procedure  seems to be better than other 
assisted enteroscopy : the over tube, that fix the endoscope with a coupler during spiral 
advancement and permit to disengage it for conventional manipulation, allows the scope to 
be removed and reintroduced after every polipectomy while holding the position deep in 
the small bowel (Figure 6). 
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Fig. 6. Enteroscope through the overtube, polyp retrieved 
Moreover,  the disengagement and the rotation of the endoscope permits  the best approach  
particularly to big polyps.  
No major complications (perforation or bleeding) occurred during the procedure; the 
elevation of transaminases is related to transient edema  in ampullary region due to trauma 
of the device. 
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Fig. 6. Enteroscope through the overtube, polyp retrieved 
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1. Introduction 
The colorectal cancer (CRC) is one of the most common tumors in Western countries. It is 
the most common gastrointestinal tumor and it is estimated that between 5 and 6% of the 
population will suffer it along their lives. Colorectal cancer is a tumor in which it is possible 
to perform primary and secondary prevention. Primary prevention consists of all actions 
aimed to prevent the development of cancer or precancerous lesions, whereas secondary 
prevention is the detection and removal of these premalignant lesions, avoiding then the 
development of colorectal cancer (CRC). 
CRC is a disease with a well-known natural history, fulfilling in most cases the adenoma-
carcinoma sequence (Figure 1), and its natural history is long enough so it can be 
interrupted by various diagnostic and therapeutic strategies.  In fact, in sporadic CRC, 
which represents most cases, the time since the appearance of a polyp in a colon without 
neoplastic disease, the posterior growing and degeneration of the lesion to finally become an 
invasive cancer, is usually not lower than 10-15 years. We therefore have a long time, 
enough to detect and remove these lesions, interrupting then the natural history of the 
disease and preventing the development of CRC; so endoscopic polypectomy is a 
therapeutic key point in the prevention of colorectal carcinoma. 
Not all polyps degenerate into cancer and, consequently, not all colonic polyps should be 
removed. Although we already have endoscopic technology that allows us to accurately 
differentiate neoplastic from hyperplastic polyps, the standard practice is to remove all 
polyps.  Definitely the result of histological examination of the polyp is which determines 
the way to approach in the future. The technique for the removal of polyps depends on 
several factors, such as size, location and morphology of the lesions. We can solve most 
pedunculated and sessile polyps with a simple polypectomy. Most colonic polyps are small 
and pedunculated, and its removal becomes relatively easy. When sessile polyps are located 
in the right colon due to the reduced thickness of the colonic wall in this location, injection 
of drugs into the submucosa before polypectomy decreases the risk of perforation. In large 
pedunculated polyps with thick pedicles, it can be helpful to use techniques to prevent 
bleeding after colonic polypectomy. Submucosal adrenaline injection at the base of the 
polyp or the placement of endoloop or hemostatic clips on the pedicle can prevent the 
development of bleeding complications. But this is not the aim of this work. Then we would 
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try to describe in a practical way the different techniques for treatment of large sessile or flat 
lesions that can be found in the colon.  
 
 
Fig. 1. The picture shows a conventional endoscopy where a flat lesion, slightly elevated and 
with indistinct edges can be observed.  
We consider that sessile or flat lesions are large when they exceed 20 mm in diameter and 
giant polyps would be those whose size exceeds 30 mm. As well as polyps smaller than 2 cm 
can be removed en bloc in most cases, those larger than 2 cm are not always achieved, and 
lesions larger than 3 cm are almost never achieved. It is accepted that lesions of this size or 
greater should not be removed on a single piece using a polypectomy snare. The risk of 
perforation is extremely high in these cases so it is recommended to perform a piecemeal 
resection of these lesions. The performance of this technique to achieve success, 
understanding it as a complete resection of the lesion, the absence of recurrence of the 
lesion, and the absence of complications, requires the knowledge and practice of a number 
of endoscopic skills that we would describe below. In many centers, these large lesions are 
considered in most cases for surgical treatment. We should not forget that surgery, even in 
case of laparoscopic surgery, involves a large increase of health costs and it is not free of 
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morbidity and mortality. We should also consider that many of the patients in whom these 
lesions are detected have an advanced age and high comorbidity, which increases the 
surgical risk. On the other hand, the use of CRC screening programs makes it more frequent 
to diagnose this type of lesions. Therefore, adopting therapeutic strategies with lower risk to 
patients, lower consumption of economic resources, greater respect to organ´s functionality 
and similar outcomes for patients seem to be more than reasonable. Naturally, we must 
correctly select the cases that can be solved endoscopically, avoiding then unnecessary risks 
and consumption of resources that will not prevent to refer patients to other interventions. 
Finally, treatment options that can be offered to an individual patient depend on the 
possibilities of each place. In very large series from reference hospitals where there are 
expert endoscopists show that up to two thirds of the benign lesions that are referred to 
surgery can be endoscopically resolved.  
2. Endoscopic resection of large colorectal lesions 
2.1 Endoscopic Mucosal Resection (EMR) 
As it is well known this is a technique that is not exceedingly challenging from the 
endoscopic point of view, with little risk for complications but, rarely, it may allow 
removing en bloc lesions larger than 2 cm in diameter. However, as we will explain below, 
we believe that it does have an important role in colorectal neoplastic disease. It should not 
be, of course, a universal technique, but it would have its indications based on its benefits 
and its limitations. 
2.1.1 Detection and characterization of the lesion 
Nonpolypoid lesions are those consisting of dysplastic tissue that does not protrude or that 
protrudes a little into the intestinal lumen, reaching a maximum thickness of two times that 
of the surrounding mucosa. Flat lesions are often undetectable with conventional 
endoscopy, being essential to use endoscopic techniques such as chromoendoscopy (Figure 
2), virtual chromoendoscopy or Narrow Band Imaging for the correct demarcation of the 
lesions. The nonpolypoid lesions of the colon can be flat and reach large dimensions but 
instead of growing into the intestinal lumen, they expand along the colonic wall, and they 
are called laterally spreading tumors (LST). These lesions have an invasive growth risk 
significantly lower than sessile lesions of the same size. Initially, what differentiates them it 
is its appearance, but there are great differences regarding their biological behavior, so in 
both cases, the therapeutic attitudes may be slightly different. This is, quite often, the 
presentation form of the lesions diagnosed in patients with long-standing ulcerative colitis 
and in the context of Lynch syndrome. 
In order to plan the most appropriate therapeutic approach for a particular lesion we should 
correctly characterize it. According to most authors there are three aspects to consider in 
order of predicting the degree of invasion of the lesion. Some authors support performing 
whenever it is possible, an echoendoscopic study with high frequency miniprobes to 
evaluate the involvement of the colonic wall by the neoplasm. Other authors argue that 
endosonographic study is not essential since endoscopic appearance can greatly predict the 
degree of invasion of the lesion. First, the general appearance of the lesion must be defined, 
being strongly recommended the use of the Paris classification of superficial neoplastic 
lesions (2003). Most superficial endoscopic lesions are classified according to type 0. 
Polypoid lesions are subtype 0I (including two variants: pedunculated (0Ip) and sessile 
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(0Is)).  Non-polypoid lesions are classified in subtype 0II (slightly elevated 0IIa, completely 
flat 0IIb and slightly depressed without ulcer 0IIc).  Finally, subtype 0III represents non-
polypoid lesions with a frank ulcer.  The risk of malignant degeneration of the lesion 
depends on the existence of submucosa invasion, being the maximum risk in subtype III and 
the minimum risk in type I lesions. Thus, those benign lesions (flat adenomas and laterally 
spreading tumors) and adenocarcinoma IIa lesions with a diameter less than 20 mm and IIb 
and IIc lesions less than 10 mm. can be subsidiaries of endoscopic treatment. In lesions 
classified as subtype III (ulcerated) will never be indicated endoscopic treatment, so surgery 
would be unavoidable.  
 
 
Fig. 2. Staining with indigo carmine 0.2% shows in greater detail the surface of the lesion 
with well defined edges.  
Secondly, the appearance of the surface of the lesion has also a great transcendence, 
especially in LST. These LST are classified into two types according to their morphology, 
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granular type (LST-G) (figure 3) and non-granular type (LST-NG) (Figure 4). LST-G lesions 
may reach large dimensions without presenting invasive growth, by contrast, this fact is 
much more likely in LST-NG. Therefore, endoscopic piecemeal mucosal resection (that is a 
lower complex technique and that is more available for any endoscopist) can be a 
therapeutic strategy for LST-G and en bloc resection with endoscopic submucosal dissection 
(ESD) should be applied to LST-NG, which is technically much more complex and with an 
increased risk of complications.  
Finally, the study of crypts patterns according to Kudo´s classification using 
chromoendoscopy and magnification endoscopy has shown a great accuracy in predicting 
the invasive behavior. This classification states that: type I crypt pattern consists of regular 
round crypts, type II consists of stellar or papillary crypts, type IIIL consists of large 
roundish or tubular pits, type IIIS consists of small  roundish or tubular pits, type IV 
consists of sulcus, branch, or gyrus-like crypts, and type V consists of irregular or severely 
distorted crypts. Types I and II are non-neoplastic (hyperplasic lesions) and excepting some 
circunstances they do not require treatment. Type IIIL, IIIS and IV are non-invasive lesions 
so endoscopic removal can be performed and type V represents invasive lesions so surgical 
resection is the best choice for treatment.  
 
 
Fig. 3. Laterally spreading tumor with granular surface. It is classified as LST-G, and after its 
endoscopic resection a villous adenoma with low grade dysplasia was confirmed. 
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Fig. 3. Laterally spreading tumor with granular surface. It is classified as LST-G, and after its 
endoscopic resection a villous adenoma with low grade dysplasia was confirmed. 
 




Fig. 4. Laterally spreading tumor with a smooth surface, not granular. Surgical resection was 
refused and the histological analysis revealed the presence of an invasive adenocarcinoma 
over a villous adenoma. 
In conclusion, the characteristics of the lesion determine the correct treatment options: 
surgical or endoscopic resection. LST-NG lesions have twice the risk of presenting invasive 
growth, especially if pit pattern is suggestive of malignancy Kudo (V), lesions are greater 
than 20 mm of diameter and sclerotic changes are evident in the intestinal wall close to the 
lesion. In these cases it may be indicated surgical treatment, or in any case, a technique that 
allows "en bloc” resections of the lesion. In LST-G, the probability of invasive growth is 
increased if nodular areas larger than 10 mm or depressed areas are present or if the sign 
called "no lifting" after submucosal injection is present. So, LST-G have an infiltrative 
growth in less than 6% of cases, and if this takes place, more than 84% of the lesions present 
large nodular areas.  In the absence of these data, piecemeal resection, technically easier, can 
be a good choice. There are some other endoscopic data that could be associated with an 
increased risk of invasive growth, although they do not achieve statistical significance in 
multivariate analysis, like for example colonic chicken skin mucosa, the presence of 
erythema over the lesion and the convergence of folds to the lesion. 
2.1.2 Delimitation the edges of the lesion 
The most experienced endoscopists suggest that it is essential to resect at least 1-2 mm of 
healthy edge to guarantee a complete resection of the lesion and to reduce the risk of 
 
Endoscopic Resection of Large Colorectal Lesions 
 
203 
recurrence. Some studies also suggest that ablation the edges of the lesion with argon 
plasma would reduce the risk of recurrence. However, other authors state that removing the 
entire lesion and including a small portion of healthy tissue in the surgical specimen would 
achieve the same result.   
When an en bloc resection is achieved, this is less important. But when there is a large lesion 
that requires a piecemeal resection, the burn deforms tissue and it is more difficult to 
demark the lesion. Although the use of chromoendoscopy and NBI may be useful to detect 
the remaining tissue, it seems more useful to have a correct demarcation of the lesion before 
to start the resection. On the other hand, performing submucosal injection for lifting the 
lesion may distort its appearance by making the edges difficult to identify at the time of 
resection. Therefore, our standard practice is to define the edges of the lesion with a 
minimum burn that can be easily seen, which can be performed with argon plasma or with 
the tip of the polypectomy snare (Figure 5).  These burns are easily recognizable; marking 
the entire periphery of the lesion. They are located at 1-2 mm from the edge of the lesion and 
they are separated from each other by 5-6 mm. At the end of resection of the lesion, if none 
of these burns is visible, we can be sure that we have performed a resection as extensive as 
originally planned.  
 
 
Fig. 5. After clearly limit the edges of the lesion using chromoendoscopy, in this case, 
computed virtual chromoendoscopy (CVC-FICE). The edges can be marked by burns 
performed with plasma argon or with snare tip from 3-5 mm at the edge of the lesion. 
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In our center, to correctly identify the edges of the lesion we usually use indigo carmine 
0.2% (Figure 6). In recent years, since we have Computerized Virtual chromoendoscopy 
(CVC-FICE) (Figure 7) both techniques are used without distinction with identical results. 
 
 
Fig. 6. Flat lesion, stained with 0.2% indigo carmine, which highlights the surface of the 
lesion and clearly defines the edges. 
2.1.3 Submucosa injection 
The injection of drugs into the submucosa aims to create a space between the mucosa and 
submucosa and muscular layer.  Thus, resection of sessile or flat lesions is easier, and the 
risk of complications is reduced, especially perforation. The substance normally used is 
saline, with or without epinephrine. Since it is an isotonic substance, it spreads quickly, so 
the lifting disappears, that is why it is important to perform multiple injections, especially 
in large lesions. We have used other substances, such as glycerol, hyaluronic acid, 
hydroxypropylmethylcellulose or autologous blood anticoagulated with citrated 
substances. The lifting they generate is more lasting, allowing a small number of 
injections. Its major limitation is their high cost so they are no available in most centers. 
Hypertonic solutions of dextrose 50% with epinephrine have also been used, with better 
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results than normal saline solution, allowing to remove lesions with lower volume of 
solution injected, fewer number of injections and less time consuming to complete 
resection. These differences are only significant in case of large lesions. However, it is 
found a higher frequency of postpolypectomy syndrome that can suggest a possible 
damage of the colonic wall, probably due to vascular disturbances caused by the 
hypertonic nature of this solution. It has been recently recommended the use of 
succilinated gelantine, a very cheap plasma expander, whose only limitation is that it can 
not be used in patients with hypersensitivity to gelatin. This study asserts that the lift is 
more lasting and that the number of injections, the total volume injected and the time 
consumed in the resection are lower. Additionally, the size of the resected fragments is 
larger and, consequently, lesions of the same size are removed in a smaller number of 
fragments. Finally, the en bloc resections are almost double that when the lesion is raised 
just with saline. In our experience, with a saline, methylene blue and epinephrine 
1/10,000 mixture most lesions are successfully completely removed. We have recently 
started to use succilinated gelantine (Gelafundina), instead of saline, with good results. 
Apparently, the lift that it provides is more lasting, requiring less number of injections to 
complete the resection of the lesions. However, in this moment we do not have enough 
experience to ensure the superiority of a solution over the classic one.  
 
 
Fig. 7. Computed virtual chromoendoscopy (CVC) is useful for the characterization of 
colorectal lesions, avoiding the use of coloring agents, catheters and only requiring the use 
of an endoscope. 
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Submucosal injection has to be done very carefully, in small aliquots distributed all over 
the extent of the lesion to achieve a correct elevation (Figure 8). Especially in lesions 
located on a fold, it is essential to start lifting the distal part to ensure the lesion gets 
"closer" to the endoscope, instead of being placed in positions that can difficult the 
visibility. When a lesion that has not been previously biopsied does not lift ("non lifting 
sign) it fairly predicts the infiltration of the submucosa by a possible focus of 
adenocarcinoma (Figure 9). However, biopsies, especially in flat or very small lesions, can 
cause fibrosis in the submucosa and difficult its correct lift. In the absence of previous 
biopsies, the "non lifting sign" has a sensitivity of 100% and a specificity of 99% in 
predicting invasive growth. In any case, no elevation of the lesion, just because it is a 
malignant lesion or because the high risk of perforation, make it reasonable to not 
perform an endoscopic resection of the lesion. 
 
 
Fig. 8. Submucosal injection, with an adequate lift of the lesion prior to its removal. It is 
recommended to start injecting at the distal part of the lesion to avoid losing perspective 
and also to avoid not to see that part of the lesion during the excision. Otherwise, we may be 
forced to confront the farthest part of it to us in retroversion. 
 




Fig. 9. "Non lifting sign": The lesion is not lifted after submucosal injection. This, if there is 
no submucosal fibrosis caused by previous attempts of resection, sugests submucosal 
invasive growth 
2.1.4 Endoscopic mucosal resection technique 
The most commonly technique used is the conventional one consistent on lifting and 
cutting. After submucosal injection of different substances, the lesion is totally or partly 
included on a typical polypectomy snare and it is removed in one or more fragments. As we 
have stated, performing en bloc resection of lesions larger than 2 cm is neither possible nor 
desirable, due to the high risk of perforation. If a piecemeal resection is needed, it must be 
done in the lowest number of fragments as possible in order to restore and "reset" the lesion 
as close as possible to reality. Thus resection can be achieved for the vast majority of the 
lesions identified in the colon. Even in a study presented by experienced endoscopists, 
remarkable results were achieved without making any submucosal injection. It is essential 
to keep a carefully systematic resection to prevent the persistence of viable tissue areas at 
the confluence of the different fragments resected. Some authors suggest the possibility of 
APC ablation of this tissue to prevent recurrence of the lesion, although this practice could 
increase the possibility of developing postpolypectomy syndrome. Some authors also 
suggest coagulating the edges of the lesion with APC, thus reducing the risk of recurrence. 
However, in opinion of leading experts and also ours, this is not necessary if you perform a 
wide resection including at least 1-2 mm of healthy mucosa in the resected specimen. 
In general, with this simple technique of lifting and cutting, most authors report a technical 
success rate above 90%. That is, with a simple technique we can achieve resection of most 
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lesions. However, some authors have reported small series of cases in which the resection of 
colorectal lesions is achieved with great success and low risk of complications, using suction 
and cutting techniques, especially Cap assisted mucusectomy. In our opinion, on a regular 
basis, it would not be necessary to add complexity to a simple and effective technique in 
most situations; although this might be a good alternative in case of lesions where the loop 
can not be placed over them.  To facilitate the inclusion of the lesion inside the loop it is 
often useful to suck as much gas as possible, almost to collapse the lumen. This causes lower 
intestinal wall tension and this facilitates catching the lesion. 
Some authors, in both animal and patients models , have suggested making a 
circumferential incision at the edges of the lesion before using the snare, allowing it to be 
snared, thus achieving en bloc resection of large lesions in lesser time. In animal models 
specimens have been achieved up to 50 mm in diameter, excised by en bloc resection, 
without a great risk of perforation. This technique, known as IT-EMR (EMR-incision 
technique) or as CSI-EMR (circunferential submucosal incision-EMR) could be an alternative 
to ESD as a tool to achieve en bloc resection of some lesions.  
For resection of these lesions we usually use mixed stream, cutting and coagulation, with 
the Endo-cut system. We use a 120W cutting power in rectum and left colon and 80W in the 
right colon, and a coagulation power of 60W in both right and left colon. When argon 
plasma is needed, we use power 100W and a flow of 2 liters / min in rectum and power 
60W and a flow of 1 to 1.2 liters / min in right colon. Some authors have suggested that the 
use of pure cutting power causes lesser thermal artifact on the specimen, facilitating the 
study and a more accurate pathological staging in case of lesions with an infiltrative growth 
pattern. This would increase the risk of bleeding, which could be controlled using hemoclips 
as a preventive treatment.  
It is essential to complete successful resection of the lesion performing it in a single session. 
The removal of the lesions, the coagulation of the scar produces fibrosis that would make 
impossible to lift the lesion in a second time, adding an increasing risk of complications. If in 
consecutive endoscopic examinations adenomatous tissue is detected, it has to be removed. 
However, in these cases, the elevation of the lesion with submucosal injection is usually very 
difficult, and due to the submucosa fibrosis it usually spreads to the lateral areas, lifting 
more healthy mucosal tissue than residual adenomatous tissue. In one of the largest series 
published, which belongs to an Australian multicenter group, including 479 patients, it was 
established an eradication rate of lesions in a single session of 89.2%. Failure factors were 
involvement of the ileocecal valve by the lesion and the existence of a previous attempt to 
resection. Submucosal injection is considered an attempted resection, even without resection 
just because submucosal injection results in submucosal fibrosis. In this case, the probability 
of failure in the resection is multiplied by 6. In the same series, it is established as predictors 
of relapse of the lesion an initial size greater than 40 mm and the need of using APC to 
eradicate adenomatous tissue.  
2.1.5 Medium and long term results 
Large lesions (> 20 mm) can rarely be en bloc resected, with an estimated recurrence rate of 
20% (0-52% in different series published). However, in very large series recurrence rates of 
lesions have been reported below 10%. 
To ensure the success of the procedure, it is essential to perform a systematic resection of the 
lesions, but also a strict monitoring system of the scars, especially when a piecemeal 
resection has been carried out.  Most authors recommend a first review of the scar 3 months 
after resection. . In case of detecting residual tumor tissue, resection must be attempted and, 
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if it is not possible, we should apply argon plasma. We perform a review and biopsy of the 
scar at 3 months after initial resection. We perform quarterly reviews until the scar biopsies 
are negative, making then a review after 6 and 12 months. If after one year of the last 
examination in which neoplastic tissue was removed there is no evidence of recurrence we 
consider that we have achieved the cure of the lesion. Some authors believe that a NBI, 
chromoendoscopy or magnification endoscopy study could be performed to review the scar, 
so the presence of residual tumor could be ruled out fairly confidently. We combine the 
study with NBI and biopsy of the scar, especially in large scars where biopsies may not be 
representative of the entire surface of it. As recently reported normal appearance of the scar 
and negative biopsies, performed three months after resection, predict with a negative 
predictive value of 97.4% freedom from relapse during follow-up. On contrast, it is the size 
of the lesions (> 4 cm), the most strongly factor associated with a possible recurrence of the 
lesion.  In recent years the term late relapse has been established to define those relapses 
that can be seen after one or more revisions with negative biopsy scar. In some series, they 
represent more than half of all recurrences, so patients must be followed for long periods of 
time. This may be a limiting factor, because if it is impossible to make a correct follow-up 
this may be the cause of the failure. Therefore, the need for repeating colonoscopy several 
times is something that should be clearly discussed with the patient before make the 
decision to choose this form of treatment. 
 
 
Fig. 10. Piecemeal resection of a large lesion of 6 cm in diameter, located in the upper 
rectum. After finishing the resection, CVC is used to check the absence of residual 
adenomatous tissue in the scar. 
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The results of endoscopic resection of large lesions, make that this could be the best 
therapeutic approach in properly selected patients. The development of laparoscopic 
techniques for segmental colon resection has questioned the usefulness of such complex 
endoscopic procedures. There is no doubt that in patients with extremely complex lesions, 
where a complete resection is not possible, like in case of lesions involving the appendiceal 
orifice, those affecting two consecutive folds, or those that fail to raise properly, are serious 
candidates for surgical treatment. However, we must not forget that the surgical resection, 
even in case of laparoscopic surgery, it is not free of morbidity and mortality, especially in 
patients with high surgical risk. Secondly, cost of laparoscopic surgery and hospitalization 
are significantly higher than the cost of endoscopic procedures, even if it is necessary to 
perform several colonoscopies during follow-up period. Obviously, if endoscopic treatment 
represents a serious alternative to surgery, it must be safe and effective, so it is necessary to 
concentrate the most complex cases in expert hands. This is especially interesting in rectum, 
where the risks of endoscopic resection are lower and potential consequences of surgery are 
greater. Thus, an Australian group was able to avoid surgery in 90% of patients that were 
referred to them from centers where endoscopists had refused endoscopic resection, and 
they achieved a saving of $ 7,000 per patient that could be endoscopically managed. 
2.1.6 Complications 
The most common complications of endoscopic resection of colorectal lesions, regardless 
complications due to sedation when performing endoscopy, are bleeding and perforation of 
the intestinal wall. Bleeding is the most common complication. It is estimated that it occurs 
in 1 of every 100 procedures. Proper lift of the lesion allows us to avoid the section of the 
thick vessels of the submucosa, achieving prevention of bleeding. In case that these vessels 
get exposed or are partially damaged by resection, its coagulation can be performed with 
thermal methods (coagulation forceps, APC, heat probe) or mechanical ligation can also 
been performed with hemoclips; although some authors doubt about the profitability of 
performing prophylactic coagulation of these vessels. What is important, surely, is to make 
the cut with sufficient calm to properly coagulate the vessels of submucosa. If bleeding 
occurs, immediate treatment must be done with the same methods described to prevent this 
complication. Once bleeding is controlled, resection can be continued. We must avoid, 
obviously, the contact of the polypectomy snare with metal clips, as they can transmit power 
through the colonic wall and perforate it in the area where they have been inserted. In most 
cases bleeding is controlled immediately, having no impact on patient. However, bleeding is 
not always immediate as it can be deferred (between the 24 hours after the procedure, even 
up to 14-21 days later). In this case, patient usually presents anemia, so admission and blood 
transfusion can be required.  
Perforation is less frequent, but a much more serious complication. It happens when in a 
fragment of the lesion that has to be resected it is included the muscular layer or the whole 
wall, damaging it. It can produce a frank perforation or simply the interruption of the 
muscular layer. To prevent this complication is essential to make a correct lift of the lesion, 
allowing us to obtain a cutting plane large enough to avoid the muscular layer.  It is also 
essential to recognize the "non lifting sign" because if the lesion is not correctly raised we 
should not proceed to resection. Once the lesion is inside the loop it can be useful to make 
traction of it towards the intestinal lumen, achieving to separate the cutting plane from the 
muscular layer. We can also liberate the muscular layer, if it has been trapped, making soft 
forward and backward movements. It is also recommended to to suck as much gas as 
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possible because this causes lower intestinal wall tension. Most authors also recommend, as 
a preventive measure, to avoid performing multiple resections of large lesions located on 
the same place. Finally, it is essential to be extremely careful when removing lesions located 
on a fold, because its section results in transmural resection. Sometimes, it is difficult to fully 
recognize the situation of the fold as the anatomy of the colon can be altered by the lesion 
and submucosal injection. 
 
 
Fig. 11. Resection of a large lesion in the sigmoid colon with hemorrhage during the 
procedure, controlled by the placement of several hemoclips. 
Perforation can occur immediately, being recognized during the procedure so it can be 
directly solved, not having serious consequences for the patient. On other occasions, 
perforation can be deferred or delayed, produced by a spontaneous "rupture" of the wall 
under a large scar. In these cases the colon is not clean, so the patient would present 
symptoms. It usually requires systematically surgical repair, and it is usually needed to 
perform a temporal colostomy. In case that perforation is detected during resection of the 
lesion it can be endoscopically managed, covering the defect by suturing using hemoclips. 
Modern Ovesco devices (“over the scope hemoclips ") or different tools to perform 
endoscopic suturing could allow closing large defects. Indeed, the possibility of transmural 
sutures would allow closing large defects, providing a security level that would allow 
endoscopists face larger or more complex lesions. If there has been a transection of the 
muscular layer without frank perforation, this can be sufficient, but if there is a complete 
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perforation of the wall, it is usually necessary to restrict oral intake, to establish broad-
spectrum antibiotics and, depending on the magnitude of the pneumoperitoneum, to drain 
it. In most cases, we can solve problem and so avoid surgery. Consequently, it is essential to 
immediately detect the complication. Some authors define "target sign" as a whitish lesion 
on a muscular layer stained in blue (methylene blue) and "mirror target sign" on the surgical 
specimen that includes a section of the muscular layer. If this sign is observed, we should act 
accordingly. 
Sometimes there is a transmural burn in the colonic wall, without frank perforation. The 
patient can present abdominal pain and signs of peritoneal irritation, but in the absence of 
pneumoperitoneum. This is called postpolypectomy syndrome. Conservative management, 
based on analgesics, broad spectrum antibiotics and fluid therapy is usually enough. 
 
 
Fig. 12. Resection of large sessile lesion in sigmoid colon. After completing the resection it is 
clearly seen a lesion of the muscular layer, approximately 10 mm in length, which is 
completely closed by applying hemoclips. The patient remained in hospital during 48 hours 
and after restarting oral intake he was discharged without complications. 
Resection of large colorectal lesions involves performing submucosal injection through a 
non-sterile system. In addition, a huge defect in the mucosa will persist over a long time. 
Both situations could represent the entry point for infections. However, it has not been 
observed a significant incidence of bacteremia after these procedures, so it is not justified a 
systematic antibiotic prophylaxis. 
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In conclusion, complications are rare on endoscopic resection of large colorectal lesions and, 
in most cases; these can be solved in a conservative way, endoscopically. 
 
 
Fig. 13. In the picture we can visualize the piecemeal resection of a large sesile lesion, in the 
distal sigmoid colon. In this particular case we completed the resection with the coagulation 
of the lesion edges with argon plasma. In the last image, we can see the scar of the lesion, 
without recurrence. 
2.2 Endoscopic Submucosal Dissection 
Resection of large lesions generates uncertainty in the physician and patient, especially in 
those that are more likely to have invasive growth.  En block resection of the lesions results 
in more certain of achieving a complete resection, a lower recurrence rate, and facilitates a 
better interpretation of the spcimen by the pathologist, achieving a correct classification of 
lesions that present an infiltrative growth.  
The Endoscopic Submucosal Dissection (ESD) is a technique originally designed for the 
resection of gastric lesions, but later it was adapted to esophageal lesions and ultimately it 
was used for en bloc removal of large colorectal lesions. The great attraction of this 
technique is that, in fact, it allows the resection of large lesions in a single piece. The great 
inconvenient is its technical complexity, with an increased risk of complications, so its use in 
the Western countries is quite restricted. 
As it has been already explained, it is in lesions that are more likely to have an invasive 
growth where it is more important to perform an en bloc resection. Then, the pathologist 
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would be able to study the whole specimen, to perform accurate staging and, consequently, 
to establish the cure of the lesion or the need for surgery. It is considered that endoscopic 
removal of a lesion presenting adenocarcinoma with infiltration of submucosa can be 
curative if the following conditions are present: 
- Well or moderately differentiated adenocarcinoma 
- Absence of lymphatic and vascular permeation 
- Presence of intramucosal adenocarcinoma 
- Adenocarcinoma that infiltrates submucosa, but only in the most superficial portion 
(invasive growth of no more than 1000 microns from the muscularis mucosae) 
- Edges of resection free of lesion          
Endoscopic resection can be considered curative if lesions fulfil these conditions because the 
risk of lymphatic metastasis is minimal. 
Given this, it could be said that indications of ESD in colon could be the following: 
- Colonic polyps or lesions presenting intramucosal adenocarcinoma 
- Early Neoplasms IIa (Paris classification) with a diameter less than 2 cms 
- Neoplasms IIb IIc (Paris classification) with a diameter less than 10 mms 
- Laterally spreading tumors 
2.2.1 Endoscopic Submucosal Dissection technique 
The procedure is very similar, in the majority of the phases, to endoscopic mucosa resection. 
It begins, as it is logical, with a correct identification, visualization, demarcation and 
characterization of lesions. Everything explained in EMR is valid now. Using 
chromoendoscopy, NBI and all the available technology are helpful. The characterization of 
the lesion according to morphology, Paris classification, and crypts pattern should lead us to 
the final decision to proceed or not to perform endoscopic resection and also to choose the 
most appropriate technique. After considering endoscopic treatment, firstly we have to 
demark the edges of the lesion in the same way as for EMR. In this case, submucosal 
injection is more important than in EMR, since it is necessary to achieve a good level of 
separation of the outer layers of the wall respecting to the muscular layer to avoid injury. 
For this reason, glycerol or hyaluronic acid are preferable because they remain longer in the 
submucosa. Then, a circumferential incision is performed, which isolates the lesion from the 
rest of the surrounding mucosa and it allows to open a space to introduce the endoscope 
and finally to start the dissection. This incision can be made using a conventional needle 
knife or material especially designed for that purpose. The placement of a transparent cap 
on the tip of the endoscope is essential to facilitate the visibility at the submucosa level and 
to permit the management of the material used for dissection. Finally, the lesion is dissected 
until complete the resection of the lesion in only one fragment. 
Various instruments have been designed for the dissection of the submucosa, all of them 
with common and differentiating elements. They all have advocates and detractors, and 
each expert recommends the use of the one that best suits to the way of working of the 
endoscopist. However, experts also recommend mastering more than one of them, because 
in some lesions an instrument can be adapted better than another. Today there is a wide 
variety of instruments available: the IT knife (isolated tipped knife), the flex knife, the hook 
knife (needle point hook-shaped) and the triangle tip knife (triangular-tipped). In addition, 
recently new instruments have been designed such as the flush knife, which allows 
submucosal injection and cutting with a single device, allowing saving time by not having to 
exchange instruments. 
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In addition, there are specially designed coagulation forceps to coagulate vessels in the 
submucosa, either as bleeding prevention or as treatment. However, coagulation of vessels 
can be performed with the same cutting instrument, as long as there is a good domain of the 
technique. 
2.2.2 Medium and long term results 
In Japan there are already quite large series of colorectal neoplasms removed by ESD. In all 
cases, they are great experts in the technique, with many hundreds of procedures performed 
in the upper gastrointestinal tract. In all cases the results are quite similar. The en bloc 
resection rate is 85-94%, with a cure rate of 80-90%. As expected the en bloc resection rate is 
clearly superior to the one achieved with the conventional mucusectomy, and the cure rate 
is also slightly higher, not being necessary in this case to perform several sessions to 
complete the treatment of the lesion. In contrast, as expected in a more technically 
demanding and complex procedure from a technical standpoint, the time spent on each 
patient is significantly higher than used in EMR. 
2.2.3 Complications 
Complications, both in the case of perforation or bleeding, are considerably higher in the 
ESD than in EMR. This fact, together with the time consumed by each procedure, makes that 
the technique has not spread too much in Europe. If in upper gastrointestinal tract the 
number of procedures performed in Europe is reduced to a few hundreds of patients, in the 
colorectal area, theoretically more complex due to the reduced thickness of the wall and 
with an increased risk of complications, the number is even lower.  
Complications related to ESD are the same as for EMR, but considerably more frequent, 
even in the case of Japanese experts. After reviewing the different series there is a 
perforation rate of around 5% and bleeding occurs with a frequency of 2-3%. In most cases, 
as in EMR, these complications can be resolved by endoscopic treatment, being exceptional 
the need to refer the patient for surgery to solve the complication. 
3. Conclusions 
The vast majority of benign lesions of the colon and lesions that present malignant 
degeneration, but without a massive infiltration of the submucosa by cancer, can be 
endoscopically managed and endoscopic resection may be considered curative. However, 
endoscopic resection of these lesions is not always simple and sometimes it requires great 
technical skill and perfect mastery of technique and material used. In addition, it is essential 
to properly master the different hemostatic techniques as well as the available devices to 
close perforations in order to be able to solve complications that could happen during the 
procedure. The security and confidence in resolving complications, makes these less feared, 
so indications for endoscopic procedures would be extended. 
ESD and EMR are complementary techniques in colorectal disease. ESD is much more 
complex and it is associated with a greater number of complications and requires 
considerably more time consuming. EMR is easier, and involves the use of material with 
which the endoscopists are usually familiar; it presents a lower risk of complications but in 
contrast, it presents a major limitation in en bloc resection of large lesions. However, EMR 
can keep its place: we believe that it is the ideal technique for resection of all those lesions 
that can be en bloc resected using this technique and it may not be unreasonable to perform 
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a piecemeal resection of those lesions with very low risk of developing invasive growth 
(laterally spreading tumors with granular surface). By contrast, those lesions more likely to 
present invasive component always without breaking the clearly established indications for 
endoscopic resection and fulfilling the curative criteria of lesions, should be resected using 
the ESD. 
Finally, as we have seen, the adecuate selection of patients for the endoscopic procedure and 
its results, require a great domain of it. This is only possible if the management of these 
patients is carried out in the context of specialized units, by expert endoscopists and with 
special dedication to this type of pathologies. 
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Endoscopy has had a big role in the development of modern gastroenterology. Modern 
endoscopy will certainly be more therapeutic. It started with endoscopic hemostasis and 
polipectomy, than beginning of the 1970’s with the advent of endoscopic sphincterotomy 
extended to biliopancreatic pathology and has a huge impact in this difficult pathology.  
Plastic stents made the first steps in endoscopic palliation of neoplastic jaundice, metallic 
stents, covered or uncovered are better for biliary palliation and can be used also for 
palliation neoplastic obstruction at different levels of the digestive tube. Resection of 
digestive tumors has evolved now to sub-mucosal resection, looking to have one-piece 
complete resection. Interventional endoscopy is now very complex and takes a lot of time 
for endoscopists to learn properly these techniques. This book is a very good up-to-date 
overview of new techniques of interventional endoscopy for those who want to learn or 
develop their knowledges in this field.
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